Flygut: an atlas of the Drosophila adult midgut

Mouche Logo lab lemaitre Bbcf logo

Home Overview of gut regions Anatomy Histology Transgene expression mapping Gene expression

Mean expression enrichment by gut region

Filter out everything which GO terms when the expression scale ratio is comprised between -1.5 and 1.5 for all regions
GO term Number of genes Crop
/ Full gut
R2
/ Full gut
R3
/ Full gut
R4
/ Full gut
R5
/ Full gut
Hindgut
/ Full gut
Cardia/R1
/ Full gut
exocyst 6 -1.08 1.29 1.41 1.24 1.37 1.05 1.07
M phase 379 1.18 1.09 1.2 1.09 1.24 1.18 1.08
protein deneddylation 3 1.57 -1.01 1.18 1.14 1.14 1.07 -1.1
cell morphogenesis 428 1.11 1.09 1.24 1.04 1.25 1.24 1.24
stress fiber 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
glycoprotein binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
lymphocyte mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
renal sodium ion transport 1 -52.82 -1.7 -31.49 1.13 -9.63 16.55 -13.85
molecular_function 8833 1.01 -1.01 1.0 1.01 1.05 1.02 -1.0
ferrochelatase activity 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
mesoderm development 91 1.26 -1.02 1.08 -1.05 1.17 1.32 1.03
RNA splicing 186 1.18 1.12 1.22 1.22 1.31 1.16 1.02
nicotinamidase activity 1 -2.04 1.72 -1.29 1.07 1.25 4.26 2.23
lipoate biosynthetic process 2 1.65 1.07 1.42 1.08 1.12 2.67 -1.13
FMN binding 10 1.36 1.09 1.23 1.12 -1.05 1.11 -1.08
response to UV-B 1 1.85 -1.14 1.04 1.61 1.1 1.04 1.04
ectodermal cell differentiation 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
vesicle membrane 23 -1.12 1.13 1.13 1.07 1.16 1.18 1.23
nuclear matrix 3 -1.0 1.28 1.38 1.16 1.24 1.52 1.32
ceramidase activity 2 -7.56 -2.15 -1.17 1.28 -1.14 -15.17 -6.93
acyl-CoA delta11-desaturase activity 1 -3.53 -3.34 -2.71 -4.29 -3.06 -2.31 4.71
peptidyl-serine modification 3 1.28 1.07 1.17 1.15 1.14 1.08 -1.08
cytokine binding 3 1.17 1.12 1.1 1.02 1.54 1.2 1.72
T-tubule 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
autosome 1 1.07 1.1 1.33 1.13 1.37 -1.12 1.05
A band 9 1.95 -1.09 -1.15 -1.11 1.13 1.79 1.07
cleavage furrow 9 -1.04 1.09 1.57 1.01 1.45 1.33 1.15
macromolecule localization 473 1.01 1.1 1.21 1.1 1.24 1.12 1.09
ESCRT-0 complex 2 -1.75 1.13 2.24 1.06 1.39 1.34 1.26
ribosome localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
protein localization in Golgi apparatus 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
pupation 4 2.01 -1.05 1.24 -1.24 1.14 2.15 1.25
DNA dealkylation 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
AP-2 adaptor complex binding 1 1.51 1.33 2.01 1.25 1.81 2.91 1.9
cargo receptor activity 36 1.1 -1.14 -1.08 -1.02 -1.03 1.05 -1.08
regulation of growth 153 1.13 1.15 1.39 1.07 1.32 1.3 1.24
DNA protection 1 1.02 -1.01 1.31 1.02 1.58 1.3 1.2
presynaptic membrane 8 -1.25 1.03 1.27 -1.02 1.34 1.8 1.18
fibril 1 1.02 -1.0 1.14 1.18 1.1 1.03 -1.08
DNA hypermethylation 3 1.11 1.01 1.05 1.05 1.09 1.06 -1.09
main axon 2 -1.07 -1.38 -1.02 -1.09 1.18 3.54 1.59
actin nucleation 4 -2.38 1.35 1.23 1.09 1.22 -1.94 1.21
negative regulation of S phase of mitotic cell cycle 11 1.34 1.21 1.41 1.15 1.44 1.65 1.53
imaginal disc fusion 16 1.01 1.24 1.46 1.12 1.3 1.23 1.22
female sex differentiation 19 1.28 1.1 1.09 1.01 1.21 1.14 1.12
protein autophosphorylation 7 -1.02 1.18 1.21 1.11 1.22 1.16 1.21
habituation 4 1.3 -1.01 1.62 1.18 1.4 1.83 1.26
eye pigmentation 34 1.13 -1.1 -1.23 1.11 1.01 -1.18 -1.07
chromosome localization 18 1.21 1.05 1.2 1.17 1.42 1.12 -1.0
localization 1626 -1.02 1.02 1.05 1.01 1.11 1.1 1.04
actin crosslink formation 1 2.2 1.13 -1.01 1.18 1.16 -1.08 1.17
glycolipid binding 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
catecholamine transport 2 3.07 -1.44 -1.47 -1.28 -1.45 -1.2 -1.42
carboxylic ester hydrolase activity 99 -1.69 -1.12 -1.47 -1.07 -1.31 -2.03 -1.33
foraging behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
regulation of canonical Wnt receptor signaling pathway 6 1.19 1.08 1.68 1.07 1.07 1.06 1.46
establishment of blood-brain barrier 19 2.5 -1.26 1.24 -1.17 1.21 2.3 1.4
neuroendocrine cell differentiation 2 -1.09 1.14 1.11 1.1 1.07 -1.24 1.07
Wnt protein secretion 1 1.86 -1.05 2.03 1.04 1.26 2.03 1.19
vitamin B6 binding 40 1.01 1.02 -1.27 -1.04 -1.03 -1.02 1.04
RISC-loading complex 1 1.44 1.23 1.89 1.19 2.25 1.64 1.56
cellular response to ecdysone 11 1.32 1.19 1.43 1.13 1.47 1.53 1.33
circulatory system development 70 1.28 -1.02 1.19 -1.07 1.17 1.3 1.17
regulation of ion homeostasis 3 1.14 1.14 1.39 1.16 1.04 1.71 1.47
mitochondrial genome maintenance 8 -1.05 1.17 1.44 1.18 1.23 1.21 -1.27
reproduction 846 1.12 1.06 1.15 1.03 1.18 1.14 1.14
ribosome biogenesis 52 1.28 1.16 1.24 1.3 1.29 1.06 1.05
protein binding involved in protein folding 2 1.49 1.24 1.02 1.11 1.08 1.24 1.18
unfolded protein binding 80 1.1 1.04 1.1 1.14 1.14 1.02 -1.05
protein thiol-disulfide exchange 1 -1.26 1.49 1.56 1.08 1.23 -1.31 1.33
disulfide oxidoreductase activity 30 1.14 1.05 -1.02 1.16 1.09 -1.11 -1.1
alpha-1,6-mannosyltransferase activity 1 1.2 1.3 1.28 1.05 1.27 1.14 1.6
trans-hexaprenyltranstransferase activity 2 2.38 1.18 1.12 1.03 1.43 1.86 1.15
single strand break repair 2 1.23 1.1 1.14 1.12 1.12 1.05 1.04
single-stranded DNA specific endodeoxyribonuclease activity 3 1.42 1.05 1.38 1.12 1.4 1.2 -1.23
phosphopyruvate hydratase complex 1 1.97 1.06 -1.39 -1.17 -1.32 2.59 1.17
alpha-glucoside transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
regulation of DNA recombination 2 -1.59 1.15 1.13 1.19 1.42 -1.74 -1.31
regulation of mitotic recombination 1 -2.02 1.1 1.06 1.2 1.9 -2.66 -1.77
negative regulation of mitotic recombination 1 -2.02 1.1 1.06 1.2 1.9 -2.66 -1.77
mitotic spindle elongation 72 1.4 1.08 1.2 1.04 1.24 1.24 1.15
alpha-1,2-mannosyltransferase activity 1 -1.58 1.15 -1.08 1.11 -1.2 -1.77 1.49
mannosyltransferase activity 12 -1.24 1.17 1.3 1.07 1.33 -1.21 1.12
acyl carrier activity 6 1.59 1.03 1.12 1.01 1.14 1.4 1.17
very long-chain fatty acid metabolic process 5 3.63 -2.39 -2.2 -3.1 -1.91 -1.08 3.71
long-chain fatty acid transporter activity 7 -2.15 1.3 -1.32 -1.52 -2.35 -1.39 -1.5
plasma membrane 575 1.16 1.01 1.11 -1.03 1.11 1.23 1.16
transition metal ion transport 17 1.11 1.0 1.11 -1.05 -1.09 1.21 1.05
protein targeting to Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
autophagic vacuole assembly 2 1.21 1.14 -1.0 1.38 1.03 -1.03 -1.25
autophagic vacuole fusion 2 1.14 1.16 1.85 1.13 1.26 1.5 1.09
electron carrier activity 154 -1.07 -1.09 -1.18 -1.02 1.01 -1.08 -1.1
tRNA binding 9 1.2 1.27 1.24 1.22 1.15 1.15 1.01
urea cycle 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
argininosuccinate metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
ribosomal subunit export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
ribosomal large subunit export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
protein import into nucleus, docking 2 -1.85 1.21 1.23 1.37 1.53 -1.37 -1.23
protein import into nucleus, translocation 2 1.98 -1.11 1.05 1.22 1.33 2.03 -1.05
fatty-acyl-CoA binding 8 -2.25 -1.27 -1.85 1.18 1.35 -2.52 -1.44
L-ornithine transmembrane transporter activity 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
mitochondrial ornithine transport 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
DNA replication 73 1.08 1.13 1.19 1.17 1.34 1.13 -1.02
chromosome segregation 124 1.15 1.1 1.25 1.11 1.3 1.2 1.1
chromosome organization 265 1.2 1.11 1.27 1.13 1.32 1.2 1.15
mitotic sister chromatid segregation 55 1.25 1.07 1.29 1.1 1.36 1.27 1.09
M phase specific microtubule process 1 1.59 1.65 -1.13 1.13 1.0 -1.46 -1.04
cell cycle checkpoint 84 1.23 1.14 1.35 1.19 1.41 1.29 1.15
DNA replication checkpoint 3 -1.03 -1.02 1.14 1.12 1.37 1.02 -1.1
DNA damage checkpoint 69 1.23 1.15 1.38 1.19 1.41 1.31 1.15
regulation of cyclin-dependent protein kinase activity 15 1.32 1.16 1.36 1.2 1.41 1.07 1.15
G1 phase of mitotic cell cycle 1 -1.2 1.72 1.55 1.31 1.53 1.21 1.72
G1/S transition of mitotic cell cycle 14 1.35 1.24 1.43 1.21 1.54 1.24 1.25
regulation of transcription involved in G1/S phase of mitotic cell cycle 1 1.31 1.43 1.45 1.16 1.14 1.54 1.46
S phase of mitotic cell cycle 3 -1.1 1.13 1.05 1.24 1.2 -1.11 -1.1
astral microtubule 4 -1.02 1.17 1.36 -1.01 1.32 1.27 1.24
G2 phase of mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
G2/M transition of mitotic cell cycle 71 1.21 1.14 1.34 1.19 1.41 1.24 1.13
M phase of mitotic cell cycle 148 1.21 1.1 1.27 1.12 1.33 1.23 1.1
mitotic metaphase 1 -1.06 1.01 -1.03 1.11 -1.07 -1.08 -1.08
mitotic anaphase 19 1.3 1.13 1.29 1.17 1.36 1.32 1.11
mitotic anaphase A 4 -1.13 1.29 1.25 1.15 1.37 1.13 1.24
mitotic anaphase B 2 1.04 1.25 1.4 1.16 1.52 -1.16 1.12
mitotic telophase 1 1.4 1.02 1.15 1.14 1.72 -1.18 -1.16
sulfur amino acid metabolic process 11 1.06 -1.1 -1.32 1.02 -1.36 1.08 -1.14
sulfur amino acid biosynthetic process 3 1.32 1.11 1.04 -1.09 -1.92 1.19 1.3
sulfur amino acid catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
sulfur amino acid transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
sulfur amino acid transport 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
sulfate assimilation 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
succinate dehydrogenase activity 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
nucleotide-excision repair complex 3 1.73 1.2 1.21 1.15 1.32 1.1 -1.16
regulation of transcription involved in G2/M-phase of mitotic cell cycle 1 1.12 1.4 1.69 -1.0 1.67 1.7 1.71
histone deacetylase complex 16 1.3 1.16 1.3 1.17 1.34 1.37 1.21
negative regulation of transcription from RNA polymerase II promoter 104 1.12 1.05 1.08 -1.01 1.16 1.18 1.11
histone acetyltransferase complex 40 1.37 1.14 1.22 1.23 1.26 1.13 1.06
SAGA complex 20 1.38 1.1 1.14 1.26 1.22 1.03 -1.02
transcription factor TFIIIB complex 2 1.19 1.29 1.5 1.13 1.51 1.31 1.18
establishment of mitotic spindle orientation 2 1.02 1.4 1.82 1.21 1.49 1.4 1.34
Golgi cis cisterna 1 -1.12 1.19 1.36 1.12 1.23 -1.28 1.74
Golgi trans cisterna 2 -1.03 1.16 1.1 1.38 1.81 1.12 1.1
Golgi membrane 37 1.04 1.11 1.07 1.1 1.06 1.29 1.38
microfilament motor activity 3 6.28 -1.75 1.12 -1.66 1.09 3.74 -1.21
SNARE binding 6 -1.14 1.05 1.42 1.11 1.29 1.2 1.24
recombinase activity 4 1.15 1.04 -1.05 1.11 1.09 -1.16 -1.08
ubiquitin ligase complex 43 1.31 1.15 1.31 1.16 1.28 1.18 1.18
nuclear ubiquitin ligase complex 19 1.18 1.15 1.35 1.18 1.34 1.11 1.14
cytoplasmic ubiquitin ligase complex 1 2.69 1.18 1.72 1.15 -1.01 -1.18 -1.08
rRNA modification 5 1.57 1.18 1.26 1.33 1.41 1.18 -1.02
two-component sensor activity 3 1.12 -1.13 1.03 -1.08 1.69 1.52 -1.14
two-component response regulator activity 1 -1.1 1.39 1.36 1.05 1.38 3.53 1.68
protein phosphatase type 2A complex 8 1.09 1.04 1.37 1.07 1.23 2.15 1.1
two-component signal transduction system (phosphorelay) 3 -1.1 1.14 1.08 -1.02 -1.02 1.53 1.01
protein phosphatase type 1 complex 5 1.43 1.05 1.28 1.01 1.16 1.5 1.4
MAPK cascade 35 -1.01 1.14 1.46 1.09 1.46 1.19 1.31
nucleotide binding 1153 1.12 1.07 1.11 1.06 1.16 1.16 1.09
ribonuclease MRP complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
3'-5'-exoribonuclease activity 15 1.46 1.13 1.16 1.27 1.25 1.2 1.04
nuclear exosome (RNase complex) 13 1.3 1.17 1.14 1.29 1.27 1.13 1.05
cytoplasmic exosome (RNase complex) 8 1.45 1.11 1.16 1.3 1.29 1.15 -1.0
exosome (RNase complex) 13 1.3 1.17 1.14 1.29 1.27 1.13 1.05
rRNA (adenine-N6,N6-)-dimethyltransferase activity 2 1.61 1.27 1.44 1.22 1.57 1.46 1.13
cytosolic large ribosomal subunit 50 1.38 1.02 1.09 1.0 1.14 1.2 1.09
cytosolic small ribosomal subunit 33 1.37 1.02 1.1 1.02 1.14 1.17 1.04
rDNA binding 2 -1.04 1.15 1.82 1.29 2.02 1.26 1.15
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 12 -1.19 1.17 1.13 1.22 1.25 -1.02 1.0
activation of MAPKKK activity 1 -1.25 1.21 1.4 1.19 1.07 1.11 1.44
activation of MAPKK activity 3 1.19 1.2 1.4 1.2 1.34 1.15 1.19
activation of MAPK activity 7 1.11 1.21 1.54 1.12 1.37 2.0 1.14
inactivation of MAPK activity 1 2.84 1.44 1.69 1.19 1.68 4.37 1.83
MAPK import into nucleus 1 1.14 1.19 1.6 1.04 1.48 1.45 1.57
protein binding 1244 1.17 1.05 1.21 1.04 1.22 1.2 1.14
modification-dependent protein catabolic process 94 1.17 1.13 1.33 1.13 1.3 1.1 1.12
protein ubiquitination involved in ubiquitin-dependent protein catabolic process 5 1.02 1.13 2.15 1.07 1.56 1.16 1.11
meiotic spindle organization 22 1.17 -1.06 -1.01 -1.07 1.19 1.02 1.17
tRNA-intron endonuclease activity 1 1.37 1.2 -1.07 1.24 1.11 -1.16 -1.02
tRNA-intron endonuclease complex 1 1.37 1.2 -1.07 1.24 1.11 -1.16 -1.02
DNA secondary structure binding 3 -1.08 1.33 1.37 1.18 1.48 -1.09 1.25
proton-transporting two-sector ATPase complex 48 -1.18 1.0 1.27 -1.11 -1.06 1.39 -1.15
vacuolar proton-transporting V-type ATPase, V0 domain 13 -2.32 -1.03 1.35 -1.29 -1.38 1.02 -1.29
vacuolar proton-transporting V-type ATPase, V1 domain 12 -1.17 1.02 1.44 -1.12 -1.04 1.8 -1.01
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity 1 -1.09 1.27 1.39 1.28 1.54 -1.1 1.18
microtubule cytoskeleton organization 338 1.13 1.1 1.24 1.09 1.26 1.18 1.09
nuclear chromosome 88 1.19 1.12 1.23 1.14 1.27 1.13 1.03
cytoplasmic chromosome 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
condensed nuclear chromosome 15 1.25 1.06 1.23 1.06 1.25 1.24 1.09
condensed chromosome 38 1.15 1.06 1.23 1.09 1.3 1.2 1.07
mitotic prometaphase 1 -1.39 -1.16 -1.07 1.34 1.62 -1.16 -1.17
pericentriolar material 6 1.07 1.05 1.08 1.04 1.14 1.08 1.03
spliceosomal complex assembly 14 1.26 1.11 1.27 1.23 1.28 1.21 -1.02
C-4 methylsterol oxidase activity 2 -1.31 -6.89 -7.44 -1.07 -3.2 -1.65 -1.68
allantoin metabolic process 2 3.32 -1.45 -1.35 -1.39 -1.17 1.29 -1.34
allantoin catabolic process 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
nitrilase activity 2 1.33 1.42 -1.12 1.25 1.47 1.28 -1.05
sodium:amino acid symporter activity 5 1.26 1.14 -2.06 -1.96 -1.76 -1.26 1.36
nucleoside transmembrane transporter activity 6 -1.51 1.3 -1.37 1.14 -1.09 -1.36 -1.05
intracellular 4036 1.14 1.07 1.15 1.08 1.18 1.16 1.05
proton-transporting ATPase activity, rotational mechanism 21 1.15 -1.01 1.22 -1.1 -1.03 1.64 -1.08
mitochondrial chromosome 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
GTPase activity 136 1.2 1.08 1.29 1.07 1.22 1.09 1.05
heterotrimeric G-protein complex 18 1.39 1.11 1.42 1.06 1.22 1.03 1.1
mitochondrial fission 2 1.47 -1.03 1.65 1.15 1.07 1.58 -1.11
cell fraction 106 -1.02 -1.12 -1.21 -1.02 1.06 -1.09 -1.04
peroxisome targeting sequence binding 3 1.2 -1.04 -1.07 1.13 1.12 -1.21 -1.06
peptidoglycan metabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
polysaccharide biosynthetic process 22 1.55 1.02 -1.01 1.03 1.12 1.58 1.25
polysaccharide catabolic process 30 -1.17 -1.91 -2.09 -1.67 -1.68 -1.04 1.4
mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) 8 1.58 -1.08 1.12 -1.1 1.01 1.92 -1.31
mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) 9 1.19 1.04 1.31 1.01 1.22 1.62 -1.14
mitotic cell cycle 399 1.21 1.11 1.24 1.12 1.29 1.21 1.1
nuclear division 149 1.23 1.09 1.27 1.11 1.32 1.26 1.12
cytokinesis after mitosis 5 -1.12 1.17 1.26 1.17 1.24 -1.37 1.01
1-phosphatidylinositol-3-phosphate 5-kinase activity 1 -1.33 1.29 1.91 1.33 2.36 1.28 1.16
magnesium ion binding 46 1.08 1.06 1.18 1.05 1.15 1.38 1.01
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay 10 1.48 1.17 1.74 1.19 1.61 1.9 1.56
nuclear-transcribed mRNA poly(A) tail shortening 7 1.62 1.13 1.74 1.15 1.59 2.05 1.42
deadenylation-dependent decapping of nuclear-transcribed mRNA 2 1.27 1.29 1.78 1.53 1.51 1.59 1.46
nuclear-transcribed mRNA catabolic process, exonucleolytic 1 -1.45 1.76 1.14 1.42 1.29 -1.3 1.32
integral to membrane of membrane fraction 2 1.74 1.04 1.6 1.07 1.43 2.77 1.46
peripheral to membrane of membrane fraction 2 -1.06 1.15 1.33 1.33 1.33 1.07 -1.07
retrograde transport, vesicle recycling within Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
response to reactive oxygen species 16 1.05 1.06 1.08 1.15 1.2 -1.01 -1.15
response to superoxide 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
response to oxygen radical 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
cyclin-dependent protein kinase holoenzyme complex 7 1.06 1.09 1.22 1.21 1.41 -1.23 -1.12
nicotinamide-nucleotide adenylyltransferase activity 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
organellar ribosome 72 1.04 1.07 1.23 1.29 1.25 1.45 -1.55
organellar small ribosomal subunit 30 1.04 1.09 1.24 1.27 1.23 1.47 -1.48
organellar large ribosomal subunit 44 1.03 1.05 1.24 1.3 1.28 1.46 -1.6
protein-methionine-R-oxide reductase activity 1 2.04 1.02 -1.15 -1.19 -1.3 1.08 -1.25
lytic vacuole 28 -2.58 -1.1 -2.35 1.15 -1.08 -2.06 -3.03
negative regulation of transposition, DNA-mediated 1 -1.25 1.2 1.21 1.19 1.06 -1.14 1.03
regulation of transposition, DNA-mediated 1 -1.25 1.2 1.21 1.19 1.06 -1.14 1.03
RNA cap binding 13 1.12 1.12 1.2 1.04 1.14 1.12 1.32
RNA 7-methylguanosine cap binding 9 1.06 1.12 1.24 -1.0 1.11 1.11 1.44
THO complex 5 1.18 1.1 1.39 1.17 1.27 1.37 1.09
RNA splicing, via transesterification reactions 180 1.17 1.11 1.21 1.23 1.31 1.16 1.0
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile 177 1.17 1.11 1.21 1.23 1.31 1.15 1.0
alternative nuclear mRNA splicing, via spliceosome 1 1.52 1.27 1.61 1.3 1.51 2.77 1.58
regulation of alternative nuclear mRNA splicing, via spliceosome 52 1.22 1.17 1.28 1.16 1.24 1.42 1.09
spliceosomal snRNP assembly 1 1.14 -1.01 1.12 1.41 1.03 -1.2 -1.43
spliceosomal complex disassembly 1 1.69 1.29 1.56 1.32 1.6 1.63 1.44
RNA splicing, via endonucleolytic cleavage and ligation 3 1.93 1.15 1.42 1.2 1.36 1.44 1.34
nuclear mRNA splicing, via spliceosome 177 1.17 1.11 1.21 1.23 1.31 1.15 1.0
four-way junction DNA binding 1 -1.12 1.35 2.36 1.33 2.9 1.28 1.43
Y-form DNA binding 1 1.11 1.31 -1.06 1.14 -1.02 -1.04 1.09
mitochondrion degradation 1 2.65 1.08 1.15 1.38 1.25 2.74 1.17
DNA-directed RNA polymerase complex 23 1.32 1.14 1.23 1.25 1.26 1.12 1.07
core TFIIH complex 4 1.37 1.09 1.37 1.35 1.33 1.15 1.06
SSL2-core TFIIH complex 4 1.37 1.09 1.37 1.35 1.33 1.15 1.06
maturation of 2S rRNA 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
base pairing 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
base pairing with RNA 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
proteasome complex 55 1.37 1.04 1.2 1.15 1.17 -1.02 1.02
embryonic axis specification 118 1.23 1.09 1.29 1.05 1.24 1.31 1.25
mismatch base pair DNA N-glycosylase activity 1 -1.08 1.06 -1.04 1.0 -1.17 1.06 -1.14
oxidized base lesion DNA N-glycosylase activity 3 2.16 -1.01 1.16 1.13 1.13 1.51 -1.03
oxidized pyrimidine base lesion DNA N-glycosylase activity 1 3.75 1.0 1.19 1.14 1.11 1.95 1.06
achiasmate meiosis I 1 -1.17 1.02 -1.13 1.11 -1.02 -1.2 -1.13
meiotic DNA recombinase assembly 1 -1.21 1.44 1.1 1.2 1.03 -1.18 1.17
meiotic mismatch repair 1 1.34 1.15 1.36 1.37 1.61 1.16 1.18
resolution of meiotic recombination intermediates 4 1.0 1.09 1.25 1.17 1.45 1.14 1.06
nucleotide-excision repair, DNA damage recognition 1 1.35 1.22 1.6 1.15 1.67 2.6 1.56
telomere maintenance 14 1.19 1.12 1.39 1.17 1.35 1.2 1.11
double-strand break repair via homologous recombination 7 1.12 1.16 1.16 1.17 1.22 -1.03 1.11
recombinational repair 7 1.12 1.16 1.16 1.17 1.22 -1.03 1.11
non-recombinational repair 6 -1.06 1.22 1.37 1.12 1.33 -1.11 1.14
DNA recombinase assembly 1 -1.21 1.44 1.1 1.2 1.03 -1.18 1.17
DNA synthesis involved in DNA repair 1 1.11 1.31 -1.06 1.14 -1.02 -1.04 1.09
strand displacement 1 1.11 1.31 -1.06 1.14 -1.02 -1.04 1.09
DNA catabolic process, endonucleolytic 4 1.64 1.12 1.39 1.15 1.35 1.4 1.54
DNA catabolic process, exonucleolytic 2 -1.31 1.21 1.11 1.22 1.62 -1.59 -1.29
DNA strand annealing activity 2 1.04 1.17 1.07 1.09 1.08 1.05 1.03
karyogamy 6 1.05 1.11 1.23 1.09 1.44 1.02 1.13
syncytium formation by plasma membrane fusion 27 1.01 1.06 1.27 -1.02 1.21 1.27 1.14
adenyl-nucleotide exchange factor activity 1 -1.14 1.21 -1.05 1.17 1.0 -1.29 -1.36
chromosome, centromeric region 54 1.2 1.07 1.19 1.11 1.31 1.15 1.07
kinetochore 31 1.18 1.08 1.16 1.14 1.33 1.13 -1.0
condensed chromosome kinetochore 9 1.03 1.06 1.14 1.12 1.28 -1.06 -1.03
condensed nuclear chromosome kinetochore 1 1.0 1.07 -1.07 1.19 -1.13 -1.28 1.01
condensed chromosome, centromeric region 13 1.09 1.06 1.24 1.12 1.37 1.11 1.02
condensed nuclear chromosome, centromeric region 7 1.24 1.07 1.34 1.12 1.41 1.38 1.12
chromosome, telomeric region 10 1.35 1.09 1.3 1.17 1.42 1.18 1.05
nuclear chromosome, telomeric region 2 1.89 1.01 1.39 1.11 1.79 1.05 1.11
chromatin 122 1.11 1.12 1.24 1.14 1.27 1.15 1.12
nucleosome 15 -1.1 1.01 1.25 1.15 1.09 -1.35 -1.01
nuclear nucleosome 1 1.0 1.07 -1.07 1.19 -1.13 -1.28 1.01
nuclear chromatin 49 1.15 1.15 1.25 1.15 1.27 1.14 1.09
euchromatin 12 1.14 1.22 1.34 1.18 1.46 1.33 1.26
heterochromatin 22 1.14 1.16 1.29 1.08 1.32 1.36 1.33
synaptonemal complex 4 1.04 1.05 1.03 1.0 -1.02 -1.06 1.06
condensin complex 8 1.13 1.05 1.18 1.06 1.26 1.27 1.12
sex chromosome 7 1.3 1.17 1.32 1.09 1.18 1.39 1.28
X chromosome 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
Y chromosome 1 -1.03 -1.14 -1.12 -1.01 -1.12 -1.2 -1.19
origin recognition complex 7 1.06 1.15 1.09 1.19 1.24 1.01 -1.08
GINS complex 2 1.77 1.11 1.3 1.14 1.18 1.14 -1.06
sister chromatid segregation 56 1.25 1.07 1.3 1.11 1.37 1.27 1.09
inositol-1,4,5-trisphosphate 6-kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
inositol hexakisphosphate kinase activity 1 -1.38 1.16 2.02 -1.07 2.12 1.33 1.59
translation repressor activity, nucleic acid binding 6 1.94 1.04 2.03 1.04 1.61 1.46 1.82
cell morphogenesis involved in differentiation 351 1.14 1.09 1.26 1.04 1.28 1.28 1.26
cytokinesis 81 1.03 1.07 1.23 1.06 1.32 1.09 1.11
assembly of actomyosin apparatus involved in cell cycle cytokinesis 14 1.26 -1.24 -1.03 -1.27 1.08 1.13 1.08
cytokinesis, actomyosin contractile ring assembly 14 1.26 -1.24 -1.03 -1.27 1.08 1.13 1.08
contractile ring contraction involved in cell cycle cytokinesis 7 1.0 1.24 1.32 1.18 1.42 1.29 1.17
cytokinetic cell separation 1 -1.24 -1.05 1.11 1.18 1.4 -1.36 -1.18
spindle pole 23 1.28 1.12 1.43 1.06 1.39 1.41 1.26
gamma-tubulin complex 8 1.55 1.01 1.26 1.07 1.31 1.48 1.15
gamma-tubulin large complex 5 1.67 -1.04 1.23 1.09 1.31 1.41 1.1
cytoplasmic mRNA processing body 13 1.31 1.27 1.6 1.18 1.51 1.59 1.3
condensed chromosome inner kinetochore 1 1.0 1.07 -1.07 1.19 -1.13 -1.28 1.01
condensed chromosome outer kinetochore 7 -1.03 1.07 1.16 1.1 1.38 -1.08 -1.04
condensed nuclear chromosome inner kinetochore 1 1.0 1.07 -1.07 1.19 -1.13 -1.28 1.01
base pairing with rRNA 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
nuclear-transcribed mRNA catabolic process 23 1.11 1.16 1.34 1.18 1.37 1.32 1.21
mitochondrial RNA metabolic process 3 1.29 1.23 1.41 1.12 1.47 1.73 -1.1
regulatory region DNA binding 74 1.02 1.03 1.06 1.02 1.11 1.13 1.07
transcription regulatory region sequence-specific DNA binding 65 1.03 1.01 1.06 1.01 1.09 1.15 1.08
RNA polymerase II regulatory region sequence-specific DNA binding 45 1.09 -1.0 1.06 1.02 1.1 1.12 1.05
RNA polymerase II core promoter proximal region sequence-specific DNA binding 4 1.25 1.09 1.19 1.0 1.33 1.57 1.45
RNA polymerase II distal enhancer sequence-specific DNA binding 17 1.22 1.05 1.08 -1.03 1.01 1.06 1.21
sequence-specific DNA binding RNA polymerase II transcription factor activity 150 1.13 1.02 1.1 -1.01 1.12 1.15 1.16
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity 59 1.12 1.09 1.16 1.01 1.21 1.12 1.21
RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity 19 1.4 1.13 1.24 1.2 1.34 1.2 1.07
core promoter proximal region sequence-specific DNA binding 5 1.34 1.15 1.24 1.06 1.3 1.49 1.32
protein binding transcription factor activity 95 1.28 1.11 1.27 1.15 1.34 1.24 1.16
transcription factor binding transcription factor activity 95 1.28 1.11 1.27 1.15 1.34 1.24 1.16
RNA polymerase II regulatory region DNA binding 47 1.09 1.0 1.06 1.02 1.1 1.12 1.04
core promoter sequence-specific DNA binding 2 -1.01 1.32 1.26 1.21 1.46 1.11 1.06
core promoter binding 2 -1.01 1.32 1.26 1.21 1.46 1.11 1.06
regulatory region nucleic acid binding 74 1.02 1.03 1.06 1.02 1.11 1.13 1.07
nucleic acid binding transcription factor activity 411 1.09 1.04 1.09 1.01 1.1 1.11 1.09
sequence-specific core promoter binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly 18 1.41 1.13 1.25 1.21 1.36 1.2 1.08
RNA polymerase II transcription factor binding transcription factor activity 46 1.44 1.04 1.23 1.18 1.35 1.26 1.1
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription 40 1.12 1.13 1.2 1.01 1.21 1.17 1.23
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription 21 1.21 1.02 1.09 1.02 1.19 1.01 1.17
RNA polymerase II basal transcription factor binding transcription factor activity 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
RNA polymerase II transcription factor binding 15 1.46 -1.02 1.01 1.1 1.19 1.25 1.17
RNA polymerase II basal transcription factor binding 7 1.26 1.21 1.29 1.22 1.32 1.14 1.2
TFIIA-class transcription factor binding 3 1.34 1.29 1.39 1.2 1.61 1.37 1.28
TFIIB-class transcription factor binding 1 1.15 1.32 1.1 1.22 1.43 1.06 1.02
TFIID-class transcription factor binding 2 1.34 1.01 -1.02 1.28 1.04 -1.14 -1.12
TFIIF-class transcription factor binding 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
basal transcription machinery binding 8 1.09 1.07 1.15 1.14 1.23 1.02 1.08
basal RNA polymerase II transcription machinery binding 8 1.09 1.07 1.15 1.14 1.23 1.02 1.08
response to acid 5 1.44 -1.04 1.24 1.2 1.26 1.13 -1.15
RNA polymerase II activating transcription factor binding 4 2.11 -1.73 -1.85 -1.26 -1.03 1.44 1.34
RNA polymerase II repressing transcription factor binding 2 1.24 1.19 1.36 1.24 1.29 1.42 1.1
RNA polymerase II transcription cofactor activity 41 1.42 1.04 1.22 1.19 1.34 1.27 1.09
RNA polymerase II transcription coactivator activity 8 1.57 -1.19 -1.01 1.03 1.27 1.49 1.13
RNA polymerase II transcription corepressor activity 2 1.12 1.2 1.26 1.29 1.7 1.19 1.25
promoter clearance during DNA-dependent transcription 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
promoter clearance from RNA polymerase II promoter 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
DNA-dependent transcriptional open complex formation 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
transcriptional open complex formation at RNA polymerase II promoter 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
protein-DNA complex remodeling 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly 2 1.66 -1.04 1.36 1.21 1.19 1.16 -1.0
TBP-class protein binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
TBP-class protein binding RNA polymerase II transcription factor activity 6 1.58 1.1 1.46 1.16 1.41 1.29 1.2
enhancer sequence-specific DNA binding 18 1.2 1.05 1.07 -1.02 1.0 1.04 1.19
core promoter proximal region DNA binding 5 1.34 1.15 1.24 1.06 1.3 1.49 1.32
DNA-dependent transcriptional start site selection 1 2.19 1.23 -1.08 1.33 1.17 -1.1 1.1
transcriptional start site selection at RNA polymerase II promoter 1 2.19 1.23 -1.08 1.33 1.17 -1.1 1.1
RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription 8 1.57 -1.19 -1.01 1.03 1.27 1.49 1.13
RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription 3 1.37 1.05 1.07 1.1 1.48 -1.12 1.13
age-dependent response to oxidative stress 1 -1.1 1.09 1.19 1.01 1.01 1.19 1.25
entry into host 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
neurotransmitter uptake 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
regulation of neurotransmitter levels 106 -1.07 1.06 1.19 1.11 1.22 1.06 1.07
neurotransmitter biosynthetic process 4 1.15 -1.01 -1.13 -1.06 1.01 -1.12 -1.05
acetylcholine catabolic process in synaptic cleft 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
regulation of action potential 8 1.57 -1.04 1.3 -1.12 1.17 2.65 1.29
cysteine-type endopeptidase activity 29 -1.39 -1.19 1.01 -1.08 1.27 -1.29 -1.2
RNA methylation 10 1.62 1.18 1.23 1.26 1.35 1.29 1.02
microfibril 1 1.02 -1.0 1.14 1.18 1.1 1.03 -1.08
calcium ion binding 192 1.36 -1.02 1.1 -1.05 1.09 1.28 1.2
selenocysteine incorporation 1 1.74 1.02 1.02 1.41 1.48 -1.49 -1.06
voltage-gated sodium channel complex 1 1.49 1.1 1.18 1.37 1.22 1.19 1.04
peptide amidation 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
pseudouridine synthesis 12 1.48 1.3 1.18 1.15 1.18 1.37 1.11
retinoid metabolic process 3 1.01 -1.01 1.02 1.05 -1.08 1.07 -1.1
oxygen transporter activity 11 1.36 1.04 1.04 -1.04 -1.15 1.01 -1.01
proteoglycan metabolic process 18 1.24 1.14 1.2 1.07 1.15 1.23 1.5
sulfur compound metabolic process 37 -1.0 1.04 1.02 1.1 1.02 1.18 1.06
lipopolysaccharide binding 1 8.83 -1.7 -1.73 -1.63 -1.34 3.89 1.3
ciliary or flagellar motility 2 1.0 -1.02 -1.01 -1.04 -1.08 -1.04 1.1
beta-amyloid binding 1 -1.11 1.12 -1.05 1.06 -1.09 -1.06 -1.01
ovarian follicle development 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
oocyte growth 2 1.25 1.36 1.54 1.22 1.6 1.07 1.72
oocyte maturation 3 -1.0 1.13 -1.07 -1.01 -1.03 -1.0 1.1
metabolic process 3907 -1.04 -1.03 -1.04 1.02 1.06 -1.04 -1.05
cell growth 59 1.22 1.13 1.38 1.04 1.43 1.35 1.28
regulation of cell growth 38 1.09 1.19 1.46 1.1 1.43 1.53 1.25
heterophilic cell-cell adhesion 12 -1.44 1.04 1.3 -1.02 1.46 -1.24 1.32
galactoside binding 2 1.45 -1.07 1.88 1.03 1.06 1.31 1.14
microtubule bundle formation 16 -1.31 1.1 1.24 1.11 1.2 -1.29 -1.07
detection of chemical stimulus involved in sensory perception of bitter taste 1 -1.77 -1.51 -1.46 -1.66 9.03 1.38 -1.43
detection of chemical stimulus involved in sensory perception of sweet taste 1 15.43 1.05 -1.1 -1.34 2.06 11.73 3.15
Gi/o-coupled serotonin receptor activity 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
Gq/11-coupled serotonin receptor activity 1 1.13 -1.11 -1.04 -1.12 -1.18 1.14 1.05
dopamine receptor activity, coupled via Gs 2 -1.21 1.11 -1.21 1.0 -1.21 -1.22 -1.28
dopamine receptor activity, coupled via Gi/Go 1 -1.08 -1.06 -1.29 1.12 -1.04 -1.27 -1.07
neuromedin U receptor activity 1 -1.22 -1.11 -1.12 -1.18 -1.25 -1.3 -1.2
G-protein coupled adenosine receptor activity 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
dense fibrillar component 1 -1.19 1.16 -1.05 1.68 1.27 -1.6 -1.28
peptide receptor activity 45 1.11 -1.06 1.03 -1.06 -1.05 1.15 1.01
eye development 265 1.14 1.1 1.26 1.06 1.27 1.23 1.24
urogenital system development 69 1.2 -1.03 1.12 -1.01 1.21 1.35 1.08
conditioned taste aversion 3 1.58 1.48 1.62 -1.13 1.26 1.28 1.57
G-protein coupled receptor binding 7 -1.1 -1.01 1.12 -1.08 1.17 1.16 1.2
response to hypoxia 43 1.14 1.14 1.22 1.08 1.27 1.28 1.2
ameboidal cell migration 35 1.62 -1.01 1.31 -1.06 1.21 1.46 1.11
acrosomal vesicle 1 -1.22 1.14 1.06 1.01 -1.52 -1.37 1.04
ATPase activator activity 3 1.77 1.07 1.2 1.24 1.37 1.32 1.35
regulation of chromatin assembly or disassembly 6 1.1 1.2 1.31 1.12 1.3 1.19 1.21
male germ cell nucleus 10 -1.1 1.13 1.01 1.03 -1.05 -1.24 1.05
female germ cell nucleus 1 1.04 1.22 1.16 1.15 1.04 -1.0 -1.09
long-chain fatty acid metabolic process 8 2.31 -2.32 -1.73 -1.98 -1.14 -1.49 1.69
formation of translation initiation ternary complex 1 1.02 1.21 1.26 1.24 1.31 1.17 1.22
tRNA 5'-leader removal 1 -1.05 1.03 -1.13 -1.0 -1.0 -1.23 -1.11
axonemal dynein complex 12 -1.02 1.03 1.04 1.02 -1.05 1.0 -1.11
cytoplasmic dynein complex 11 -1.01 1.07 1.14 1.01 1.06 1.15 -1.02
histamine metabolic process 2 1.02 -1.27 1.33 1.09 1.3 1.8 1.14
histamine biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
embryonic development via the syncytial blastoderm 159 1.1 1.06 1.3 1.03 1.34 1.33 1.22
gastrulation with mouth forming first 30 1.11 -1.0 1.2 1.03 1.32 1.16 1.06
formation of primary germ layer 28 1.53 -1.01 1.18 -1.09 1.11 1.67 1.15
ectoderm formation 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
endoderm formation 4 2.13 -1.15 1.08 -1.19 1.07 2.11 1.76
mesoderm formation 26 1.41 1.01 1.15 -1.07 1.1 1.6 1.11
cell fate specification 59 1.11 1.06 1.1 1.04 1.17 -1.02 1.22
cell fate determination 122 1.2 1.07 1.23 1.02 1.24 1.19 1.2
mesodermal cell fate commitment 16 1.47 1.02 1.02 -1.04 1.04 1.32 1.13
endodermal cell fate commitment 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
ectodermal cell fate commitment 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
ectodermal cell fate specification 2 4.98 -1.19 1.75 -1.46 1.16 1.31 1.35
intermediate filament 2 1.28 1.06 -1.0 1.32 1.15 -1.17 -1.1
ruffle 2 1.28 1.39 2.24 -1.02 2.03 1.81 1.72
lipid kinase activity 2 1.57 1.08 1.68 -1.01 1.59 1.77 1.96
ceramide kinase activity 1 2.79 -1.02 1.66 -1.11 1.24 2.25 2.21
establishment of planar polarity 70 1.2 1.06 1.23 1.01 1.28 1.24 1.46
establishment of imaginal disc-derived wing hair orientation 22 1.56 1.08 1.28 1.02 1.4 1.32 1.3
morphogenesis of a polarized epithelium 79 1.19 1.08 1.28 1.02 1.3 1.27 1.44
oenocyte differentiation 8 1.23 1.09 1.12 1.12 1.24 1.37 1.16
optic placode formation 4 -1.14 1.1 1.23 1.12 1.47 -1.2 -1.08
optic lobe placode formation 4 -1.14 1.1 1.23 1.12 1.47 -1.2 -1.08
compound eye morphogenesis 198 1.16 1.1 1.25 1.06 1.25 1.2 1.26
Bolwig's organ morphogenesis 9 1.23 -1.01 1.15 1.06 1.23 1.18 1.03
optic lobe placode development 8 -1.18 1.11 1.22 1.1 1.34 -1.02 1.03
compound eye photoreceptor cell differentiation 117 1.22 1.11 1.3 1.08 1.29 1.25 1.2
compound eye photoreceptor fate commitment 51 1.32 1.09 1.23 1.09 1.32 1.24 1.18
compound eye photoreceptor development 60 1.11 1.12 1.33 1.04 1.24 1.21 1.22
eye photoreceptor cell differentiation 120 1.21 1.12 1.32 1.08 1.29 1.26 1.21
morphogenesis of a branching structure 48 1.11 1.11 1.43 1.03 1.35 1.27 1.3
neuron migration 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
cell activation 10 1.19 1.04 1.07 1.06 -1.05 1.15 1.06
phosphotyrosine binding 1 -1.42 1.22 1.22 1.19 1.41 -1.04 -1.04
kidney development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
epithelial to mesenchymal transition 1 1.47 1.13 -1.02 1.1 -1.07 -1.03 1.1
embryonic epithelial tube formation 6 1.03 -1.09 1.01 -1.18 -1.08 1.45 1.48
opsonin receptor activity 1 1.18 1.16 1.11 1.22 1.12 1.2 1.16
pattern binding 116 -1.88 -1.54 -1.66 -1.39 -1.53 -1.88 1.19
response to yeast 1 5.18 -1.34 1.33 -1.5 1.33 6.7 1.77
nucleoside binding 5 -2.97 1.34 -1.45 1.07 -1.17 -2.3 -1.24
endothelial cell development 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
selenium compound metabolic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity 1 1.03 1.3 1.31 1.09 1.28 -1.03 1.49
tissue homeostasis 20 1.33 -1.02 1.13 -1.12 1.22 1.46 1.54
retina homeostasis 2 -1.1 1.15 1.07 1.1 1.01 1.07 1.17
regulation of protein phosphorylation 65 1.23 1.16 1.37 1.12 1.3 1.37 1.18
negative regulation of protein phosphorylation 2 -1.04 1.11 1.79 -1.0 1.29 1.24 1.01
positive regulation of protein phosphorylation 5 1.08 1.17 1.78 1.11 1.35 1.9 1.34
regulation of cell-matrix adhesion 2 1.91 1.0 2.08 1.07 1.96 1.63 1.31
negative regulation of cell-matrix adhesion 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
startle response 13 1.09 1.15 1.46 1.07 1.52 1.19 1.26
G-protein alpha-subunit binding 2 -1.16 1.18 -1.02 1.16 1.01 -1.6 -1.07
morphogenesis of an epithelium 238 1.18 1.05 1.28 1.02 1.3 1.33 1.27
morphogenesis of an epithelial sheet 1 1.57 1.36 1.53 1.09 1.59 1.28 1.35
regulation of heart rate 3 -2.33 1.98 1.4 -1.73 -1.39 2.29 -1.17
regulation of sodium ion transport 6 -1.09 1.11 1.21 1.02 1.05 -1.15 1.01
p53 binding 1 1.78 1.16 2.67 1.12 2.53 3.19 2.15
positive regulation of neuroblast proliferation 2 -1.35 1.28 1.19 1.29 1.21 -1.02 1.09
epithelial cell development 14 1.16 1.1 1.33 1.01 1.23 1.71 1.39
protein depalmitoylation 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
regulation of receptor internalization 2 2.64 -1.34 1.04 -1.28 -1.11 2.63 1.36
positive regulation of receptor internalization 2 2.64 -1.34 1.04 -1.28 -1.11 2.63 1.36
polyprenyltransferase activity 1 1.04 1.26 1.1 1.28 -1.02 -1.97 -1.12
tRNA wobble base modification 2 1.94 1.19 1.23 1.17 1.27 1.92 1.12
tRNA wobble uridine modification 2 1.94 1.19 1.23 1.17 1.27 1.92 1.12
podosome 1 -1.23 -1.76 -1.82 -1.76 -2.16 17.9 -1.88
store-operated calcium entry 1 2.66 -1.14 1.6 1.07 1.44 4.2 2.14
aggressive behavior 44 1.19 1.05 1.23 -1.02 1.15 1.61 1.24
inter-male aggressive behavior 42 1.18 1.06 1.2 1.0 1.15 1.58 1.25
G-quadruplex RNA binding 1 1.1 1.52 1.31 1.18 1.34 1.42 1.38
larval development 73 1.16 1.08 1.33 1.02 1.21 1.2 1.27
instar larval or pupal development 424 1.18 1.05 1.22 1.02 1.26 1.27 1.22
instar larval development 48 1.09 1.08 1.31 1.01 1.22 1.22 1.26
palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
defense response to insect 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
positive regulation of antimicrobial peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
innate immune response in mucosa 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
response to molecule of bacterial origin 3 2.15 1.03 1.06 -1.04 1.33 1.63 1.06
adaptive immune response 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
organ or tissue specific immune response 7 1.24 1.06 1.29 -1.06 1.56 1.62 1.43
immune effector process 20 1.79 -1.15 1.28 -1.11 1.26 1.41 1.26
activation of immune response 1 1.17 1.46 1.63 1.36 1.42 1.78 1.19
myeloid leukocyte activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
immune system process 193 1.3 -1.15 -1.02 -1.12 1.05 1.17 1.2
mucosal immune response 7 1.24 1.06 1.29 -1.06 1.56 1.62 1.43
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis 3 1.28 -1.17 2.05 1.18 1.64 1.24 1.18
inflammatory response to antigenic stimulus 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
acute inflammatory response to antigenic stimulus 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
production of molecular mediator of immune response 2 -1.54 1.11 1.81 1.12 1.7 3.17 1.43
leukocyte mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
immune system development 52 1.16 1.07 1.33 1.05 1.3 1.2 1.34
hypersensitivity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
acute inflammatory response 3 -1.45 1.14 1.29 1.15 1.43 -1.36 1.17
regulation of immune system process 73 1.33 -1.01 1.08 -1.01 1.11 1.27 1.26
negative regulation of immune system process 16 1.45 1.01 1.09 -1.01 1.17 1.27 1.37
positive regulation of immune system process 8 1.43 1.03 1.15 1.01 1.19 1.8 1.48
regulation of immune effector process 36 1.47 -1.08 1.0 -1.04 1.04 1.31 1.19
positive regulation of immune effector process 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
regulation of production of molecular mediator of immune response 34 1.45 -1.09 -1.02 -1.05 1.03 1.32 1.2
positive regulation of production of molecular mediator of immune response 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
regulation of antimicrobial humoral response 39 1.26 -1.07 1.01 -1.04 1.05 1.16 1.17
antimicrobial peptide production 2 -1.54 1.11 1.81 1.12 1.7 3.17 1.43
antifungal peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
regulation of antimicrobial peptide production 34 1.45 -1.09 -1.02 -1.05 1.03 1.32 1.2
regulation of antibacterial peptide production 19 1.47 -1.12 1.02 -1.12 1.06 1.26 1.29
regulation of antifungal peptide production 7 2.0 -1.32 -1.17 1.03 1.03 1.92 1.18
peptide secretion 1 1.36 -1.09 1.47 1.03 1.67 -1.23 2.47
regulation of peptide secretion 1 1.12 1.15 1.24 1.0 1.0 1.1 -1.06
positive regulation of peptide secretion 1 1.12 1.15 1.24 1.0 1.0 1.1 -1.06
positive regulation of antifungal peptide production 1 -1.72 1.19 -1.18 1.31 1.64 3.16 1.11
regulation of antimicrobial peptide biosynthetic process 34 1.45 -1.09 -1.02 -1.05 1.03 1.32 1.2
negative regulation of antimicrobial peptide biosynthetic process 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
positive regulation of antimicrobial peptide biosynthetic process 23 1.75 -1.22 -1.09 -1.11 -1.01 1.39 1.29
regulation of antibacterial peptide biosynthetic process 19 1.47 -1.12 1.02 -1.12 1.06 1.26 1.29
negative regulation of antibacterial peptide biosynthetic process 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
regulation of antifungal peptide biosynthetic process 6 2.45 -1.42 -1.16 -1.01 -1.05 1.77 1.2
regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 7 1.96 -1.11 1.11 -1.19 1.09 1.65 1.22
negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 2 1.03 1.14 1.57 1.07 1.57 -1.03 -1.32
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria 4 1.05 -1.9 -2.24 -1.85 -1.9 -1.18 1.68
regulation of response to biotic stimulus 44 1.36 -1.07 1.05 -1.02 1.04 1.11 1.1
negative regulation of response to biotic stimulus 7 1.37 1.0 1.62 1.21 1.38 -1.12 -1.13
positive regulation of response to biotic stimulus 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
regulation of humoral immune response 39 1.26 -1.07 1.01 -1.04 1.05 1.16 1.17
negative regulation of humoral immune response 4 1.35 1.1 1.46 1.15 1.8 1.12 1.2
generation of a signal involved in cell-cell signaling 101 -1.07 1.04 1.24 1.13 1.26 1.1 1.03
regionalization 378 1.18 1.05 1.18 1.02 1.22 1.26 1.24
developmental process involved in reproduction 482 1.13 1.1 1.22 1.05 1.26 1.18 1.17
heart morphogenesis 12 1.02 -1.01 1.12 1.1 1.36 1.23 1.2
system process 634 1.08 1.03 1.09 -1.0 1.08 1.15 1.06
skeletal muscle contraction 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
voluntary skeletal muscle contraction 1 -1.18 -1.0 1.06 -1.02 -1.12 1.04 1.04
muscle system process 13 1.35 -1.07 1.09 -1.24 1.12 1.46 1.24
circulatory system process 8 1.03 1.14 -1.1 1.05 1.17 1.15 1.14
renal system process 6 -4.46 1.18 -1.92 -1.14 -3.52 -1.44 -1.93
heart process 8 1.03 1.14 -1.1 1.05 1.17 1.15 1.14
detection of carbon dioxide 2 -1.18 -1.02 1.02 -1.08 -1.1 -1.05 -1.18
negative regulation of heart induction by canonical Wnt receptor signaling pathway 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
outflow tract morphogenesis 3 -1.03 1.08 1.55 1.17 2.15 1.03 1.48
regulation of organ formation 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
endothelium development 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
Wnt receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
amino acid transmembrane transport 30 -1.61 -1.12 -1.51 -1.16 -1.02 -1.08 -1.1
epithelial cell morphogenesis 9 1.12 1.09 1.33 1.05 1.18 1.38 1.22
apical constriction 4 -1.26 1.28 1.59 1.06 1.39 1.15 1.23
cytoneme morphogenesis 2 -1.85 -1.12 1.68 1.29 1.66 1.71 -2.53
neural retina development 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
nucleic acid binding 1407 1.18 1.11 1.19 1.1 1.2 1.16 1.11
DNA binding 669 1.15 1.09 1.17 1.08 1.17 1.12 1.11
DNA helicase activity 34 1.08 1.15 1.32 1.19 1.42 1.11 1.09
AT DNA binding 5 1.49 -1.14 -1.13 1.14 1.47 1.04 1.12
bent DNA binding 2 1.7 1.14 1.37 1.1 1.36 1.18 1.22
chromatin binding 72 1.18 1.18 1.3 1.16 1.38 1.26 1.23
lamin binding 1 1.4 1.14 1.18 1.58 1.38 1.2 1.19
damaged DNA binding 15 1.32 1.12 1.34 1.15 1.3 1.19 1.11
DNA clamp loader activity 3 1.23 1.05 1.23 1.24 1.24 1.1 -1.01
double-stranded DNA binding 10 1.24 1.11 1.11 1.14 1.22 1.09 -1.07
satellite DNA binding 5 1.25 1.13 1.51 1.21 1.5 1.17 1.18
single-stranded DNA binding 13 -1.04 1.24 1.4 1.15 1.2 1.2 1.1
sequence-specific DNA binding transcription factor activity 411 1.09 1.04 1.09 1.01 1.1 1.11 1.09
transcription from RNA polymerase I promoter 6 1.31 1.13 1.31 1.22 1.28 1.23 1.04
transcription from RNA polymerase II promoter 91 1.33 1.12 1.23 1.17 1.25 1.17 1.11
copper ion transport 7 -1.13 1.18 1.31 1.05 -1.07 1.09 1.04
sequence-specific distal enhancer binding RNA polymerase II transcription factor activity 50 1.18 -1.11 -1.01 -1.13 -1.1 1.13 1.1
ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity 20 1.3 1.06 1.02 -1.03 1.08 1.23 1.26
steroid hormone receptor activity 19 1.11 1.08 1.02 -1.0 1.09 1.16 1.16
retinoic acid receptor activity 1 1.03 1.25 1.07 1.02 1.08 1.24 1.08
transcription from RNA polymerase III promoter 12 1.28 1.21 1.25 1.18 1.32 1.03 1.12
regulation of transcription elongation, DNA-dependent 18 -1.27 1.2 1.28 -1.03 -1.04 -1.12 1.41
transcription cofactor activity 90 1.26 1.11 1.26 1.16 1.34 1.25 1.15
transcription coactivator activity 41 1.32 1.06 1.24 1.13 1.34 1.33 1.18
transcription corepressor activity 19 1.19 1.16 1.26 1.18 1.37 1.12 1.16
transcription termination, DNA-dependent 2 -1.11 1.05 1.39 1.1 1.37 1.26 -1.23
termination of RNA polymerase II transcription 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
cytoplasmic sequestering of transcription factor 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
RNA binding 381 1.26 1.16 1.26 1.13 1.22 1.27 1.13
RNA helicase activity 45 1.22 1.23 1.32 1.18 1.31 1.38 1.21
double-stranded RNA binding 16 1.33 -1.04 1.19 -1.13 1.16 1.42 1.51
double-stranded RNA adenosine deaminase activity 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
single-stranded RNA binding 20 1.32 1.14 1.42 1.11 1.32 1.44 1.23
mRNA binding 170 1.24 1.17 1.28 1.15 1.25 1.26 1.16
mRNA 3'-UTR binding 17 1.34 1.14 1.46 1.02 1.31 1.89 1.29
ribonucleoprotein complex 427 1.18 1.1 1.2 1.16 1.24 1.21 -1.02
small nuclear ribonucleoprotein complex 54 1.14 1.14 1.25 1.27 1.31 1.06 -1.02
structural constituent of ribosome 167 1.21 1.04 1.14 1.12 1.17 1.28 -1.18
translation initiation factor activity 53 1.33 1.18 1.26 1.09 1.18 1.35 1.16
translation elongation factor activity 16 1.48 1.11 1.26 1.06 1.23 1.46 1.05
translation release factor activity 7 1.27 1.16 1.25 1.13 1.18 1.49 1.09
regulation of cell cycle 240 1.19 1.13 1.28 1.13 1.34 1.28 1.16
protein folding 118 1.15 1.04 1.09 1.13 1.17 1.02 1.01
peptidyl-prolyl cis-trans isomerase activity 26 1.38 1.03 1.1 1.15 1.25 1.1 1.02
protein disulfide isomerase activity 10 1.1 -1.01 1.22 1.11 1.12 1.08 1.12
chromatin assembly or disassembly 34 1.01 1.07 1.29 1.13 1.25 -1.04 1.07
nucleosome assembly 27 1.02 1.05 1.3 1.15 1.22 -1.07 1.03
nucleosome organization 36 1.09 1.07 1.28 1.16 1.21 1.01 1.03
histone binding 10 1.48 1.07 1.28 1.23 1.28 1.39 1.04
histone exchange 7 1.15 1.19 1.23 1.17 1.15 1.2 1.05
ATPase activity, coupled 283 -1.01 1.06 1.16 1.03 1.13 1.15 1.04
chaperone binding 16 -1.03 -1.17 1.06 1.16 1.34 1.16 -1.27
response to unfolded protein 2 1.04 1.38 1.16 -1.1 1.05 1.03 1.56
protein refolding 7 1.25 1.05 1.14 -1.0 1.11 -1.26 1.35
motor activity 76 -1.02 1.07 1.2 1.02 1.14 1.1 1.03
microtubule motor activity 51 1.03 1.09 1.15 1.06 1.12 1.1 1.04
axoneme 14 -1.03 1.04 1.03 1.02 -1.05 -1.01 -1.1
muscle contraction 12 1.16 -1.04 1.06 -1.18 1.13 1.33 1.25
contractile fiber 33 2.45 -1.47 -1.08 -1.25 1.2 1.97 -1.14
actin binding 114 -1.07 1.06 1.38 -1.0 1.31 1.09 1.15
protein binding, bridging 17 -1.01 1.02 1.14 1.03 1.09 1.16 1.1
actin filament binding 8 -1.01 -1.14 1.31 -1.17 1.11 1.2 1.33
actin filament bundle assembly 17 1.57 -1.02 1.24 -1.1 1.24 1.29 1.51
barbed-end actin filament capping 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
actin monomer binding 1 -3.23 -1.14 1.86 -1.09 2.26 -4.44 -1.1
actin filament depolymerization 4 -1.06 1.03 1.27 1.14 1.25 -1.37 -1.31
actin cytoskeleton organization 160 1.17 1.02 1.34 -1.03 1.29 1.3 1.17
membrane 2078 1.02 -1.01 1.0 -1.02 1.04 1.09 1.03
regulation of actin filament length 20 -1.48 1.08 1.45 1.05 1.38 -1.21 1.18
defense response 178 1.35 -1.27 -1.19 -1.18 -1.1 1.18 1.09
acute-phase response 1 1.84 1.22 1.59 1.61 1.65 1.41 1.04
lysozyme activity 14 1.98 -1.64 -2.07 -1.66 -1.61 -1.16 1.06
defense response to bacterium 84 1.33 -1.21 -1.16 -1.18 -1.05 1.15 1.15
male-specific defense response to bacterium 1 -1.1 -1.03 -1.03 -1.0 -1.23 -1.2 -1.1
defense response to fungus 28 1.68 -1.27 -1.31 -1.29 -1.25 1.08 1.24
response to virus 12 2.35 -1.64 -1.09 -1.61 1.07 1.84 1.26
serine-type endopeptidase activity 263 -2.24 -1.42 -1.67 -1.14 -1.46 -2.32 -1.65
blood coagulation 1 1.05 1.37 1.17 1.34 1.05 1.15 1.1
protein-glutamine gamma-glutamyltransferase activity 2 5.84 -1.94 -1.03 -1.59 -1.03 2.32 1.28
antigen binding 1 -1.71 -1.18 -1.3 -1.15 -1.23 -1.3 1.07
catalytic activity 3804 -1.08 -1.02 -1.07 1.01 1.04 -1.07 -1.05
alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity 1 1.32 -4.96 -6.02 -4.98 -1.62 7.64 -3.94
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity 1 3.18 1.02 1.47 1.11 1.44 4.09 2.36
beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity 1 3.39 -1.12 1.06 -1.11 1.06 1.27 -1.12
beta-alanyl-dopamine hydrolase activity 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
beta-alanyl-dopamine synthase activity 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
beta-carotene 15,15'-monooxygenase activity 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
beta-galactoside alpha-2,6-sialyltransferase activity 1 1.19 1.12 1.07 1.08 1.03 1.22 -1.05
beta-ureidopropionase activity 1 17.28 -3.07 -1.83 -2.92 -2.4 3.32 1.6
gamma-glutamylcyclotransferase activity 2 1.29 1.27 1.3 -1.14 -1.14 1.15 -1.11
gamma-glutamyltransferase activity 4 1.24 -1.34 -1.15 1.08 1.94 1.31 -1.06
1-acylglycerol-3-phosphate O-acyltransferase activity 6 -1.56 -1.19 -1.0 1.18 2.24 -2.62 -1.99
1-pyrroline-5-carboxylate dehydrogenase activity 3 1.56 -1.48 -1.15 -1.62 -1.43 2.14 1.15
1,3-beta-D-glucan synthase activity 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
1,4-alpha-glucan branching enzyme activity 1 3.55 -1.35 -1.97 1.08 1.09 1.58 1.19
1-alkyl-2-acetylglycerophosphocholine esterase activity 1 3.85 1.07 1.8 1.09 1.57 2.16 1.8
2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity 5 -4.34 1.01 1.27 1.24 1.5 -3.41 -1.26
3-beta-hydroxy-delta5-steroid dehydrogenase activity 1 7.52 -1.63 -1.52 -1.44 -1.48 2.76 1.78
3-hydroxyacyl-CoA dehydrogenase activity 4 1.05 1.0 -1.41 1.24 -1.28 1.08 1.21
3-hydroxyisobutyryl-CoA hydrolase activity 1 1.35 1.24 1.18 -1.16 -1.11 6.95 -1.22
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity 2 1.67 1.29 1.69 -1.02 1.34 1.99 1.11
3-oxo-5-alpha-steroid 4-dehydrogenase activity 1 -1.31 1.28 -1.32 1.3 1.08 -2.32 -1.18
4-aminobutyrate transaminase activity 1 -1.88 3.07 -1.92 -1.52 -1.3 -2.05 1.06
4-hydroxyphenylpyruvate dioxygenase activity 1 1.86 -1.07 1.21 1.03 1.14 1.09 -1.06
4-nitrophenylphosphatase activity 9 -1.32 1.18 -1.3 1.06 1.01 -1.31 1.07
5-aminolevulinate synthase activity 1 1.58 1.36 -1.31 -1.09 -1.26 1.25 1.23
6-phosphofructokinase activity 1 2.63 -1.22 -1.22 1.02 -1.12 5.11 1.3
6-phosphofructo-2-kinase activity 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
6-pyruvoyltetrahydropterin synthase activity 1 2.12 1.31 1.32 1.23 1.73 1.01 2.0
AMP deaminase activity 1 1.21 1.11 1.3 -1.14 1.24 3.4 1.06
ATP citrate synthase activity 4 -1.02 -1.02 -1.04 -1.09 -1.21 1.05 -1.32
protein C-terminal carboxyl O-methyltransferase activity 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity 1 2.1 -1.04 1.71 -1.1 1.9 -1.29 1.13
CDP-diacylglycerol-serine O-phosphatidyltransferase activity 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
D-amino-acid oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
DNA (cytosine-5-)-methyltransferase activity 2 1.2 1.07 1.01 1.32 1.13 -1.12 -1.02
DNA-directed DNA polymerase activity 18 1.05 1.09 1.17 1.07 1.16 1.1 -1.1
DNA primase activity 2 1.15 1.13 1.17 1.19 1.37 1.14 -1.16
DNA-directed RNA polymerase activity 28 1.31 1.12 1.19 1.24 1.24 1.06 1.0
deoxyribodipyrimidine photo-lyase activity 1 -1.34 -1.01 -1.03 1.23 1.09 -1.47 -1.1
DNA-(apurinic or apyrimidinic site) lyase activity 5 1.72 -1.0 1.07 1.11 1.19 1.32 1.0
methylated-DNA-[protein]-cysteine S-methyltransferase activity 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
DNA ligase activity 3 1.18 1.28 1.26 1.14 1.32 1.13 1.13
DNA ligase (ATP) activity 2 1.29 1.46 1.49 1.24 1.5 1.27 1.28
DNA photolyase activity 3 1.02 -1.07 -1.02 1.07 1.04 1.25 -1.04
DNA (6-4) photolyase activity 1 1.03 -1.11 1.01 -1.14 1.01 1.07 -1.17
DNA topoisomerase activity 7 1.03 1.16 1.23 1.17 1.3 1.13 1.25
DNA topoisomerase type I activity 3 -1.14 1.27 1.28 1.28 1.24 1.04 1.14
DNA topoisomerase (ATP-hydrolyzing) activity 3 -1.26 1.43 1.56 1.29 1.52 1.12 1.27
FMN adenylyltransferase activity 2 1.48 1.18 1.47 1.03 -1.01 1.23 1.07
GMP synthase activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
GMP synthase (glutamine-hydrolyzing) activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
GPI-anchor transamidase activity 1 1.21 1.1 1.8 1.25 1.66 -1.16 1.35
synaptic vesicle uncoating 2 -1.44 1.22 1.71 1.06 1.91 1.53 1.42
vesicle-mediated transport 402 1.05 1.08 1.23 1.09 1.24 1.19 1.14
protein import into nucleus 36 1.11 1.22 1.35 1.2 1.37 1.25 1.17
cytoskeleton organization 516 1.14 1.08 1.28 1.06 1.28 1.2 1.11
secretion 145 -1.04 1.05 1.22 1.11 1.24 1.07 1.07
GTP cyclohydrolase activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
GTP cyclohydrolase I activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
hydrogen ion transporting ATP synthase activity, rotational mechanism 16 1.35 -1.04 1.11 -1.09 -1.01 1.54 -1.13
IMP cyclohydrolase activity 1 -1.39 1.0 -1.49 -1.01 -1.06 1.63 -1.09
IMP dehydrogenase activity 1 1.16 1.34 1.12 1.03 1.08 -1.1 1.99
L-iditol 2-dehydrogenase activity 3 1.17 -1.39 -1.37 1.12 1.23 1.74 -1.02
L-iduronidase activity 1 -1.71 1.0 1.11 -1.04 1.62 -1.12 -1.27
N-acetylgalactosamine-4-sulfatase activity 4 1.55 -1.16 -1.4 1.09 1.42 2.61 -1.17
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity 3 -1.38 1.01 1.13 1.06 1.15 -1.4 1.08
NAD+ ADP-ribosyltransferase activity 1 -2.18 1.38 1.41 1.1 1.13 -1.47 1.05
NAD+ kinase activity 3 1.2 1.17 -1.08 1.1 1.06 -1.04 1.02
NAD+ synthase (glutamine-hydrolyzing) activity 1 2.07 1.6 1.04 1.19 1.4 2.13 1.77
NADH dehydrogenase activity 36 1.13 1.03 1.27 1.06 1.1 1.72 -1.29
NAD(P)+-protein-arginine ADP-ribosyltransferase activity 2 1.3 1.3 1.14 1.02 1.15 -1.14 1.12
NADPH-hemoprotein reductase activity 1 1.63 1.35 1.12 -1.0 1.2 -1.04 1.34
NADPH dehydrogenase activity 1 -1.51 1.45 1.08 1.06 -1.12 -1.58 -1.42
RNA-3'-phosphate cyclase activity 2 1.22 1.13 -1.15 1.27 1.07 -1.19 -1.17
RNA-directed DNA polymerase activity 1 1.54 1.82 1.92 -1.04 1.87 1.15 2.39
UDP-N-acetylglucosamine diphosphorylase activity 1 -1.57 -1.13 1.65 -1.09 1.26 -1.83 1.72
UDP-glucose 4-epimerase activity 3 -1.33 1.08 -1.17 -1.19 -1.1 -1.47 1.1
UDP-glucose:glycoprotein glucosyltransferase activity 1 1.21 1.16 1.35 -1.04 1.59 1.69 2.54
UTP:glucose-1-phosphate uridylyltransferase activity 1 1.07 -1.0 -1.14 -1.11 -1.05 -1.01 1.08
acetyl-CoA C-acetyltransferase activity 2 1.25 1.16 -1.11 1.2 -1.13 1.26 -1.35
acetate-CoA ligase activity 2 1.63 1.11 -1.36 -1.04 -1.71 1.16 1.18
acetyl-CoA C-acyltransferase activity 4 1.58 1.11 -1.25 1.12 1.08 1.06 -1.32
acetyl-CoA carboxylase activity 1 7.73 1.2 -1.41 -2.71 1.2 3.14 4.69
acetylcholinesterase activity 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
acid phosphatase activity 12 1.44 1.13 -1.05 -1.03 -1.02 1.81 1.28
aconitate hydratase activity 4 1.11 1.25 1.22 -1.14 -1.03 1.75 1.32
acyl-CoA dehydrogenase activity 15 -1.17 1.11 -1.37 1.1 1.1 -1.79 -1.3
acyl-CoA oxidase activity 6 -2.19 1.03 -1.7 1.08 1.14 -3.66 -1.47
acylphosphatase activity 6 1.57 1.0 -1.02 1.01 -1.1 1.04 -1.12
adenine phosphoribosyltransferase activity 1 1.17 1.37 1.23 1.24 1.3 1.33 -1.5
adenosine deaminase activity 8 -1.69 1.1 1.06 -1.03 -1.09 1.15 -1.16
adenosine kinase activity 4 1.16 1.08 -1.11 1.18 1.12 1.14 -1.1
ATP-dependent DNA helicase activity 19 1.12 1.17 1.33 1.14 1.3 1.15 1.17
ATP-dependent RNA helicase activity 38 1.22 1.21 1.3 1.2 1.31 1.37 1.16
cation-transporting ATPase activity 26 1.1 1.0 1.24 -1.08 1.02 1.51 -1.05
metal ion transmembrane transporter activity 144 -1.31 -1.08 -1.41 -1.18 -1.18 1.02 -1.13
copper-exporting ATPase activity 1 -2.22 1.33 3.02 1.07 -1.16 -1.12 1.08
ATPase activity, coupled to transmembrane movement of substances 120 -1.08 -1.04 1.03 -1.07 1.02 1.16 -1.05
ATP-binding cassette (ABC) transporter complex 41 1.23 -1.2 -1.24 -1.08 1.0 1.04 -1.04
phospholipid-translocating ATPase activity 6 -2.65 1.11 -1.12 1.22 1.24 -1.33 -1.09
adenosylhomocysteinase activity 3 -2.93 -1.82 -1.21 -1.07 1.22 1.86 -1.16
adenosylmethionine decarboxylase activity 1 1.82 1.07 1.08 1.22 1.03 1.75 -1.05
adenylate cyclase activity 12 1.43 1.1 1.07 -1.04 1.13 1.5 1.22
adenylate kinase activity 6 1.61 -1.18 1.01 1.04 1.05 1.04 -1.33
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity 1 1.1 1.08 1.31 1.11 1.27 1.3 1.19
adenylosuccinate synthase activity 1 2.08 1.19 1.56 -1.1 -1.15 1.56 -1.05
adenylylsulfate kinase activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
L-alanine:2-oxoglutarate aminotransferase activity 1 -2.33 1.13 1.14 1.09 1.76 1.77 -1.09
alcohol dehydrogenase (NAD) activity 5 1.66 -1.09 -1.8 -1.39 -1.21 1.37 1.27
aldehyde dehydrogenase (NAD) activity 3 -1.65 1.15 -1.65 1.05 -1.41 -1.9 -1.31
aldehyde dehydrogenase [NAD(P)+] activity 1 1.67 -1.24 -1.26 1.36 2.03 -1.43 1.25
alditol:NADP+ 1-oxidoreductase activity 6 -1.18 1.24 -1.3 -1.16 -1.25 -1.07 1.15
aldo-keto reductase (NADP) activity 7 1.25 1.15 -1.37 -1.18 -1.21 1.14 1.22
aldose 1-epimerase activity 3 -1.46 1.17 -1.47 -1.07 1.13 -1.58 -1.03
alkaline phosphatase activity 13 -5.32 -1.81 -4.2 -1.19 -1.19 -4.42 -4.05
allantoinase activity 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
amidase activity 1 1.54 -1.32 2.9 1.39 -1.83 -6.19 -2.79
amidophosphoribosyltransferase activity 2 1.11 1.02 -1.15 -1.13 -1.43 1.89 -1.09
aminoacyl-tRNA hydrolase activity 3 1.72 -1.02 1.14 1.1 1.0 1.49 -1.08
aminoacylase activity 6 -1.72 -1.86 -1.07 -1.63 1.29 -1.6 -1.71
aminomethyltransferase activity 4 1.27 1.14 1.17 1.01 -1.01 1.6 1.08
nucleoside-diphosphatase activity 3 -2.29 1.44 -2.09 1.33 -1.38 -3.32 1.1
nucleoside-triphosphatase activity 535 1.04 1.07 1.18 1.06 1.16 1.12 1.03
arginase activity 2 1.73 -1.09 1.02 -1.05 -1.18 2.27 1.17
arginine kinase activity 3 1.01 1.07 1.29 1.05 -1.11 1.23 -1.22
argininosuccinate synthase activity 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
argininosuccinate lyase activity 1 -15.39 1.51 -7.96 1.39 1.15 -4.77 -1.11
arginyltransferase activity 1 1.03 1.39 1.46 1.24 1.37 1.69 1.36
aromatic-L-amino-acid decarboxylase activity 4 2.04 -1.66 -1.74 -1.59 -1.59 1.51 1.84
aralkylamine N-acetyltransferase activity 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
arylamine N-acetyltransferase activity 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
aryl sulfotransferase activity 1 1.25 -1.11 -1.17 -1.08 -1.01 1.11 1.01
aryldialkylphosphatase activity 1 1.9 -1.44 -1.39 -2.02 1.17 21.38 -1.25
asparagine synthase (glutamine-hydrolyzing) activity 2 -1.07 1.2 1.14 1.26 1.17 1.27 -1.14
asparaginase activity 4 1.31 -1.05 -1.24 -1.15 1.04 1.97 1.03
aspartate 1-decarboxylase activity 1 1.44 -1.11 -1.15 1.16 -1.17 -1.1 -1.2
L-aspartate:2-oxoglutarate aminotransferase activity 2 1.83 1.18 -1.32 -1.0 1.19 1.57 1.14
aspartate carbamoyltransferase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
biliverdin reductase activity 1 -1.51 1.45 1.08 1.06 -1.12 -1.58 -1.42
biotin carboxylase activity 3 2.88 1.25 -1.21 -1.16 -1.0 2.26 1.91
biotin-[acetyl-CoA-carboxylase] ligase activity 1 1.43 1.46 1.44 1.24 1.28 1.18 1.38
biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity 1 1.43 1.46 1.44 1.24 1.28 1.18 1.38
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity 1 -1.85 1.12 1.37 1.12 1.23 -1.02 1.02
branched-chain-amino-acid transaminase activity 1 5.21 1.63 1.44 -1.45 -2.46 1.42 2.6
carbamoyl-phosphate synthase (ammonia) activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbonate dehydratase activity 17 -1.34 -1.07 1.2 -1.25 1.01 1.12 1.01
carbonyl reductase (NADPH) activity 3 1.57 1.0 -1.52 -1.25 -1.09 1.43 1.09
carboxylesterase activity 33 -1.1 1.01 -1.29 -1.03 -1.13 -1.36 -1.13
carnitine O-acetyltransferase activity 3 -1.35 1.07 -1.21 1.11 1.17 -1.19 -1.2
carnitine O-palmitoyltransferase activity 1 1.55 1.41 -1.09 1.13 1.34 -1.06 1.05
catalase activity 3 1.88 -1.66 -2.02 -1.59 -1.55 2.15 -1.21
catechol oxidase activity 1 1.73 1.33 1.02 1.13 -1.06 -1.05 1.06
chitin deacetylase activity 2 2.14 -1.13 1.05 -1.06 -1.29 -1.18 -1.25
chitin synthase activity 2 -4.74 1.25 1.37 -1.3 1.38 1.09 1.15
choline O-acetyltransferase activity 1 1.49 -1.03 -1.23 1.03 1.04 -1.13 1.06
choline kinase activity 2 1.11 1.13 1.36 1.19 1.43 2.57 1.13
cholinesterase activity 2 -1.12 1.28 -2.63 -1.13 -1.28 -3.75 2.43
choline-phosphate cytidylyltransferase activity 2 1.06 -1.23 1.07 1.02 1.15 -1.4 1.55
citrate (Si)-synthase activity 1 -1.05 1.1 -1.11 1.07 -1.23 -1.06 -1.08
coproporphyrinogen oxidase activity 1 -1.38 1.31 1.39 1.26 1.22 -1.88 -1.39
cyclic-nucleotide phosphodiesterase activity 8 1.68 1.07 1.28 1.01 1.26 2.25 1.48
3',5'-cyclic-nucleotide phosphodiesterase activity 8 1.68 1.07 1.28 1.01 1.26 2.25 1.48
3',5'-cyclic-AMP phosphodiesterase activity 4 1.06 1.26 1.31 1.05 1.3 1.79 1.4
calmodulin-dependent cyclic-nucleotide phosphodiesterase activity 1 -1.09 -1.0 1.07 1.3 -1.04 -1.15 -1.07
cystathionine beta-synthase activity 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
cystathionine gamma-lyase activity 2 1.42 1.32 1.04 1.04 1.07 -1.09 1.37
cytidine deaminase activity 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
cytidylate kinase activity 1 -1.35 1.03 1.12 1.16 1.1 -1.2 -1.23
cytochrome-b5 reductase activity 1 -1.1 1.03 -1.07 1.37 1.05 -1.32 1.01
cytochrome-c oxidase activity 18 -1.12 -1.08 1.07 -1.07 1.03 1.19 -1.31
cytosine deaminase activity 1 1.58 1.21 -1.04 1.33 -1.0 -1.93 1.34
dCMP deaminase activity 1 2.54 -1.17 -1.05 1.35 1.96 1.77 -1.1
glycogen debranching enzyme activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
4-alpha-glucanotransferase activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
amylo-alpha-1,6-glucosidase activity 1 1.91 -1.57 -1.98 1.36 -1.16 2.47 1.07
deoxyribose-phosphate aldolase activity 1 -1.52 1.52 -1.38 1.37 -1.06 -2.8 1.21
dephospho-CoA kinase activity 2 1.04 1.25 -1.2 1.45 1.19 -1.52 -1.32
diacylglycerol cholinephosphotransferase activity 1 -3.65 1.65 3.17 1.08 1.15 -2.09 2.51
diacylglycerol kinase activity 8 1.65 1.05 -1.03 -1.02 -1.04 1.17 1.24
diacylglycerol O-acyltransferase activity 1 -1.05 1.33 3.49 1.16 1.98 2.09 1.25
dihydrofolate reductase activity 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
dihydrolipoamide branched chain acyltransferase activity 1 1.74 1.44 1.67 1.01 1.35 1.38 1.19
dihydrolipoyl dehydrogenase activity 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
dihydrolipoyllysine-residue succinyltransferase activity 1 1.27 -1.02 1.79 -1.24 1.05 3.95 -1.37
dihydroorotase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
dihydroorotate dehydrogenase activity 2 -1.09 1.44 1.03 1.31 -1.02 -1.29 -1.1
6,7-dihydropteridine reductase activity 1 2.26 1.17 1.35 1.12 1.23 1.64 1.14
dihydropyrimidinase activity 1 -1.0 1.2 1.11 1.02 1.13 1.01 1.16
dihydroorotate oxidase activity 2 -1.09 1.44 1.03 1.31 -1.02 -1.29 -1.1
dihydrouracil dehydrogenase (NAD+) activity 1 -2.4 1.52 -1.09 1.53 -1.18 -2.54 -1.54
dimethylallyltranstransferase activity 2 2.38 1.13 2.21 -1.02 1.58 1.4 1.7
diphosphomevalonate decarboxylase activity 1 2.36 -1.19 -1.1 1.02 -1.17 1.09 1.24
diphthine synthase activity 1 1.75 1.22 1.1 1.3 1.08 -1.18 -1.03
dodecenoyl-CoA delta-isomerase activity 5 1.65 1.02 -1.16 1.25 1.08 1.17 -1.36
dopachrome isomerase activity 2 2.9 -1.22 -1.25 -1.08 -1.28 3.34 -1.14
dolichol kinase activity 1 -2.66 1.27 -1.76 1.39 1.67 -4.72 -1.84
dolichyl-phosphate-mannose-protein mannosyltransferase activity 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
dUTP diphosphatase activity 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
peptidyl-lysine modification to hypusine 2 1.15 1.07 1.04 1.07 1.11 1.08 -1.05
deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase 1 -1.3 1.12 1.08 1.3 1.03 -1.14 -1.27
ecdysteroid UDP-glucosyltransferase activity 2 -2.06 1.41 -1.15 1.08 1.07 -2.31 -1.09
electron-transferring-flavoprotein dehydrogenase activity 1 2.09 1.59 -1.41 1.19 1.36 1.02 -1.19
endopeptidase activity 433 -1.75 -1.28 -1.35 -1.08 -1.23 -1.79 -1.45
ATP-dependent peptidase activity 3 -1.2 1.29 1.23 1.11 1.07 1.26 1.04
aminopeptidase activity 36 -2.28 -1.12 -1.52 1.05 1.14 -1.43 -1.98
metalloexopeptidase activity 41 -2.37 -1.56 -1.46 1.02 -1.31 -2.4 -1.85
carboxypeptidase activity 35 -2.91 -1.85 -1.55 -1.01 -1.63 -3.14 -1.86
metallocarboxypeptidase activity 24 -4.15 -2.21 -1.86 -1.01 -1.57 -4.07 -2.61
serine-type carboxypeptidase activity 11 -1.26 -1.29 -1.05 -1.03 -1.8 -1.77 1.1
aspartic-type endopeptidase activity 19 -1.6 -1.03 1.15 -1.16 -1.46 -1.86 -1.32
calcium-dependent cysteine-type endopeptidase activity 4 2.12 1.16 1.44 1.14 1.21 1.24 1.16
apoptotic process 69 1.05 1.06 1.22 1.08 1.24 -1.05 1.11
lysosome 28 -2.58 -1.1 -2.35 1.15 -1.08 -2.06 -3.03
cysteine-type peptidase activity 43 -1.18 -1.07 1.14 -1.01 1.29 -1.03 -1.06
dipeptidyl-peptidase activity 13 -1.05 1.04 -1.41 1.07 1.08 -1.08 1.15
pyroglutamyl-peptidase activity 2 2.37 -1.16 1.04 -1.04 1.14 1.57 1.04
ubiquitin thiolesterase activity 27 1.19 1.22 1.57 1.17 1.42 1.39 1.24
metalloendopeptidase activity 79 -1.34 -1.11 -1.09 1.01 1.06 -1.1 -1.21
dipeptidase activity 7 -1.14 -1.08 -1.07 1.19 1.09 -1.2 -1.2
mitochondrion 480 1.05 1.07 1.13 1.06 1.11 1.38 -1.19
metallopeptidase activity 153 -1.78 -1.24 -1.3 1.02 -1.0 -1.44 -1.51
peptidyl-dipeptidase activity 6 -1.43 -1.17 -1.51 -1.07 1.03 1.0 -1.19
vacuole 54 -2.1 -1.04 -1.32 -1.01 -1.13 -1.28 -1.9
serine-type peptidase activity 288 -2.24 -1.4 -1.61 -1.12 -1.45 -2.28 -1.59
tripeptidyl-peptidase activity 2 -2.48 1.24 -1.3 1.26 1.28 -1.53 -1.15
threonine-type endopeptidase activity 23 1.34 -1.02 1.1 1.11 1.12 -1.15 -1.1
peptidase activity 576 -1.77 -1.28 -1.36 -1.05 -1.15 -1.74 -1.45
enoyl-CoA hydratase activity 5 1.01 1.21 -1.01 1.14 1.18 -1.41 -1.2
epoxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
estradiol 17-beta-dehydrogenase activity 2 1.13 -1.01 -1.43 1.15 1.17 -1.17 -1.46
ethanolamine kinase activity 2 1.11 1.13 1.36 1.19 1.43 2.57 1.13
ethanolamine-phosphate cytidylyltransferase activity 1 1.81 -1.85 1.07 -1.42 1.03 1.7 2.82
ethanolaminephosphotransferase activity 1 -1.35 1.28 1.66 1.08 1.2 1.32 1.18
farnesyltranstransferase activity 2 1.07 1.18 1.54 1.21 1.32 1.31 -1.04
fatty acid synthase activity 8 1.58 -1.38 -1.32 -1.5 -1.29 1.18 1.72
[acyl-carrier-protein] S-acetyltransferase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
[acyl-carrier-protein] S-malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
3-oxoacyl-[acyl-carrier-protein] synthase activity 3 2.25 -1.02 -1.08 -1.11 1.15 1.9 1.44
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
oleoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
fatty-acyl-CoA synthase activity 1 2.47 -1.2 -1.84 1.79 2.31 -2.71 -1.43
ferroxidase activity 3 -1.88 -2.6 -2.43 -2.04 1.07 -1.41 2.03
iron ion transmembrane transporter activity 7 1.31 -1.87 -2.05 -1.74 -1.19 1.52 1.79
ferredoxin-NADP+ reductase activity 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
tetrahydrofolylpolyglutamate synthase activity 2 -1.63 1.22 -1.26 1.27 -1.21 -1.7 -1.32
S-(hydroxymethyl)glutathione dehydrogenase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
formate-tetrahydrofolate ligase activity 1 -2.72 1.36 -1.4 1.55 -1.7 -1.17 -2.58
fructose-2,6-bisphosphate 2-phosphatase activity 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fructose-bisphosphate aldolase activity 1 1.83 1.08 -1.27 -1.04 1.23 2.05 1.42
fumarate hydratase activity 4 -1.03 1.03 -1.06 -1.09 -1.22 1.2 -1.26
fumarylacetoacetase activity 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
geranyltranstransferase activity 2 2.38 1.13 2.21 -1.02 1.58 1.4 1.7
glucosamine-6-phosphate deaminase activity 1 -1.22 1.14 1.64 1.24 2.02 -2.96 -2.72
glucosamine 6-phosphate N-acetyltransferase activity 1 1.02 1.09 -1.02 1.16 1.08 -1.06 2.5
glucose dehydrogenase activity 4 2.07 -1.33 -1.32 -1.38 -1.39 2.15 -1.49
glucose-6-phosphate dehydrogenase activity 2 1.97 -1.14 -2.0 -1.18 -1.53 1.18 1.65
glucose-6-phosphatase activity 1 1.02 1.09 1.02 1.0 -1.15 -1.1 -1.14
glucose-6-phosphate isomerase activity 1 4.0 1.26 -2.38 -1.3 -1.5 3.87 2.36
glucosylceramidase activity 3 -3.7 -1.06 -2.39 1.57 -1.6 -3.65 -2.05
glutamate 5-kinase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
glutamate-5-semialdehyde dehydrogenase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
glutamate decarboxylase activity 2 1.13 -1.03 -1.11 1.07 -1.17 -1.16 -1.18
glutamate dehydrogenase (NAD+) activity 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
glutamate dehydrogenase [NAD(P)+] activity 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
glutamate synthase (NADPH) activity 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
glutamate-ammonia ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
glutamate-cysteine ligase activity 2 -1.84 1.49 -1.21 1.04 -1.06 1.03 1.54
glutamine-fructose-6-phosphate transaminase (isomerizing) activity 2 -1.0 -1.44 1.48 -1.44 1.38 1.11 2.78
glutaryl-CoA dehydrogenase activity 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
glutathione-disulfide reductase activity 1 -1.86 1.42 -1.95 1.12 1.15 -1.81 1.13
glutathione synthase activity 1 -4.56 1.3 -1.17 1.44 -1.72 -2.63 -1.17
glutathione transferase activity 36 -1.24 1.1 1.04 -1.09 -1.01 -1.48 -1.09
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity 3 1.41 -1.11 -1.14 -1.08 -1.06 1.76 1.01
glycerol-3-phosphate O-acyltransferase activity 2 3.16 -1.05 -1.54 1.04 2.3 -1.34 1.05
glycerol-3-phosphate dehydrogenase [NAD+] activity 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
glycerol-3-phosphate dehydrogenase activity 5 -1.02 -1.05 1.01 1.08 1.13 1.19 -1.09
glycerol kinase activity 5 1.42 -1.01 1.08 1.36 1.35 1.01 -1.3
glycine hydroxymethyltransferase activity 1 4.17 -1.15 1.23 1.12 1.08 1.16 -1.19
glycogen (starch) synthase activity 1 3.34 -1.14 1.48 -1.05 1.39 2.94 1.3
glycine decarboxylation via glycine cleavage system 1 1.73 -1.01 1.7 -1.04 1.38 3.31 -1.03
glycine dehydrogenase (decarboxylating) activity 1 -1.37 -1.08 -1.16 -1.21 -1.14 1.68 -1.06
glycolipid mannosyltransferase activity 1 -1.85 1.22 -1.04 1.31 1.1 -2.17 1.06
glycylpeptide N-tetradecanoyltransferase activity 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
guanosine-diphosphatase activity 1 -1.51 1.28 -1.3 1.09 -1.1 -3.57 1.37
guanylate cyclase activity 13 -1.19 -1.02 -1.04 1.02 -1.07 -1.19 -1.11
guanylate kinase activity 5 3.22 1.04 1.21 -1.15 1.05 2.62 1.29
receptor binding 174 1.06 -1.15 -1.03 -1.09 1.07 1.13 1.05
cell adhesion 161 1.22 -1.06 1.07 -1.06 1.21 1.38 1.25
integral to membrane 1123 -1.03 -1.03 -1.04 -1.04 -1.01 1.02 -1.0
cell adhesion molecule binding 17 -1.29 -1.01 1.2 -1.06 1.34 -1.06 1.2
helicase activity 105 1.14 1.19 1.33 1.17 1.34 1.27 1.17
heme oxygenase (decyclizing) activity 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
heparan sulfate 2-O-sulfotransferase activity 2 2.25 1.13 1.26 1.01 1.22 1.54 1.62
hexaprenyldihydroxybenzoate methyltransferase activity 1 -1.1 1.09 1.22 1.29 1.3 1.24 -1.16
hexokinase activity 4 -1.31 1.0 -1.96 1.11 1.37 1.21 -1.77
histidine decarboxylase activity 1 1.05 1.13 1.16 1.21 1.16 1.14 1.09
histone acetyltransferase activity 13 1.18 1.17 1.35 1.18 1.29 1.36 1.21
histone deacetylase activity 8 1.29 1.14 1.07 1.21 1.24 1.41 1.17
holocytochrome-c synthase activity 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
homogentisate 1,2-dioxygenase activity 1 -1.11 -1.1 -1.19 1.12 -1.15 -1.2 -1.15
hyalurononglucosaminidase activity 1 1.16 1.5 1.47 1.26 1.67 1.16 1.31
hydroxyacylglutathione hydrolase activity 1 -2.43 1.25 -1.81 1.44 1.13 -2.07 -1.36
hydroxymethylbilane synthase activity 1 -1.1 1.02 -1.19 -1.23 -1.41 1.01 -1.14
hydroxymethylglutaryl-CoA lyase activity 1 -1.23 1.82 1.48 1.33 1.52 1.63 1.08
hydroxymethylglutaryl-CoA synthase activity 1 1.84 -1.29 1.3 -1.14 1.76 1.59 1.19
iduronate-2-sulfatase activity 1 1.62 1.05 1.28 1.01 1.11 1.28 1.12
inorganic diphosphatase activity 3 1.21 -1.0 1.05 1.15 1.08 1.12 -1.14
phosphatidylinositol phosphate kinase activity 6 -1.3 1.22 1.48 1.12 1.58 1.08 1.01
phosphatidylinositol kinase activity 5 -1.09 1.17 1.62 1.11 1.75 1.32 1.12
phosphatidylinositol bisphosphate kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
1-phosphatidylinositol 4-kinase activity 2 1.44 1.21 1.76 1.02 1.71 2.28 1.63
1-phosphatidylinositol-4-phosphate 5-kinase activity 3 -1.16 1.29 1.43 1.06 1.4 1.27 1.16
phosphatidylinositol phospholipase C activity 2 2.58 1.12 1.89 -1.08 1.02 1.84 1.76
phosphatidylinositol bisphosphate phosphatase activity 3 1.28 1.18 1.39 1.05 1.29 1.32 1.32
phosphatidylinositol trisphosphate phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
phosphatidylinositol monophosphate phosphatase activity 2 -1.31 1.16 1.29 1.21 -1.01 1.04 -1.19
inositol phosphate phosphatase activity 13 1.85 -1.04 -1.08 -1.1 1.15 1.89 1.3
phosphatidylinositol-3-phosphatase activity 1 -1.51 1.05 1.08 1.24 -1.11 -1.13 -1.35
inositol-1,4-bisphosphate 1-phosphatase activity 1 3.45 -1.15 1.32 1.0 -1.07 1.6 -1.16
phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity 1 -1.07 1.22 1.09 1.37 -1.04 -1.17 -1.02
inositol trisphosphate phosphatase activity 6 1.66 1.07 1.37 -1.03 1.33 2.5 1.26
inositol-polyphosphate 5-phosphatase activity 3 1.23 1.22 1.55 1.08 1.34 1.47 1.38
isocitrate dehydrogenase activity 7 1.09 1.14 1.28 -1.23 1.01 1.93 1.09
isocitrate dehydrogenase (NAD+) activity 6 1.03 1.08 1.46 -1.19 1.02 2.18 1.06
isocitrate dehydrogenase (NADP+) activity 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
isopentenyl-diphosphate delta-isomerase activity 1 3.32 -1.02 1.27 1.26 1.27 1.92 1.53
juvenile-hormone esterase activity 1 1.2 -1.02 -1.01 -1.01 1.01 -1.01 -1.05
ketohexokinase activity 4 1.16 1.19 1.03 1.01 1.17 1.1 -1.01
lactate dehydrogenase activity 2 1.05 1.2 1.7 -1.34 -1.08 -2.44 1.33
L-lactate dehydrogenase activity 2 1.05 1.2 1.7 -1.34 -1.08 -2.44 1.33
lactoylglutathione lyase activity 1 -1.59 1.09 -1.01 1.22 -1.05 -1.39 -1.43
leukotriene-A4 hydrolase activity 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
lipoprotein lipase activity 5 -2.69 -1.1 -1.42 1.06 1.23 -1.76 -1.32
long-chain-acyl-CoA dehydrogenase activity 2 1.45 1.45 -1.3 -1.02 1.11 1.33 -1.15
long-chain fatty acid-CoA ligase activity 7 1.81 -1.3 -1.35 1.09 1.2 -1.91 -1.26
lysine N-acetyltransferase activity 1 1.11 1.34 1.12 1.23 1.07 1.27 1.32
malic enzyme activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
mannose-1-phosphate guanylyltransferase activity 2 -2.09 1.14 1.2 1.25 1.24 -1.89 1.17
mannose-6-phosphate isomerase activity 2 3.41 1.03 1.33 -1.05 -1.02 3.9 1.9
methenyltetrahydrofolate cyclohydrolase activity 2 1.63 -1.3 -1.28 -1.04 -1.47 2.82 -1.53
methionine adenosyltransferase activity 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
methionyl-tRNA formyltransferase activity 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
mRNA (guanine-N7-)-methyltransferase activity 1 1.22 1.12 1.34 1.19 1.11 -1.08 1.0
mRNA guanylyltransferase activity 1 1.69 1.28 1.3 1.3 1.17 1.5 1.34
methylcrotonoyl-CoA carboxylase activity 2 1.38 1.49 1.32 1.28 1.37 1.61 1.17
methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity 1 2.55 -3.49 -3.06 -4.0 -1.9 6.63 -1.86
methylenetetrahydrofolate dehydrogenase (NAD+) activity 1 7.21 -2.31 -1.17 -1.68 -1.27 9.3 1.1
methylenetetrahydrofolate dehydrogenase (NADP+) activity 2 1.63 -1.3 -1.28 -1.04 -1.47 2.82 -1.53
methylenetetrahydrofolate reductase (NADPH) activity 1 1.73 -1.17 -1.14 -1.13 -1.11 2.12 -1.29
methylmalonate-semialdehyde dehydrogenase (acylating) activity 1 -1.74 1.44 -1.08 -1.1 -1.07 1.5 1.28
mevalonate kinase activity 1 1.42 1.16 1.14 1.22 1.05 1.2 -1.02
monooxygenase activity 35 1.52 -1.2 -1.23 -1.13 -1.16 -1.04 1.06
N,N-dimethylaniline monooxygenase activity 2 1.33 1.51 -1.79 -1.37 -1.35 1.43 1.59
dopamine beta-monooxygenase activity 3 1.25 1.07 -1.02 -1.01 1.04 1.12 1.05
ecdysone 20-monooxygenase activity 1 -1.22 -1.23 1.13 -1.06 1.31 -1.16 -1.34
kynurenine 3-monooxygenase activity 1 1.05 1.0 -1.01 1.01 -1.05 -1.09 -1.05
monophenol monooxygenase activity 3 1.29 1.11 -1.09 -1.0 -1.13 -1.11 -1.01
peptidylglycine monooxygenase activity 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
phenylalanine 4-monooxygenase activity 2 1.24 -1.3 -1.46 -1.42 -1.18 2.11 -1.36
tryptophan 5-monooxygenase activity 2 1.24 -1.3 -1.46 -1.42 -1.18 2.11 -1.36
tyrosine 3-monooxygenase activity 1 -1.05 -1.1 1.05 1.12 -1.1 -1.1 1.78
inositol-3-phosphate synthase activity 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
nicotinate-nucleotide diphosphorylase (carboxylating) activity 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinate phosphoribosyltransferase activity 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nitric-oxide synthase activity 1 1.08 1.06 1.02 1.1 1.05 -1.07 -1.02
nuclease activity 79 1.35 1.08 1.23 1.13 1.28 1.26 1.07
endonuclease activity 38 1.44 1.02 1.21 1.09 1.25 1.3 1.05
endodeoxyribonuclease activity 15 1.39 -1.02 1.1 -1.02 1.11 1.13 1.04
endoribonuclease activity 19 1.25 1.08 1.3 1.22 1.37 1.23 -1.0
ribonuclease H activity 2 -1.13 1.13 1.07 1.39 1.3 -1.08 -1.14
ribonuclease III activity 4 1.01 1.12 1.7 -1.0 1.33 1.5 1.2
ribonuclease P activity 3 1.41 -1.04 -1.03 1.27 1.1 1.0 -1.33
exonuclease activity 33 1.16 1.17 1.21 1.21 1.29 1.11 1.04
exodeoxyribonuclease activity 7 -1.09 1.11 1.04 1.05 1.14 -1.05 -1.01
deoxyribonuclease II activity 1 3.57 -3.74 -3.12 -4.14 -2.27 -1.33 4.32
exoribonuclease activity 18 1.38 1.17 1.2 1.26 1.28 1.2 1.08
5'-3' exoribonuclease activity 2 -1.11 1.53 1.16 1.33 1.34 -1.11 1.19
poly(A)-specific ribonuclease activity 2 1.33 1.15 1.69 1.2 1.62 2.01 1.48
deoxyribonuclease activity 24 1.28 1.02 1.14 1.01 1.16 1.13 1.07
ribonuclease activity 41 1.37 1.11 1.23 1.22 1.32 1.27 1.04
tRNA-specific ribonuclease activity 4 1.4 1.02 -1.04 1.26 1.1 -1.04 -1.24
nucleoside diphosphate kinase activity 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
nucleotide diphosphatase activity 2 1.11 1.19 1.38 1.17 1.36 1.15 -1.0
octanol dehydrogenase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
hydrolase activity, hydrolyzing O-glycosyl compounds 93 -1.83 -1.29 -2.4 -1.22 -1.47 -1.78 -1.26
alpha,alpha-trehalase activity 3 -2.73 1.23 -2.68 1.17 -1.22 -2.41 1.01
alpha-amylase activity 2 -34.84 -2.22 -3.89 2.13 -10.58 -52.06 -2.46
alpha-galactosidase activity 1 -4.17 1.11 -1.19 -1.11 -1.3 -2.49 3.87
alpha-glucosidase activity 13 -7.82 -1.11 -3.92 1.01 -2.19 -4.92 -2.34
alpha-mannosidase activity 9 -14.64 -1.14 -7.39 1.54 -1.15 -14.33 -25.61
alpha-L-fucosidase activity 1 -1.1 -1.19 -1.53 -1.9 -1.86 -1.28 7.99
alpha-N-acetylglucosaminidase activity 1 -1.03 -1.29 -2.28 -2.21 -1.93 20.24 3.19
beta-N-acetylhexosaminidase activity 4 2.6 -1.04 -1.38 1.02 1.14 -1.03 1.23
beta-galactosidase activity 2 -4.22 1.94 -2.65 -1.31 -2.65 -1.75 -2.68
beta-glucuronidase activity 2 -2.98 1.22 1.8 1.28 1.95 -1.65 1.15
beta-mannosidase activity 1 -5.95 1.18 1.25 1.37 1.4 -3.3 -1.02
chitinase activity 17 -1.5 -2.2 -3.34 -2.35 -1.62 1.11 2.06
mannosyl-oligosaccharide 1,2-alpha-mannosidase activity 5 1.56 1.24 -1.27 -1.11 -1.07 2.0 1.29
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity 2 2.21 -1.18 -1.12 1.09 -1.0 4.22 1.53
mannosyl-oligosaccharide glucosidase activity 1 1.11 1.54 -1.06 1.25 1.09 -1.47 1.06
oligo-1,6-glucosidase activity 1 -7.77 -4.97 -3.61 4.46 -5.62 -8.7 -6.61
oligosaccharyl transferase activity 5 -1.28 1.21 1.16 1.14 1.2 -1.13 1.35
dolichyl-diphosphooligosaccharide-protein glycotransferase activity 2 -2.3 1.16 -1.02 1.14 1.1 -1.42 1.33
dolichyl-phosphate beta-glucosyltransferase activity 1 -1.18 1.16 1.9 1.06 1.5 -1.14 1.68
dolichyl-phosphate beta-D-mannosyltransferase activity 1 1.01 1.25 1.35 1.09 1.77 -1.32 1.33
ornithine decarboxylase activity 2 -1.3 -1.56 -1.58 -1.19 -1.51 1.68 -1.8
ornithine-oxo-acid transaminase activity 2 -3.39 1.33 -4.62 1.16 1.17 -3.49 1.2
orotate phosphoribosyltransferase activity 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
orotidine-5'-phosphate decarboxylase activity 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
oxoglutarate dehydrogenase (succinyl-transferring) activity 2 -2.58 1.25 1.08 -1.04 1.34 -1.08 -1.45
pantothenate kinase activity 1 2.17 1.37 -1.41 1.23 1.4 -1.72 1.12
pantetheine-phosphate adenylyltransferase activity 1 -1.07 1.17 -1.47 1.46 1.3 -2.5 -1.32
peptide alpha-N-acetyltransferase activity 2 -1.32 1.41 1.74 1.19 1.16 -1.05 -1.05
peptide-aspartate beta-dioxygenase activity 1 1.22 -1.0 1.11 -1.0 1.04 1.19 -1.11
cyclosporin A binding 1 -1.56 1.12 -1.6 -1.09 -1.49 -1.56 -1.26
peroxidase activity 22 -1.07 -1.02 -1.12 -1.17 -1.19 -1.23 1.01
glutathione peroxidase activity 8 -1.36 1.09 -1.0 -1.35 -1.25 -2.14 1.1
phosphatidate cytidylyltransferase activity 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
phosphatidylserine decarboxylase activity 1 2.68 -1.15 1.36 1.05 1.26 2.6 1.26
phosphoacetylglucosamine mutase activity 1 -2.86 1.51 1.12 1.09 1.09 -5.18 1.1
phosphoenolpyruvate carboxykinase activity 2 -2.6 -1.77 1.37 -1.78 2.07 1.05 -1.67
phosphoenolpyruvate carboxykinase (GTP) activity 2 -2.6 -1.77 1.37 -1.78 2.07 1.05 -1.67
phosphoglucomutase activity 1 3.54 -1.2 -2.31 -1.28 -1.28 4.52 1.34
phosphomannomutase activity 3 -1.23 -1.01 1.33 1.13 1.42 -1.37 1.13
phosphogluconate dehydrogenase (decarboxylating) activity 4 1.7 1.24 -1.62 -1.03 -1.05 1.36 1.59
phosphoglycerate dehydrogenase activity 2 2.82 -1.08 -1.11 1.42 -1.05 1.77 -1.02
phosphoglycerate kinase activity 2 1.52 -1.04 -1.22 1.01 -1.05 1.8 -1.0
phosphoglycerate mutase activity 4 1.53 -1.02 -1.23 -1.07 -1.15 1.51 1.11
phospholipase activity 42 -2.02 -1.32 -1.4 -1.24 -1.44 -1.94 -1.19
lysophospholipase activity 5 -1.5 -1.08 -1.31 -1.5 -1.48 1.02 1.77
phospholipase A2 activity 10 1.72 -1.05 -1.16 -1.1 -1.05 -1.02 1.07
extracellular region 527 -1.12 -1.32 -1.37 -1.26 -1.26 -1.16 1.03
calcium-dependent phospholipase A2 activity 1 -1.04 -1.03 -1.01 -1.13 -1.15 1.09 -1.0
cytosol 213 1.26 1.07 1.15 1.06 1.18 1.2 1.04
calcium-independent phospholipase A2 activity 2 1.71 1.33 1.36 1.12 1.41 1.4 1.33
phospholipase C activity 8 1.4 1.12 1.15 -1.01 -1.08 1.08 1.32
phosphomevalonate kinase activity 1 2.16 -1.1 1.03 -1.13 1.06 2.2 1.18
phosphopantothenate--cysteine ligase activity 1 -1.95 1.39 1.68 1.01 1.49 -1.24 1.08
phosphopantothenoylcysteine decarboxylase activity 1 3.72 -1.03 1.39 1.15 1.52 2.47 1.16
phosphopyruvate hydratase activity 1 1.97 1.06 -1.39 -1.17 -1.32 2.59 1.17
phosphoribosylamine-glycine ligase activity 1 1.35 1.17 1.22 1.29 1.23 1.38 1.07
phosphoribosylaminoimidazole carboxylase activity 2 -1.17 -1.46 -1.46 -1.15 -1.17 1.65 -1.07
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity 2 -1.17 -1.46 -1.46 -1.15 -1.17 1.65 -1.07
phosphoribosylformylglycinamidine cyclo-ligase activity 1 1.35 1.17 1.22 1.29 1.23 1.38 1.07
phosphoribosylformylglycinamidine synthase activity 1 -1.91 1.54 -1.81 1.0 -1.5 -1.22 1.08
phosphoribosylaminoimidazolecarboxamide formyltransferase activity 1 -1.39 1.0 -1.49 -1.01 -1.06 1.63 -1.09
phosphoribosylglycinamide formyltransferase activity 1 1.35 1.17 1.22 1.29 1.23 1.38 1.07
phosphorylase activity 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
phosphoserine phosphatase activity 1 2.48 1.99 -2.53 -1.16 1.91 2.86 1.87
O-phospho-L-serine:2-oxoglutarate aminotransferase activity 1 2.63 -1.02 -1.9 1.11 -1.04 2.51 1.93
poly(ADP-ribose) glycohydrolase activity 1 1.16 1.03 1.19 1.34 1.67 -1.1 1.01
polynucleotide 5'-phosphatase activity 1 1.69 1.28 1.3 1.3 1.17 1.5 1.34
polynucleotide adenylyltransferase activity 6 1.11 1.12 1.2 1.08 1.07 1.17 1.11
polypeptide N-acetylgalactosaminyltransferase activity 14 -1.29 -1.23 -1.25 -1.28 -1.26 -1.61 1.75
polyribonucleotide nucleotidyltransferase activity 1 -1.12 1.21 1.17 1.13 1.3 1.14 -1.02
porphobilinogen synthase activity 1 -2.33 1.65 -1.72 1.07 -2.09 -1.28 -1.14
iron ion transport 7 1.59 -1.3 -1.22 -1.23 -1.14 1.5 1.12
procollagen-proline 4-dioxygenase activity 26 -1.01 -1.0 -1.08 -1.01 -1.13 -1.04 -1.05
proline dehydrogenase activity 1 2.07 -7.1 -4.47 -7.74 -3.15 31.25 -1.33
propionyl-CoA carboxylase activity 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
prenyltransferase activity 12 -1.12 1.14 1.32 1.1 1.21 -1.16 1.28
protein farnesyltransferase activity 1 -1.83 -1.28 -1.22 1.05 -1.01 -1.04 2.75
protein geranylgeranyltransferase activity 6 -1.57 1.19 1.22 1.14 1.21 -1.62 1.21
CAAX-protein geranylgeranyltransferase activity 2 -2.28 1.15 1.11 1.06 1.05 -2.22 1.78
Rab geranylgeranyltransferase activity 4 -1.3 1.2 1.28 1.18 1.3 -1.38 -1.0
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
protein kinase activity 255 1.18 1.11 1.27 1.06 1.27 1.34 1.17
protein histidine kinase activity 3 1.12 -1.13 1.03 -1.08 1.69 1.52 -1.14
protein serine/threonine kinase activity 183 1.12 1.13 1.33 1.08 1.3 1.3 1.15
transmembrane receptor protein serine/threonine kinase activity 5 -1.03 1.52 1.48 1.18 1.61 1.07 1.49
DNA-dependent protein kinase activity 1 1.33 1.54 1.93 1.1 1.72 1.13 1.74
AMP-activated protein kinase activity 3 1.06 1.32 1.11 1.03 -1.06 1.31 1.11
calmodulin-dependent protein kinase activity 8 2.03 1.07 1.21 1.02 1.3 2.02 1.5
elongation factor-2 kinase activity 2 1.62 1.17 1.62 -1.04 1.48 1.47 1.77
myosin light chain kinase activity 4 1.66 -1.14 1.36 -1.04 1.61 1.38 1.02
phosphorylase kinase activity 1 1.92 1.23 1.07 1.1 1.35 3.19 1.58
cyclic nucleotide-dependent protein kinase activity 6 -1.04 -1.05 1.23 -1.15 1.2 2.46 1.34
cAMP-dependent protein kinase activity 3 1.72 -1.04 1.4 -1.32 1.33 4.14 1.26
cGMP-dependent protein kinase activity 3 -1.85 -1.05 1.07 1.01 1.09 1.46 1.42
cyclin-dependent protein kinase activity 15 1.14 1.12 1.32 1.15 1.42 1.04 -1.02
protein kinase C activity 7 1.66 -1.04 1.77 -1.14 1.06 2.51 1.12
calcium-dependent protein kinase C activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
receptor signaling protein serine/threonine kinase activity 31 -1.19 1.17 1.44 1.1 1.38 1.04 1.15
G-protein coupled receptor kinase activity 3 1.16 1.4 1.53 1.09 1.29 1.52 1.29
JUN kinase activity 2 -1.09 1.03 1.52 1.15 1.41 -1.08 1.01
JUN kinase kinase kinase activity 2 1.23 1.27 1.56 1.2 1.54 1.23 1.3
MAP kinase activity 9 -1.46 1.12 1.25 1.14 1.35 -1.25 1.02
MAP kinase kinase activity 3 -1.23 1.23 1.34 1.19 1.4 1.25 1.23
MAP kinase kinase kinase activity 5 -1.39 1.21 1.48 1.15 1.82 1.09 1.04
MAPK/ERK kinase kinase activity 1 1.83 1.46 1.17 -1.02 1.24 1.79 1.33
ribosomal protein S6 kinase activity 1 -2.62 1.78 1.7 1.33 1.66 1.52 1.3
protein serine/threonine/tyrosine kinase activity 7 -1.0 1.17 1.32 1.17 1.33 1.18 1.15
protein tyrosine kinase activity 43 1.39 1.05 1.14 1.01 1.19 1.42 1.33
transmembrane receptor protein tyrosine kinase activity 21 1.55 -1.07 1.14 -1.01 1.13 1.58 1.42
non-membrane spanning protein tyrosine kinase activity 7 1.37 1.16 1.77 1.12 1.46 1.64 1.42
receptor signaling protein tyrosine kinase activity 3 -1.0 1.08 -1.13 -1.05 -1.16 -1.03 -1.05
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity 1 2.93 1.03 1.2 1.19 1.05 1.97 1.02
protein-lysine 6-oxidase activity 2 -1.01 1.14 -1.1 1.01 -1.1 -1.06 -1.07
phosphoprotein phosphatase activity 86 1.24 1.12 1.24 1.06 1.2 1.31 1.16
protein serine/threonine phosphatase activity 42 1.25 1.09 1.29 1.04 1.19 1.37 1.15
calcium-dependent protein serine/threonine phosphatase activity 6 1.52 -1.02 1.2 1.05 1.13 1.24 1.06
protein tyrosine phosphatase activity 39 1.24 1.12 1.28 1.06 1.27 1.3 1.17
non-membrane spanning protein tyrosine phosphatase activity 5 1.49 1.12 1.2 1.1 1.4 1.22 1.1
prenylated protein tyrosine phosphatase activity 1 1.54 1.27 2.19 -1.23 1.74 3.0 1.51
receptor signaling protein tyrosine phosphatase activity 3 2.8 -1.06 1.33 -1.06 1.35 3.49 1.47
oxygen-dependent protoporphyrinogen oxidase activity 2 -1.11 1.24 1.36 1.38 1.3 1.17 -1.16
pseudouridylate synthase activity 3 1.57 1.31 1.17 1.55 1.45 1.03 1.08
purine-nucleoside phosphorylase activity 2 1.43 1.02 1.21 1.12 1.16 -1.08 1.07
pyridoxamine-phosphate oxidase activity 3 1.93 1.06 -1.17 1.32 1.07 1.07 -1.07
pyrimidodiazepine synthase activity 4 1.29 1.17 1.1 1.04 1.18 -1.03 1.04
pyrroline-5-carboxylate reductase activity 2 -1.77 1.27 -1.94 1.07 -1.03 -1.14 -1.01
pyruvate carboxylase activity 1 2.41 -1.07 -1.67 1.11 -2.11 1.65 1.08
pyruvate dehydrogenase activity 3 -1.02 1.01 1.31 1.1 -1.0 1.57 -1.25
pyruvate dehydrogenase (acetyl-transferring) activity 3 -1.02 1.01 1.31 1.1 -1.0 1.57 -1.25
pyruvate dehydrogenase (acetyl-transferring) kinase activity 1 1.67 -1.54 1.2 -1.13 7.02 3.44 1.09
[pyruvate dehydrogenase (lipoamide)] phosphatase activity 1 1.78 1.13 1.46 1.23 1.08 1.92 1.02
dihydrolipoyllysine-residue acetyltransferase activity 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
pyruvate kinase activity 7 1.18 1.01 1.0 -1.0 -1.04 1.2 -1.0
retinal isomerase activity 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
retinol dehydrogenase activity 1 -1.07 1.02 1.03 -1.03 -1.28 1.11 -1.06
ribokinase activity 2 -1.21 1.07 -1.3 1.1 -1.27 -1.38 -1.12
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
ribose phosphate diphosphokinase activity 2 2.41 1.04 1.7 -1.06 1.1 2.9 1.34
ribulose-phosphate 3-epimerase activity 1 3.69 1.12 -1.44 1.15 1.15 1.38 1.6
ribose-5-phosphate isomerase activity 1 2.8 1.42 -1.73 1.16 1.1 1.26 1.25
saccharopine dehydrogenase activity 1 1.21 1.36 -1.07 1.24 -1.06 1.55 1.4
saccharopine dehydrogenase (NAD+, L-lysine-forming) activity 1 1.21 1.36 -1.07 1.24 -1.06 1.55 1.4
selenide, water dikinase activity 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
sepiapterin reductase activity 3 2.14 -1.76 -1.79 -1.65 -1.36 2.93 -1.29
serine C-palmitoyltransferase activity 2 -2.24 1.07 2.48 1.17 1.31 -1.71 -1.18
serine-pyruvate transaminase activity 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
spermidine synthase activity 2 1.05 1.2 1.25 1.18 1.33 1.44 -1.0
sphingomyelin phosphodiesterase activity 5 -5.07 -3.51 -4.56 1.49 -1.12 -3.62 -4.08
stearoyl-CoA 9-desaturase activity 7 -1.4 1.15 -1.2 1.26 1.01 -1.67 -1.18
sterol esterase activity 1 -139.1 -18.6 -1.99 2.08 -24.32 -152.96 -197.4
sterol O-acyltransferase activity 3 -2.3 -1.64 -1.24 1.46 1.26 -1.59 -2.16
succinate-CoA ligase activity 6 1.06 -1.06 1.08 -1.08 1.02 1.3 -1.31
succinate-CoA ligase (ADP-forming) activity 5 1.09 -1.04 1.18 -1.15 -1.09 1.43 -1.27
succinate-CoA ligase (GDP-forming) activity 3 1.16 -1.04 -1.07 -1.04 1.11 1.22 -1.42
succinate-semialdehyde dehydrogenase activity 1 -2.19 1.37 2.06 1.34 1.0 1.58 -1.11
sulfate adenylyltransferase activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
sulfate adenylyltransferase (ATP) activity 1 -2.63 1.06 1.41 1.07 1.11 -1.64 -1.02
sulfinoalanine decarboxylase activity 1 -1.56 1.66 -7.28 1.14 -1.03 -3.47 1.18
superoxide dismutase activity 5 1.45 1.15 -1.15 1.12 -1.07 1.37 -1.06
thiamine diphosphokinase activity 2 -1.04 1.3 1.02 1.32 1.14 -1.17 -1.06
thioredoxin-disulfide reductase activity 2 -1.32 1.3 -1.35 1.1 1.1 -1.38 1.15
thiosulfate sulfurtransferase activity 1 1.15 -1.38 2.62 1.38 1.04 -1.42 -1.83
threonine aldolase activity 1 1.44 -1.1 -1.93 1.6 -1.06 1.8 -2.26
L-threonine ammonia-lyase activity 1 -3.81 -2.74 -2.14 -1.15 11.07 -1.69 -3.46
thymidine kinase activity 1 1.02 1.09 1.32 1.32 1.3 -1.29 -1.13
thymidylate kinase activity 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
thymidylate synthase activity 1 -1.63 -1.08 1.19 1.46 1.72 -2.2 -2.17
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity 1 3.18 1.11 -3.27 1.02 -1.44 -1.1 1.46
transketolase activity 2 2.03 1.17 -1.56 1.02 1.12 1.44 1.62
transposase activity 1 1.07 -1.04 -1.16 1.02 1.48 -1.27 -1.22
trehalose-phosphatase activity 2 5.88 -2.14 -1.49 -1.62 1.02 4.6 1.12
triglyceride lipase activity 38 -3.83 -1.33 -1.88 -1.09 -1.77 -4.41 -2.22
tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity 1 1.03 1.15 1.06 1.36 -1.06 -1.46 -1.19
tRNA (guanine-N2-)-methyltransferase activity 1 1.09 1.31 1.08 1.21 1.15 1.13 1.18
aminoacyl-tRNA ligase activity 40 -1.07 1.26 1.26 1.14 1.18 1.05 1.09
alanine-tRNA ligase activity 3 -1.05 1.37 1.07 1.17 1.09 1.18 1.07
arginine-tRNA ligase activity 3 1.35 1.15 1.32 1.15 1.24 1.15 1.05
aspartate-tRNA ligase activity 1 -1.97 1.61 1.28 -1.18 1.45 -1.88 1.38
asparagine-tRNA ligase activity 2 -1.04 1.15 1.12 1.09 1.19 -1.05 1.03
cysteine-tRNA ligase activity 2 -1.01 1.37 1.43 1.08 1.22 1.24 1.76
glutamate-tRNA ligase activity 3 -1.23 1.31 1.44 1.01 1.37 1.11 1.37
glutamine-tRNA ligase activity 1 1.03 1.27 1.03 1.21 1.05 1.24 1.09
glycine-tRNA ligase activity 3 1.01 1.17 1.37 1.21 1.21 1.27 -1.07
histidine-tRNA ligase activity 1 -1.32 1.37 -1.07 1.31 -1.14 -1.74 -1.19
isoleucine-tRNA ligase activity 2 1.35 1.22 1.54 1.02 1.38 1.61 1.38
leucine-tRNA ligase activity 2 -1.17 1.4 1.1 1.12 1.07 1.1 1.24
lysine-tRNA ligase activity 1 1.12 1.29 1.39 1.11 1.29 1.02 1.14
methionine-tRNA ligase activity 2 -1.59 1.18 1.28 1.38 1.17 -1.27 -1.03
phenylalanine-tRNA ligase activity 3 -1.16 1.27 1.38 1.24 1.13 -1.0 -1.14
proline-tRNA ligase activity 2 -1.08 1.19 1.31 1.06 1.32 1.47 1.15
serine-tRNA ligase activity 3 -1.3 1.34 1.25 1.17 1.28 -1.22 -1.0
threonine-tRNA ligase activity 2 -1.65 1.24 1.06 1.13 -1.08 -1.17 1.02
tryptophan-tRNA ligase activity 2 1.09 1.09 1.24 1.11 1.12 1.12 1.03
tyrosine-tRNA ligase activity 2 1.14 1.27 1.29 1.14 1.19 1.03 -1.04
valine-tRNA ligase activity 2 -1.62 1.31 1.29 1.15 1.04 -1.25 1.17
tryptophan 2,3-dioxygenase activity 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
tubulin-tyrosine ligase activity 11 1.17 1.01 -1.01 1.04 -1.02 1.1 1.04
tyrosine decarboxylase activity 2 2.12 -1.17 -1.18 -1.17 1.11 1.9 -1.07
L-tyrosine:2-oxoglutarate aminotransferase activity 1 1.14 1.12 -1.09 -1.15 1.09 -1.15 -1.05
ubiquitin activating enzyme activity 3 1.07 1.19 1.42 1.25 1.55 1.31 1.05
ubiquitin-protein ligase activity 83 1.15 1.18 1.45 1.14 1.34 1.23 1.22
ubiquitin-specific protease activity 8 1.17 1.21 1.8 1.18 1.58 1.96 1.41
uracil DNA N-glycosylase activity 2 2.91 -1.23 -1.13 -1.34 1.04 2.88 1.17
uracil phosphoribosyltransferase activity 1 1.85 1.12 1.41 1.03 1.01 1.67 1.33
urate oxidase activity 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
uridine kinase activity 2 4.18 -1.72 1.72 -1.65 -1.27 3.76 1.43
uridine phosphorylase activity 3 -2.2 -1.73 1.35 -1.47 -1.37 -2.19 1.39
uroporphyrinogen-III synthase activity 2 1.15 -1.11 -1.12 1.02 -1.09 1.11 -1.25
uroporphyrinogen decarboxylase activity 1 2.27 -1.08 -1.25 1.43 1.04 1.18 1.26
xanthine dehydrogenase activity 2 1.25 1.78 -1.17 -1.32 -1.19 -1.3 1.66
xanthine oxidase activity 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
xylulokinase activity 2 1.23 1.04 -1.16 -1.08 1.26 1.41 1.22
enzyme inhibitor activity 101 1.28 -1.39 -1.39 -1.37 -1.17 1.33 1.03
protein kinase inhibitor activity 6 1.32 1.13 1.13 1.05 1.2 1.27 1.35
cyclin-dependent protein kinase inhibitor activity 2 1.97 -1.0 1.05 1.02 1.15 1.58 1.04
protein phosphatase inhibitor activity 7 1.59 -1.08 -1.01 -1.03 1.27 1.27 -1.01
protein serine/threonine phosphatase inhibitor activity 1 1.57 1.1 -1.11 1.22 1.13 -1.01 -1.25
endopeptidase inhibitor activity 73 1.41 -1.48 -1.45 -1.49 -1.3 1.51 1.04
serine-type endopeptidase inhibitor activity 58 1.2 -1.48 -1.57 -1.54 -1.37 1.38 -1.05
cysteine-type endopeptidase inhibitor activity 6 3.11 -1.78 -1.05 -1.54 -1.18 1.44 1.41
signal transducer activity 443 1.09 1.01 1.1 1.0 1.08 1.12 1.06
receptor activity 428 1.12 -1.03 1.04 -1.02 1.04 1.12 1.04
ecdysteroid hormone receptor activity 2 1.39 1.12 1.31 1.09 1.22 1.45 1.35
thyroid hormone receptor activity 2 -1.28 1.12 1.08 -1.12 -1.1 -1.03 -1.04
transmembrane signaling receptor activity 332 1.1 -1.02 1.05 -1.02 1.03 1.1 1.04
acetylcholine-activated cation-selective channel activity 9 -1.07 1.01 -1.02 -1.03 -1.09 -1.06 -1.03
GABA-A receptor activity 3 1.07 1.04 1.03 -1.04 -1.11 -1.02 -1.07
carbohydrate binding 166 -1.92 -1.36 -1.53 -1.23 -1.33 -1.85 -1.01
cytokine receptor activity 1 1.28 1.03 1.08 -1.21 -1.11 1.23 -1.01
boss receptor activity 1 2.09 -1.24 -1.34 -1.08 -1.33 -1.62 1.07
Wnt-activated receptor activity 5 1.17 1.03 1.52 -1.14 1.66 -1.04 1.31
Wnt receptor signaling pathway 56 1.24 1.03 1.2 -1.03 1.29 1.38 1.28
Wnt receptor signaling pathway, calcium modulating pathway 2 1.15 1.15 1.16 1.02 1.3 1.14 2.54
G-protein coupled receptor activity 168 1.06 -1.03 1.05 -1.02 1.01 1.02 -1.02
adrenergic receptor activity 2 -1.09 1.2 -1.08 -1.0 -1.18 -1.21 -1.07
bombesin receptor activity 2 1.03 1.12 1.37 -1.03 -1.15 1.42 1.13
calcitonin receptor activity 5 1.36 -1.25 1.11 -1.21 1.02 -1.07 1.56
cholecystokinin receptor activity 2 -1.2 -1.05 1.02 -1.05 -1.23 -1.25 -1.17
dopamine receptor activity 4 -1.05 1.04 -1.1 1.03 -1.07 -1.17 -1.14
G-protein coupled GABA receptor activity 4 -1.05 1.06 -1.02 1.01 -1.05 -1.07 -1.16
galanin receptor activity 1 -1.14 1.16 1.12 1.07 1.38 -1.13 1.15
gonadotropin-releasing hormone receptor activity 2 1.14 1.03 1.06 1.02 -1.01 -1.0 -1.03
ionotropic glutamate receptor activity 35 1.11 -1.01 1.02 -1.04 -1.06 -1.02 -1.03
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity 2 -1.07 -1.07 -1.18 -1.06 -1.13 -1.05 -1.13
N-methyl-D-aspartate selective glutamate receptor activity 5 -2.2 1.03 -1.01 -1.04 -1.02 -1.52 1.05
leukotriene receptor activity 1 1.34 1.16 1.19 1.06 1.04 1.4 -1.06
neuropeptide Y receptor activity 6 -1.12 -1.28 1.15 -1.08 1.23 2.07 -1.01
olfactory receptor activity 58 -1.05 1.02 -1.02 1.02 -1.07 -1.04 -1.08
opioid receptor activity 1 1.11 1.13 -1.05 1.1 1.01 1.15 1.06
octopamine receptor activity 6 1.21 1.06 1.02 1.02 1.02 1.0 1.01
serotonin receptor activity 3 1.27 -1.02 1.07 1.0 1.01 1.11 1.03
somatostatin receptor activity 2 -1.22 1.13 1.03 -1.13 -1.24 -1.37 -1.14
tachykinin receptor activity 6 -1.02 -1.12 1.07 -1.2 -1.05 1.79 1.44
vasopressin receptor activity 1 -1.03 1.09 1.19 1.15 1.1 -1.1 1.13
transmembrane receptor protein tyrosine phosphatase activity 6 1.57 1.05 1.23 1.03 1.35 2.22 1.25
ephrin receptor activity 1 2.31 1.1 1.68 1.08 2.32 2.06 2.34
epidermal growth factor-activated receptor activity 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
fibroblast growth factor-activated receptor activity 3 1.8 -1.38 2.01 1.04 -1.27 -1.03 -1.21
insulin-activated receptor activity 1 1.01 1.43 1.57 1.5 2.27 1.72 1.64
insulin-like growth factor-activated receptor activity 2 -1.08 -1.38 -1.23 -1.3 -1.24 5.4 3.24
signal transduction 876 1.14 1.03 1.16 1.02 1.16 1.16 1.12
growth factor binding 5 -1.0 1.2 1.22 1.22 1.63 1.18 1.29
platelet-derived growth factor-activated receptor activity 1 -1.05 1.27 1.32 -1.04 1.15 1.36 1.38
vascular endothelial growth factor-activated receptor activity 1 -1.05 1.27 1.32 -1.04 1.15 1.36 1.38
transforming growth factor beta-activated receptor activity 5 -1.03 1.52 1.48 1.18 1.61 1.07 1.49
transforming growth factor beta receptor activity, type I 3 -1.44 1.44 1.63 1.24 1.98 1.37 1.58
transforming growth factor beta receptor activity, type II 2 1.6 1.65 1.28 1.09 1.17 -1.35 1.36
tumor necrosis factor-activated receptor activity 1 10.08 -2.23 1.27 -2.86 -1.97 3.13 1.07
neurotrophin receptor activity 1 -1.26 -1.0 -1.26 -1.09 -1.23 -1.44 -1.14
osmosensor activity 1 -6.38 -3.77 -11.1 -5.2 -1.19 28.07 -1.66
death receptor activity 1 10.08 -2.23 1.27 -2.86 -1.97 3.13 1.07
death receptor binding 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
low-density lipoprotein receptor activity 9 1.21 1.15 1.29 -1.02 -1.05 1.37 1.08
netrin receptor activity 2 -1.2 1.24 1.26 1.34 2.11 -1.46 1.04
netrin receptor activity involved in chemorepulsion 1 1.29 1.16 1.2 1.17 1.22 1.22 1.2
scavenger receptor activity 24 1.07 -1.29 -1.24 -1.03 -1.04 -1.04 -1.17
endoplasmic reticulum 211 -1.05 1.06 1.07 1.02 1.06 -1.08 1.12
KDEL sequence binding 1 -1.48 1.27 1.01 1.14 -1.01 -1.37 1.53
signal recognition particle binding 3 -1.47 1.36 1.04 1.08 -1.23 -1.47 1.4
signal sequence binding 10 -1.31 1.23 -1.06 1.11 -1.02 -1.42 1.25
nuclear export signal receptor activity 3 1.18 1.05 2.95 1.07 1.92 2.19 1.34
peroxisome 39 1.3 -1.06 -1.53 1.05 1.16 -1.5 -1.16
peroxisome matrix targeting signal-2 binding 2 -1.03 -1.06 -1.0 -1.0 1.01 -1.02 1.0
peroxisomal membrane 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
laminin receptor activity 1 -9.63 1.35 1.66 1.05 1.52 -7.44 1.13
receptor signaling protein activity 45 -1.03 1.15 1.35 1.07 1.29 1.13 1.16
transmembrane receptor protein tyrosine kinase signaling pathway 107 1.24 1.04 1.28 1.05 1.21 1.28 1.23
intracellular signal transduction 268 1.18 1.1 1.26 1.06 1.23 1.24 1.17
SH3/SH2 adaptor activity 9 1.2 -1.01 1.23 1.07 1.17 1.44 -1.06
transmembrane receptor protein serine/threonine kinase signaling pathway 44 1.2 1.13 1.35 1.05 1.35 1.29 1.24
transforming growth factor beta receptor, cytoplasmic mediator activity 4 1.26 1.21 1.59 1.07 1.32 1.36 1.28
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity 1 1.02 1.23 1.11 -1.09 -1.09 -1.03 -1.05
transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity 1 2.8 1.17 2.77 -1.14 1.51 2.43 1.42
transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity 1 -2.15 1.12 -1.08 1.29 -1.07 -2.29 1.33
protein localization 361 1.08 1.14 1.29 1.1 1.27 1.17 1.16
protein kinase A binding 3 -1.23 1.19 1.19 1.03 1.27 1.0 1.5
protein kinase C binding 5 1.76 1.33 1.56 1.07 1.48 1.92 1.83
small GTPase regulator activity 92 1.05 1.14 1.38 1.04 1.28 1.25 1.21
guanyl-nucleotide exchange factor activity 52 1.11 1.15 1.38 1.01 1.29 1.52 1.26
ARF guanyl-nucleotide exchange factor activity 6 -1.22 1.21 1.27 -1.01 1.25 1.49 1.58
Ran guanyl-nucleotide exchange factor activity 1 -1.45 1.36 1.25 1.07 1.01 -1.05 -1.05
Ras guanyl-nucleotide exchange factor activity 28 1.05 1.14 1.41 1.02 1.33 1.5 1.21
Rho guanyl-nucleotide exchange factor activity 21 1.01 1.13 1.41 1.07 1.35 1.47 1.21
GDP-dissociation inhibitor activity 2 -1.01 -1.04 1.34 1.09 1.21 -1.08 -1.54
Rab GDP-dissociation inhibitor activity 1 1.43 1.0 1.11 1.08 1.12 1.1 -1.39
Rho GDP-dissociation inhibitor activity 1 -1.46 -1.08 1.63 1.09 1.3 -1.27 -1.71
GTPase activator activity 62 1.02 1.15 1.36 1.05 1.23 1.09 1.2
Rab GTPase activator activity 27 1.13 1.14 1.41 1.07 1.24 1.21 1.16
Ran GTPase activator activity 1 1.34 1.36 1.62 1.42 1.91 1.35 1.2
Ras GTPase activator activity 41 1.16 1.16 1.42 1.06 1.27 1.21 1.19
Rho GTPase activator activity 7 1.29 1.18 1.47 1.05 1.37 1.25 1.31
fibroblast growth factor receptor binding 3 1.57 1.01 2.07 -1.12 1.29 2.72 1.05
ephrin receptor binding 1 1.81 1.29 1.78 1.1 1.94 2.77 1.53
anchored to plasma membrane 3 3.1 -2.01 -3.22 -2.43 -1.37 2.44 1.37
integral to plasma membrane 194 1.07 -1.04 1.01 -1.03 1.0 1.05 1.06
frizzled binding 3 -1.65 -1.07 1.18 -1.29 1.31 1.28 1.51
frizzled-2 binding 2 -1.8 1.01 1.43 -1.3 -1.11 1.61 2.1
Notch binding 13 -1.08 1.09 1.12 1.16 1.26 1.32 1.32
patched binding 2 -1.41 -1.16 1.11 1.42 1.34 -1.32 -2.31
sevenless binding 2 2.05 1.08 1.52 1.1 1.59 1.98 1.31
smoothened binding 1 1.33 1.48 1.27 1.38 1.17 1.23 1.56
Toll binding 6 2.0 -1.13 -1.18 -1.1 -1.05 3.64 1.27
torso binding 2 4.82 -2.22 -1.24 -1.06 1.12 2.59 1.13
cytokine activity 3 2.09 -1.14 -1.06 -1.07 1.06 1.89 1.58
cytokine receptor binding 13 1.33 1.01 -1.03 -1.2 1.15 1.04 1.28
epidermal growth factor receptor binding 8 2.02 -1.02 1.33 1.03 1.43 2.13 1.51
transmembrane receptor protein tyrosine kinase activator activity 1 1.23 1.27 1.15 1.19 1.2 1.15 1.07
positive regulation of epidermal growth factor-activated receptor activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
negative regulation of epidermal growth factor-activated receptor activity 3 1.29 1.07 1.31 1.06 1.37 1.41 1.15
insulin receptor binding 12 1.04 1.01 1.16 1.14 1.03 1.08 1.07
insulin-like growth factor receptor binding 1 2.22 1.3 2.31 -1.1 1.87 2.8 1.91
transforming growth factor beta receptor binding 7 1.67 1.01 -1.0 -1.48 -1.16 1.33 1.27
tumor necrosis factor receptor binding 1 1.09 -1.11 -1.93 -1.35 4.12 -1.38 6.18
neurotrophin receptor binding 1 1.14 1.02 -1.14 -1.05 -1.16 -1.16 -1.16
vascular endothelial growth factor receptor binding 3 -1.25 -1.01 -1.01 1.19 1.41 -1.38 -1.06
neurexin family protein binding 4 1.03 1.04 -1.12 -1.02 -1.15 -1.08 -1.04
integrin binding 2 -1.2 -1.12 -1.15 -1.24 -1.4 -1.2 -1.15
hormone activity 52 -1.48 -1.33 -1.19 -1.09 -1.16 -1.59 -1.16
neuropeptide hormone activity 35 -1.76 -1.5 -1.27 -1.18 -1.19 -1.89 -1.23
nutrient reservoir activity 6 1.04 1.0 -1.18 -1.1 -1.23 -1.11 1.17
structural molecule activity 451 1.11 -1.08 -1.04 -1.04 -1.01 1.08 -1.06
structural constituent of cell wall 2 4.29 -1.81 -1.38 -1.64 -1.67 1.06 1.01
structural constituent of cytoskeleton 43 1.03 1.02 1.24 1.01 1.24 1.12 1.03
extracellular matrix structural constituent 4 -1.38 -1.31 1.16 -1.34 -1.07 -1.08 1.23
collagen 3 1.14 -1.43 1.08 -1.25 -1.21 1.82 -1.14
structural constituent of eye lens 1 -23.09 -8.59 -4.86 2.62 -1.02 -36.83 -31.54
structural constituent of chorion 9 1.18 1.05 -1.08 1.04 -1.21 -1.1 -1.03
structural constituent of chitin-based cuticle 129 1.11 -1.12 -1.19 -1.13 -1.23 -1.09 -1.11
transporter activity 817 -1.14 -1.04 -1.14 -1.08 -1.06 1.05 -1.07
ion channel activity 205 1.06 -1.01 1.0 -1.05 -1.04 1.07 -1.01
intracellular ligand-gated ion channel activity 7 1.42 1.03 1.28 1.0 1.1 1.59 1.16
intracellular ligand-gated calcium channel activity 3 1.97 -1.03 1.18 1.08 1.09 1.76 1.17
ryanodine-sensitive calcium-release channel activity 1 3.82 -1.03 1.3 -1.12 1.16 2.73 1.18
inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
intracellular cyclic nucleotide activated cation channel activity 3 -1.19 1.0 1.03 -1.02 1.02 -1.02 -1.19
volume-sensitive anion channel activity 2 1.92 1.08 -1.06 -1.08 2.11 2.25 1.09
calcium activated cation channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
extracellular ligand-gated ion channel activity 58 1.01 1.01 -1.01 -1.09 -1.14 -1.1 1.02
excitatory extracellular ligand-gated ion channel activity 51 1.09 1.0 -1.01 -1.09 -1.16 -1.07 1.03
extracellular-glutamate-gated ion channel activity 34 1.25 -1.01 1.01 -1.04 -1.06 1.04 -1.03
inhibitory extracellular ligand-gated ion channel activity 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
inward rectifier potassium channel activity 4 -1.18 -1.13 -1.58 -3.21 -3.46 1.87 -1.7
gap junction channel activity 6 -1.73 -1.09 -1.05 -1.09 -1.25 -1.21 1.35
voltage-gated ion channel activity 44 1.07 -1.01 1.02 -1.09 -1.09 1.15 -1.09
voltage-gated calcium channel activity 8 1.1 -1.05 -1.01 -1.01 -1.07 1.04 -1.11
calcium channel regulator activity 2 -1.03 -1.06 -1.05 -1.01 -1.02 -1.08 -1.24
voltage-gated chloride channel activity 3 -1.31 1.23 -1.16 1.19 1.05 1.88 1.52
voltage-gated sodium channel activity 2 1.16 1.04 1.11 1.14 1.08 1.02 1.02
voltage-gated potassium channel activity 25 1.14 -1.03 1.01 -1.2 -1.15 1.11 -1.15
A-type (transient outward) potassium channel activity 2 3.38 -1.08 1.04 -1.08 1.22 1.8 -1.38
open rectifier potassium channel activity 3 2.34 -1.1 -1.13 -1.16 1.03 1.04 -1.38
anion channel activity 23 -1.01 1.02 -1.01 -1.14 -1.11 1.24 1.08
chloride channel activity 13 -1.14 1.15 1.04 -1.13 -1.12 1.12 1.12
cation channel activity 105 1.11 -1.02 1.01 -1.05 -1.0 1.12 -1.03
calcium channel activity 24 1.39 -1.04 1.09 -1.06 1.15 1.41 1.14
potassium channel activity 31 1.1 -1.02 -1.0 -1.15 -1.14 1.09 -1.12
sodium channel activity 32 -1.0 -1.01 -1.01 1.05 1.03 1.01 -1.07
amine transmembrane transporter activity 58 -1.3 -1.08 -1.61 -1.23 -1.04 -1.08 -1.11
vesicular hydrogen:amino acid antiporter activity 1 -1.42 -1.04 1.11 -1.1 -1.1 -1.22 -1.18
acetylcholine transmembrane transporter activity 1 1.16 1.14 1.1 1.05 1.08 1.11 1.02
acetylcholine:hydrogen antiporter activity 1 1.16 1.14 1.1 1.05 1.08 1.11 1.02
hydrogen:amino acid symporter activity 2 1.74 1.43 -1.72 -1.09 1.17 -1.0 1.38
amino acid transmembrane transporter activity 53 -1.39 -1.07 -1.67 -1.24 -1.03 -1.11 -1.1
neutral L-amino acid secondary active transmembrane transporter activity 1 -1.01 1.0 1.27 1.1 -1.12 1.05 -1.06
proline:sodium symporter activity 1 1.01 -1.09 -1.18 -1.18 1.11 -1.08 -1.12
L-tyrosine transmembrane transporter activity 2 3.0 -1.1 1.15 -1.28 -1.42 2.49 1.13
transmembrane transporter activity 713 -1.15 -1.03 -1.13 -1.08 -1.07 1.06 -1.07
dicarboxylic acid transmembrane transporter activity 13 1.1 -1.01 -1.14 -1.45 -1.24 1.31 1.09
organic acid:sodium symporter activity 8 -1.17 1.19 -1.85 -1.42 -1.96 -1.64 1.15
tricarboxylic acid transmembrane transporter activity 10 1.18 1.18 -1.1 -1.17 -1.22 1.3 1.11
L-glutamate transmembrane transporter activity 4 -2.07 1.33 -5.17 -2.48 -1.62 -1.72 -2.15
high-affinity glutamate transmembrane transporter activity 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
inorganic phosphate transmembrane transporter activity 3 2.26 -1.45 1.37 -1.34 1.47 3.74 -1.03
high affinity inorganic phosphate:sodium symporter activity 18 -3.67 1.02 -3.81 -1.03 -1.98 -1.81 -2.84
lipid transporter activity 29 -1.34 -1.01 -1.21 -1.16 -1.06 -1.03 -1.19
neurotransmitter transporter activity 24 1.11 -1.3 -1.53 -1.28 1.11 1.77 1.29
neurotransmitter:sodium symporter activity 18 1.0 -1.4 -1.72 -1.34 1.19 1.93 1.23
dopamine transmembrane transporter activity 1 -1.02 1.06 -1.1 1.08 -1.08 1.0 -1.01
dopamine:sodium symporter activity 1 -1.02 1.06 -1.1 1.08 -1.08 1.0 -1.01
gamma-aminobutyric acid:sodium symporter activity 1 1.23 1.09 1.07 1.18 1.17 -1.0 -1.09
nucleotide-sugar transmembrane transporter activity 8 1.01 1.23 -1.01 1.24 1.15 -1.17 1.39
organic acid transmembrane transporter activity 88 -1.4 -1.03 -1.4 -1.13 -1.01 -1.05 -1.12
sugar:hydrogen symporter activity 8 1.06 -1.15 -1.17 -1.12 -1.18 -1.05 1.82
fructose transmembrane transporter activity 3 1.33 -1.15 -1.45 -1.42 -1.39 -1.07 -1.47
glucose transmembrane transporter activity 15 -1.29 -1.15 -1.91 -1.13 -1.42 -1.88 1.23
zinc ion transport 2 -1.19 1.21 1.46 1.02 -1.06 1.08 -1.05
taurine transmembrane transporter activity 1 1.14 1.06 -1.1 -1.01 -1.05 1.05 1.32
taurine:sodium symporter activity 1 1.14 1.06 -1.1 -1.01 -1.05 1.05 1.32
tricarboxylate secondary active transmembrane transporter activity 3 -1.58 1.64 -1.92 -1.18 -1.42 1.07 1.16
water transmembrane transporter activity 7 -2.13 1.26 -1.34 -1.07 -2.07 -2.5 -1.23
secondary active transmembrane transporter activity 155 -1.44 -1.11 -1.62 -1.18 -1.13 1.21 -1.17
copper ion transmembrane transporter activity 4 -1.47 1.29 1.37 1.11 1.01 -1.04 1.08
manganese ion transmembrane transporter activity 2 -1.53 1.28 -1.11 1.02 -1.23 -1.54 1.12
zinc ion transmembrane transporter activity 7 -1.46 1.19 1.4 1.14 1.09 -1.16 -1.34
calcium-transporting ATPase activity 4 -1.18 -1.01 1.34 -1.06 1.25 -1.0 1.03
sodium:potassium-exchanging ATPase activity 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
eye pigment precursor transporter activity 3 1.41 -1.1 -1.26 -1.07 -1.12 -1.06 -1.05
cation:sugar symporter activity 8 1.06 -1.15 -1.17 -1.12 -1.18 -1.05 1.82
nucleoside:sodium symporter activity 2 -7.59 1.47 -2.97 -1.0 -2.3 -5.85 -2.0
cation:amino acid symporter activity 13 1.13 -1.27 -2.32 -1.57 1.11 1.18 1.23
proton-dependent oligopeptide secondary active transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
synaptic vesicle amine transmembrane transporter activity 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
calcium:sodium antiporter activity 2 -1.37 1.7 1.3 -1.23 1.65 2.01 1.96
sodium:phosphate symporter activity 21 -3.19 1.03 -3.12 -1.03 -1.89 -1.53 -2.45
monovalent cation:hydrogen antiporter activity 4 -2.37 -1.01 -1.35 1.01 -1.74 3.33 -1.27
inorganic anion exchanger activity 2 -3.68 -3.74 3.73 -4.0 -1.27 -1.18 -1.53
CMP-N-acetylneuraminate transmembrane transporter activity 3 -1.73 1.25 -1.03 1.28 -1.06 -1.84 1.23
GDP-fucose transmembrane transporter activity 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
GDP-mannose transmembrane transporter activity 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
UDP-galactose transmembrane transporter activity 6 -1.21 1.24 1.0 1.15 1.18 -1.35 1.53
UDP-glucose transmembrane transporter activity 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
UDP-glucuronic acid transmembrane transporter activity 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
UDP-N-acetylglucosamine transmembrane transporter activity 4 1.24 1.2 -1.03 1.43 1.23 -1.03 1.1
UDP-N-acetylgalactosamine transmembrane transporter activity 2 -2.31 1.25 -1.08 1.21 1.09 -2.5 1.48
UDP-xylose transmembrane transporter activity 3 -1.4 1.3 1.05 1.18 -1.06 -1.45 1.9
ATP:ADP antiporter activity 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
carnitine:acyl carnitine antiporter activity 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
vacuole organization 13 1.03 1.12 1.06 1.24 1.09 1.02 1.01
vesicle fusion 8 -1.38 -1.08 1.22 1.35 1.26 -1.28 -1.21
synaptic vesicle to endosome fusion 1 1.73 -1.06 2.32 1.09 1.39 3.26 1.36
vesicle targeting 12 -1.08 1.24 1.4 1.15 1.31 1.23 1.25
synaptic vesicle targeting 9 1.07 1.25 1.5 1.16 1.39 1.39 1.23
soluble NSF attachment protein activity 6 1.55 1.06 1.18 1.07 1.23 1.28 1.16
SNAP receptor activity 20 1.03 1.15 1.31 1.2 1.21 -1.11 1.1
nucleocytoplasmic transporter activity 2 1.05 1.3 -1.0 1.23 1.14 1.08 -1.04
binding 4696 1.06 1.02 1.07 1.04 1.11 1.08 1.06
steroid binding 19 -2.28 -1.49 -1.79 1.11 -1.16 -2.3 -2.31
juvenile hormone binding 2 -1.14 1.17 1.21 1.18 1.14 1.31 1.23
retinoid binding 8 2.32 -6.6 -7.06 -2.49 -1.68 1.78 1.1
fatty acid binding 11 -1.61 -1.59 -2.07 -1.15 1.3 -1.68 -1.56
metal ion binding 1381 1.03 1.02 1.04 1.03 1.11 1.05 1.01
iron ion binding 192 -1.02 -1.13 -1.23 -1.06 -1.06 1.0 -1.09
copper ion binding 20 -1.87 -1.23 -1.09 -1.21 -1.25 -1.59 1.03
detection of calcium ion 3 -1.58 -1.06 -1.06 1.03 1.08 -1.26 -1.33
sequestering of calcium ion 1 1.04 1.04 -1.04 -1.09 -1.16 -1.14 -1.1
calmodulin binding 30 1.18 1.09 1.27 1.05 1.23 1.34 1.23
cytoskeletal regulatory protein binding 1 -1.55 1.24 2.16 1.01 1.73 1.49 1.71
insulin-like growth factor binding 3 -1.07 1.13 1.1 1.18 1.32 1.03 1.12
tropomyosin binding 3 5.21 -1.74 1.31 -1.52 1.36 3.43 -1.33
ATP binding 652 1.06 1.1 1.17 1.09 1.22 1.18 1.09
GTP binding 159 1.18 1.08 1.28 1.06 1.23 1.12 1.08
macrolide binding 6 1.43 1.09 1.09 1.21 1.26 -1.11 1.17
FK506 binding 6 1.43 1.09 1.09 1.21 1.26 -1.11 1.17
sugar binding 27 -1.35 -1.07 1.19 -1.03 -1.02 -1.16 1.2
galactose binding 11 -1.6 -1.21 1.22 -1.04 -1.07 -1.49 -1.08
mannose binding 5 -1.02 1.06 -1.04 1.06 -1.07 -1.19 -1.02
glycosaminoglycan binding 23 -1.14 -1.26 -1.03 -1.01 -1.23 -1.43 -1.0
folic acid binding 4 -1.96 -1.02 -2.85 1.48 -1.35 -1.15 -2.07
phospholipid binding 112 1.08 1.08 1.36 1.02 1.26 1.28 1.26
calcium-dependent phospholipid binding 11 1.19 -1.05 1.13 1.02 1.21 1.24 1.15
1-phosphatidylinositol binding 1 -1.06 1.07 1.15 -1.0 1.23 1.29 1.44
phosphatidylinositol-4,5-bisphosphate binding 2 -1.07 1.2 1.71 1.09 1.37 1.09 1.1
phospholipid transporter activity 14 1.01 1.02 1.0 1.1 1.38 1.01 -1.05
odorant binding 110 1.09 -1.06 -1.12 -1.07 -1.13 1.0 -1.08
pheromone binding 8 1.18 1.02 -1.04 1.02 -1.03 -1.03 -1.04
protein ubiquitination 41 1.11 1.13 1.39 1.14 1.24 1.15 1.15
protein tag 2 2.12 -1.08 -1.18 1.19 1.03 -1.14 1.1
ribosome 169 1.2 1.05 1.14 1.12 1.17 1.28 -1.17
RNA modification guide activity 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
snRNA binding 5 1.33 1.08 1.1 1.25 1.13 1.17 -1.18
cellular_component 6965 1.08 1.01 1.05 1.02 1.09 1.09 1.03
fibrinogen complex 1 -1.06 -1.12 -1.04 1.02 1.07 -1.19 -1.22
proteinaceous extracellular matrix 59 1.22 -1.04 1.03 -1.11 1.03 1.19 -1.01
collagen type IV 2 1.15 -1.7 -1.07 -1.48 -1.42 2.42 -1.33
basement membrane 10 1.55 -1.19 1.13 -1.32 1.1 2.13 1.42
basal lamina 3 2.42 -1.01 1.11 -1.14 1.47 4.1 1.43
laminin-1 complex 1 3.52 1.3 1.81 1.23 2.46 6.46 1.6
integrin complex 8 -1.75 1.03 1.23 -1.07 1.36 -1.33 1.18
interstitial matrix 1 -3.11 1.08 3.33 -1.03 2.28 -1.55 -1.14
extracellular space 146 -1.07 -1.23 -1.37 -1.25 -1.26 -1.13 1.11
larval serum protein complex 5 1.15 1.01 -1.14 -1.06 -1.16 -1.08 1.13
cell 4600 1.14 1.06 1.13 1.06 1.16 1.15 1.06
membrane fraction 100 -1.02 -1.13 -1.22 -1.03 1.06 -1.14 -1.06
soluble fraction 6 1.33 1.04 1.25 1.02 1.26 1.47 1.19
insoluble fraction 103 -1.03 -1.12 -1.22 -1.02 1.06 -1.11 -1.05
nucleus 1578 1.19 1.1 1.2 1.12 1.23 1.17 1.1
nuclear envelope 72 1.34 1.09 1.32 1.13 1.35 1.29 1.14
nuclear inner membrane 7 1.5 -1.14 1.37 1.22 1.72 1.02 -1.06
lamin filament 2 1.28 1.06 -1.0 1.32 1.15 -1.17 -1.1
integral to nuclear inner membrane 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
nuclear outer membrane 1 2.5 -1.28 -1.45 -1.24 1.61 3.68 4.91
nuclear envelope lumen 2 1.16 1.03 1.1 1.15 1.11 1.57 -1.14
annulate lamellae 1 -1.39 1.32 -1.25 1.42 1.03 -1.29 -1.2
nuclear pore 32 1.22 1.16 1.46 1.19 1.42 1.4 1.18
Ran GTPase binding 7 -1.02 1.21 1.82 1.21 1.53 1.48 1.33
cytoplasm 2075 1.11 1.05 1.12 1.05 1.15 1.18 1.02
nuclear lamina 10 1.31 1.14 1.08 1.26 1.18 1.04 1.01
nucleoplasm 294 1.23 1.14 1.27 1.18 1.27 1.17 1.1
nucleolar ribonuclease P complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
pre-replicative complex 9 -1.14 1.11 1.17 1.27 1.56 -1.1 -1.11
replication fork 18 1.16 1.11 1.19 1.26 1.39 1.09 -1.16
alpha DNA polymerase:primase complex 4 -1.1 1.07 1.15 1.07 1.18 1.06 -1.25
DNA replication factor C complex 5 1.37 1.06 1.26 1.45 1.6 1.11 -1.08
PCNA complex 2 -1.29 1.09 1.33 1.22 1.3 -1.6 -1.28
DNA replication factor A complex 3 1.13 1.13 1.31 1.42 1.65 1.03 -1.21
nuclear origin of replication recognition complex 7 1.06 1.15 1.09 1.19 1.24 1.01 -1.08
DNA-directed RNA polymerase II, core complex 10 1.42 1.09 1.2 1.31 1.23 1.16 1.03
DNA-directed RNA polymerase III complex 8 1.27 1.21 1.22 1.2 1.28 -1.02 1.11
transcription factor complex 83 1.26 1.14 1.3 1.14 1.22 1.14 1.12
transcription factor TFIID complex 23 1.34 1.16 1.26 1.14 1.29 1.17 1.16
Ada2/Gcn5/Ada3 transcription activator complex 8 1.4 1.19 1.36 1.24 1.39 1.07 1.22
transcription factor TFIIA complex 3 1.45 -1.03 1.19 1.13 1.14 1.08 -1.02
transcription factor TFIIE complex 2 1.86 1.06 1.16 1.23 1.25 1.2 1.16
transcription factor TFIIF complex 3 1.12 1.22 1.41 1.15 1.25 1.15 1.46
holo TFIIH complex 7 1.28 1.1 1.43 1.31 1.4 1.21 1.09
chromatin assembly complex 8 1.08 -1.4 -1.04 -1.4 1.24 1.6 1.04
anaphase-promoting complex 10 1.4 1.11 1.22 1.13 1.2 1.12 1.1
spliceosomal complex 164 1.16 1.11 1.2 1.23 1.3 1.15 -1.0
U5 snRNP 8 1.02 1.2 1.42 1.19 1.41 1.3 1.19
U7 snRNP 1 1.17 -1.14 -1.02 1.29 1.33 -1.04 -1.48
U2-type spliceosomal complex 1 -1.28 1.17 1.49 1.3 1.15 1.37 -1.07
U1 snRNP 9 1.08 1.24 1.47 1.25 1.39 1.33 1.11
U2 snRNP 13 1.25 1.19 1.29 1.24 1.28 1.19 1.05
U4 snRNP 2 1.38 1.31 1.34 1.36 1.44 1.2 1.04
U6 snRNP 9 1.23 -1.02 1.09 1.34 1.26 -1.1 -1.27
U11 snRNP 2 1.15 1.06 1.1 1.32 1.06 1.17 -1.28
U12 snRNP 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
chromosome 301 1.18 1.13 1.24 1.14 1.29 1.19 1.11
polytene chromosome 101 1.23 1.19 1.33 1.13 1.37 1.36 1.27
polytene chromosome chromocenter 12 1.15 1.01 1.1 1.06 1.4 1.13 1.11
polytene chromosome puff 21 1.18 1.24 1.27 1.17 1.25 1.41 1.23
polytene chromosome band 8 1.19 1.12 1.3 1.15 1.48 1.11 1.11
polytene chromosome interband 20 1.23 1.21 1.27 1.2 1.3 1.27 1.15
nuclear euchromatin 4 1.52 1.39 1.51 1.2 1.41 1.55 1.43
nuclear heterochromatin 9 1.18 1.12 1.33 1.09 1.48 1.23 1.27
centromeric heterochromatin 10 1.2 1.1 1.3 1.02 1.42 1.45 1.42
beta-heterochromatin 1 1.4 1.27 1.49 -1.01 1.2 1.7 1.58
alpha-heterochromatin 1 1.02 1.05 1.18 1.16 1.33 1.09 1.01
nuclear telomeric heterochromatin 1 -1.17 1.26 1.25 1.08 2.11 -1.1 1.25
intercalary heterochromatin 6 1.31 1.18 1.31 1.11 1.44 1.27 1.36
nucleolus 70 1.19 1.16 1.25 1.22 1.26 1.08 1.1
small nucleolar ribonucleoprotein complex 5 1.37 1.06 1.15 1.38 1.26 -1.06 -1.08
DNA-directed RNA polymerase I complex 6 1.23 1.16 1.31 1.23 1.28 1.23 1.09
mitochondrial envelope 204 1.05 1.07 1.15 1.05 1.1 1.39 -1.2
mitochondrial outer membrane 23 1.13 -1.01 1.18 1.12 1.17 1.29 -1.07
mitochondrial outer membrane translocase complex 7 1.18 1.07 1.36 1.14 1.17 1.44 -1.07
mitochondrial inner membrane 153 1.04 1.06 1.17 1.05 1.09 1.4 -1.23
mitochondrial inner membrane presequence translocase complex 11 1.06 1.12 1.2 1.14 1.14 1.28 -1.15
mitochondrial respiratory chain 68 1.11 1.0 1.19 1.01 1.07 1.57 -1.31
mitochondrial respiratory chain complex I 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
mitochondrial respiratory chain complex II 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
mitochondrial respiratory chain complex III 11 -1.13 1.03 1.1 1.04 -1.01 1.3 -1.48
mitochondrial respiratory chain complex IV 13 1.04 -1.01 1.2 -1.0 1.14 1.38 -1.29
mitochondrial proton-transporting ATP synthase complex 18 1.31 -1.01 1.22 -1.03 1.11 1.68 -1.22
proton-transporting ATP synthase complex, coupling factor F(o) 9 1.19 1.04 1.31 1.01 1.22 1.62 -1.14
mitochondrial proton-transporting ATP synthase, central stalk 1 1.03 1.03 1.17 1.01 1.11 1.58 -1.38
mitochondrial intermembrane space 11 1.06 1.14 1.24 1.17 1.16 1.38 -1.17
mitochondrial matrix 144 1.1 1.08 1.17 1.11 1.17 1.48 -1.3
gamma DNA polymerase complex 2 -1.07 1.23 1.2 1.04 1.03 1.03 -1.12
mitochondrial ribosome 72 1.04 1.07 1.23 1.29 1.25 1.45 -1.55
mitochondrial large ribosomal subunit 44 1.03 1.05 1.24 1.3 1.28 1.46 -1.6
mitochondrial small ribosomal subunit 30 1.04 1.09 1.24 1.27 1.23 1.47 -1.48
lysosomal membrane 4 1.09 -1.11 -1.38 1.13 1.63 2.55 1.04
secondary lysosome 1 1.17 -2.03 2.67 -1.12 -2.24 1.02 -1.06
endosome 44 -1.01 1.1 1.4 1.04 1.31 1.27 1.37
early endosome 19 -1.03 1.08 1.36 1.01 1.16 1.2 1.43
late endosome 17 -1.09 1.11 1.22 1.07 1.21 1.3 1.36
multivesicular body 6 -1.01 1.0 1.49 1.07 1.26 1.31 1.59
vacuolar membrane 30 -1.55 -1.0 1.28 -1.14 -1.08 1.41 -1.12
integral to peroxisomal membrane 5 1.37 1.29 -1.51 1.15 1.08 -1.33 -1.13
protein targeting to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
peroxisomal part 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
Sec61 translocon complex 8 -1.51 1.3 -1.14 -1.0 -1.28 -1.7 1.22
signal recognition particle receptor complex 4 -1.91 1.42 -1.08 1.06 -1.35 -1.79 1.42
signal recognition particle, endoplasmic reticulum targeting 9 -1.25 1.37 1.01 1.14 -1.09 -1.57 1.26
signal peptidase complex 3 1.12 -1.0 1.0 -1.02 -1.02 -1.01 1.75
endoplasmic reticulum lumen 9 1.27 -1.04 1.01 1.06 1.11 -1.04 1.39
endoplasmic reticulum membrane 64 -1.15 1.18 1.16 1.11 1.13 -1.17 1.12
smooth endoplasmic reticulum 5 2.12 -1.15 1.68 -1.13 1.04 1.12 1.23
rough endoplasmic reticulum 15 -1.44 1.23 -1.0 1.01 -1.26 -1.5 1.29
microsome 85 -1.05 -1.16 -1.3 -1.04 1.03 -1.24 -1.12
endoplasmic reticulum-Golgi intermediate compartment 1 -1.08 1.49 -1.64 1.02 -1.4 -2.11 -1.11
Golgi apparatus 138 1.04 1.15 1.18 1.1 1.19 1.13 1.3
Golgi stack 31 1.11 1.08 1.07 1.04 1.18 1.12 1.47
Golgi-associated vesicle 20 -1.22 1.18 1.09 1.15 1.06 1.03 1.23
COPI vesicle coat 9 -1.24 1.16 -1.05 1.14 -1.11 -1.1 1.28
COPI-coated vesicle 9 -1.24 1.16 -1.05 1.14 -1.11 -1.1 1.28
ER to Golgi transport vesicle 4 1.31 1.22 1.29 1.04 1.28 1.43 2.03
cis-Golgi network 9 1.04 1.19 1.21 1.18 1.15 1.12 1.14
trans-Golgi network 6 -1.72 1.13 1.32 1.15 1.37 1.03 1.11
transport vesicle 15 1.23 1.06 1.2 -1.01 1.17 1.53 1.45
secretory granule 4 -1.19 1.11 1.32 1.05 1.1 -1.29 1.16
transport vesicle membrane 4 -1.16 1.25 1.59 1.05 1.44 1.76 1.54
endocytic vesicle 10 -1.1 -1.41 -1.31 -1.37 1.06 1.46 1.02
lipid particle 232 1.17 -1.07 -1.13 -1.09 1.05 1.16 -1.03
centrosome 62 1.25 1.07 1.27 1.05 1.21 1.28 1.12
centriole 10 1.09 1.08 1.02 1.1 1.08 -1.01 -1.07
microtubule organizing center 72 1.25 1.07 1.25 1.06 1.21 1.27 1.11
aster 7 -1.26 1.17 1.31 1.12 1.35 -1.04 1.04
spindle 81 1.21 1.11 1.28 1.11 1.35 1.24 1.13
actomyosin contractile ring 4 -1.06 1.15 1.51 1.14 1.77 1.47 1.16
polar microtubule 2 -1.12 1.17 1.2 1.12 1.31 1.44 1.21
kinetochore microtubule 9 -1.0 1.13 1.07 1.14 1.19 1.02 1.02
chaperonin-containing T-complex 8 -1.27 1.13 1.1 1.15 -1.02 -1.22 -1.18
fatty acid synthase complex 1 1.39 -1.11 1.17 1.12 1.04 1.29 -1.0
proteasome regulatory particle 24 1.35 1.08 1.26 1.17 1.2 1.06 1.07
proteasome core complex 23 1.34 -1.02 1.1 1.11 1.12 -1.15 -1.1
polysome 1 2.2 1.38 1.27 1.25 1.7 1.45 1.27
mRNA cap binding complex 2 1.35 1.18 1.45 1.11 1.5 1.76 1.35
nuclear cap binding complex 2 1.33 1.12 1.23 1.21 1.34 1.16 1.07
mRNA cleavage and polyadenylation specificity factor complex 7 1.3 1.31 1.42 1.47 1.64 1.34 1.15
mRNA cleavage stimulating factor complex 4 1.19 1.15 1.23 1.16 1.21 1.09 1.06
mRNA cleavage factor complex 13 1.19 1.28 1.36 1.32 1.43 1.3 1.14
eukaryotic translation initiation factor 2 complex 3 1.23 1.22 1.28 1.08 1.12 1.46 1.17
eukaryotic translation initiation factor 2B complex 6 1.27 1.3 1.06 1.17 1.06 1.14 1.04
eukaryotic translation initiation factor 3 complex 16 1.44 1.14 1.33 1.03 1.2 1.61 1.17
eukaryotic translation elongation factor 1 complex 5 2.72 -1.02 1.29 -1.13 1.23 1.37 1.32
nascent polypeptide-associated complex 3 1.55 -1.11 1.12 1.0 1.05 1.16 1.07
cytoskeleton 548 1.09 1.04 1.16 1.03 1.2 1.15 1.06
muscle myosin complex 5 4.08 -1.62 1.08 -1.52 1.03 2.86 -1.26
troponin complex 2 6.95 -2.33 -1.12 -1.86 1.08 3.33 -1.76
muscle thin filament tropomyosin 2 3.23 -1.38 1.31 -1.15 1.21 2.24 -1.26
striated muscle myosin thick filament 3 2.91 -1.49 1.05 -1.32 1.04 2.39 -1.29
striated muscle thin filament 5 3.24 -1.5 1.09 -1.38 1.25 2.3 -1.28
dynactin complex 10 1.11 1.07 1.24 1.19 1.25 1.09 -1.06
kinesin complex 29 1.08 1.11 1.16 1.1 1.2 1.14 1.1
minus-end kinesin complex 1 -1.34 -1.01 1.11 1.33 1.45 -1.15 -1.3
plus-end kinesin complex 3 1.17 1.1 1.09 1.07 1.19 1.04 -1.14
microtubule 54 1.03 1.09 1.21 1.07 1.23 1.11 1.08
microtubule associated complex 344 1.12 1.03 1.11 1.03 1.19 1.17 1.06
spindle microtubule 24 1.15 1.11 1.33 1.06 1.29 1.35 1.18
axonemal microtubule 1 -1.31 -1.04 -1.2 -1.01 -1.13 -1.03 -1.15
nuclear microtubule 1 1.51 1.15 1.47 1.1 1.35 1.02 -1.14
cytoplasmic microtubule 9 -1.07 1.19 1.41 1.03 1.48 1.12 1.24
actin filament 26 -1.06 -1.0 1.14 -1.03 1.19 1.09 1.05
Arp2/3 protein complex 5 -3.04 -1.69 -1.35 1.45 1.29 -2.9 -1.36
sodium:potassium-exchanging ATPase complex 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
voltage-gated calcium channel complex 4 1.36 -1.08 -1.02 1.02 -1.08 1.17 -1.12
acetylcholine-gated channel complex 9 -1.07 1.01 -1.02 -1.03 -1.09 -1.06 -1.03
insulin receptor complex 1 1.01 1.43 1.57 1.5 2.27 1.72 1.64
caveola 1 3.68 -1.06 -1.03 1.16 1.0 1.99 -1.04
microvillus 5 1.36 1.2 1.61 -1.02 1.17 1.09 1.29
brush border 3 -22.7 -1.04 -2.81 1.01 -1.94 1.91 -2.7
coated pit 6 -1.26 1.18 1.24 1.12 1.21 1.33 1.27
AP-type membrane coat adaptor complex 9 -1.11 1.2 1.31 1.16 1.2 1.14 1.2
AP-1 adaptor complex 1 -1.46 1.16 1.32 1.12 1.05 1.44 1.08
cell-cell junction 66 1.52 -1.07 1.19 -1.11 1.18 1.85 1.41
adherens junction 58 1.23 1.15 1.4 1.04 1.4 1.35 1.31
cell-cell adherens junction 13 1.51 1.27 1.67 1.06 1.61 1.75 1.74
spot adherens junction 4 1.12 1.24 1.44 1.07 1.52 1.53 1.48
zonula adherens 9 1.2 1.26 1.62 1.08 1.63 1.49 1.6
nephrocyte diaphragm 3 -3.44 1.01 1.01 1.15 1.01 -2.84 -1.29
septate junction 22 2.96 -1.28 1.21 -1.34 1.26 3.68 1.76
pleated septate junction 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
gap junction 8 -1.22 -1.27 -1.23 -1.25 -1.39 1.09 1.54
tight junction 4 1.14 1.05 1.46 1.03 1.1 1.55 1.04
cell-substrate adherens junction 21 1.3 1.08 1.33 1.01 1.35 1.25 1.25
focal adhesion 15 1.13 1.11 1.37 1.02 1.47 1.18 1.23
connecting hemi-adherens junction 1 1.1 1.42 2.42 1.36 2.63 2.12 3.14
muscle tendon junction 5 2.04 -1.05 1.1 -1.07 -1.09 1.36 1.08
cilium 6 1.05 1.08 1.01 1.11 -1.01 -1.05 1.1
microtubule basal body 4 1.06 -1.02 1.03 1.0 -1.01 1.11 -1.03
cell cortex 86 -1.07 1.18 1.41 1.09 1.4 1.22 1.2
septin ring 5 -1.56 1.08 1.09 1.16 1.34 -1.29 1.06
phosphatidylinositol 3-kinase complex 4 -1.6 1.29 1.4 1.19 1.74 -1.12 -1.04
1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex 2 -1.54 1.47 1.35 1.15 1.83 1.07 1.48
6-phosphofructokinase complex 1 2.63 -1.22 -1.22 1.02 -1.12 5.11 1.3
mitochondrial alpha-ketoglutarate dehydrogenase complex 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
cAMP-dependent protein kinase complex 6 1.3 1.06 1.3 -1.12 1.18 1.98 1.03
calcium- and calmodulin-dependent protein kinase complex 2 1.81 1.24 1.48 1.18 1.44 2.31 1.51
calcineurin complex 5 1.63 -1.01 1.24 1.04 1.14 1.3 1.06
protein kinase CK2 complex 5 -1.01 -1.08 1.03 -1.07 1.06 -1.06 -1.08
DNA-dependent protein kinase-DNA ligase 4 complex 2 -1.03 1.29 1.58 1.29 1.51 -1.21 1.27
glycine cleavage complex 4 1.1 -1.07 1.31 -1.13 -1.08 2.33 -1.17
mitochondrial isocitrate dehydrogenase complex (NAD+) 1 -1.07 1.16 -1.05 -1.13 1.15 1.71 1.06
phosphorylase kinase complex 3 1.8 1.28 1.21 1.07 1.13 2.26 1.63
protein farnesyltransferase complex 1 -1.83 -1.28 -1.22 1.05 -1.01 -1.04 2.75
mitochondrial pyruvate dehydrogenase complex 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
Rab-protein geranylgeranyltransferase complex 4 -1.3 1.2 1.28 1.18 1.3 -1.38 -1.0
ribonucleoside-diphosphate reductase complex 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
carbohydrate metabolic process 349 -1.3 -1.19 -1.48 -1.16 -1.22 -1.28 1.04
polysaccharide metabolic process 131 -1.49 -1.56 -1.71 -1.43 -1.46 -1.36 1.27
glycogen metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
glycogen biosynthetic process 5 2.74 -1.19 -1.42 1.04 1.07 2.78 1.29
glycogen catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
disaccharide metabolic process 5 2.21 -1.79 -2.13 -1.71 -1.22 2.7 -1.01
trehalose metabolic process 5 2.21 -1.79 -2.13 -1.71 -1.22 2.7 -1.01
trehalose biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
monosaccharide metabolic process 74 -1.39 -1.01 -1.54 1.02 -1.04 -1.38 -1.41
fructose metabolic process 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fructose 2,6-bisphosphate metabolic process 1 1.09 -1.34 2.59 -1.04 1.14 3.38 -1.06
fucose metabolic process 4 -1.24 1.16 -1.09 -1.11 1.15 -1.73 2.16
L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
glucose metabolic process 42 -1.0 -1.08 -1.42 -1.06 -1.11 1.05 -1.04
glucose catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
galactose metabolic process 1 -2.18 1.44 -1.11 -1.39 1.11 -2.6 2.04
mannose metabolic process 11 -9.63 -1.07 -4.72 1.44 -1.08 -9.35 -13.32
D-ribose metabolic process 2 -1.21 1.07 -1.3 1.1 -1.27 -1.38 -1.12
inositol metabolic process 2 2.7 -2.43 -2.03 -2.2 -1.38 3.25 -1.23
inositol biosynthetic process 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
aminoglycan metabolic process 120 -1.64 -1.63 -1.78 -1.48 -1.53 -1.5 1.27
aminoglycan biosynthetic process 15 1.36 1.11 1.12 1.03 1.14 1.41 1.3
glycosaminoglycan biosynthetic process 11 1.22 1.23 1.19 1.13 1.29 1.22 1.28
aminoglycan catabolic process 29 -1.22 -1.95 -2.17 -1.68 -1.71 -1.1 1.4
glycosaminoglycan catabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
chitin metabolic process 96 -1.91 -1.76 -2.05 -1.64 -1.62 -1.64 1.34
chitin biosynthetic process 4 1.85 -1.21 -1.08 -1.24 -1.23 2.11 1.33
chitin catabolic process 17 -1.28 -2.2 -3.31 -2.38 -1.64 1.24 2.14
cuticle chitin metabolic process 7 -1.6 -1.5 -2.17 -1.7 -1.06 1.36 1.67
cuticle chitin biosynthetic process 3 1.16 -1.14 1.05 -1.21 -1.11 2.09 1.42
cuticle chitin catabolic process 4 -2.55 -1.85 -4.04 -2.19 -1.03 -1.02 1.9
amino sugar metabolic process 9 1.34 1.24 1.13 1.09 1.26 1.2 1.12
glucosamine metabolic process 8 1.39 1.28 1.16 1.11 1.3 1.22 1.15
N-acetylglucosamine metabolic process 8 1.39 1.28 1.16 1.11 1.3 1.22 1.15
N-acetylneuraminate metabolic process 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
CMP-N-acetylneuraminate biosynthetic process 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
alcohol metabolic process 137 -1.15 -1.03 -1.35 1.01 -1.01 -1.18 -1.15
ethanol metabolic process 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
ethanol oxidation 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
glycerol metabolic process 16 -1.18 1.1 -1.05 1.11 1.01 -1.33 -1.11
glycerol-3-phosphate metabolic process 10 1.18 -1.01 -1.04 1.17 1.39 1.07 -1.25
cellular glucan metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
cellular aldehyde metabolic process 8 1.58 -1.07 -1.41 -1.33 -1.03 1.21 1.04
organic acid metabolic process 239 -1.01 -1.01 -1.15 -1.03 1.0 1.06 -1.05
acetyl-CoA metabolic process 39 -1.0 1.09 1.25 -1.05 1.07 1.5 -1.03
acetyl-CoA biosynthetic process 2 -1.03 1.03 1.25 -1.03 1.02 1.46 -1.0
acetyl-CoA biosynthetic process from pyruvate 1 1.23 1.19 1.96 -1.07 1.35 3.33 1.11
pyruvate metabolic process 10 1.06 1.22 1.23 -1.11 1.04 1.51 1.12
generation of precursor metabolites and energy 140 1.11 1.05 1.13 1.0 1.09 1.53 -1.12
gluconeogenesis 4 1.09 -1.28 -1.21 -1.39 1.08 1.63 -1.02
glycolysis 25 1.37 1.03 -1.05 -1.05 -1.07 1.43 1.11
glyoxylate cycle 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
pentose-phosphate shunt 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
tricarboxylic acid cycle 36 -1.0 1.09 1.26 -1.05 1.07 1.52 -1.04
citrate metabolic process 2 -1.17 -1.01 -1.18 1.04 -1.26 -1.29 -1.1
2-oxoglutarate metabolic process 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
succinate metabolic process 2 -1.04 1.09 1.19 1.01 1.02 1.36 -1.32
fumarate metabolic process 6 -1.06 -1.08 1.01 -1.19 1.09 1.49 -1.51
malate metabolic process 6 -1.07 1.16 1.1 -1.34 -1.06 1.05 1.38
isocitrate metabolic process 1 1.5 1.55 -1.65 -1.56 -1.01 -1.09 1.26
regulation of carbohydrate metabolic process 3 -1.56 -1.05 -1.43 -1.32 1.05 1.6 2.11
energy reserve metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
NADH oxidation 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
acetaldehyde metabolic process 2 2.78 -1.16 -2.38 -2.31 -1.44 1.4 1.22
oxidation-reduction process 538 1.03 -1.05 -1.16 -1.04 -1.02 1.09 -1.04
oxidoreductase activity 612 1.05 -1.06 -1.18 -1.04 -1.04 1.03 -1.05
respiratory electron transport chain 63 1.04 1.03 1.18 1.06 1.12 1.53 -1.32
oxidative phosphorylation 65 1.08 1.05 1.19 1.05 1.1 1.53 -1.32
mitochondrial electron transport, NADH to ubiquinone 31 1.15 1.03 1.29 1.07 1.13 1.74 -1.29
mitochondrial electron transport, succinate to ubiquinone 3 -1.1 1.07 1.36 -1.03 -1.0 1.57 -1.31
mitochondrial electron transport, ubiquinol to cytochrome c 12 -1.09 1.04 1.06 1.05 -1.0 1.32 -1.48
mitochondrial electron transport, cytochrome c to oxygen 11 1.03 -1.01 1.21 1.02 1.15 1.4 -1.32
cell redox homeostasis 50 1.14 1.05 1.09 1.13 1.1 1.12 -1.05
electron transport chain 67 -1.04 1.03 1.17 1.06 1.11 1.45 -1.31
glycerophosphate shuttle 2 1.11 -1.19 -1.41 1.22 2.52 1.34 -1.21
glutathione metabolic process 4 -2.31 1.0 -1.94 1.16 1.13 -1.72 1.13
nucleobase-containing compound metabolic process 986 1.18 1.11 1.19 1.14 1.24 1.16 1.06
regulation of nucleotide metabolic process 51 1.09 1.14 1.33 1.05 1.25 1.28 1.17
purine base metabolic process 6 1.48 1.02 -1.13 -1.0 -1.02 1.22 -1.12
purine nucleotide metabolic process 118 1.13 1.02 1.13 1.0 1.06 1.27 -1.04
purine nucleoside metabolic process 12 1.18 1.15 -1.0 1.18 1.26 -1.09 -1.09
purine nucleotide biosynthetic process 67 1.06 1.03 1.1 1.0 1.03 1.3 -1.07
nucleoside diphosphate phosphorylation 5 1.01 1.09 1.35 1.24 1.35 -1.0 -1.14
purine ribonucleoside salvage 4 1.03 1.11 -1.11 1.23 1.2 1.03 -1.31
adenine salvage 1 1.17 1.37 1.23 1.24 1.3 1.33 -1.5
cAMP biosynthetic process 6 1.38 -1.01 1.27 1.01 1.07 1.29 1.16
ADP biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
GMP biosynthetic process 2 1.15 1.21 1.23 -1.01 1.16 1.11 2.05
cGMP biosynthetic process 10 -1.15 -1.02 -1.07 1.01 -1.08 -1.14 -1.12
GTP biosynthetic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
GTP catabolic process 37 1.17 1.04 1.14 1.08 1.12 1.08 1.0
IMP biosynthetic process 7 1.14 1.03 -1.12 -1.04 -1.13 1.95 -1.01
'de novo' IMP biosynthetic process 6 1.13 1.02 -1.2 -1.03 -1.2 1.78 -1.03
purine nucleotide catabolic process 40 1.18 1.04 1.15 1.09 1.13 1.08 1.01
ATP catabolic process 2 1.12 1.21 1.11 1.15 1.2 1.05 1.15
pyrimidine base metabolic process 9 1.42 1.06 -1.02 1.04 -1.01 1.03 1.1
pyrimidine nucleoside metabolic process 10 -1.32 1.14 1.04 1.22 1.27 -1.25 -1.09
pyrimidine nucleotide metabolic process 13 1.09 1.09 1.18 1.27 1.29 -1.05 -1.17
'de novo' pyrimidine base biosynthetic process 6 1.66 -1.0 1.02 -1.03 -1.03 1.11 1.08
pyrimidine base catabolic process 3 2.92 -1.42 -1.24 -1.35 -1.35 1.45 1.16
uracil catabolic process 1 1.44 -1.11 -1.15 1.16 -1.17 -1.1 -1.2
cytidine catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
pyrimidine nucleotide biosynthetic process 11 1.06 1.14 1.21 1.24 1.28 -1.02 -1.1
UMP biosynthetic process 3 1.1 1.3 1.05 1.25 1.1 -1.22 -1.06
UTP biosynthetic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
TMP biosynthetic process 1 1.02 1.09 1.32 1.32 1.3 -1.29 -1.13
dTMP biosynthetic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
dTDP biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
CTP biosynthetic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
DNA metabolic process 257 1.17 1.09 1.23 1.13 1.3 1.15 1.06
DNA-dependent DNA replication 46 1.03 1.13 1.18 1.17 1.36 1.14 -1.01
mitochondrial DNA replication 5 -1.01 1.2 1.25 1.15 1.21 1.2 -1.15
DNA topological change 7 1.09 1.2 1.22 1.21 1.33 1.09 1.23
DNA ligation 2 1.6 1.14 1.36 1.04 1.35 1.44 1.13
pre-replicative complex assembly 7 -1.21 1.08 1.17 1.27 1.62 -1.3 -1.19
DNA unwinding involved in replication 2 -1.01 1.27 1.01 -1.0 -1.05 1.15 1.27
DNA replication, synthesis of RNA primer 2 1.15 1.13 1.17 1.19 1.37 1.14 -1.16
DNA-dependent DNA replication initiation 13 -1.05 1.12 1.14 1.28 1.49 -1.11 -1.11
DNA strand elongation involved in DNA replication 3 -1.21 -1.08 1.4 1.14 1.61 -1.08 -1.25
leading strand elongation 1 -1.9 -1.01 1.54 1.17 1.67 -2.38 -1.41
regulation of DNA replication 17 -1.04 1.13 1.23 1.15 1.36 -1.13 1.15
DNA amplification 20 1.07 1.2 1.36 1.18 1.45 1.1 1.11
RNA-dependent DNA replication 1 1.54 1.82 1.92 -1.04 1.87 1.15 2.39
DNA repair 93 1.23 1.08 1.27 1.13 1.31 1.19 1.06
base-excision repair 6 1.51 -1.01 1.25 1.11 1.19 1.33 -1.13
base-excision repair, AP site formation 1 1.23 1.13 1.14 1.14 1.15 1.01 1.07
nucleotide-excision repair 24 1.23 1.1 1.38 1.15 1.33 1.2 1.06
nucleotide-excision repair, DNA incision, 5'-to lesion 1 1.98 1.16 1.33 1.18 1.39 1.07 1.02
mismatch repair 8 1.32 1.07 1.23 1.15 1.41 1.18 -1.02
postreplication repair 6 1.36 1.02 1.3 1.15 1.44 1.29 1.03
double-strand break repair 19 1.08 1.18 1.26 1.17 1.32 -1.01 1.13
double-strand break repair via nonhomologous end joining 4 -1.13 1.35 1.38 1.24 1.37 -1.21 1.19
DNA modification 4 1.35 1.09 1.41 1.21 1.32 1.35 1.17
DNA alkylation 3 1.44 1.12 1.49 1.07 1.37 1.47 1.26
DNA methylation 3 1.44 1.12 1.49 1.07 1.37 1.47 1.26
DNA dealkylation involved in DNA repair 1 1.12 -1.01 1.19 1.74 1.2 1.06 -1.09
DNA catabolic process 9 1.71 -1.1 1.05 -1.12 1.18 1.29 1.41
DNA fragmentation involved in apoptotic nuclear change 3 1.86 1.09 1.48 1.14 1.43 1.6 1.67
DNA recombination 40 1.06 1.13 1.16 1.14 1.25 1.02 1.05
transposition, DNA-mediated 1 1.07 -1.04 -1.16 1.02 1.48 -1.27 -1.22
DNA packaging 70 1.1 1.09 1.27 1.13 1.3 1.1 1.1
chromatin organization 143 1.2 1.13 1.29 1.13 1.31 1.21 1.19
DNA replication-independent nucleosome assembly 1 -1.49 1.47 -1.04 1.39 1.42 -1.65 -1.06
chromatin remodeling 35 1.33 1.21 1.43 1.13 1.4 1.41 1.3
chromatin silencing 40 1.29 1.14 1.31 1.13 1.32 1.3 1.18
chromatin-mediated maintenance of transcription 8 1.92 1.19 1.53 1.04 1.43 1.72 1.45
chromatin insulator sequence binding 7 1.43 1.12 1.23 1.26 1.29 1.26 1.14
establishment of chromatin silencing 1 1.04 -1.03 1.41 1.25 1.4 1.24 -1.08
chromatin silencing at telomere 2 1.51 1.1 1.54 1.1 1.65 2.14 1.15
regulation of gene expression by genetic imprinting 1 1.01 1.1 1.09 1.14 -1.01 1.17 1.11
transcription, DNA-dependent 149 1.27 1.12 1.22 1.16 1.25 1.16 1.13
transcription initiation, DNA-dependent 68 1.28 1.1 1.25 1.16 1.25 1.15 1.14
transcription elongation, DNA-dependent 7 1.13 1.24 1.33 1.14 1.27 1.28 1.28
regulation of transcription, DNA-dependent 671 1.13 1.08 1.17 1.06 1.16 1.15 1.13
regulation of transcription from RNA polymerase I promoter 1 1.03 1.42 1.12 1.32 1.22 1.06 1.31
regulation of transcription from RNA polymerase II promoter 306 1.09 1.06 1.16 1.04 1.13 1.13 1.11
regulation of transcription from RNA polymerase III promoter 5 1.56 1.19 1.46 1.24 1.48 1.38 1.12
rRNA processing 27 1.21 1.16 1.21 1.32 1.31 1.02 1.04
transcription initiation from RNA polymerase II promoter 62 1.34 1.12 1.27 1.18 1.28 1.18 1.11
transcription elongation from RNA polymerase II promoter 6 1.12 1.24 1.29 1.14 1.22 1.21 1.27
mRNA capping 2 1.43 1.2 1.32 1.24 1.14 1.18 1.16
mRNA splice site selection 8 1.08 1.11 1.22 1.24 1.25 1.14 -1.09
mRNA polyadenylation 16 1.4 1.12 1.26 1.13 1.32 1.72 1.2
mRNA cleavage 15 1.21 1.25 1.41 1.3 1.43 1.28 1.15
poly(A) RNA binding 5 1.32 1.19 1.41 1.19 1.38 1.34 1.35
adenosine to inosine editing 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
transcription initiation from RNA polymerase III promoter 1 1.15 1.32 1.1 1.22 1.43 1.06 1.02
tRNA splicing, via endonucleolytic cleavage and ligation 3 1.93 1.15 1.42 1.2 1.36 1.44 1.34
transcription from mitochondrial promoter 3 1.29 1.23 1.41 1.12 1.47 1.73 -1.1
termination of mitochondrial transcription 1 1.24 1.11 1.4 1.15 1.32 1.42 -1.37
RNA processing 315 1.22 1.13 1.23 1.22 1.29 1.19 1.03
mRNA processing 228 1.21 1.12 1.23 1.22 1.31 1.2 1.04
histone mRNA 3'-end processing 8 1.38 1.09 1.19 1.27 1.38 1.29 1.05
tRNA metabolic process 74 1.1 1.19 1.2 1.18 1.17 1.07 1.01
tRNA modification 16 1.24 1.15 1.11 1.21 1.19 1.09 -1.07
RNA catabolic process 30 1.13 1.15 1.32 1.17 1.34 1.34 1.22
mRNA catabolic process 24 1.1 1.16 1.33 1.18 1.37 1.31 1.2
RNA localization 99 1.01 1.16 1.28 1.14 1.27 1.16 1.09
RNA import into nucleus 1 1.13 1.03 1.18 1.15 1.1 1.24 -1.22
RNA export from nucleus 20 1.14 1.1 1.18 1.19 1.21 1.08 -1.04
mRNA export from nucleus 18 1.1 1.09 1.18 1.2 1.21 1.06 -1.05
snRNA export from nucleus 2 1.9 1.18 1.33 1.29 1.62 1.23 1.13
tRNA export from nucleus 1 1.48 1.1 1.33 1.32 1.54 -1.18 -1.04
translation 279 1.2 1.1 1.19 1.11 1.18 1.26 -1.04
translational initiation 52 1.32 1.17 1.24 1.09 1.16 1.33 1.15
translational elongation 18 1.46 1.07 1.16 1.06 1.21 1.3 1.01
translational termination 6 1.2 1.18 1.21 1.16 1.16 1.51 1.06
regulation of translation 53 1.42 1.08 1.27 1.03 1.3 1.38 1.28
tRNA aminoacylation for protein translation 41 -1.07 1.25 1.27 1.14 1.19 1.05 1.09
alanyl-tRNA aminoacylation 3 -1.05 1.37 1.07 1.17 1.09 1.18 1.07
arginyl-tRNA aminoacylation 3 1.35 1.15 1.32 1.15 1.24 1.15 1.05
asparaginyl-tRNA aminoacylation 2 -1.04 1.15 1.12 1.09 1.19 -1.05 1.03
aspartyl-tRNA aminoacylation 1 -1.97 1.61 1.28 -1.18 1.45 -1.88 1.38
cysteinyl-tRNA aminoacylation 2 -1.01 1.37 1.43 1.08 1.22 1.24 1.76
glutamyl-tRNA aminoacylation 2 1.05 1.23 1.54 -1.01 1.6 1.42 1.27
glutaminyl-tRNA aminoacylation 2 1.01 1.2 1.18 1.26 1.25 1.22 -1.02
glycyl-tRNA aminoacylation 3 1.01 1.17 1.37 1.21 1.21 1.27 -1.07
histidyl-tRNA aminoacylation 1 -1.32 1.37 -1.07 1.31 -1.14 -1.74 -1.19
isoleucyl-tRNA aminoacylation 2 1.35 1.22 1.54 1.02 1.38 1.61 1.38
leucyl-tRNA aminoacylation 2 -1.17 1.4 1.1 1.12 1.07 1.1 1.24
lysyl-tRNA aminoacylation 1 1.12 1.29 1.39 1.11 1.29 1.02 1.14
methionyl-tRNA aminoacylation 2 -1.59 1.18 1.28 1.38 1.17 -1.27 -1.03
phenylalanyl-tRNA aminoacylation 3 -1.16 1.27 1.38 1.24 1.13 -1.0 -1.14
prolyl-tRNA aminoacylation 2 -1.08 1.19 1.31 1.06 1.32 1.47 1.15
seryl-tRNA aminoacylation 3 -1.3 1.34 1.25 1.17 1.28 -1.22 -1.0
threonyl-tRNA aminoacylation 2 -1.65 1.24 1.06 1.13 -1.08 -1.17 1.02
tryptophanyl-tRNA aminoacylation 2 1.09 1.09 1.24 1.11 1.12 1.12 1.03
tyrosyl-tRNA aminoacylation 2 1.14 1.27 1.29 1.14 1.19 1.03 -1.04
valyl-tRNA aminoacylation 2 -1.62 1.31 1.29 1.15 1.04 -1.25 1.17
regulation of translational initiation 10 1.76 -1.0 1.08 -1.04 1.23 1.53 1.27
regulation of translational initiation by iron 2 1.36 1.24 1.32 -1.06 1.1 1.69 1.16
regulation of translational elongation 3 1.5 1.19 1.07 1.08 1.04 1.01 1.17
regulation of translational termination 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
translational readthrough 2 1.54 1.17 1.08 1.41 1.45 -1.1 -1.08
translational frameshifting 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
'de novo' protein folding 13 1.11 1.05 1.16 1.13 1.14 -1.02 -1.03
protein complex assembly 80 1.0 1.09 1.26 1.1 1.24 1.12 -1.01
protein modification process 623 1.16 1.1 1.22 1.07 1.22 1.25 1.13
signal peptide processing 3 1.12 -1.0 1.0 -1.02 -1.02 -1.01 1.75
protein phosphorylation 241 1.17 1.1 1.26 1.06 1.28 1.37 1.18
negative regulation of protein kinase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
protein dephosphorylation 81 1.24 1.1 1.23 1.06 1.22 1.31 1.13
protein ADP-ribosylation 10 1.1 1.07 1.16 1.06 1.17 -1.04 1.01
protein acetylation 16 1.31 1.25 1.45 1.18 1.34 1.36 1.25
N-terminal protein amino acid acetylation 1 -1.5 1.47 2.65 1.15 1.31 -1.14 -1.06
internal protein amino acid acetylation 14 1.4 1.24 1.42 1.18 1.37 1.44 1.29
protein deacetylation 9 1.34 1.15 1.08 1.23 1.2 1.41 1.12
protein methylation 32 1.29 1.19 1.36 1.15 1.36 1.34 1.2
C-terminal protein methylation 1 -2.13 1.18 1.09 1.41 1.8 -1.71 -1.76
protein demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
protein glycosylation 51 1.14 1.04 1.06 1.04 1.1 1.12 1.22
protein N-linked glycosylation 14 1.33 1.02 1.11 1.03 1.13 1.55 1.26
dolichol-linked oligosaccharide biosynthetic process 2 1.08 1.14 1.16 -1.01 1.12 1.06 1.17
oligosaccharide-lipid intermediate biosynthetic process 1 -1.04 -1.0 1.06 -1.08 -1.02 -1.02 -1.17
N-glycan processing 1 3.13 1.28 1.73 1.05 1.33 2.12 2.37
protein O-linked glycosylation 10 -1.06 1.11 1.08 1.09 1.19 -1.37 1.29
protein lipidation 50 -1.11 1.0 1.04 1.04 1.13 -1.02 -1.14
N-terminal protein lipidation 2 -1.18 1.31 1.73 1.36 1.77 -1.01 -1.01
N-terminal protein myristoylation 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
N-terminal protein palmitoylation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
protein prenylation 4 -1.32 1.12 1.23 1.09 1.23 -1.12 1.41
protein geranylgeranylation 1 1.07 1.22 1.65 1.13 1.53 -1.02 -1.05
GPI anchor metabolic process 25 -1.3 -1.04 1.04 -1.0 1.2 1.0 -1.25
GPI anchor biosynthetic process 22 -1.36 -1.06 -1.0 -1.0 1.15 -1.03 -1.34
GPI anchor release 1 1.09 1.12 1.02 1.1 1.11 1.04 1.13
proteolysis 624 -1.68 -1.23 -1.28 -1.03 -1.1 -1.65 -1.4
membrane protein ectodomain proteolysis 2 -1.1 1.22 1.43 1.31 1.8 -1.31 1.17
protein processing 33 1.26 -1.01 1.14 -1.0 1.11 1.16 1.21
proteolysis involved in cellular protein catabolic process 106 1.15 1.12 1.31 1.13 1.28 1.07 1.08
ubiquitin-dependent protein catabolic process 92 1.16 1.13 1.33 1.13 1.29 1.1 1.13
protein monoubiquitination 1 -1.01 -1.28 2.49 -1.24 1.59 -1.44 -1.52
misfolded or incompletely synthesized protein catabolic process 1 2.66 -1.19 -1.04 1.2 -1.17 1.37 1.41
glycoprotein catabolic process 1 -1.09 1.27 1.39 1.28 1.54 -1.1 1.18
protein deglycosylation 1 3.0 -1.25 -1.04 1.43 1.17 2.32 1.34
peptide metabolic process 9 -1.21 1.04 -1.26 1.07 1.11 -1.18 1.4
cellular amino acid metabolic process 161 -1.02 1.04 -1.09 -1.01 1.01 1.14 -1.04
alanine metabolic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
alanine biosynthetic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
arginine metabolic process 5 -5.16 1.27 -5.44 1.2 1.07 -3.1 -1.21
arginine biosynthetic process 2 -22.15 1.64 -12.84 1.4 1.07 -7.77 -1.97
arginine catabolic process 2 -3.2 -1.06 -5.13 -1.12 -1.07 -1.58 1.05
asparagine metabolic process 2 -1.07 1.2 1.14 1.26 1.17 1.27 -1.14
asparagine biosynthetic process 2 -1.07 1.2 1.14 1.26 1.17 1.27 -1.14
aspartate metabolic process 2 1.83 1.18 -1.32 -1.0 1.19 1.57 1.14
cysteine metabolic process 3 1.38 1.11 1.22 -1.23 -2.05 -1.02 1.55
cysteine biosynthetic process from serine 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
glutamate metabolic process 10 -1.06 -1.22 -1.57 -1.37 1.12 1.73 -1.05
glutamate biosynthetic process 5 1.59 -1.31 -1.43 -1.5 -1.34 2.96 1.23
glutamate catabolic process 4 -1.09 -1.24 1.09 -1.34 1.82 1.75 -1.68
glutamine metabolic process 5 -1.72 -1.12 -1.2 -1.13 1.54 -1.57 -3.03
glutamine biosynthetic process 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
glutamine catabolic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
glycine metabolic process 9 1.41 1.01 1.25 -1.01 -1.01 1.77 -1.06
glycine biosynthetic process 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
glycine catabolic process 6 1.21 1.07 1.39 -1.04 -1.02 1.86 -1.02
isoleucine metabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
isoleucine catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
leucine metabolic process 4 1.15 1.54 1.31 1.24 1.31 1.45 1.1
leucine catabolic process 1 1.14 1.39 1.15 1.11 1.04 1.05 1.01
lysine metabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
lysine catabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
methionine metabolic process 6 1.26 -1.05 -1.1 -1.03 -1.11 1.66 -1.23
S-adenosylmethionine biosynthetic process 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
L-phenylalanine metabolic process 4 1.52 -1.14 -1.01 -1.01 -1.02 2.14 -1.13
L-phenylalanine catabolic process 4 1.52 -1.14 -1.01 -1.01 -1.02 2.14 -1.13
proline metabolic process 7 -1.43 -1.33 -1.79 -1.62 -1.41 1.63 1.05
proline biosynthetic process 4 -1.95 -1.03 -1.89 -1.37 -1.23 1.12 1.21
proline catabolic process 2 1.19 -2.55 -2.04 -2.77 -1.87 5.01 -1.07
L-serine metabolic process 5 2.33 1.11 -1.22 1.0 -1.34 1.61 1.43
L-serine biosynthetic process 4 2.73 1.12 -1.41 1.19 1.13 1.89 1.23
threonine metabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
threonine catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
tryptophan metabolic process 7 1.13 -1.34 -1.47 -1.15 -1.37 1.23 1.22
tryptophan catabolic process 2 1.18 -1.21 -1.17 -1.24 -1.21 1.62 -1.18
tyrosine metabolic process 8 1.53 -1.29 -1.23 -1.14 -1.34 1.56 1.15
tyrosine catabolic process 3 1.31 -1.03 1.15 1.15 1.06 1.47 -1.07
valine metabolic process 3 -1.09 1.41 -1.02 -1.03 -1.14 1.15 1.23
valine catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
cellular modified amino acid metabolic process 27 -1.23 1.06 -1.31 1.01 -1.04 -1.11 -1.06
cellular biogenic amine metabolic process 29 1.1 -1.1 -1.15 -1.04 -1.12 1.08 1.25
betaine metabolic process 2 -1.01 -1.08 -1.06 -1.12 -1.16 1.15 -1.15
betaine biosynthetic process 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
ethanolamine metabolic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
acetylcholine catabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
melanin metabolic process 16 2.27 -1.2 -1.16 -1.18 1.1 1.65 1.32
melanin biosynthetic process from tyrosine 4 1.82 -1.08 -1.09 -1.03 -1.18 1.82 -1.13
catecholamine metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
dopamine biosynthetic process from tyrosine 1 1.23 -4.96 -5.74 -3.75 -6.41 -1.0 6.11
indolalkylamine metabolic process 8 -1.18 -1.2 -1.54 -1.13 -1.45 -1.17 1.22
serotonin biosynthetic process from tryptophan 2 1.67 -2.04 -2.31 -1.94 -2.17 1.48 3.91
activation of tryptophan 5-monooxygenase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
octopamine biosynthetic process 1 1.3 1.0 -1.05 -1.09 1.04 -1.06 -1.0
ornithine metabolic process 3 -2.2 1.14 -2.13 1.11 -1.02 -1.24 -1.28
polyamine metabolic process 6 -1.02 -1.06 -1.06 1.08 -1.03 1.44 -1.28
polyamine biosynthetic process 5 1.03 -1.1 -1.08 1.04 -1.04 1.59 -1.28
spermine biosynthetic process 2 1.12 1.21 1.31 1.22 1.2 1.92 1.01
polyamine catabolic process 1 -1.3 1.12 1.08 1.3 1.03 -1.14 -1.27
protein targeting 109 1.05 1.18 1.26 1.14 1.21 1.12 1.14
NLS-bearing substrate import into nucleus 7 -1.09 1.31 1.37 1.28 1.56 1.0 1.17
protein export from nucleus 5 1.19 1.11 2.28 1.15 1.72 1.71 1.32
protein targeting to membrane 25 -1.09 1.24 1.08 1.08 -1.04 -1.21 1.13
cotranslational protein targeting to membrane 16 -1.27 1.37 -1.06 1.05 -1.21 -1.6 1.25
SRP-dependent cotranslational protein targeting to membrane 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
SRP-dependent cotranslational protein targeting to membrane, translocation 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition 1 -1.09 1.62 1.41 1.12 1.35 1.19 1.81
protein retention in ER lumen 3 -1.9 1.28 -1.09 1.08 -1.19 -2.08 1.34
protein targeting to lysosome 3 1.19 1.18 1.82 1.21 1.4 1.29 1.24
protein targeting to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
protein targeting to mitochondrion 28 1.07 1.09 1.21 1.13 1.12 1.18 -1.1
protein processing involved in protein targeting to mitochondrion 2 1.16 1.04 1.32 1.16 1.03 1.09 -1.27
lipid metabolic process 302 -1.17 -1.16 -1.23 -1.08 -1.04 -1.3 -1.11
lipid binding 177 1.05 -1.11 1.02 -1.03 1.14 1.13 1.06
fatty acid metabolic process 49 1.06 -1.23 -1.39 -1.08 -1.07 -1.23 -1.05
fatty acid biosynthetic process 25 1.1 -1.38 -1.52 -1.26 -1.29 1.04 1.14
fatty acid beta-oxidation 12 -1.2 1.1 -1.58 1.06 1.17 -2.29 -1.36
unsaturated fatty acid biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
acyl-CoA metabolic process 6 2.01 1.03 1.27 1.12 1.42 1.33 1.06
neutral lipid metabolic process 10 1.74 -1.01 1.02 -1.04 1.58 -1.11 -1.1
acylglycerol metabolic process 10 1.74 -1.01 1.02 -1.04 1.58 -1.11 -1.1
triglyceride metabolic process 7 1.7 1.03 -1.06 -1.02 1.5 1.09 -1.06
triglyceride mobilization 1 -2.11 1.69 -1.72 -1.16 2.47 -2.75 -1.82
membrane lipid metabolic process 28 -2.18 -1.19 -1.19 1.18 1.02 -2.06 -1.41
phospholipid metabolic process 93 1.02 -1.05 1.02 1.02 1.23 1.02 -1.04
phosphatidylethanolamine biosynthetic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
glycerophospholipid metabolic process 66 1.09 1.03 1.13 1.01 1.25 1.18 1.06
diacylglycerol biosynthetic process 2 4.42 -1.06 2.12 -1.4 1.56 1.46 1.74
phosphatidylglycerol biosynthetic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidylcholine biosynthetic process 1 -1.0 -1.38 1.09 1.05 1.26 -1.4 2.06
phosphatidylserine metabolic process 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
phosphatidylserine biosynthetic process 1 1.61 1.37 2.22 1.0 1.13 1.67 1.83
phosphatidylinositol biosynthetic process 24 -1.24 -1.05 1.03 -1.01 1.12 -1.0 -1.25
glycerol ether metabolic process 26 1.41 -1.13 -1.09 -1.07 1.17 -1.17 1.01
glycolipid metabolic process 8 1.02 1.23 1.09 1.02 1.05 -1.13 1.74
sphingolipid metabolic process 24 -2.32 -1.33 -1.28 1.19 1.03 -2.16 -1.6
ceramide metabolic process 7 -1.82 -1.06 1.22 1.15 1.12 -2.11 -1.7
glycosylceramide metabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
glucosylceramide metabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
glucosylceramide catabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
sphingomyelin metabolic process 5 -5.26 -3.33 -4.18 1.39 -1.08 -3.6 -4.11
sphingomyelin catabolic process 3 -14.19 -8.88 -14.23 1.69 -1.38 -9.59 -10.93
sphingomyelin biosynthetic process 1 -1.01 1.47 1.74 -1.23 1.22 1.11 1.04
glycosphingolipid metabolic process 5 1.35 1.03 1.0 1.01 1.04 1.17 1.95
glycosphingolipid biosynthetic process 4 1.47 1.01 -1.03 -1.08 1.02 1.2 2.34
icosanoid metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
leukotriene metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
steroid biosynthetic process 18 1.4 -1.12 -1.0 -1.04 1.07 1.48 1.09
cholesterol biosynthetic process 1 2.16 -1.1 1.03 -1.13 1.06 2.2 1.18
ecdysone biosynthetic process 7 1.01 1.04 1.04 1.09 -1.04 1.04 1.01
steroid catabolic process 2 -1.06 1.06 1.18 1.13 1.19 1.01 -1.1
cholesterol catabolic process 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
sesquiterpenoid metabolic process 6 -1.16 -1.26 -1.56 -1.5 -1.43 -2.35 1.61
juvenile hormone metabolic process 6 -1.16 -1.26 -1.56 -1.5 -1.43 -2.35 1.61
juvenile hormone biosynthetic process 2 1.77 -2.92 -3.1 -3.09 -1.69 -1.43 2.62
juvenile hormone catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
isoprenoid metabolic process 19 1.13 -1.14 -1.16 -1.06 1.01 -1.18 1.11
terpenoid metabolic process 11 -1.32 -1.26 -1.61 -1.13 -1.21 -1.86 1.01
cuticle hydrocarbon biosynthetic process 3 1.33 -1.03 -1.15 1.2 1.17 1.22 1.02
cellular aromatic compound metabolic process 72 1.45 -1.01 -1.02 -1.0 -1.03 1.22 1.11
eye pigment biosynthetic process 29 1.05 -1.06 -1.17 1.17 1.04 -1.09 -1.16
ommochrome biosynthetic process 18 1.35 1.13 1.12 1.06 1.06 1.08 1.16
pteridine biosynthetic process 5 2.4 -1.22 -1.26 -1.24 -1.16 -1.04 1.7
tetrahydrobiopterin biosynthetic process 4 7.84 -1.48 -1.41 -1.58 -1.23 1.76 2.48
one-carbon metabolic process 15 -1.73 -1.28 1.21 -1.29 1.06 1.32 -1.1
coenzyme metabolic process 86 1.32 1.09 1.09 1.0 1.09 1.34 1.06
prosthetic group metabolic process 5 1.14 1.31 1.37 1.14 1.16 -1.34 1.2
oxidoreduction coenzyme metabolic process 16 1.6 1.17 -1.26 1.03 1.09 1.19 1.2
NADH metabolic process 1 -1.32 -1.9 1.3 -2.14 3.35 4.87 -4.48
NADP metabolic process 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
NADPH regeneration 7 2.13 1.17 -1.85 1.03 -1.09 1.03 1.53
ubiquinone metabolic process 5 1.12 1.18 1.13 1.21 1.09 1.08 -1.08
ubiquinone biosynthetic process 4 1.15 1.16 1.14 1.19 1.12 1.3 -1.07
lipoamide metabolic process 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
glutathione biosynthetic process 3 -2.99 1.44 -1.36 1.22 -1.32 -2.2 1.15
nucleoside phosphate metabolic process 167 1.11 1.05 1.05 1.02 1.07 1.16 1.0
ATP biosynthetic process 25 1.34 1.04 1.24 -1.05 1.09 1.66 -1.1
folic acid-containing compound metabolic process 8 1.68 -1.27 -1.29 -1.11 -1.33 1.27 1.0
vitamin metabolic process 11 1.53 1.22 -1.23 -1.04 -1.18 1.35 1.13
water-soluble vitamin metabolic process 7 1.81 1.34 -1.5 -1.06 -1.3 1.43 1.2
riboflavin metabolic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
thiamine metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
fat-soluble vitamin metabolic process 3 1.15 1.02 1.22 -1.01 1.05 1.32 1.08
vitamin A metabolic process 2 1.02 1.01 1.08 1.02 -1.08 1.12 -1.06
Mo-molybdopterin cofactor biosynthetic process 5 1.14 1.31 1.37 1.14 1.16 -1.34 1.2
porphyrin-containing compound metabolic process 9 1.28 1.21 1.24 1.17 1.12 1.19 -1.04
porphyrin-containing compound biosynthetic process 8 1.22 1.23 1.16 1.18 1.09 1.1 -1.06
protoporphyrinogen IX biosynthetic process 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
heme biosynthetic process 8 1.22 1.23 1.16 1.18 1.09 1.1 -1.06
heme a biosynthetic process 1 -1.08 1.29 1.99 1.12 1.3 1.57 -1.3
porphyrin-containing compound catabolic process 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
heme oxidation 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
phosphorus metabolic process 462 1.19 1.08 1.21 1.06 1.23 1.36 1.08
phosphate-containing compound metabolic process 462 1.19 1.08 1.21 1.06 1.23 1.36 1.08
reactive oxygen species metabolic process 13 1.12 1.07 -1.12 1.06 -1.02 1.06 -1.05
superoxide metabolic process 7 1.3 1.1 -1.14 1.03 -1.08 1.27 -1.04
xenobiotic metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
response to insecticide 16 1.05 1.09 -1.54 -1.14 -1.27 -1.41 1.29
nitrogen compound metabolic process 1275 1.09 1.03 1.06 1.06 1.13 1.1 1.06
nitric oxide biosynthetic process 1 1.08 1.06 1.02 1.1 1.05 -1.07 -1.02
transport 1327 -1.07 1.01 1.01 -1.01 1.06 1.08 1.01
ion transport 298 -1.06 -1.04 1.01 -1.1 -1.05 1.19 -1.05
cation transport 213 -1.06 -1.03 1.05 -1.06 -1.02 1.21 -1.05
potassium ion transport 37 1.08 -1.04 1.02 -1.19 -1.13 1.09 -1.11
sodium ion transport 50 -1.09 -1.07 -1.07 -1.01 -1.03 1.13 -1.05
calcium ion transport 24 1.54 -1.04 1.07 -1.11 1.19 1.63 1.19
phosphate ion transport 10 -1.16 -1.04 -1.52 -1.15 1.01 2.17 -1.68
hydrogen transport 51 -1.18 1.0 1.25 -1.1 -1.04 1.38 -1.15
anion transport 43 -1.18 -1.09 -1.23 -1.24 -1.09 1.32 -1.06
chloride transport 6 1.12 1.13 -1.09 1.06 1.34 1.82 1.32
metal ion transport 132 1.02 -1.06 1.01 -1.06 -1.03 1.18 -1.03
water transport 3 -1.65 1.03 -1.57 1.34 -1.36 -2.48 1.11
dicarboxylic acid transport 8 1.09 -1.04 -1.41 -1.66 -1.35 1.44 1.09
neurotransmitter transport 121 -1.01 -1.02 1.09 1.04 1.22 1.22 1.08
serotonin transport 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
mitochondrial transport 49 1.06 1.1 1.12 1.12 1.18 1.27 -1.05
oxoglutarate:malate antiporter activity 4 -1.11 -1.07 1.09 -1.04 -1.13 1.37 -1.22
alpha-ketoglutarate transport 3 -1.11 -1.06 1.14 -1.03 -1.15 1.61 -1.21
malate transport 5 -1.06 -1.22 1.26 -1.12 1.12 2.23 -1.26
tricarboxylic acid transport 6 1.38 1.1 -1.07 -1.11 -1.31 1.27 -1.04
mitochondrial citrate transport 1 -1.29 1.86 -1.38 -1.29 -2.25 1.02 -1.13
acyl carnitine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
aspartate transport 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
L-glutamate transport 4 -2.92 -1.1 -4.98 -1.98 -1.32 -2.35 -3.75
mitochondrial calcium ion transport 1 1.01 1.3 1.51 1.08 2.35 4.41 1.77
drug transmembrane transport 1 -10.37 1.6 -11.08 1.04 2.2 -3.48 1.28
eye pigment precursor transport 5 -1.06 1.05 1.08 -1.01 1.12 -1.21 1.04
oligopeptide transport 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
nucleotide transport 3 1.1 1.07 1.13 1.06 1.12 1.41 -1.2
amino acid transport 39 -1.51 -1.14 -1.83 -1.24 1.0 -1.08 -1.16
glutamine transport 1 -3.47 -4.26 1.06 2.44 2.17 -3.37 -7.09
lipid transport 28 -2.26 -1.6 -1.93 -1.01 -1.22 -1.56 -1.89
cellular ion homeostasis 52 1.12 1.02 1.16 -1.19 -1.12 1.37 1.11
cellular calcium ion homeostasis 10 1.86 -1.02 1.36 -1.1 -1.04 1.64 1.18
cellular metal ion homeostasis 20 1.2 -1.1 1.18 -1.09 -1.21 1.18 -1.03
cellular copper ion homeostasis 2 -1.26 1.35 2.1 1.13 1.14 1.39 1.07
cellular iron ion homeostasis 8 1.49 -1.19 -1.16 -1.17 -1.18 1.48 1.09
cellular zinc ion homeostasis 1 -1.15 1.5 3.36 1.09 -1.02 -1.02 -1.03
cell volume homeostasis 2 1.92 1.08 -1.06 -1.08 2.11 2.25 1.09
regulation of pH 9 -1.27 1.25 1.91 -1.01 1.19 1.86 1.45
intracellular protein transport 172 1.02 1.18 1.29 1.13 1.21 1.11 1.17
exocytosis 60 -1.02 1.08 1.27 1.11 1.21 1.16 1.11
ER to Golgi vesicle-mediated transport 17 1.16 1.15 1.31 1.14 1.22 1.36 1.31
retrograde vesicle-mediated transport, Golgi to ER 8 -1.71 1.25 -1.07 1.15 -1.15 -1.33 1.34
intra-Golgi vesicle-mediated transport 18 -1.13 1.2 1.21 1.08 1.18 1.32 1.58
post-Golgi vesicle-mediated transport 8 -1.19 1.11 1.49 1.14 1.49 -1.0 1.24
Golgi to plasma membrane transport 1 1.1 -1.05 1.04 -1.06 1.01 -1.16 1.25
Golgi to endosome transport 2 1.21 1.22 1.46 1.16 1.27 -1.02 1.39
Golgi to vacuole transport 1 1.54 1.27 1.89 1.07 1.6 1.7 1.58
endocytosis 269 1.08 1.09 1.24 1.07 1.23 1.23 1.15
receptor-mediated endocytosis 11 1.09 1.13 1.29 1.01 1.19 1.55 1.26
membrane budding 17 -1.05 1.2 1.38 1.12 1.21 1.27 1.27
vesicle coating 13 1.08 1.18 1.38 1.12 1.27 1.41 1.34
vesicle docking involved in exocytosis 27 -1.1 1.16 1.4 1.15 1.26 1.14 1.1
phagocytosis 196 1.09 1.06 1.17 1.06 1.21 1.18 1.12
phagocytosis, recognition 1 1.05 1.01 1.06 1.12 1.02 -1.02 -1.17
phagocytosis, engulfment 183 1.09 1.08 1.18 1.07 1.21 1.18 1.13
nucleocytoplasmic transport 70 1.17 1.16 1.34 1.19 1.33 1.24 1.11
autophagy 25 1.13 1.2 1.42 1.16 1.34 1.29 1.18
anti-apoptosis 18 1.77 1.02 1.32 -1.0 1.46 1.51 1.52
induction of apoptosis 25 1.08 1.15 1.03 1.12 1.26 -1.08 1.24
activation of cysteine-type endopeptidase activity involved in apoptotic process 13 1.0 1.15 1.25 1.21 1.45 1.21 1.07
cellular component disassembly involved in apoptotic process 4 -1.16 1.19 1.65 1.21 1.51 -1.05 -1.11
cleavage of lamin 1 -11.86 1.52 2.29 1.45 1.79 -4.95 -7.15
cleavage of cytoskeletal proteins involved in apoptosis 1 -11.86 1.52 2.29 1.45 1.79 -4.95 -7.15
cellular component movement 320 1.09 1.09 1.24 1.05 1.25 1.16 1.13
substrate-dependent cell migration 3 -1.11 1.15 1.36 -1.0 1.31 1.01 1.09
substrate-dependent cell migration, cell extension 3 -1.11 1.15 1.36 -1.0 1.31 1.01 1.09
chemotaxis 189 1.1 1.08 1.23 1.01 1.28 1.28 1.28
regulation of muscle contraction 5 2.39 -1.02 -2.05 -2.54 -2.17 1.16 1.24
smooth muscle contraction 3 1.0 1.28 1.13 -1.04 1.24 1.32 1.1
regulation of smooth muscle contraction 1 1.0 -1.08 -1.22 1.04 -1.09 -1.09 -1.09
striated muscle contraction 4 -1.17 -1.12 -1.49 -1.32 -1.09 1.16 1.78
regulation of striated muscle contraction 2 1.48 1.35 -6.16 -5.66 -4.42 -1.74 2.14
response to mechanical stimulus 14 1.05 -1.27 1.01 -1.36 -1.07 1.88 1.17
sensory perception of mechanical stimulus 23 1.04 1.07 1.22 1.04 1.17 1.31 1.04
cellular membrane fusion 16 -1.15 1.08 1.27 1.24 1.25 1.01 -1.03
syncytium formation 27 1.01 1.06 1.27 -1.02 1.21 1.27 1.14
response to stress 636 1.22 -1.02 1.06 -1.01 1.12 1.19 1.12
inflammatory response 3 -1.45 1.14 1.29 1.15 1.43 -1.36 1.17
immune response 137 1.38 -1.24 -1.13 -1.19 -1.03 1.17 1.17
humoral immune response 72 1.45 -1.32 -1.21 -1.31 -1.05 1.33 1.25
male-specific antibacterial humoral response 1 -1.1 -1.03 -1.03 -1.0 -1.23 -1.2 -1.1
pattern orientation 1 1.15 1.52 1.62 1.11 1.74 1.53 2.02
positive regulation of antibacterial peptide biosynthetic process 17 1.54 -1.16 -1.04 -1.14 1.02 1.29 1.37
positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria 5 2.54 -1.22 -1.03 -1.31 -1.06 2.04 1.48
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria 4 1.05 -1.9 -2.24 -1.85 -1.9 -1.18 1.68
positive regulation of antifungal peptide biosynthetic process 6 2.45 -1.42 -1.16 -1.01 -1.05 1.77 1.2
cellular defense response 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
response to osmotic stress 8 1.24 -1.08 1.33 -1.08 1.22 1.12 1.39
hyperosmotic response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
response to DNA damage stimulus 227 1.22 1.12 1.25 1.15 1.3 1.15 1.09
response to oxidative stress 70 1.24 1.01 -1.04 -1.06 1.02 1.38 1.1
response to lipid hydroperoxide 1 2.0 -1.09 -1.07 1.14 1.47 1.02 -1.28
ER overload response 2 -1.22 1.43 1.56 1.09 1.42 -1.17 1.79
ER-nucleus signaling pathway 9 1.04 1.26 1.24 1.08 1.25 -1.07 1.26
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response 1 -1.05 1.27 -1.17 -1.24 -1.49 -1.01 1.19
response to sterol depletion 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
organelle organization 973 1.15 1.09 1.25 1.09 1.27 1.18 1.1
nucleus organization 36 1.03 1.15 1.23 1.12 1.36 1.0 1.13
nuclear envelope organization 6 1.25 1.18 1.06 1.25 1.16 -1.19 -1.0
nuclear pore organization 1 1.8 1.61 2.39 1.2 2.33 2.16 2.46
nucleolus organization 3 1.16 1.19 1.66 1.24 2.3 1.1 1.42
mitochondrion organization 74 1.04 1.08 1.25 1.08 1.18 1.25 -1.14
mitochondrial membrane organization 10 1.09 1.08 1.26 1.13 1.21 1.18 -1.04
inner mitochondrial membrane organization 7 1.09 1.08 1.28 1.16 1.18 1.3 -1.13
plasma membrane organization 12 1.23 1.13 1.5 1.02 1.84 1.37 1.27
actin filament organization 87 1.01 1.07 1.38 1.03 1.32 1.12 1.17
cytoskeletal anchoring at plasma membrane 17 1.37 1.1 1.43 1.03 1.41 1.51 1.32
microtubule-based process 438 1.12 1.09 1.22 1.08 1.22 1.17 1.08
microtubule-based movement 107 -1.02 1.09 1.13 1.07 1.1 1.04 -1.01
microtubule depolymerization 3 -1.13 1.2 1.15 1.08 1.3 1.07 1.1
microtubule nucleation 7 1.67 1.03 1.42 1.09 1.45 1.62 1.17
tubulin complex assembly 4 1.19 1.1 1.33 1.15 1.38 -1.02 1.05
negative regulation of microtubule depolymerization 15 1.06 1.15 1.48 1.04 1.41 1.59 1.26
cytoplasm organization 51 1.09 -1.03 1.09 -1.08 1.21 1.39 1.18
endoplasmic reticulum organization 7 1.12 1.24 1.29 1.1 1.28 1.04 1.52
Golgi organization 47 1.19 1.1 1.16 1.09 1.17 1.1 1.13
peroxisome organization 15 1.58 1.07 -1.39 1.25 1.36 -1.44 -1.19
endosome organization 5 1.15 1.16 1.31 1.2 1.26 1.15 1.21
vacuolar transport 17 1.14 1.17 1.78 1.13 1.5 1.47 1.29
vacuolar acidification 4 -2.16 1.36 2.14 -1.07 1.21 2.24 1.25
lysosome organization 10 -1.08 1.12 1.05 1.24 1.07 -1.05 1.03
lysosomal transport 13 -1.01 1.15 1.71 1.13 1.47 1.31 1.22
cell-cell junction assembly 36 1.91 -1.1 1.31 -1.15 1.22 2.16 1.42
cell-substrate junction assembly 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
cell cycle 573 1.19 1.11 1.23 1.11 1.27 1.19 1.1
cell cycle arrest 8 1.45 1.2 1.34 1.1 1.36 1.5 1.38
spindle organization 213 1.2 1.08 1.21 1.07 1.26 1.2 1.09
mitotic spindle organization 189 1.21 1.09 1.21 1.1 1.26 1.18 1.06
spindle assembly involved in male meiosis 3 -1.71 1.36 1.08 1.16 1.08 -1.71 1.01
spindle assembly involved in male meiosis I 1 1.11 1.51 1.01 1.21 1.06 -1.41 1.26
spindle assembly involved in female meiosis 11 1.05 1.02 1.05 1.05 1.26 -1.08 -1.04
spindle assembly involved in female meiosis I 3 1.06 -1.05 -1.08 -1.02 1.25 -1.28 -1.07
spindle assembly involved in female meiosis II 4 1.32 1.05 1.25 1.09 1.47 1.13 1.04
male meiosis chromosome segregation 9 1.31 1.09 1.3 1.08 1.38 1.2 1.09
sister chromatid cohesion 20 1.2 1.1 1.27 1.08 1.29 1.25 1.11
mitotic sister chromatid cohesion 5 1.6 1.06 1.64 1.1 1.59 1.67 1.28
male meiosis sister chromatid cohesion 4 -1.07 1.07 1.03 1.03 1.12 -1.1 -1.1
female meiosis sister chromatid cohesion 1 1.04 1.22 1.16 1.15 1.04 -1.0 -1.09
mitosis 144 1.21 1.1 1.27 1.12 1.33 1.24 1.1
negative regulation of transcription during mitosis 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
negative regulation of transcription from RNA polymerase II promoter during mitosis 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
mitotic chromosome condensation 20 1.29 1.08 1.28 1.1 1.34 1.37 1.15
mitotic chromosome movement towards spindle pole 1 1.43 1.0 -1.06 1.15 1.3 -1.5 -1.26
mitotic metaphase plate congression 13 1.3 1.03 1.22 1.18 1.42 1.19 -1.01
mitotic nuclear envelope reassembly 2 1.28 1.06 -1.0 1.32 1.15 -1.17 -1.1
regulation of mitosis 45 1.26 1.07 1.15 1.07 1.27 1.23 1.12
regulation of S phase of mitotic cell cycle 16 1.38 1.18 1.34 1.13 1.4 1.63 1.43
mitotic cell cycle checkpoint 76 1.22 1.15 1.34 1.18 1.38 1.28 1.15
mitotic cell cycle spindle assembly checkpoint 10 1.07 1.09 1.16 1.15 1.32 1.1 1.03
optokinetic behavior 2 1.16 1.09 1.72 1.19 1.37 1.2 2.11
mitotic cell cycle G2/M transition DNA damage checkpoint 62 1.22 1.15 1.36 1.19 1.38 1.27 1.14
regulation of exit from mitosis 9 1.33 1.04 1.03 1.01 1.18 1.35 -1.03
nuclear migration 21 1.07 1.19 1.32 1.14 1.34 1.16 1.17
centrosome cycle 87 1.19 1.09 1.2 1.08 1.26 1.16 1.1
centriole replication 18 1.17 1.08 1.22 1.05 1.29 1.15 1.1
mitotic centrosome separation 5 -1.07 1.01 -1.06 1.11 1.17 -1.05 -1.17
cytokinesis, completion of separation 1 -1.24 -1.05 1.11 1.18 1.4 -1.36 -1.18
cytokinesis after meiosis I 8 1.52 -1.23 1.02 -1.47 1.08 1.67 1.38
cytokinesis after meiosis II 7 1.71 -1.31 -1.08 -1.6 1.08 2.04 1.46
male meiosis cytokinesis 14 1.82 -1.04 1.11 -1.11 1.39 1.32 1.33
endomitotic cell cycle 9 1.39 1.23 1.35 1.28 1.47 1.22 1.19
establishment of cell polarity 27 1.11 1.12 1.49 1.04 1.4 1.27 1.22
meiosis 124 1.1 1.11 1.17 1.11 1.22 1.09 1.08
meiosis I 52 1.05 1.13 1.13 1.1 1.19 1.04 1.05
meiotic prophase I 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
synapsis 2 1.33 1.05 1.23 1.11 1.31 -1.03 1.07
synaptonemal complex assembly 1 1.0 1.01 -1.04 1.07 -1.07 -1.07 -1.01
reciprocal meiotic recombination 22 1.06 1.12 1.07 1.13 1.17 1.01 1.01
meiotic metaphase I 1 1.38 1.21 1.33 1.18 1.64 1.12 1.06
meiotic anaphase I 4 1.0 1.05 1.11 1.01 1.1 1.09 1.06
meiosis II 8 1.18 1.02 1.12 1.03 1.24 1.13 1.02
meiotic anaphase II 2 1.2 1.05 1.15 1.01 1.2 1.43 1.16
male meiosis 41 -1.02 1.14 1.17 1.1 1.19 -1.06 1.05
male meiosis I 8 -1.07 1.2 1.15 1.06 1.14 -1.22 1.12
female meiosis 61 1.13 1.07 1.17 1.1 1.24 1.12 1.07
female meiosis I 6 1.01 -1.05 -1.08 -1.0 1.15 -1.17 -1.1
meiotic recombination nodule assembly 1 -1.21 1.44 1.1 1.2 1.03 -1.18 1.17
female meiosis II 6 1.18 1.01 1.11 1.04 1.25 1.04 -1.03
growth 135 1.26 1.12 1.23 -1.01 1.26 1.34 1.29
cell communication 1251 1.14 1.03 1.15 1.03 1.17 1.18 1.11
homophilic cell adhesion 27 1.7 -1.16 -1.1 -1.17 1.12 1.92 1.39
neuron cell-cell adhesion 1 1.45 1.31 1.24 1.07 1.17 1.33 1.2
cell-matrix adhesion 16 -1.41 1.01 1.24 -1.06 1.3 -1.06 1.21
negative regulation of cell adhesion 9 1.95 1.17 1.32 1.03 1.28 1.88 1.51
establishment or maintenance of cell polarity 152 1.11 1.11 1.36 1.05 1.29 1.3 1.31
establishment of tissue polarity 70 1.2 1.06 1.23 1.01 1.28 1.24 1.46
cell surface receptor signaling pathway 482 1.17 -1.01 1.15 -1.01 1.13 1.17 1.12
enzyme linked receptor protein signaling pathway 151 1.22 1.07 1.3 1.05 1.25 1.29 1.24
signal complex assembly 1 1.01 1.19 1.87 1.24 1.92 1.43 1.32
epidermal growth factor receptor signaling pathway 34 1.44 1.08 1.27 1.08 1.29 1.29 1.22
regulation of epidermal growth factor-activated receptor activity 4 1.16 1.09 1.49 1.02 1.37 1.48 1.2
transforming growth factor beta receptor signaling pathway 20 1.22 1.04 1.25 -1.09 1.26 1.29 1.17
transforming growth factor beta binding 1 -2.53 1.23 -1.01 1.28 2.46 1.22 1.76
transforming growth factor beta receptor complex assembly 1 -2.53 1.23 -1.01 1.28 2.46 1.22 1.76
SMAD protein import into nucleus 12 -1.03 1.3 1.39 1.26 1.48 1.18 1.22
transmembrane receptor protein tyrosine phosphatase signaling pathway 1 1.65 1.02 2.09 -1.05 1.83 4.08 1.95
G-protein coupled receptor signaling pathway 176 1.02 -1.09 1.05 -1.05 1.0 -1.09 -1.02
G-protein signaling, coupled to cyclic nucleotide second messenger 6 1.08 1.08 1.0 1.05 -1.0 -1.03 -1.04
G-protein signaling, coupled to cAMP nucleotide second messenger 6 1.08 1.08 1.0 1.05 -1.0 -1.03 -1.04
activation of adenylate cyclase activity by G-protein signaling pathway 3 -1.05 1.08 -1.04 1.0 -1.08 -1.13 -1.16
activation of adenylate cyclase activity 5 1.21 1.07 1.13 1.0 1.06 1.08 -1.01
activation of adenylate cyclase activity by dopamine receptor signaling pathway 2 -1.21 1.11 -1.21 1.0 -1.21 -1.22 -1.28
activation of adenylate cyclase activity by serotonin receptor signaling pathway 1 1.27 1.02 1.28 1.01 1.16 1.03 1.05
inhibition of adenylate cyclase activity by G-protein signaling pathway 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
negative regulation of adenylate cyclase activity 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
inhibition of adenylate cyclase activity by serotonin receptor signaling pathway 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger 4 1.12 1.13 1.06 1.07 1.06 1.07 1.09
activation of phospholipase C activity 6 1.13 1.12 1.17 1.04 1.09 1.14 1.05
elevation of cytosolic calcium ion concentration 3 1.46 1.16 1.52 -1.0 1.18 1.77 1.54
activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway 8 1.65 1.05 -1.03 -1.02 -1.04 1.17 1.24
activation of phospholipase C activity by serotonin receptor signaling pathway 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
serotonin receptor signaling pathway 3 1.27 -1.02 1.07 1.0 1.01 1.11 1.03
octopamine or tyramine signaling pathway 4 -1.04 1.16 -1.05 1.12 1.02 -1.17 1.09
dopamine receptor signaling pathway 3 -1.16 1.05 -1.23 1.04 -1.15 -1.24 -1.21
G-protein coupled acetylcholine receptor signaling pathway 2 1.0 1.08 1.1 1.16 1.17 1.06 1.05
gamma-aminobutyric acid signaling pathway 1 -1.12 -1.07 -1.06 -1.08 -1.01 1.07 -1.02
glutamate receptor signaling pathway 5 -1.03 1.1 1.0 1.09 -1.01 1.02 1.02
G-protein coupled glutamate receptor signaling pathway 3 1.11 1.14 1.05 1.15 1.03 1.07 1.0
tachykinin receptor signaling pathway 5 -1.04 -1.19 1.08 -1.24 -1.02 1.95 1.43
neuropeptide signaling pathway 38 -1.86 -1.39 -1.2 -1.15 -1.16 -1.83 -1.26
Notch signaling pathway 41 -1.09 1.14 1.18 1.13 1.3 1.07 1.15
Notch receptor processing 4 -1.0 1.17 1.21 1.25 1.56 1.22 1.41
smoothened signaling pathway 30 1.48 1.03 1.07 -1.08 1.17 1.49 1.16
patched ligand maturation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
signal transduction downstream of smoothened 5 1.03 1.18 1.56 1.12 1.42 1.4 1.07
positive regulation of hh target transcription factor activity 5 1.03 1.18 1.56 1.12 1.42 1.4 1.07
integrin-mediated signaling pathway 4 -1.54 1.07 1.65 1.1 1.77 -1.22 1.11
calcium-mediated signaling 8 -1.04 1.02 -1.11 1.01 -1.17 1.07 -1.03
intracellular protein kinase cascade 51 -1.02 1.16 1.44 1.09 1.44 1.16 1.28
I-kappaB kinase/NF-kappaB cascade 2 1.26 1.28 1.33 1.08 1.48 1.61 1.39
JNK cascade 25 1.0 1.14 1.47 1.1 1.5 1.24 1.42
activation of JNKK activity 2 1.23 1.27 1.56 1.2 1.54 1.23 1.3
activation of JUN kinase activity 2 -1.08 1.31 1.72 1.2 1.5 1.32 1.54
JUN phosphorylation 1 -1.04 -1.12 1.46 1.28 1.4 -1.15 1.1
JAK-STAT cascade 11 -1.2 1.17 1.35 1.1 1.37 -1.26 1.18
tyrosine phosphorylation of STAT protein 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
STAT protein import into nucleus 1 1.57 1.3 1.87 1.1 1.6 2.04 2.1
small GTPase mediated signal transduction 105 1.17 1.12 1.35 1.08 1.3 1.17 1.18
Ras protein signal transduction 25 1.08 1.28 1.57 1.08 1.47 1.22 1.49
Rho protein signal transduction 4 -1.15 1.27 1.54 1.2 1.45 1.01 1.39
cell-cell signaling 419 1.13 1.06 1.16 1.07 1.2 1.18 1.08
synaptic transmission 216 1.09 1.08 1.21 1.04 1.19 1.18 1.13
neurotransmitter secretion 99 -1.06 1.05 1.24 1.12 1.25 1.11 1.05
neuron-neuron synaptic transmission 5 1.1 -1.05 -1.09 -1.15 1.01 2.0 1.04
synaptic transmission, cholinergic 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
ensheathment of neurons 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
neuromuscular synaptic transmission 27 1.22 1.11 1.27 1.0 1.12 1.31 1.11
multicellular organismal development 2108 1.15 1.05 1.17 1.04 1.19 1.21 1.13
gamete generation 583 1.14 1.1 1.22 1.05 1.25 1.21 1.19
pole cell development 21 1.16 1.17 1.47 1.09 1.43 1.28 1.24
pole cell fate determination 3 2.8 1.18 2.04 1.19 1.51 2.12 1.41
pole cell formation 17 1.13 1.16 1.33 1.07 1.3 1.17 1.22
pole cell migration 19 1.23 -1.05 1.15 1.01 1.33 1.36 1.04
germ cell development 228 1.1 1.14 1.29 1.08 1.3 1.25 1.19
cystoblast division 9 1.07 1.12 1.19 1.15 1.29 1.17 1.17
spermatogenesis 150 1.07 1.14 1.22 1.07 1.24 1.12 1.11
spermatogonial cell division 5 -1.04 1.03 1.09 1.21 1.28 -1.18 -1.02
primary spermatocyte growth 5 2.0 1.25 1.67 1.27 1.92 1.51 1.27
spermatid development 79 1.04 1.12 1.3 1.04 1.29 1.22 1.17
Nebenkern assembly 2 1.05 1.03 1.07 -1.02 1.14 1.17 1.07
sperm axoneme assembly 7 -1.01 1.09 1.1 1.07 1.15 -1.0 1.02
spermatid nucleus differentiation 9 -1.34 1.07 1.03 1.03 1.26 -1.23 1.02
spermatid nucleus elongation 2 1.34 1.05 1.39 1.01 1.37 1.32 1.14
sperm individualization 44 -1.12 1.16 1.4 1.06 1.35 1.23 1.23
female gamete generation 427 1.13 1.08 1.22 1.04 1.24 1.22 1.2
germarium-derived egg chamber formation 61 1.02 1.14 1.23 1.1 1.31 1.21 1.23
germarium-derived oocyte fate determination 21 1.11 1.14 1.23 1.09 1.21 1.3 1.23
growth of a germarium-derived egg chamber 5 1.5 1.13 1.67 1.04 1.5 1.59 1.41
vitellogenesis 7 1.4 -3.65 -4.11 -4.07 -1.34 2.21 1.12
ovarian follicle cell migration 79 1.03 1.16 1.44 1.13 1.47 1.15 1.19
border follicle cell migration 72 1.05 1.17 1.45 1.13 1.49 1.2 1.21
ovarian follicle cell-cell adhesion 3 -1.5 1.41 1.37 1.22 1.72 -1.12 -1.09
ovarian nurse cell to oocyte transport 32 -1.11 1.14 1.27 1.11 1.3 -1.14 1.1
female germline ring canal formation 9 -1.09 1.12 1.17 1.11 1.32 1.12 1.24
nurse cell nucleus anchoring 1 -1.33 1.57 2.09 1.17 1.77 1.11 1.58
cytoplasmic transport, nurse cell to oocyte 17 -1.19 1.13 1.2 1.1 1.19 -1.42 -1.04
chorion-containing eggshell formation 78 1.18 1.1 1.22 1.06 1.23 1.11 1.17
vitelline membrane formation involved in chorion-containing eggshell formation 12 1.14 1.01 -1.05 -1.02 -1.08 1.01 -1.0
eggshell chorion assembly 60 1.26 1.11 1.27 1.08 1.27 1.14 1.2
eggshell chorion gene amplification 17 1.11 1.21 1.43 1.19 1.52 1.14 1.14
oocyte construction 96 1.16 1.13 1.34 1.07 1.27 1.39 1.25
oocyte axis specification 93 1.19 1.13 1.33 1.07 1.25 1.4 1.25
oocyte dorsal/ventral axis specification 34 1.43 1.04 1.13 1.01 1.1 1.5 1.28
maternal specification of dorsal/ventral axis, oocyte, germ-line encoded 7 1.96 -1.07 -1.01 -1.08 1.03 2.21 1.39
oocyte nucleus migration involved in oocyte dorsal/ventral axis specification 5 1.19 1.19 1.21 1.12 1.21 1.46 1.07
maternal specification of dorsal/ventral axis, oocyte, soma encoded 6 1.43 -1.12 1.09 -1.23 -1.1 -1.09 1.5
oocyte anterior/posterior axis specification 62 1.11 1.18 1.4 1.13 1.34 1.37 1.21
pole plasm assembly 44 1.05 1.19 1.38 1.14 1.31 1.29 1.19
pole plasm RNA localization 37 1.02 1.19 1.31 1.15 1.26 1.21 1.17
regulation of pole plasm oskar mRNA localization 25 -1.02 1.16 1.34 1.11 1.28 1.31 1.17
pole plasm protein localization 10 1.29 1.15 1.44 1.11 1.37 1.64 1.23
negative regulation of oskar mRNA translation 8 1.19 -1.01 1.28 -1.09 1.13 1.88 1.01
insemination 17 1.27 -1.21 -1.24 -1.29 -1.17 1.36 -1.21
sperm displacement 3 1.07 1.02 1.02 1.02 1.05 -1.05 -1.0
single fertilization 21 1.03 1.13 1.12 1.07 1.1 1.04 1.03
egg activation 9 1.11 1.13 -1.02 1.02 -1.1 1.13 1.03
pronuclear fusion 6 1.05 1.11 1.23 1.09 1.44 1.02 1.13
anatomical structure morphogenesis 1160 1.14 1.06 1.19 1.02 1.21 1.23 1.19
embryo development 457 1.16 1.04 1.23 1.01 1.25 1.28 1.21
regulation of mitotic cell cycle 169 1.21 1.12 1.24 1.12 1.31 1.26 1.14
regulation of preblastoderm mitotic cell cycle 1 2.87 1.19 1.15 1.16 1.39 3.16 1.43
regulation of syncytial blastoderm mitotic cell cycle 4 -1.06 1.09 1.06 1.04 -1.06 -1.05 -1.09
cellularization 88 1.03 1.13 1.34 1.07 1.31 1.26 1.23
blastoderm segmentation 173 1.2 1.1 1.26 1.04 1.23 1.26 1.24
tripartite regional subdivision 114 1.21 1.09 1.29 1.04 1.25 1.28 1.24
zygotic specification of dorsal/ventral axis 5 1.69 1.14 1.51 1.04 1.21 1.21 1.19
embryonic pattern specification 187 1.24 1.08 1.23 1.02 1.22 1.28 1.27
zygotic determination of anterior/posterior axis, embryo 31 1.57 -1.1 1.04 -1.14 1.04 1.27 1.27
anterior region determination 3 1.62 -1.05 1.0 -1.14 -1.1 1.06 -1.02
posterior abdomen determination 1 2.58 1.01 1.0 1.14 -1.0 -1.14 1.0
terminal region determination 24 1.44 -1.08 1.07 -1.1 1.09 1.37 1.32
periodic partitioning 36 1.13 1.1 1.13 -1.03 1.27 1.27 1.33
periodic partitioning by pair rule gene 8 1.03 1.2 -1.11 -1.37 1.26 1.17 1.1
segment polarity determination 23 1.21 1.06 1.16 1.04 1.26 1.35 1.41
determination of left/right symmetry 4 -3.48 1.34 1.25 1.01 1.41 -1.67 1.12
gastrulation 69 1.19 1.03 1.19 1.02 1.24 1.29 1.11
ventral furrow formation 13 1.35 1.11 1.28 1.08 1.5 1.38 1.28
posterior midgut invagination 4 1.75 1.13 1.9 1.13 1.88 1.93 1.72
anterior midgut invagination 3 1.4 1.11 1.46 1.17 1.72 1.88 1.31
cephalic furrow formation 2 1.01 1.11 1.05 -1.06 1.03 1.09 1.05
germ-band extension 8 -1.08 -1.25 1.17 1.08 1.55 1.32 -1.22
amnioserosa formation 5 1.56 -1.06 1.14 -1.19 -1.08 -1.04 1.05
segment specification 32 1.1 1.02 1.19 1.11 1.15 1.21 1.01
specification of segmental identity, head 14 1.19 1.01 1.1 1.09 -1.11 -1.03 -1.01
specification of segmental identity, labial segment 3 1.02 1.03 1.12 1.05 -1.06 1.02 1.01
specification of segmental identity, maxillary segment 2 1.16 1.08 1.11 1.03 1.02 -1.01 -1.01
specification of segmental identity, antennal segment 3 1.59 -1.13 1.32 1.09 -1.18 -1.05 -1.16
specification of segmental identity, thorax 2 1.34 1.12 1.12 1.65 -1.14 1.05 -1.1
specification of segmental identity, abdomen 5 1.18 1.16 1.14 1.3 -1.04 1.14 -1.03
compartment pattern specification 4 -1.06 -1.16 1.12 1.16 1.23 -1.31 -1.4
posterior compartment specification 1 -1.02 -1.34 -1.22 -1.07 -1.24 -1.21 -1.17
pattern specification process 406 1.19 1.05 1.18 1.01 1.22 1.26 1.25
germ-band shortening 18 1.2 1.11 1.38 1.07 1.46 1.23 1.55
dorsal closure 88 1.12 1.1 1.41 1.05 1.37 1.28 1.31
initiation of dorsal closure 17 1.16 1.17 1.59 1.07 1.56 1.2 1.36
dorsal closure, leading edge cell fate determination 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
dorsal closure, elongation of leading edge cells 12 1.22 1.22 1.4 1.12 1.59 1.38 1.41
dorsal closure, spreading of leading edge cells 4 1.03 1.07 2.59 -1.02 1.79 1.38 1.66
suture of dorsal opening 3 -1.66 1.12 1.92 -1.03 1.4 -1.35 1.31
organ morphogenesis 472 1.18 1.09 1.26 1.04 1.27 1.27 1.24
tissue development 483 1.17 1.03 1.19 1.01 1.23 1.27 1.18
ectoderm development 21 1.37 -1.09 1.05 1.01 1.24 1.01 1.03
nervous system development 1192 1.14 1.06 1.21 1.07 1.22 1.19 1.13
neuroblast fate determination 25 1.13 1.09 1.19 1.07 1.23 -1.0 1.07
neurological system process 607 1.09 1.03 1.1 1.0 1.09 1.15 1.07
ganglion mother cell fate determination 8 1.18 1.1 1.09 1.08 1.22 1.05 1.11
glial cell fate determination 3 1.44 1.3 1.68 1.12 1.63 1.5 1.59
neuroblast proliferation 40 -1.13 1.17 1.36 1.16 1.4 1.07 1.11
negative regulation of neuroblast proliferation 7 -1.32 1.13 1.47 1.06 1.79 1.22 1.08
axonogenesis 233 1.11 1.08 1.25 1.0 1.27 1.27 1.31
axon guidance 181 1.1 1.08 1.23 1.01 1.27 1.29 1.31
axon target recognition 15 -1.0 1.14 1.31 1.09 1.01 -1.17 1.08
axonal fasciculation 14 -1.38 -1.31 -1.09 -1.08 1.2 1.11 -1.02
axonal defasciculation 11 -1.03 -1.0 1.06 -1.05 1.13 1.11 1.26
defasciculation of motor neuron axon 7 1.05 -1.01 1.02 1.01 1.05 1.08 1.18
synapse assembly 33 1.25 1.16 1.26 1.01 1.24 1.48 1.24
central nervous system development 184 1.13 1.07 1.29 1.04 1.2 1.15 1.15
ventral midline development 6 -1.04 -1.05 1.01 1.07 1.13 -1.04 1.11
ventral cord development 31 1.44 1.02 1.19 -1.02 1.16 1.12 1.17
brain development 99 1.09 1.08 1.33 1.05 1.24 1.12 1.14
chemosensory behavior 89 1.01 1.02 1.17 -1.01 1.16 1.11 1.15
stomatogastric nervous system development 3 1.52 1.02 1.2 1.12 1.56 1.54 1.47
peripheral nervous system development 83 1.1 1.04 1.18 1.03 1.32 1.2 1.23
sensory organ development 366 1.13 1.09 1.25 1.06 1.24 1.18 1.19
open tracheal system development 179 1.41 1.03 1.26 -1.02 1.26 1.52 1.28
epithelial cell fate determination, open tracheal system 5 1.83 1.1 1.52 -1.02 1.42 1.21 1.34
tracheal outgrowth, open tracheal system 24 1.41 1.06 1.45 1.03 1.41 1.42 1.26
epithelial cell migration, open tracheal system 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
primary branching, open tracheal system 14 1.41 1.06 1.72 1.04 1.34 1.6 1.2
secondary branching, open tracheal system 4 -1.26 1.18 1.54 -1.02 1.25 1.45 1.01
terminal branching, open tracheal system 10 1.25 1.17 1.56 1.07 1.46 1.37 1.13
salivary gland development 141 1.08 1.0 1.15 1.05 1.27 1.18 1.17
salivary gland boundary specification 12 1.24 1.02 1.3 1.14 1.55 1.11 1.19
salivary gland morphogenesis 122 1.06 1.0 1.13 1.04 1.25 1.23 1.18
larval salivary gland morphogenesis 6 -1.03 1.12 1.25 1.04 1.36 1.52 1.57
oenocyte development 7 1.11 1.13 1.16 1.11 1.2 1.21 1.08
ectodermal digestive tract development 5 1.46 1.11 -1.0 1.02 1.62 1.8 1.33
foregut morphogenesis 10 -1.4 -1.11 -1.17 -1.1 1.29 -1.3 1.37
hindgut morphogenesis 56 1.24 -1.1 1.09 -1.03 1.35 1.37 1.13
Malpighian tubule morphogenesis 44 1.29 -1.1 1.07 -1.04 1.27 1.38 1.09
imaginal disc development 435 1.23 1.04 1.19 1.01 1.23 1.3 1.24
determination of imaginal disc primordium 10 1.07 1.03 1.07 -1.02 1.18 1.04 1.37
imaginal disc growth 17 1.45 1.18 1.4 1.14 1.42 1.3 1.32
imaginal disc pattern formation 93 1.23 1.0 1.11 1.04 1.22 1.28 1.18
anterior/posterior pattern specification, imaginal disc 20 1.23 -1.26 1.02 -1.03 1.24 1.42 -1.03
proximal/distal pattern formation, imaginal disc 21 1.34 -1.0 1.11 1.1 1.1 -1.01 1.11
dorsal/ventral pattern formation, imaginal disc 46 1.31 1.01 1.09 -1.0 1.25 1.33 1.29
dorsal/ventral lineage restriction, imaginal disc 7 1.04 1.11 1.08 1.07 1.41 1.38 1.52
eye-antennal disc morphogenesis 37 1.29 1.08 1.27 1.08 1.29 1.31 1.24
progression of morphogenetic furrow involved in compound eye morphogenesis 8 1.62 -1.01 1.33 1.05 1.35 1.15 1.12
R8 cell fate commitment 14 1.18 1.05 1.18 1.13 1.28 -1.01 1.04
R1/R6 cell fate commitment 2 1.08 1.03 -1.12 -1.19 -1.15 -1.01 1.1
R3/R4 cell fate commitment 14 1.45 1.1 1.12 1.04 1.4 1.31 1.24
R7 cell fate commitment 20 1.3 1.11 1.31 1.06 1.32 1.34 1.27
regulation of rhodopsin gene expression 2 1.63 1.26 1.37 1.04 1.38 1.48 1.42
antennal development 21 -1.03 1.02 1.12 1.04 1.07 1.26 1.08
wing disc morphogenesis 207 1.31 1.07 1.29 1.02 1.28 1.37 1.34
wing disc proximal/distal pattern formation 6 1.82 -1.07 1.3 1.34 1.32 1.02 -1.06
imaginal disc-derived wing vein specification 33 1.21 1.03 1.14 1.0 1.19 1.17 1.38
apposition of dorsal and ventral imaginal disc-derived wing surfaces 17 1.92 1.04 1.15 -1.07 1.24 1.93 1.28
imaginal disc-derived wing morphogenesis 203 1.31 1.07 1.28 1.02 1.28 1.38 1.34
notum development 8 1.04 1.0 1.09 1.1 1.29 -1.05 1.15
leg disc morphogenesis 54 -1.03 1.07 1.1 1.02 1.38 1.23 1.22
leg disc proximal/distal pattern formation 16 1.45 1.01 1.11 1.07 1.06 1.05 1.22
imaginal disc-derived leg morphogenesis 53 -1.02 1.08 1.1 1.01 1.37 1.25 1.26
haltere disc morphogenesis 2 2.21 -1.24 1.11 1.19 -1.26 -1.2 -1.1
haltere development 9 1.36 -1.03 -1.02 1.14 1.16 -1.19 1.04
genital disc morphogenesis 17 1.4 1.1 1.29 1.07 1.2 1.04 1.22
imaginal disc-derived genitalia development 22 1.56 1.05 1.18 1.02 1.13 1.11 1.24
imaginal disc-derived male genitalia development 20 1.63 1.05 1.2 1.02 1.16 1.13 1.28
imaginal disc-derived female genitalia development 6 1.5 1.12 1.14 1.04 1.07 1.14 1.13
analia development 6 -1.15 -1.64 -1.26 1.2 1.4 -1.24 -1.79
histoblast morphogenesis 8 -1.19 1.09 1.37 1.16 1.65 -1.2 1.21
maintenance of imaginal histoblast diploidy 1 -10.7 -1.04 2.18 1.33 2.43 -8.45 -1.16
endoderm development 8 1.22 -1.04 1.07 1.01 1.2 1.25 1.45
endodermal cell fate determination 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
midgut development 31 -1.29 -1.1 1.1 -1.15 -1.0 1.01 1.05
anterior midgut development 3 -1.08 1.25 1.25 -1.4 1.12 1.13 1.58
posterior midgut development 1 1.06 -1.06 -1.11 -1.03 -1.09 -1.08 -1.11
ectoderm and mesoderm interaction 2 1.28 1.06 1.06 1.18 1.33 1.49 1.08
mesodermal cell fate determination 5 1.66 1.11 1.13 -1.01 1.25 1.53 1.29
mesodermal cell fate specification 11 1.38 -1.02 -1.0 -1.04 1.01 1.33 -1.02
digestive tract mesoderm development 3 1.05 1.02 1.08 1.02 1.19 -1.09 -1.12
fat body development 3 1.03 1.03 -1.06 -1.03 -1.1 -1.05 1.49
gonadal mesoderm development 8 1.06 -1.02 1.26 1.06 1.16 1.0 -1.13
heart development 70 1.28 -1.02 1.19 -1.07 1.17 1.3 1.17
larval heart development 2 1.04 -1.11 1.46 -1.3 -1.07 -1.65 1.78
mesoderm migration involved in gastrulation 10 1.62 -1.05 1.42 -1.16 1.22 2.32 1.08
cardioblast cell fate determination 4 1.32 1.0 1.08 -1.04 -1.05 -1.0 1.04
lymph gland development 22 1.29 1.04 1.21 1.05 1.2 1.21 1.38
hemocyte development 5 1.5 1.11 1.52 1.05 1.28 1.12 1.43
muscle organ development 163 1.31 1.06 1.2 1.02 1.21 1.31 1.18
myoblast cell fate determination 1 -1.07 -1.09 1.09 -1.1 1.09 -1.05 1.02
skeletal muscle tissue development 79 1.17 1.09 1.25 1.03 1.19 1.34 1.16
myoblast fusion 27 1.01 1.06 1.27 -1.02 1.21 1.27 1.14
muscle cell fate determination 3 1.16 1.17 1.3 1.2 1.33 -1.2 1.28
visceral muscle development 11 1.37 -1.08 1.14 -1.13 1.1 1.25 1.21
larval visceral muscle development 5 1.28 -1.03 1.19 -1.12 1.18 1.12 1.5
somatic muscle development 32 1.35 1.09 1.29 1.02 1.2 1.12 1.09
larval somatic muscle development 8 1.66 1.08 1.35 1.03 1.17 1.3 1.22
adult somatic muscle development 10 1.25 1.07 1.59 1.07 1.35 1.16 1.08
neuromuscular junction development 47 1.2 1.17 1.29 1.08 1.21 1.33 1.23
sex determination 25 1.28 1.14 1.27 1.1 1.2 1.19 1.13
primary sex determination 17 1.27 1.11 1.28 1.06 1.22 1.26 1.15
primary sex determination, soma 13 1.13 1.12 1.28 1.07 1.19 1.09 1.1
sex determination, establishment of X:A ratio 5 -1.07 1.05 1.18 1.02 1.03 -1.1 -1.09
sex determination, primary response to X:A ratio 5 1.36 1.19 1.41 1.08 1.34 1.16 1.31
primary sex determination, germ-line 4 1.82 1.02 1.1 1.07 1.07 1.73 1.13
sex differentiation 82 1.2 -1.07 -1.04 -1.09 1.12 1.09 1.08
dosage compensation 11 1.22 1.11 1.25 -1.03 1.17 1.34 1.47
metamorphosis 374 1.17 1.04 1.18 1.01 1.26 1.25 1.24
regulation of ecdysteroid metabolic process 1 -1.55 1.2 1.21 -1.19 -1.12 1.05 1.03
regulation of ecdysteroid secretion 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
regulation of juvenile hormone metabolic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
regulation of juvenile hormone biosynthetic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
histolysis 79 -1.03 1.02 1.13 1.07 1.24 1.12 1.1
imaginal disc morphogenesis 285 1.23 1.07 1.25 1.02 1.3 1.3 1.29
imaginal disc eversion 8 -1.35 1.14 1.18 1.03 1.2 1.09 1.17
eclosion 15 1.14 1.03 1.09 -1.05 -1.02 1.17 1.27
regulation of eclosion 5 1.16 1.13 1.1 1.07 1.05 -1.04 -1.04
regulation of chitin-based cuticle tanning 13 -1.19 -1.03 -1.1 -1.01 1.02 -1.1 1.19
aging 114 1.25 1.12 1.11 -1.02 1.16 1.37 1.25
age-dependent general metabolic decline 1 -1.1 1.09 1.19 1.01 1.01 1.19 1.25
autophagic cell death 70 1.04 -1.0 1.1 1.06 1.23 1.21 1.11
response to nutrient 14 -1.16 1.15 1.37 1.05 1.35 1.65 1.19
digestion 3 -4.6 1.02 -2.88 -1.01 -3.41 -5.92 -1.12
excretion 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
body fluid secretion 5 -1.82 -1.14 1.09 1.02 1.2 -2.0 -1.34
storage protein import into fat body 1 -1.43 -1.07 1.81 1.21 1.62 -1.56 -1.76
molting cycle, chitin-based cuticle 46 1.19 -1.01 1.03 -1.09 -1.03 1.24 1.14
protein-based cuticle development 13 1.28 -1.16 -1.04 -1.21 -1.09 1.14 1.17
chitin-based cuticle tanning 9 1.05 -1.17 -1.07 -1.06 -1.1 -1.03 1.38
puparial adhesion 11 -1.06 1.01 -1.06 -1.01 -1.12 -1.06 -1.12
hemostasis 5 1.95 -1.51 -1.67 -1.6 -1.41 1.79 -1.02
sensory perception 298 1.08 -1.01 -1.0 -1.02 -1.02 1.03 -1.03
visual perception 40 1.13 -1.01 1.16 1.08 1.1 1.09 1.01
phototransduction 43 1.04 -1.12 -1.06 1.05 1.04 -1.05 -1.09
phototransduction, visible light 19 1.05 -1.08 -1.05 1.11 1.04 -1.1 -1.12
phototransduction, UV 5 -1.46 -1.43 -1.51 1.22 -1.06 -1.54 -1.62
sensory perception of sound 21 -1.01 1.1 1.22 1.04 1.15 1.25 1.02
sensory perception of chemical stimulus 235 1.08 -1.02 -1.05 -1.04 -1.05 -1.0 -1.04
sensory perception of taste 68 -1.0 1.03 1.01 1.0 1.03 -1.02 -1.02
detection of chemical stimulus involved in sensory perception of taste 5 1.32 -1.06 -1.09 -1.07 1.79 1.58 1.13
sensory perception of smell 82 1.05 1.01 1.0 1.0 -1.03 -1.02 -1.01
behavior 399 1.11 -1.01 1.12 -1.04 1.1 1.22 1.16
learning or memory 104 1.16 1.04 1.18 -1.01 1.23 1.38 1.22
learning 62 1.11 1.07 1.18 1.02 1.21 1.32 1.22
memory 61 1.21 1.03 1.22 -1.03 1.24 1.42 1.28
short-term memory 12 1.22 1.21 1.62 -1.01 1.53 1.26 1.48
anesthesia-resistant memory 8 1.01 -1.16 -1.04 -1.21 -1.14 1.22 1.39
long-term memory 38 1.27 1.07 1.27 1.02 1.25 1.51 1.25
mating behavior 79 1.01 -1.1 -1.02 -1.04 -1.07 1.02 1.1
mating 90 1.04 -1.1 -1.03 -1.06 -1.06 1.08 1.06
courtship behavior 53 1.01 -1.16 -1.02 -1.12 -1.1 1.01 1.15
copulation 23 1.23 -1.11 -1.09 -1.17 -1.08 1.34 -1.08
negative regulation of female receptivity 8 -1.24 1.06 1.02 1.03 1.16 -1.13 -1.08
rhythmic behavior 47 -1.03 -1.07 1.06 -1.22 -1.14 1.21 1.12
circadian rhythm 55 1.08 -1.07 1.04 -1.2 -1.1 1.29 1.14
ultradian rhythm 1 -1.1 1.09 1.19 1.01 1.01 1.19 1.25
grooming behavior 2 2.8 1.39 1.39 -1.27 -1.08 1.53 1.56
locomotory behavior 119 1.1 1.06 1.22 -1.07 1.12 1.36 1.15
larval behavior 32 -1.13 1.1 1.17 -1.13 -1.02 -1.04 1.19
adult walking behavior 9 -1.95 1.22 1.15 1.1 1.23 -1.39 1.15
flight behavior 18 1.38 -1.05 1.24 -1.05 1.31 1.48 1.11
jump response 7 1.63 -1.18 1.1 -1.09 1.06 1.45 -1.03
feeding behavior 27 1.06 -1.12 1.12 -1.22 -1.11 -1.09 1.36
visual behavior 19 1.39 1.02 1.17 1.04 1.14 1.16 1.23
chemosensory jump behavior 1 -1.0 1.03 1.05 1.01 1.02 1.05 1.11
proboscis extension reflex 5 -1.0 -1.02 1.2 1.04 1.13 1.24 1.12
mechanosensory behavior 6 -1.75 1.04 1.58 1.06 1.09 1.12 -1.04
structural constituent of chitin-based larval cuticle 39 -1.05 -1.05 -1.13 -1.07 -1.2 -1.1 -1.03
structural constituent of pupal chitin-based cuticle 7 -1.04 -1.01 1.04 1.0 -1.03 -1.08 -1.07
structural constituent of adult chitin-based cuticle 4 1.11 1.06 1.05 -1.05 1.06 1.05 -1.03
beta-catenin binding 9 1.09 1.18 1.31 1.15 1.46 1.17 1.28
calcium-dependent cell-cell adhesion 18 1.55 -1.07 -1.04 -1.12 1.13 1.76 1.45
blood circulation 3 -1.25 1.41 -1.37 -1.01 1.12 1.05 1.18
regulation of heart contraction 13 -1.49 1.0 1.16 -1.05 -1.04 -1.08 -1.3
microtubule binding 63 1.08 1.04 1.33 -1.0 1.35 1.38 1.26
pattern recognition receptor activity 6 6.25 -1.32 -1.34 -1.44 -1.26 3.38 1.39
G-protein coupled photoreceptor activity 8 -1.07 -1.12 1.03 -1.04 -1.29 1.03 -1.14
synaptic vesicle 56 1.07 1.09 1.23 1.07 1.27 1.16 1.16
protein C-terminus binding 1 -1.42 1.29 1.09 1.21 1.26 -1.02 1.15
transcription elongation factor complex 27 1.25 1.16 1.35 1.13 1.31 1.3 1.17
positive transcription elongation factor complex b 3 1.59 1.11 1.57 1.18 1.65 1.7 1.24
diazepam binding 5 -4.23 -1.51 -3.23 1.14 1.44 -4.78 -1.66
ATP-dependent helicase activity 76 1.18 1.21 1.34 1.17 1.3 1.31 1.19
monocarboxylic acid transmembrane transporter activity 16 -2.06 1.03 -1.25 1.14 1.09 -1.24 -1.32
pentraxin receptor activity 1 1.18 1.16 1.11 1.22 1.12 1.2 1.16
neuronal pentraxin receptor activity 1 1.18 1.16 1.11 1.22 1.12 1.2 1.16
eclosion hormone activity 1 -1.16 1.0 -1.13 -1.07 -1.21 -1.36 -1.2
tRNA processing 33 1.3 1.13 1.13 1.23 1.16 1.1 -1.08
diuretic hormone receptor activity 3 1.32 -1.32 1.22 -1.4 -1.1 -1.32 2.54
cell recognition 57 1.01 -1.01 1.18 1.01 1.28 1.17 1.15
neuron recognition 56 1.01 -1.01 1.18 1.01 1.29 1.18 1.16
synaptic target recognition 8 1.28 -1.15 1.12 -1.06 1.36 1.36 1.15
intracellular ferritin complex 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
adult behavior 100 1.26 -1.03 1.14 -1.07 1.14 1.22 1.28
motor axon guidance 40 1.33 1.03 1.17 -1.02 1.25 1.44 1.49
axon guidance receptor activity 4 -1.18 -1.02 1.16 -1.02 1.15 -1.24 1.14
enzyme activator activity 85 1.11 1.14 1.32 1.07 1.24 1.11 1.2
calcium sensitive guanylate cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
male courtship behavior 38 -1.12 -1.17 1.06 -1.08 -1.08 -1.08 1.09
sensory organ boundary specification 21 1.12 1.05 1.15 1.04 1.26 1.14 1.19
mitochondrial fusion 4 -1.03 1.3 1.41 1.13 1.32 1.68 1.08
cyclin catabolic process 6 -1.14 1.19 1.17 1.12 1.29 -1.06 1.05
ocellus pigment biosynthetic process 18 1.35 1.13 1.12 1.06 1.06 1.08 1.16
ocellus development 3 1.06 1.06 -1.0 1.09 -1.06 -1.05 -1.05
eye pigment granule organization 10 1.1 1.2 1.42 1.14 1.25 1.18 1.2
ARF GTPase activator activity 9 -1.07 1.11 1.17 1.02 1.17 -1.02 1.45
chitin binding 82 -2.26 -1.76 -2.0 -1.6 -1.65 -2.02 1.28
eclosion rhythm 10 1.18 -1.0 1.16 -1.06 1.02 1.29 1.48
Toll signaling pathway 33 2.4 -1.26 -1.12 -1.26 -1.03 2.14 1.22
regulation of actin polymerization or depolymerization 20 -1.48 1.08 1.45 1.05 1.38 -1.21 1.18
establishment of blood-nerve barrier 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
glutamate receptor activity 40 1.1 1.01 1.02 -1.03 -1.05 -1.01 -1.02
extracellular-glutamate-gated chloride channel activity 1 1.11 1.03 -1.01 -1.03 1.01 1.02 1.03
dorsal/ventral axis specification, ovarian follicular epithelium 8 1.49 1.13 1.18 1.13 1.25 1.48 1.25
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, germ-line encoded 1 8.32 -1.09 1.22 1.02 1.27 3.95 1.61
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
ornithine decarboxylase inhibitor activity 1 1.05 1.03 -1.12 1.06 -1.03 -1.01 1.05
guanylate cyclase complex, soluble 5 -1.02 -1.02 -1.05 -1.02 -1.07 -1.02 -1.11
voltage-gated potassium channel complex 18 1.03 1.03 1.1 1.02 1.05 -1.06 -1.0
mesodermal cell migration 6 1.63 -1.09 1.53 -1.13 1.3 1.85 -1.09
translation termination factor activity 7 1.27 1.16 1.25 1.13 1.18 1.49 1.09
N-acetyltransferase activity 43 -1.1 1.17 1.01 1.17 1.18 -1.21 1.02
phosphoric diester hydrolase activity 30 -1.19 -1.12 -1.13 1.09 -1.0 -1.15 -1.05
growth factor activity 27 1.05 1.01 1.04 -1.13 -1.02 1.19 1.11
imaginal disc growth factor receptor binding 5 4.12 -4.42 -5.25 -6.0 -2.16 10.45 2.09
light-activated voltage-gated calcium channel activity 2 -1.34 -1.15 -1.19 1.14 -1.2 -1.27 -1.19
light-activated voltage-gated calcium channel complex 1 -1.32 -1.06 -1.2 1.5 -1.29 -1.26 -1.29
axon cargo transport 16 1.1 1.21 1.27 1.13 1.19 1.36 1.14
anterograde axon cargo transport 4 1.14 1.18 1.17 1.17 1.3 1.25 1.03
retrograde axon cargo transport 2 -1.28 1.31 1.1 1.11 1.09 1.07 1.09
spectrin 3 -2.12 1.38 2.51 1.03 1.66 1.56 1.52
cytoskeletal protein binding 213 1.08 1.03 1.32 -1.0 1.29 1.21 1.16
cytoskeletal adaptor activity 3 -1.31 1.01 1.0 1.13 1.08 -1.15 -1.23
DNA-dependent ATPase activity 34 1.07 1.15 1.32 1.15 1.32 1.15 1.17
juvenile hormone epoxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
5S rRNA binding 2 1.26 1.08 1.22 1.14 1.15 1.1 -1.0
5S rRNA primary transcript binding 1 1.17 1.17 1.25 1.35 1.14 -1.19 -1.07
decapentaplegic signaling pathway 11 1.19 1.18 1.63 1.11 1.61 1.49 1.44
oocyte microtubule cytoskeleton polarization 19 1.07 1.18 1.47 1.08 1.29 1.46 1.27
asymmetric protein localization 36 -1.02 1.11 1.3 1.09 1.44 1.21 1.16
alcohol dehydrogenase (NADP+) activity 7 1.25 1.15 -1.37 -1.18 -1.21 1.14 1.22
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity 1 -2.23 -1.22 -3.38 -1.38 1.35 1.93 6.67
alpha-methylacyl-CoA racemase activity 1 4.0 -1.32 -1.02 1.57 2.33 1.69 -1.27
peptide-methionine-(S)-S-oxide reductase activity 2 -1.8 -2.02 -4.93 1.56 -1.77 -2.69 -2.87
sphinganine-1-phosphate aldolase activity 1 -4.18 -1.48 1.63 1.57 1.8 -2.56 -3.36
ceramide glucosyltransferase activity 1 -2.39 1.12 1.45 -1.07 -1.2 -1.93 -1.3
ubiquinol-cytochrome-c reductase activity 10 -1.05 1.06 1.14 1.09 1.02 1.34 -1.41
4-alpha-hydroxytetrahydrobiopterin dehydratase activity 1 7.73 -1.1 1.09 -1.29 -1.0 2.46 1.16
primary amine oxidase activity 1 -1.01 1.1 1.17 1.35 1.05 -1.29 -1.96
transcription factor binding 100 1.32 1.1 1.22 1.06 1.24 1.32 1.24
translation factor activity, nucleic acid binding 74 1.34 1.17 1.26 1.09 1.19 1.38 1.12
NADH dehydrogenase (ubiquinone) activity 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
protein tyrosine/serine/threonine phosphatase activity 20 1.45 1.13 1.29 1.1 1.37 1.36 1.21
nuclear localization sequence binding 1 -1.11 1.3 1.01 1.22 1.27 1.55 1.52
cAMP response element binding protein binding 1 2.75 1.33 1.9 1.11 2.22 3.34 2.0
oxysterol binding 3 -2.13 1.47 1.84 1.14 1.36 1.14 1.32
drug binding 19 -1.19 -1.07 -1.35 1.08 1.12 -1.56 -1.08
phenylalkylamine binding 5 1.32 1.03 -1.03 1.02 -1.05 -1.01 -1.01
sulfotransferase activity 17 1.29 1.02 1.09 -1.04 1.07 -1.07 1.2
negative regulation of transcription elongation, DNA-dependent 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
biological_process 8429 1.02 -1.01 1.01 1.01 1.06 1.03 1.0
actin polymerization or depolymerization 10 -1.07 1.03 1.37 1.11 1.28 -1.26 -1.14
negative regulation of DNA replication 10 -1.21 1.1 1.22 1.13 1.36 -1.2 1.22
protein phosphatase 1 binding 25 1.23 -1.0 1.19 1.06 1.18 1.25 1.15
hedgehog receptor activity 5 1.99 1.03 1.37 -1.02 1.31 2.39 1.55
positive regulation of transcription elongation, DNA-dependent 11 1.03 1.26 1.29 -1.01 1.22 1.24 1.55
protein tyrosine phosphatase activator activity 3 1.39 1.03 1.11 1.1 1.16 1.44 1.03
response to carbamate 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
response to cyclodiene 1 1.0 1.06 1.02 -1.01 -1.21 1.06 -1.07
response to DDT 1 -5.76 1.9 -16.55 1.25 -6.77 -4.39 3.09
response to organophosphorus 2 -1.59 1.53 -9.25 -1.13 -3.86 -6.59 5.39
methyltransferase activity 99 1.29 1.12 1.16 1.16 1.2 1.2 1.04
C-methyltransferase activity 2 -1.09 1.1 1.25 1.35 1.18 1.22 -1.29
N-methyltransferase activity 28 1.25 1.16 1.31 1.09 1.25 1.3 1.16
O-methyltransferase activity 8 2.13 -1.36 -1.3 -1.24 1.01 1.32 1.14
S-methyltransferase activity 3 -1.85 1.29 -1.98 1.47 1.67 -1.31 -1.12
RNA methyltransferase activity 21 1.33 1.19 1.23 1.28 1.27 1.08 1.02
mRNA methyltransferase activity 3 1.33 1.16 1.39 1.35 1.34 1.1 1.01
tRNA methyltransferase activity 7 1.13 1.18 -1.0 1.31 1.1 -1.11 -1.05
tRNA (guanine-N7-)-methyltransferase activity 1 1.71 1.4 1.24 1.52 1.28 1.04 1.1
succinate dehydrogenase (ubiquinone) activity 4 -1.04 1.01 1.45 -1.06 -1.01 1.58 -1.36
signalosome 8 1.14 1.05 1.18 1.23 1.23 -1.06 -1.08
glycogen phosphorylase activity 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
RNA-dependent ATPase activity 38 1.22 1.21 1.3 1.2 1.31 1.37 1.16
poly-pyrimidine tract binding 11 1.49 1.11 1.46 1.08 1.34 1.6 1.2
neuropeptide receptor activity 44 1.12 -1.07 1.02 -1.07 -1.04 1.16 1.01
eukaryotic initiation factor 4E binding 1 1.26 1.58 1.86 1.05 1.71 1.8 2.46
metalloendopeptidase inhibitor activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
RNA guanylyltransferase activity 2 1.49 1.24 1.25 1.25 1.15 1.46 1.15
tRNA guanylyltransferase activity 1 1.31 1.2 1.2 1.21 1.12 1.43 -1.01
UDP-glycosyltransferase activity 97 -1.16 -1.03 -1.06 1.0 1.11 -1.15 1.15
phosphatidate phosphatase activity 9 2.18 -1.22 -1.33 -1.14 1.06 -1.03 1.06
vitellogenin receptor activity 1 1.15 -1.08 1.04 1.21 1.31 1.09 -1.03
ferrous iron binding 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
ferric iron binding 6 1.86 -1.38 -1.24 -1.34 -1.27 1.74 1.1
heparin binding 10 -1.15 1.06 1.17 1.03 1.27 -1.23 1.15
steroid metabolic process 25 1.6 -1.17 1.06 -1.05 -1.04 1.23 1.07
cholesterol metabolic process 4 1.71 1.17 -1.04 1.01 1.09 1.45 1.5
ecdysone metabolic process 9 1.02 1.03 1.05 1.08 1.14 1.15 1.0
bile acid metabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
androgen metabolic process 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
estrogen metabolic process 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
protein alkylation 32 1.29 1.19 1.36 1.15 1.36 1.34 1.2
protein dealkylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
spermine metabolic process 2 1.12 1.21 1.31 1.22 1.2 1.92 1.01
spermidine metabolic process 4 1.11 1.15 1.16 1.22 1.17 1.34 -1.08
cell death 153 1.07 1.04 1.16 1.06 1.25 1.12 1.14
programmed cell death 148 1.06 1.05 1.17 1.06 1.26 1.12 1.14
cytolysis 1 2.51 -2.79 -2.4 2.63 1.21 1.32 -1.1
defense response to Gram-positive bacterium 32 1.3 -1.43 -1.38 -1.33 -1.3 -1.1 1.27
defense response to Gram-negative bacterium 32 1.66 -1.16 -1.17 -1.19 -1.05 1.16 1.24
tyramine receptor activity 2 -1.26 1.29 -1.12 1.24 -1.01 -1.45 1.11
G-protein coupled amine receptor activity 18 1.01 1.03 1.15 1.04 1.0 -1.07 -1.05
ecdysone receptor holocomplex 4 1.21 1.23 1.34 1.21 1.4 1.24 1.26
repressor ecdysone receptor complex 2 1.38 1.15 1.29 1.1 1.25 1.35 1.22
exopeptidase activity 98 -1.97 -1.3 -1.45 1.04 -1.09 -1.69 -1.59
omega peptidase activity 7 1.51 -1.0 -1.02 1.11 1.16 1.09 1.0
oligosaccharyltransferase complex 2 -1.97 1.27 1.32 1.05 1.26 -1.0 1.71
tRNA-specific adenosine deaminase activity 1 -1.25 1.12 1.26 -1.01 -1.04 -1.21 -1.06
nucleotidase activity 10 -1.98 1.08 -1.56 1.17 -1.11 -1.91 -1.09
5'-nucleotidase activity 7 -2.99 1.07 -1.74 1.18 -1.15 -2.4 -1.14
ecdysis-triggering hormone activity 2 -1.05 1.04 -1.07 -1.01 -1.12 -1.1 -1.01
head involution 37 1.14 1.08 1.31 1.05 1.26 1.12 1.32
3-oxoacid CoA-transferase activity 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
allatostatin receptor activity 5 -1.14 -1.08 1.25 -1.02 1.16 1.25 -1.31
importin-alpha export receptor activity 1 1.02 1.3 1.9 1.26 1.85 1.34 1.32
pyrimidine-specific mismatch base pair DNA N-glycosylase activity 1 -1.08 1.06 -1.04 1.0 -1.17 1.06 -1.14
Mo-molybdopterin cofactor sulfurase activity 3 -1.23 1.5 -1.02 1.17 -1.21 -2.29 1.26
poly(U) RNA binding 4 1.37 1.1 1.19 1.12 1.19 1.46 1.12
JAK pathway signal transduction adaptor activity 1 -2.42 1.28 1.48 1.16 1.17 -1.51 1.15
zinc ion binding 854 1.03 1.05 1.1 1.09 1.18 1.04 -1.01
secondary active sulfate transmembrane transporter activity 9 -1.49 -1.12 -1.96 -1.28 -1.37 2.2 -1.04
sulfate transport 4 -1.28 -1.14 1.13 -1.09 1.33 2.21 -1.19
calcium, potassium:sodium antiporter activity 5 -1.42 1.17 -1.18 1.1 -1.14 -1.59 -1.02
gamma-tubulin ring complex 5 1.67 -1.04 1.23 1.09 1.31 1.41 1.1
gamma-tubulin small complex 4 1.69 1.04 1.32 1.06 1.39 1.77 1.19
protein methyltransferase activity 28 1.22 1.17 1.33 1.13 1.3 1.24 1.15
regulation of G-protein coupled receptor protein signaling pathway 25 1.29 1.06 1.24 1.1 1.16 1.15 1.13
cohesin complex 11 1.22 1.11 1.37 1.14 1.35 1.4 1.12
cohesin core heterodimer 1 2.72 1.09 2.08 1.56 2.05 2.2 1.21
sulfonylurea receptor activity 1 2.13 1.07 1.24 -1.07 1.02 1.64 1.13
ATP-sensitive potassium channel complex 1 2.13 1.07 1.24 -1.07 1.02 1.64 1.13
cell proliferation 156 1.11 1.12 1.26 1.11 1.32 1.15 1.12
positive regulation of cell proliferation 30 1.16 1.02 1.29 1.1 1.47 1.23 1.2
negative regulation of cell proliferation 40 1.43 1.07 1.41 1.04 1.41 1.49 1.16
insulin receptor signaling pathway 19 -1.09 1.12 1.15 1.13 1.17 1.07 1.18
protein serine/threonine phosphatase complex 28 1.25 1.08 1.34 1.05 1.22 1.54 1.16
F-actin capping protein complex 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
acetylcholine metabolic process 3 1.5 1.03 -1.96 -1.22 -1.24 -2.29 2.08
acetylcholine biosynthetic process 2 1.23 -1.06 -1.21 -1.07 1.07 -1.1 -1.02
torso signaling pathway 33 1.26 1.03 1.24 1.02 1.16 1.22 1.22
calcium- and calmodulin-responsive adenylate cyclase activity 1 4.63 2.09 1.35 -1.43 -1.28 1.63 2.43
spermidine biosynthetic process 3 1.26 1.15 1.19 1.19 1.22 1.53 -1.02
3'-5'-exodeoxyribonuclease activity 5 -1.07 1.09 1.04 -1.0 1.17 1.05 -1.01
single-stranded DNA specific exodeoxyribonuclease activity 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
intracellular mRNA localization 55 1.09 1.16 1.32 1.14 1.25 1.23 1.17
isoprenoid biosynthetic process 12 1.73 -1.18 1.02 -1.16 1.13 1.29 1.36
isoprenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
DNA binding, bending 6 1.07 1.1 1.11 1.22 1.35 -1.22 1.04
female germline ring canal formation, actin assembly 2 1.08 1.2 1.17 -1.17 1.32 2.65 1.46
caspase complex 2 -3.83 1.28 1.42 1.35 1.72 -4.2 -3.4
eukaryotic translation initiation factor 4F complex 11 1.11 1.13 1.2 1.02 1.09 1.09 1.35
associative learning 55 1.1 1.08 1.18 1.01 1.2 1.31 1.21
structural constituent of muscle 14 2.28 -1.15 1.21 -1.08 1.27 1.81 -1.09
voltage-gated anion channel activity 9 -1.16 1.09 1.05 1.07 -1.0 1.42 1.04
double-stranded DNA specific exodeoxyribonuclease activity 2 1.46 -1.04 -1.04 1.08 1.25 1.21 1.13
single-stranded DNA specific 3'-5' exodeoxyribonuclease activity 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
double-stranded DNA specific 3'-5' exodeoxyribonuclease activity 2 1.46 -1.04 -1.04 1.08 1.25 1.21 1.13
7S RNA binding 6 1.07 1.41 1.11 1.17 1.04 -1.21 1.28
gurken-activated receptor activity 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
gurken receptor signaling pathway 4 2.03 1.05 1.12 1.25 1.3 1.58 1.1
meiotic G2/MI transition 5 -1.32 1.33 1.45 1.2 1.64 1.0 1.18
structural constituent of vitelline membrane 5 -1.04 1.0 -1.05 -1.03 -1.16 -1.05 -1.08
gurken receptor binding 2 3.37 -1.03 1.31 1.11 1.37 1.92 1.47
protein prenyltransferase activity 7 -1.61 1.12 1.15 1.12 1.17 -1.52 1.36
protein transmembrane transporter activity 33 1.03 1.14 1.21 1.1 1.12 1.16 -1.01
Ral guanyl-nucleotide exchange factor activity 1 8.19 -2.13 1.05 -1.9 1.69 3.12 2.66
larval feeding behavior 14 -1.24 1.04 1.52 -1.07 -1.05 -1.09 1.18
cation transmembrane transporter activity 354 -1.17 -1.05 -1.15 -1.12 -1.07 1.16 -1.11
methyl-CpG binding 1 2.49 1.08 1.5 1.28 1.63 1.64 1.5
ionotropic glutamate receptor complex 5 -1.46 1.04 1.09 -1.04 -1.01 -1.5 1.07
protein tyrosine/threonine phosphatase activity 1 1.33 1.23 1.28 1.29 1.18 1.21 1.19
low voltage-gated calcium channel activity 1 -1.24 1.06 -1.0 1.0 -1.1 1.0 -1.05
endosome to lysosome transport 7 1.05 1.14 1.56 1.12 1.35 1.31 1.19
histone mRNA metabolic process 9 1.42 1.07 1.16 1.23 1.3 1.29 1.06
female germline ring canal stabilization 4 -1.41 1.17 1.28 1.2 1.33 -1.35 1.02
gamma-butyrobetaine dioxygenase activity 4 -2.34 -1.03 -1.77 -1.06 -1.07 -1.32 1.02
determination of adult lifespan 113 1.24 1.12 1.11 -1.02 1.16 1.36 1.25
behavioral response to cocaine 9 1.31 1.15 1.55 1.04 1.35 1.53 1.26
adult feeding behavior 7 1.32 -1.86 -1.97 -2.12 -2.07 -1.51 2.24
adult locomotory behavior 50 1.11 1.02 1.21 1.0 1.17 1.25 1.14
larval locomotory behavior 18 1.01 1.12 1.09 -1.24 -1.15 -1.09 1.14
glial cell migration 26 1.24 1.07 1.41 1.1 1.38 1.25 1.08
negative regulation of antimicrobial humoral response 4 1.35 1.1 1.46 1.15 1.8 1.12 1.2
MAP kinase kinase kinase kinase activity 1 -1.25 1.21 1.4 1.19 1.07 1.11 1.44
microtubule severing 6 -1.04 1.14 1.1 1.14 1.18 1.01 1.05
katanin complex 4 1.09 1.1 1.08 1.22 1.19 -1.04 1.02
RNA polymerase II carboxy-terminal domain kinase activity 5 1.49 1.22 1.54 1.24 1.64 1.52 1.29
germ cell migration 42 1.28 1.05 1.21 -1.02 1.39 1.39 1.26
olfactory learning 49 1.08 1.08 1.17 -1.0 1.22 1.27 1.23
asymmetric cell division 66 1.06 1.13 1.27 1.08 1.35 1.05 1.13
maternal determination of anterior/posterior axis, embryo 66 1.14 1.17 1.4 1.11 1.34 1.36 1.21
regulation of bicoid mRNA localization 2 -1.31 1.2 1.89 -1.13 1.39 2.71 1.31
regulation of cell shape 104 1.18 1.11 1.41 1.04 1.38 1.42 1.29
regulation of cell size 48 1.12 1.2 1.33 1.06 1.31 1.38 1.25
chitin-based embryonic cuticle biosynthetic process 18 1.73 -1.03 1.1 -1.15 1.04 1.97 1.4
larval chitin-based cuticle development 12 1.05 -1.05 1.07 -1.09 1.02 -1.12 1.35
pupal chitin-based cuticle development 1 14.19 -4.21 -4.1 -3.94 -3.79 21.36 -4.46
adult chitin-based cuticle development 10 1.01 -1.17 -1.08 -1.07 -1.12 -1.07 1.3
axon ensheathment 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
sialyltransferase activity 1 1.19 1.12 1.07 1.08 1.03 1.22 -1.05
O-acyltransferase activity 20 -1.13 -1.08 -1.14 1.21 1.65 -1.68 -1.37
acetylglucosaminyltransferase activity 26 1.0 1.15 1.12 1.08 1.33 1.22 1.29
acetylgalactosaminyltransferase activity 18 -1.14 -1.09 -1.18 -1.18 -1.19 -1.47 1.62
light-induced release of internally sequestered calcium ion 1 -1.32 -1.06 -1.2 1.5 -1.29 -1.26 -1.29
galactosyltransferase activity 23 -1.33 -1.04 -1.03 1.03 1.03 -1.42 1.2
thioredoxin peroxidase activity 6 -1.25 1.02 -1.13 1.12 1.03 -1.35 -1.22
mechanically-gated ion channel activity 1 -1.05 1.0 -1.06 -1.03 -1.14 1.01 1.95
IkappaB kinase activity 3 1.21 -1.06 1.39 1.12 1.46 -1.08 -1.04
IkappaB kinase complex 3 1.21 -1.06 1.39 1.12 1.46 -1.08 -1.04
steroid hydroxylase activity 5 -1.11 -1.12 1.02 -1.03 -1.09 -1.02 -1.19
gonad development 42 1.01 1.04 1.05 1.07 1.24 -1.01 1.0
chaeta morphogenesis 42 1.01 1.11 1.31 1.05 1.22 1.07 1.18
3'-5' exonuclease activity 25 1.2 1.14 1.2 1.19 1.29 1.17 1.03
5'-3' exonuclease activity 2 -1.11 1.53 1.16 1.33 1.34 -1.11 1.19
CoA-transferase activity 2 -1.15 1.38 -1.15 1.04 -1.3 1.87 -1.04
4-hydroxybutyrate CoA-transferase activity 1 1.07 1.18 1.06 1.23 1.16 -1.07 1.13
4-hydroxybenzoate octaprenyltransferase activity 1 1.04 1.26 1.1 1.28 -1.02 -1.97 -1.12
CDP-alcohol phosphotransferase activity 1 -10.11 1.17 -1.48 1.2 1.57 -5.09 -1.84
delta5-delta2,4-dienoyl-CoA isomerase activity 2 1.86 -1.05 1.02 1.19 1.39 1.16 -1.03
fucosyltransferase activity 7 -1.17 1.08 -1.01 1.15 1.23 -1.03 1.02
protein-N-terminal asparagine amidohydrolase activity 1 6.19 -1.42 -1.44 -1.3 -1.36 1.94 1.84
RNA lariat debranching enzyme activity 2 1.26 1.13 1.23 1.25 1.39 1.4 1.02
CTD phosphatase activity 2 -1.16 1.24 1.23 1.2 1.16 1.07 1.3
beta-glucosidase activity 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
glycoprotein 6-alpha-L-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity 2 -1.09 1.1 1.25 1.35 1.18 1.22 -1.29
protein kinase C inhibitor activity 2 1.45 1.07 1.48 1.05 1.45 1.77 1.84
betaine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
ribonuclease inhibitor activity 2 1.78 1.2 1.19 -1.04 1.08 2.12 1.24
phosphatidylethanolamine binding 8 1.31 -1.34 -1.15 -1.46 -1.4 1.2 1.09
selenium binding 4 1.26 1.16 1.54 1.18 1.1 1.17 -1.12
vitamin E binding 10 -2.36 -2.69 -2.86 -1.36 -1.28 -1.63 -1.06
JUN kinase binding 1 -1.08 1.01 1.18 1.12 1.07 -1.04 1.06
heterogeneous nuclear ribonucleoprotein complex 7 1.06 1.34 1.44 1.06 1.21 1.65 1.29
inositol-1,4,5-trisphosphate 3-kinase activity 5 1.28 1.12 1.04 -1.27 1.01 1.27 1.33
3'(2'),5'-bisphosphate nucleotidase activity 2 1.61 1.02 -1.31 1.13 -1.08 1.03 1.2
3-hydroxyisobutyrate dehydrogenase activity 2 -1.14 1.35 1.05 1.01 1.01 1.03 1.42
phosphofructokinase activity 2 1.69 -1.28 1.45 -1.01 1.01 4.15 1.1
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity 1 1.09 1.12 -1.13 1.16 1.11 -1.64 -1.3
D-aspartate oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
GDP-mannose 4,6-dehydratase activity 1 -3.57 1.21 1.13 1.39 1.5 -2.8 -1.34
L-ascorbate oxidase activity 1 -1.08 -1.06 -1.06 -1.17 -1.14 -1.13 -1.1
N-acetylglucosamine-6-phosphate deacetylase activity 1 1.05 -1.01 -1.53 1.51 1.2 -1.51 -1.4
N-acetylglucosamine-6-sulfatase activity 2 4.3 -1.11 1.07 -1.47 1.62 8.46 1.92
alanine-glyoxylate transaminase activity 3 -2.83 1.14 -4.47 -1.13 -1.51 -1.62 1.13
alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity 2 1.98 -1.1 1.19 -1.09 1.23 2.85 1.26
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity 1 3.56 -1.43 -1.34 -1.25 -1.02 7.35 1.28
alpha-N-acetylgalactosaminidase activity 1 1.06 -1.01 -1.01 1.04 -1.07 -1.04 1.13
carnitine O-octanoyltransferase activity 1 2.33 -1.31 -2.71 1.32 2.24 -2.61 1.02
chondroitin 6-sulfotransferase activity 1 1.06 1.47 1.34 1.13 1.02 -1.02 1.04
dTDP-glucose 4,6-dehydratase activity 1 2.45 1.09 2.09 -1.01 1.2 1.56 1.31
glycogenin glucosyltransferase activity 2 7.0 -1.59 1.16 -1.42 1.29 4.38 -1.04
[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity 2 1.57 1.14 -1.02 1.0 1.08 -1.33 -1.08
histone-arginine N-methyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
isovaleryl-CoA dehydrogenase activity 1 1.14 1.39 1.15 1.11 1.04 1.05 1.01
hydroquinone:oxygen oxidoreductase activity 2 -3.8 -3.2 -3.92 -3.61 -4.08 -3.9 3.04
palmitoyl-(protein) hydrolase activity 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
procollagen-lysine 5-dioxygenase activity 2 1.13 1.08 1.05 -1.04 1.19 1.95 1.17
protein-tyrosine sulfotransferase activity 1 -1.29 1.27 1.45 -1.08 1.08 1.07 2.33
queuine tRNA-ribosyltransferase activity 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
sarcosine dehydrogenase activity 1 1.0 1.04 -1.1 -1.02 -1.03 1.1 1.13
sulfite oxidase activity 1 -1.72 1.15 -1.04 1.56 -1.05 1.22 -1.45
transaminase activity 14 -1.03 1.19 -1.47 -1.11 -1.05 1.04 1.34
sulfuric ester hydrolase activity 8 1.82 -1.14 -1.15 -1.09 1.33 2.75 1.13
diphosphoinositol-polyphosphate diphosphatase activity 1 1.43 1.14 1.21 1.02 1.13 1.54 1.16
gamma-glutamyl carboxylase activity 1 1.13 1.29 1.08 1.08 -1.09 -1.02 1.13
arsenite secondary active transmembrane transporter activity 1 1.35 1.29 1.36 1.08 1.19 1.34 1.11
cAMP metabolic process 7 1.35 1.03 1.31 -1.01 1.11 1.49 1.22
translation activator activity 1 1.37 1.21 2.02 -1.05 1.64 2.25 1.61
protoheme IX farnesyltransferase activity 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
mannan endo-1,6-alpha-mannosidase activity 1 1.08 1.1 1.1 1.25 1.18 1.04 1.09
phospholipid scrambling 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity 7 1.21 1.06 1.08 1.06 -1.01 1.55 1.16
glycine binding 1 2.28 1.03 1.38 -1.44 -1.34 1.53 1.42
glutamate binding 4 1.16 1.11 1.12 -1.06 -1.11 1.09 1.14
thienylcyclohexylpiperidine binding 1 2.28 1.03 1.38 -1.44 -1.34 1.53 1.42
melatonin receptor activity 1 1.09 1.23 3.2 1.05 2.53 1.91 1.95
benzodiazepine receptor activity 1 -1.12 -1.26 1.76 1.06 1.23 -1.31 -1.61
monoamine transmembrane transporter activity 3 2.07 -1.32 -1.3 -1.21 -1.34 1.32 -1.28
sucrose:hydrogen symporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
sodium:iodide symporter activity 7 1.13 -1.12 -1.82 -1.93 -1.54 -1.43 1.18
bile acid:sodium symporter activity 2 -3.13 1.41 -2.05 1.29 -3.5 -4.18 -1.28
anion transmembrane transporter activity 90 -1.43 -1.05 -1.42 -1.25 -1.3 1.08 -1.17
sodium:bicarbonate symporter activity 1 1.2 -1.03 1.07 -1.04 1.13 1.1 1.23
sodium:potassium:chloride symporter activity 3 -1.68 -1.44 1.14 -1.49 -1.04 2.8 -1.1
secondary active organic cation transmembrane transporter activity 24 -1.27 -1.38 -1.63 -1.24 -1.0 2.31 -1.46
organic anion transmembrane transporter activity 8 -2.06 1.07 -1.1 -1.04 1.14 -1.35 1.33
sucrose transmembrane transporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
folic acid transporter activity 1 -1.3 -1.21 1.08 -1.14 1.42 1.82 -1.08
reduced folate carrier activity 3 -2.47 1.26 -3.59 2.04 -1.22 -1.96 -2.06
ammonium transmembrane transporter activity 1 -1.13 -1.02 -1.13 -1.06 -1.15 -1.01 -1.16
L-ascorbate:sodium symporter activity 1 1.92 -5.29 -3.19 -3.44 7.65 2.58 1.23
acetyl-CoA transporter activity 1 -1.28 1.24 -1.24 1.18 -1.13 -1.69 1.59
sodium-dependent multivitamin transmembrane transporter activity 5 1.01 1.09 -2.28 -1.32 1.1 -1.3 1.01
glucose 6-phosphate:phosphate antiporter activity 1 1.19 1.35 1.39 1.1 1.22 1.13 2.76
phosphatidylcholine transporter activity 3 3.03 -1.11 1.31 -1.04 1.16 1.62 1.22
phosphatidylinositol transporter activity 3 2.87 -1.14 1.55 -1.02 1.46 1.97 1.15
taste receptor activity 55 -1.07 1.01 -1.03 1.01 -1.01 -1.07 -1.07
G-protein coupled peptide receptor activity 44 1.12 -1.07 1.02 -1.07 -1.04 1.16 1.01
riboflavin kinase activity 1 1.06 1.33 1.06 -1.02 -1.41 1.22 1.19
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity 3 -3.66 1.03 -1.66 1.15 1.31 -2.05 -1.18
oxidized purine base lesion DNA N-glycosylase activity 2 1.64 -1.01 1.15 1.12 1.14 1.33 -1.07
respiratory chain complex IV assembly 8 1.05 1.23 1.36 1.17 1.1 1.44 -1.28
proteasome activator complex 1 1.38 1.06 -1.05 1.28 -1.05 1.16 -1.12
endopeptidase activator activity 3 1.37 1.13 1.14 1.18 1.05 1.05 1.17
regulation of proteasomal protein catabolic process 5 1.57 1.06 1.14 1.24 1.16 1.17 1.01
proteasome regulatory particle, base subcomplex 11 1.29 1.04 1.28 1.23 1.2 1.03 1.05
proteasome regulatory particle, lid subcomplex 8 1.42 1.1 1.26 1.18 1.26 1.0 1.06
visual learning 3 1.5 1.07 1.21 1.15 1.26 1.3 1.05
fibroblast growth factor receptor signaling pathway 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
epidermis development 59 1.32 1.05 1.35 1.0 1.31 1.31 1.3
JUN kinase kinase activity 2 -1.25 1.26 1.38 1.09 1.35 1.25 1.38
cadmium ion transmembrane transporter activity 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism 61 -1.2 1.0 1.27 -1.12 -1.01 1.39 -1.09
hydrogen-exporting ATPase activity, phosphorylative mechanism 41 -1.23 -1.01 1.31 -1.14 -1.07 1.48 -1.19
potassium-transporting ATPase activity 8 1.13 -1.11 1.22 -1.35 -1.0 1.53 1.06
xenobiotic-transporting ATPase activity 8 -1.32 1.18 1.1 1.25 1.08 -1.09 1.15
protein transporter activity 55 1.03 1.17 1.31 1.13 1.19 1.2 1.09
microtubule-severing ATPase activity 3 -1.13 1.2 1.15 1.08 1.3 1.07 1.1
minus-end-directed microtubule motor activity 3 1.03 1.05 1.24 1.18 1.22 1.09 -1.02
actin filament-based movement 2 -1.84 1.42 2.86 1.0 1.74 1.92 1.21
plus-end-directed microtubule motor activity 6 -1.13 1.06 1.13 1.16 1.26 -1.02 -1.11
ATPase activity 318 -1.02 1.05 1.15 1.04 1.13 1.15 1.03
JUN kinase phosphatase activity 1 -1.35 1.21 1.45 -1.04 1.43 -1.17 1.37
regulation of synaptic growth at neuromuscular junction 39 -1.02 1.12 1.32 1.09 1.24 1.09 1.21
mystery cell differentiation 1 -1.03 1.35 2.46 1.15 2.45 2.67 1.87
male gonad development 7 -1.2 1.03 -1.03 1.03 1.04 -1.14 -1.07
female gonad development 11 1.16 1.1 1.04 -1.01 1.28 1.15 1.13
imaginal disc-derived wing vein morphogenesis 36 1.27 1.09 1.25 1.03 1.32 1.38 1.31
imaginal disc-derived wing margin morphogenesis 43 1.4 1.1 1.3 1.02 1.29 1.46 1.36
release of cytoplasmic sequestered NF-kappaB 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
regulation of smoothened signaling pathway 27 1.49 1.16 1.31 1.06 1.3 1.61 1.15
regulation of Toll signaling pathway 15 2.33 -1.32 -1.29 -1.35 -1.14 1.81 1.29
regulation of Notch signaling pathway 50 -1.09 1.19 1.32 1.11 1.36 1.24 1.21
photoreceptor cell morphogenesis 13 1.11 1.16 1.43 1.14 1.34 1.12 1.26
anterior/posterior axis specification, embryo 114 1.21 1.09 1.29 1.04 1.25 1.28 1.24
calcium-dependent protein serine/threonine phosphatase regulator activity 4 1.2 1.0 1.18 1.05 1.13 -1.01 1.02
protein phosphatase type 1 regulator activity 6 1.88 -1.31 1.12 1.03 1.16 1.14 1.17
protein phosphatase type 2A regulator activity 7 1.44 -1.06 1.23 -1.02 1.16 2.34 1.17
cAMP-dependent protein kinase regulator activity 6 -1.1 1.09 1.07 1.13 1.06 -1.11 -1.2
protein kinase regulator activity 43 1.19 1.13 1.19 1.14 1.26 1.06 1.09
phosphorylase kinase regulator activity 5 1.29 1.3 1.33 1.21 1.15 1.36 1.33
attachment of spindle microtubules to kinetochore 4 -1.03 1.09 1.07 1.08 1.18 1.05 1.05
alkylglycerone-phosphate synthase activity 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
lipid biosynthetic process 111 1.08 -1.13 -1.05 -1.09 1.07 1.05 1.09
ether lipid biosynthetic process 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
diuretic hormone activity 4 -1.94 -1.06 1.2 1.12 1.34 -2.14 -1.37
pyridoxine metabolic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
pyridoxine biosynthetic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
queuosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
guanosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
7-methylguanosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
epsilon DNA polymerase complex 3 1.73 1.2 1.21 1.15 1.32 1.1 -1.16
chromatin accessibility complex 4 1.2 1.15 1.7 1.23 1.78 1.39 1.32
induction of apoptosis by extracellular signals 1 1.28 1.14 -1.32 1.35 1.43 1.41 1.45
induction of apoptosis by ionic changes 2 1.02 1.0 -1.02 -1.06 -1.0 -1.03 1.59
induction of apoptosis by hormones 1 1.28 1.14 -1.32 1.35 1.43 1.41 1.45
induction of apoptosis by intracellular signals 10 1.45 1.15 1.09 1.11 1.25 1.28 1.38
DNA damage response, signal transduction resulting in induction of apoptosis 9 1.53 1.18 1.1 1.13 1.27 1.31 1.44
activation of pro-apoptotic gene products 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
urea transport 1 1.41 1.17 -1.02 1.18 -1.05 -1.09 1.18
small protein activating enzyme activity 6 1.19 1.08 1.24 1.27 1.39 1.11 -1.07
carbohydrate transport 13 1.22 -1.13 -1.12 -1.07 1.01 1.59 1.23
hexose transport 2 -1.9 1.16 -1.07 1.04 -1.18 -1.96 1.78
rRNA methyltransferase activity 7 1.35 1.22 1.24 1.28 1.26 1.11 1.02
rRNA (uridine-2'-O-)-methyltransferase activity 3 1.55 1.21 1.1 1.32 1.19 1.02 -1.14
actin filament polymerization 6 -1.34 1.04 1.42 1.14 1.28 -1.56 -1.16
identical protein binding 70 1.32 1.03 1.02 -1.03 1.12 1.22 1.14
cellular amino acid biosynthetic process 39 1.02 1.06 -1.29 -1.04 -1.12 1.11 1.06
lipopolysaccharide metabolic process 2 1.01 -1.07 -1.02 1.06 1.11 -1.07 -1.11
phospholipid biosynthetic process 44 -1.11 1.0 1.16 1.01 1.28 -1.04 -1.11
2'-phosphotransferase activity 1 3.82 1.09 1.67 1.1 1.4 2.3 1.73
N-acetylmuramoyl-L-alanine amidase activity 11 -1.39 -1.63 -1.15 1.01 -1.87 -2.01 -1.36
oxidoreductase activity, acting on NADH or NADPH 44 1.12 1.05 1.23 1.06 1.09 1.58 -1.22
S-adenosylmethionine-dependent methyltransferase activity 52 1.26 1.1 1.1 1.12 1.21 1.16 1.09
UDP-N-acetylmuramate dehydrogenase activity 3 1.89 -2.35 -2.83 -2.17 -1.54 -1.15 1.9
acetaldehyde dehydrogenase (acetylating) activity 2 2.78 -1.16 -2.38 -2.31 -1.44 1.4 1.22
N-acylneuraminate cytidylyltransferase activity 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
bis(5'-nucleosyl)-tetraphosphatase activity 1 -1.85 1.12 1.37 1.12 1.23 -1.02 1.02
carbon-monoxide oxygenase activity 1 2.72 -3.32 -2.57 -3.03 -1.93 22.15 -2.83
cardiolipin synthase activity 1 1.31 1.29 1.34 1.27 1.36 1.03 -1.44
choline dehydrogenase activity 15 1.05 -1.22 -1.39 1.07 1.15 1.16 -1.32
crossover junction endodeoxyribonuclease activity 1 1.08 1.1 -1.01 1.17 1.1 -1.08 1.01
diaminohydroxyphosphoribosylaminopyrimidine deaminase activity 1 2.99 3.14 -4.72 -4.54 -4.51 3.75 1.74
DNA N-glycosylase activity 6 2.07 -1.07 1.03 -1.04 1.05 1.76 1.02
exodeoxyribonuclease I activity 1 1.21 1.03 1.2 1.27 1.3 -1.05 1.1
exodeoxyribonuclease III activity 1 -1.62 1.33 -1.09 1.09 -1.15 -1.69 -1.15
exoribonuclease II activity 1 1.38 1.19 2.04 1.07 1.63 2.14 1.72
glycerate kinase activity 1 1.02 1.55 -1.07 1.39 -1.43 -1.25 -1.1
glycerophosphodiester phosphodiesterase activity 6 -2.04 1.29 -1.08 1.03 -1.68 -2.4 1.09
glycine C-acetyltransferase activity 1 1.04 -1.18 -1.1 -1.3 -1.17 1.44 -1.36
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
holo-[acyl-carrier-protein] synthase activity 1 1.84 1.09 2.09 1.3 2.04 2.34 1.11
homocysteine S-methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
mannose-phosphate guanylyltransferase activity 2 -2.09 1.14 1.2 1.25 1.24 -1.89 1.17
inositol monophosphate 1-phosphatase activity 6 1.86 -1.14 -1.69 -1.19 1.02 1.47 1.43
ferredoxin-NAD(P) reductase activity 1 1.15 1.02 1.12 1.04 1.0 -1.01 1.01
oligonucleotidase activity 1 1.49 1.12 1.32 1.17 1.41 1.35 1.33
oxalyl-CoA decarboxylase activity 1 -4.09 -1.02 -5.68 1.78 1.15 -8.6 -2.19
phosphoglycolate phosphatase activity 4 1.72 1.3 -1.05 1.15 1.06 1.1 -1.14
phosphatidylcholine 1-acylhydrolase activity 9 -31.12 -1.57 -1.58 -2.13 -3.67 -22.6 -1.69
site-specific DNA-methyltransferase (adenine-specific) activity 1 1.54 1.35 -1.17 1.42 -1.06 -1.14 -1.22
DNA-methyltransferase activity 3 1.31 1.16 -1.05 1.36 1.06 -1.13 -1.08
tRNA thio-modification 3 1.78 1.18 1.12 1.35 1.22 1.11 -1.02
sulfurtransferase activity 4 1.34 1.04 1.57 1.22 1.05 1.11 -1.14
uridylate kinase activity 1 -1.35 1.03 1.12 1.16 1.1 -1.2 -1.23
dosage compensation by hyperactivation of X chromosome 6 1.52 1.11 1.3 1.04 1.23 1.53 1.43
dosage compensation by inactivation of X chromosome 1 1.21 1.08 1.29 -1.08 1.41 1.2 1.17
pentose-phosphate shunt, non-oxidative branch 2 2.98 1.26 -2.38 1.09 -1.14 1.07 1.35
catabolic process 443 1.07 -1.01 -1.01 1.0 1.07 1.05 1.06
macromolecule catabolic process 194 1.12 -1.02 1.09 1.02 1.13 1.1 1.16
biosynthetic process 1003 1.19 1.05 1.09 1.06 1.14 1.18 1.04
macromolecule biosynthetic process 633 1.18 1.09 1.17 1.11 1.2 1.2 1.03
aerobic respiration 37 -1.01 1.07 1.26 -1.07 1.11 1.57 -1.08
anaerobic respiration 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
fatty acid catabolic process 14 -1.01 1.07 -1.43 1.07 1.18 -1.97 -1.26
cellular amino acid catabolic process 26 1.02 -1.11 -1.05 -1.1 1.01 1.7 -1.18
glutamine family amino acid metabolic process 23 -1.67 -1.06 -1.81 -1.18 1.04 -1.04 -1.34
glutamine family amino acid catabolic process 9 -1.31 -1.36 -1.54 -1.44 1.15 1.66 -1.26
aspartate family amino acid metabolic process 11 1.2 -1.0 -1.12 1.08 -1.05 1.59 -1.22
aspartate family amino acid biosynthetic process 4 1.12 1.16 -1.0 1.25 1.08 1.34 -1.11
aspartate family amino acid catabolic process 2 -1.01 -1.12 -1.04 1.37 -1.27 1.52 -1.61
serine family amino acid metabolic process 17 1.58 1.09 1.09 1.0 -1.11 1.65 1.1
serine family amino acid biosynthetic process 8 2.16 1.12 -1.08 1.04 -1.18 1.67 1.19
serine family amino acid catabolic process 6 1.21 1.07 1.39 -1.04 -1.02 1.86 -1.02
aromatic amino acid family metabolic process 19 1.42 -1.17 -1.18 -1.07 -1.13 1.48 1.04
aromatic amino acid family catabolic process 6 1.4 -1.16 -1.06 -1.08 -1.08 1.95 -1.14
pyruvate family amino acid metabolic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
pyruvate family amino acid biosynthetic process 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
branched chain family amino acid metabolic process 7 1.25 1.54 1.17 1.06 -1.04 1.35 1.33
branched chain family amino acid biosynthetic process 1 5.21 1.63 1.44 -1.45 -2.46 1.42 2.6
branched chain family amino acid catabolic process 2 1.3 1.33 1.23 1.08 1.06 1.1 -1.0
glutamine family amino acid biosynthetic process 13 -1.5 -1.15 -1.86 -1.29 -1.1 1.05 -1.0
methionine biosynthetic process 2 1.35 1.12 -1.14 1.23 1.0 1.41 -1.09
methionine catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
glycoprotein metabolic process 69 1.16 1.07 1.11 1.04 1.13 1.16 1.31
glycoprotein biosynthetic process 66 1.17 1.06 1.1 1.04 1.12 1.16 1.31
lipopolysaccharide biosynthetic process 2 1.01 -1.07 -1.02 1.06 1.11 -1.07 -1.11
lipoate metabolic process 3 1.25 1.0 1.66 -1.03 -1.05 2.4 -1.24
coenzyme biosynthetic process 38 1.65 1.09 1.07 1.05 1.11 1.24 1.16
coenzyme catabolic process 37 -1.01 1.1 1.27 -1.05 1.08 1.5 -1.04
vitamin biosynthetic process 9 1.68 1.27 -1.29 -1.05 -1.17 1.44 1.19
nucleobase metabolic process 14 1.45 1.02 -1.06 -1.01 -1.04 1.16 -1.01
purine base biosynthetic process 4 1.18 1.13 1.03 1.06 -1.06 1.6 -1.13
nucleoside metabolic process 33 -1.08 1.04 1.04 1.11 1.12 -1.17 -1.05
nucleotide metabolic process 167 1.11 1.05 1.05 1.02 1.07 1.16 1.0
ribonucleoside metabolic process 22 -1.04 1.14 1.02 1.2 1.26 -1.16 -1.09
nucleoside monophosphate metabolic process 51 1.01 1.08 1.01 1.01 1.01 1.24 1.04
nucleoside monophosphate biosynthetic process 48 1.01 1.08 -1.0 1.01 -1.0 1.23 1.02
purine nucleoside monophosphate metabolic process 16 -1.24 1.08 -1.05 -1.03 -1.12 1.38 -1.02
purine nucleoside monophosphate biosynthetic process 16 -1.24 1.08 -1.05 -1.03 -1.12 1.38 -1.02
pyrimidine nucleoside monophosphate metabolic process 6 1.07 1.17 1.04 1.26 1.2 -1.05 -1.08
pyrimidine nucleoside monophosphate biosynthetic process 6 1.07 1.17 1.04 1.26 1.2 -1.05 -1.08
nucleoside diphosphate metabolic process 9 -1.16 1.05 1.27 1.28 1.4 -1.29 -1.31
nucleoside diphosphate biosynthetic process 3 -1.09 1.03 1.21 1.32 1.42 -1.7 -1.39
purine nucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
purine nucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
pyrimidine nucleoside diphosphate metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
pyrimidine nucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
nucleoside triphosphate metabolic process 78 1.23 1.01 1.2 1.0 1.11 1.29 -1.05
nucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
nucleoside triphosphate catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
purine nucleoside triphosphate metabolic process 77 1.24 1.01 1.2 -1.0 1.1 1.31 -1.04
purine nucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
purine nucleoside triphosphate catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
pyrimidine nucleoside triphosphate metabolic process 5 -1.06 1.02 1.3 1.3 1.44 -1.22 -1.3
pyrimidine nucleoside triphosphate biosynthetic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
purine ribonucleotide metabolic process 96 1.14 1.02 1.15 1.0 1.07 1.3 -1.04
purine ribonucleotide biosynthetic process 48 1.07 1.06 1.13 -1.0 1.06 1.42 -1.08
purine ribonucleotide catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
ribonucleoside monophosphate biosynthetic process 21 -1.11 1.1 -1.01 1.02 -1.07 1.26 -1.02
deoxyribonucleoside monophosphate biosynthetic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
ribonucleoside monophosphate metabolic process 21 -1.11 1.1 -1.01 1.02 -1.07 1.26 -1.02
deoxyribonucleoside monophosphate metabolic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
nucleoside biosynthetic process 7 1.07 1.09 -1.03 1.13 1.19 -1.05 -1.12
nucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
nucleotide biosynthetic process 88 1.12 1.07 1.09 1.01 1.06 1.32 -1.01
nucleotide catabolic process 49 -1.06 1.03 1.02 1.06 1.05 -1.13 1.02
purine ribonucleoside monophosphate metabolic process 16 -1.24 1.08 -1.05 -1.03 -1.12 1.38 -1.02
purine ribonucleoside monophosphate biosynthetic process 16 -1.24 1.08 -1.05 -1.03 -1.12 1.38 -1.02
pyrimidine ribonucleoside monophosphate metabolic process 4 1.08 1.24 1.11 1.27 1.15 -1.24 -1.08
pyrimidine ribonucleoside monophosphate biosynthetic process 4 1.08 1.24 1.11 1.27 1.15 -1.24 -1.08
pyrimidine deoxyribonucleoside monophosphate metabolic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
pyrimidine deoxyribonucleoside monophosphate biosynthetic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
purine ribonucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
purine ribonucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
ribonucleoside diphosphate metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
deoxyribonucleoside diphosphate metabolic process 2 -1.56 -1.01 1.45 1.31 1.53 -1.54 -1.56
cyclic nucleotide metabolic process 28 1.1 1.08 1.04 -1.0 1.05 1.22 1.09
muscle attachment 28 1.6 1.08 1.3 -1.01 1.35 1.36 1.25
ribonucleoside diphosphate biosynthetic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
deoxyribonucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
cyclic nucleotide biosynthetic process 25 1.1 1.06 1.01 -1.01 1.03 1.2 1.06
pyrimidine deoxyribonucleoside diphosphate metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
pyrimidine deoxyribonucleoside diphosphate biosynthetic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
ribonucleoside triphosphate metabolic process 77 1.24 1.01 1.2 -1.0 1.1 1.31 -1.04
deoxyribonucleoside triphosphate metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
ribonucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
ribonucleoside triphosphate catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
purine ribonucleoside triphosphate metabolic process 77 1.24 1.01 1.2 -1.0 1.1 1.31 -1.04
purine ribonucleoside triphosphate biosynthetic process 29 1.28 1.05 1.25 -1.01 1.13 1.56 -1.1
purine ribonucleoside triphosphate catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
pyrimidine ribonucleoside triphosphate metabolic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
pyrimidine ribonucleoside triphosphate biosynthetic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
pyrimidine deoxyribonucleoside triphosphate metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
pyrimidine ribonucleotide metabolic process 8 1.04 1.17 1.23 1.24 1.25 -1.08 -1.11
pyrimidine deoxyribonucleotide metabolic process 5 1.18 -1.03 1.1 1.33 1.37 -1.01 -1.27
pyrimidine ribonucleotide biosynthetic process 8 1.04 1.17 1.23 1.24 1.25 -1.08 -1.11
pyrimidine deoxyribonucleotide biosynthetic process 3 1.12 1.06 1.16 1.24 1.35 1.15 -1.08
nucleotide-sugar metabolic process 4 -1.38 1.14 1.12 1.14 1.22 -1.6 -1.01
nucleotide-sugar biosynthetic process 4 -1.38 1.14 1.12 1.14 1.22 -1.6 -1.01
thiamine diphosphate biosynthetic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
riboflavin biosynthetic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
menaquinone metabolic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
menaquinone biosynthetic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
glycolipid biosynthetic process 7 1.02 1.24 1.08 -1.02 1.04 -1.16 1.9
glucan biosynthetic process 5 2.74 -1.19 -1.42 1.04 1.07 2.78 1.29
glucan catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
peptidoglycan catabolic process 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
10-formyltetrahydrofolate metabolic process 2 2.31 -1.37 1.2 -1.19 -1.05 2.92 1.06
10-formyltetrahydrofolate catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
ribonucleotide metabolic process 101 1.15 1.03 1.15 1.01 1.07 1.28 -1.04
ribonucleotide biosynthetic process 53 1.09 1.07 1.13 1.01 1.06 1.37 -1.08
ribonucleotide catabolic process 39 1.16 1.04 1.14 1.09 1.12 1.08 1.01
deoxyribonucleotide metabolic process 7 -1.11 1.02 1.04 1.35 1.33 -1.29 -1.3
deoxyribonucleotide biosynthetic process 3 1.12 1.06 1.16 1.24 1.35 1.15 -1.08
deoxyribonucleotide catabolic process 1 -1.52 1.52 -1.38 1.37 -1.06 -2.8 1.21
2'-deoxyribonucleotide biosynthetic process 3 1.12 1.06 1.16 1.24 1.35 1.15 -1.08
response to temperature stimulus 95 1.16 -1.06 1.01 -1.09 1.09 1.11 1.17
cellular response to starvation 14 1.29 1.12 1.14 1.05 1.06 1.68 1.18
response to desiccation 2 1.15 1.22 1.01 1.25 -1.19 1.08 -1.16
response to humidity 2 2.35 -1.29 -1.39 -1.42 -1.06 2.35 1.81
cell outer membrane 2 2.45 -1.01 1.06 1.01 1.14 1.16 1.19
bacterial-type flagellum 1 -1.07 -1.0 -1.08 -1.04 -1.09 -1.14 1.31
nucleoid 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
flagellum assembly 10 -1.03 1.09 1.07 1.09 1.11 1.01 -1.02
GDP-mannose biosynthetic process 1 -1.31 1.22 1.33 1.17 1.22 -1.88 1.41
snRNA transcription 5 1.23 1.22 1.33 1.11 1.31 1.28 1.23
rRNA transcription 1 -1.18 1.5 1.2 1.21 1.41 -1.06 1.52
tRNA transcription 1 1.67 1.25 1.56 1.07 1.53 1.47 1.26
protein secretion 28 1.07 1.14 1.2 1.08 1.17 1.16 1.26
amine metabolic process 302 -1.22 -1.19 -1.33 -1.18 -1.18 -1.09 1.09
amine biosynthetic process 54 1.05 -1.02 -1.24 -1.05 -1.1 1.19 1.08
amine catabolic process 29 -1.04 -1.07 -1.13 -1.1 -1.04 1.35 -1.08
oligosaccharide metabolic process 23 1.34 -1.09 -1.13 -1.14 -1.02 1.21 1.32
oligosaccharide biosynthetic process 18 1.33 -1.18 -1.13 -1.19 -1.01 1.24 1.29
response to radiation 119 1.1 -1.05 1.01 -1.01 1.06 1.1 1.04
response to drug 6 -1.83 -1.23 -1.66 1.04 1.16 -1.94 -1.32
phenylalanine-tRNA ligase complex 2 -1.21 1.26 1.34 1.3 1.09 -1.32 -1.12
glycerol-3-phosphate dehydrogenase complex 7 1.04 1.0 -1.12 1.1 1.28 1.07 -1.09
dihydrolipoyl dehydrogenase complex 1 -1.4 -1.14 2.27 -1.25 -1.48 1.94 -1.5
pyruvate dehydrogenase complex 4 1.04 1.05 1.45 1.06 1.07 1.89 -1.15
mitochondrial oxoglutarate dehydrogenase complex 3 1.31 1.13 2.04 -1.28 1.13 2.68 -1.02
oxoglutarate dehydrogenase complex 3 1.31 1.13 2.04 -1.28 1.13 2.68 -1.02
succinate-CoA ligase complex (ADP-forming) 1 1.64 -1.15 2.7 -1.43 1.36 4.94 -1.1
endopeptidase Clp complex 1 -1.01 1.55 1.36 1.04 1.26 2.38 1.15
peptidase activity, acting on L-amino acid peptides 556 -1.79 -1.27 -1.34 -1.05 -1.19 -1.74 -1.45
2'-deoxyribonucleotide metabolic process 5 1.18 -1.03 1.1 1.33 1.37 -1.01 -1.27
phospholipid catabolic process 4 -7.22 -4.62 -6.48 1.55 -1.18 -4.98 -5.49
folic acid-containing compound biosynthetic process 6 1.83 -1.4 -1.53 -1.23 -1.52 1.23 1.04
folic acid-containing compound catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
response to toxin 23 -1.02 1.14 -1.39 -1.1 -1.24 -1.6 1.25
toxin metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
pathogenesis 1 -117.62 -1.03 2.87 -1.15 -1.31 -23.49 -2.28
viral reproduction 4 -1.08 1.06 1.14 -1.14 -1.13 1.44 1.18
toxin catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
response to heat 73 1.17 -1.05 1.01 -1.1 1.11 1.13 1.19
response to cold 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
response to xenobiotic stimulus 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
response to UV 20 -1.19 -1.26 -1.33 -1.19 -1.15 1.11 -1.01
response to metal ion 16 -1.69 1.12 1.25 1.08 1.07 -1.25 -1.13
response to water deprivation 3 -1.08 -2.2 -2.66 -2.3 -1.91 1.61 -1.02
response to water 7 1.12 -1.5 -1.68 -1.54 -1.43 1.5 1.17
response to light stimulus 106 1.09 -1.08 -1.02 -1.02 1.04 1.12 1.04
microtubule-based flagellum 2 -1.07 1.15 -1.03 1.08 1.03 -1.0 1.04
NAD biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
glyoxylate catabolic process 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
carnitine metabolic process 2 -1.01 -1.08 -1.06 -1.12 -1.16 1.15 -1.15
gamma-aminobutyric acid metabolic process 3 -1.67 1.65 -1.0 -1.05 -1.15 -1.16 -1.07
gamma-aminobutyric acid biosynthetic process 1 -1.13 1.06 -1.08 -1.01 -1.16 -1.21 -1.16
gamma-aminobutyric acid catabolic process 1 -2.19 1.37 2.06 1.34 1.0 1.58 -1.11
RNA modification 40 1.41 1.21 1.2 1.19 1.24 1.25 1.03
RNA capping 3 1.59 1.23 1.42 1.29 1.28 1.33 1.13
energy taxis 14 1.37 -1.07 1.01 -1.18 -1.0 1.35 1.36
electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity 2 -1.21 1.01 1.07 -1.08 -1.12 1.17 -1.37
electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity 2 1.19 1.13 1.42 -1.04 1.3 1.64 -1.09
glutathione disulfide oxidoreductase activity 5 1.08 1.22 -1.06 1.06 1.17 -1.15 1.05
fertilization 22 1.04 1.13 1.13 1.08 1.1 1.04 1.03
detection of external stimulus 59 1.07 -1.17 -1.01 1.04 1.0 -1.01 -1.14
detection of abiotic stimulus 53 1.09 -1.1 -1.03 1.04 1.06 1.03 -1.05
detection of light stimulus 48 1.08 -1.11 -1.03 1.04 1.06 1.01 -1.07
detection of visible light 24 1.14 -1.06 -1.0 1.09 1.08 1.04 -1.06
rhodopsin mediated phototransduction 15 1.23 1.02 1.1 1.07 1.08 1.05 1.02
UV-A, blue light phototransduction 2 1.02 -1.04 -1.16 1.02 -1.2 1.38 -1.05
detection of UV 5 -1.46 -1.43 -1.51 1.22 -1.06 -1.54 -1.62
detection of chemical stimulus 84 -1.02 1.01 -1.0 1.01 -1.0 1.03 -1.06
detection of nutrient 1 1.24 1.34 2.02 1.2 1.78 5.29 1.65
detection of biotic stimulus 6 -1.12 -1.97 1.21 1.05 -1.56 -1.46 -2.39
detection of virus 1 -1.09 1.04 3.03 -1.09 1.76 1.29 1.77
detection of symbiont 1 -1.09 1.04 3.03 -1.09 1.76 1.29 1.77
response to external stimulus 341 1.09 -1.0 1.13 -1.01 1.17 1.21 1.17
response to biotic stimulus 155 1.24 -1.24 -1.18 -1.24 -1.09 1.12 1.16
response to symbiont 7 -1.49 1.04 -1.1 1.15 1.18 -1.6 -1.03
response to symbiotic bacterium 2 -5.67 -1.13 -2.52 1.36 1.12 -4.93 -1.8
response to wounding 31 1.1 -1.06 1.05 -1.14 1.05 1.17 1.32
response to other organism 153 1.25 -1.25 -1.19 -1.24 -1.1 1.12 1.16
response to bacterium 100 1.24 -1.29 -1.25 -1.25 -1.11 1.14 1.1
response to fungus 31 1.98 -1.28 -1.31 -1.33 -1.26 1.23 1.29
response to insect 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
response to abiotic stimulus 224 1.14 -1.03 1.04 -1.02 1.09 1.14 1.1
response to gravity 12 1.09 -1.01 1.03 1.04 1.1 1.2 -1.03
response to blue light 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
response to red or far red light 2 1.78 1.07 -1.24 1.28 -1.04 1.5 -1.03
response to light intensity 3 2.14 -1.51 1.43 -1.06 -1.34 1.03 -1.36
response to high light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
photoperiodism 7 1.11 1.14 1.05 1.16 1.0 1.28 1.14
entrainment of circadian clock 12 1.23 1.12 1.14 1.12 1.09 1.34 1.18
UV protection 1 1.47 1.08 -1.62 1.31 -1.48 3.54 -1.09
response to salt stress 7 1.27 -1.08 1.33 -1.12 1.11 1.26 1.47
catechol-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
catechol-containing compound biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
response to endogenous stimulus 81 1.15 1.05 1.35 1.05 1.23 1.3 1.17
response to hormone stimulus 64 1.07 1.08 1.26 1.05 1.23 1.29 1.21
detection of carbohydrate stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
detection of sucrose stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
detection of hexose stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
response to carbohydrate stimulus 6 1.99 -1.0 1.23 1.06 1.32 1.59 1.29
response to sucrose stimulus 3 2.79 -1.08 1.21 1.01 1.44 1.96 1.48
response to hexose stimulus 2 -1.1 1.06 1.16 1.15 1.11 -1.04 -1.08
response to glucose stimulus 2 -1.1 1.06 1.16 1.15 1.11 -1.04 -1.08
hormone-mediated signaling pathway 22 1.14 1.08 1.04 1.01 1.16 1.17 1.17
carbohydrate utilization 1 1.08 -1.16 -1.09 1.12 -1.12 1.04 -1.07
regulation of asymmetric cell division 2 -1.7 1.32 1.22 1.23 1.24 -1.9 -1.09
post-embryonic development 443 1.18 1.05 1.22 1.02 1.25 1.26 1.22
embryo development ending in birth or egg hatching 163 1.1 1.06 1.3 1.03 1.33 1.32 1.23
regulation of mitotic cell cycle, embryonic 8 -1.01 1.14 1.15 1.12 1.19 1.01 1.02
axis specification 164 1.24 1.06 1.24 1.03 1.22 1.3 1.23
specification of symmetry 5 -2.92 1.25 1.15 -1.01 1.23 -1.58 1.16
unidimensional cell growth 17 1.27 1.19 1.53 1.1 1.7 1.49 1.46
SCF ubiquitin ligase complex 14 1.41 1.21 1.25 1.2 1.31 1.18 1.12
determination of bilateral symmetry 5 -2.92 1.25 1.15 -1.01 1.23 -1.58 1.16
photoreceptor activity 10 -1.25 -1.25 -1.24 -1.21 -1.25 1.46 -1.17
blue light photoreceptor activity 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
post-embryonic morphogenesis 362 1.17 1.06 1.22 1.03 1.28 1.25 1.24
regulation of biosynthetic process 771 1.15 1.07 1.16 1.05 1.17 1.16 1.13
negative regulation of biosynthetic process 219 1.16 1.07 1.18 1.04 1.23 1.2 1.14
positive regulation of biosynthetic process 252 1.15 1.03 1.12 1.02 1.13 1.2 1.17
negative regulation of metabolic process 330 1.18 1.06 1.17 1.05 1.2 1.2 1.12
positive regulation of metabolic process 281 1.17 1.04 1.14 1.02 1.14 1.22 1.17
regulation of catabolic process 74 1.15 1.14 1.25 1.08 1.23 1.24 1.17
negative regulation of catabolic process 8 -1.33 1.25 1.01 1.18 1.01 -1.53 -1.03
positive regulation of catabolic process 7 1.19 1.14 1.23 1.17 1.1 1.13 1.03
external side of plasma membrane 4 -1.07 1.05 -1.01 -1.05 -1.13 -1.02 -1.0
internal side of plasma membrane 18 1.39 1.11 1.42 1.06 1.22 1.03 1.1
epidermal cell differentiation 43 1.39 1.06 1.43 -1.01 1.34 1.35 1.33
fatty acid elongase activity 3 1.46 -2.22 -1.95 -2.84 -2.14 -1.24 3.42
basal plasma membrane 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
calcium-dependent protein serine/threonine kinase activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
proximal/distal axis specification 1 -1.27 1.59 1.07 1.18 1.42 1.16 1.47
anterior/posterior axis specification 120 1.19 1.06 1.26 1.05 1.25 1.26 1.2
polarity specification of anterior/posterior axis 5 1.18 1.04 1.06 1.17 1.12 -1.03 1.06
dorsal/ventral axis specification 58 1.48 1.04 1.12 1.02 1.11 1.41 1.25
polarity specification of dorsal/ventral axis 5 1.18 1.04 1.06 1.17 1.12 -1.03 1.06
anterior/posterior pattern specification 147 1.2 1.04 1.2 1.01 1.24 1.3 1.21
dorsal/ventral pattern formation 112 1.35 1.04 1.11 1.02 1.18 1.37 1.26
proximal/distal pattern formation 25 1.33 1.03 1.18 1.09 1.18 1.11 1.2
regulation of signal transduction 371 1.15 1.12 1.29 1.06 1.25 1.28 1.21
positive regulation of signal transduction 83 1.15 1.11 1.23 1.05 1.27 1.18 1.24
negative regulation of signal transduction 144 1.21 1.1 1.32 1.06 1.28 1.32 1.24
cytidine deamination 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
cyclase activity 29 1.15 1.04 -1.01 1.0 1.03 1.12 1.07
pseudouridine synthase activity 10 1.65 1.34 1.08 1.11 1.11 1.56 1.14
cell surface 19 -1.26 1.06 1.15 1.03 1.17 1.1 1.16
cellular process 5323 1.1 1.04 1.1 1.04 1.13 1.14 1.05
response to extracellular stimulus 43 1.1 -1.0 1.12 -1.02 1.16 1.24 1.19
oocyte differentiation 113 1.14 1.14 1.32 1.08 1.26 1.35 1.23
negative regulation of cell fate specification 18 1.02 1.09 1.22 1.03 1.24 1.12 1.22
negative regulation of cardioblast cell fate specification 7 -1.04 1.07 1.14 1.01 1.15 -1.01 1.35
glial cell differentiation 26 2.31 -1.1 1.3 -1.1 1.28 1.79 1.37
cardioblast differentiation 12 1.8 -1.05 1.29 -1.1 1.12 1.16 1.3
gastrulation involving germ band extension 30 1.11 -1.0 1.2 1.03 1.32 1.16 1.06
endosome membrane 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
meiotic chromosome condensation 1 -1.65 -1.11 -1.2 -1.08 1.07 -1.43 -1.21
response to organic substance 192 1.24 1.01 1.14 -1.04 1.16 1.25 1.21
response to inorganic substance 34 -1.24 1.1 1.16 1.08 1.11 -1.04 -1.11
response to carbon dioxide 4 -1.02 1.01 1.24 -1.05 1.06 1.13 -1.05
response to zinc ion 2 -1.79 1.33 -1.11 -1.01 -1.24 -1.87 -1.3
specification of organ identity 3 1.44 -1.09 -1.02 1.06 -1.33 -1.11 1.02
cellular response to iron ion starvation 1 1.19 -1.04 -1.01 -1.09 -1.15 -1.15 -1.12
response to red light 2 1.78 1.07 -1.24 1.28 -1.04 1.5 -1.03
regulation of proton transport 1 -1.15 -1.06 -1.02 -1.13 -1.25 -1.1 -1.2
formation of organ boundary 33 1.16 1.04 1.21 1.08 1.36 1.13 1.19
response to X-ray 4 1.1 1.11 1.34 1.23 1.84 -1.18 -1.06
body morphogenesis 19 -1.01 -1.0 -1.07 -1.04 -1.14 -1.01 -1.14
production of miRNAs involved in gene silencing by miRNA 6 1.56 1.12 1.48 1.03 1.19 1.57 1.34
response to ionizing radiation 11 1.27 1.24 1.27 1.2 1.48 -1.03 1.06
response to lithium ion 1 -1.01 -1.09 -1.11 -1.17 -1.13 13.69 -1.18
response to organic nitrogen 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
endomembrane system organization 2 -1.26 1.07 1.65 1.14 1.45 1.05 1.02
NADH dehydrogenase complex assembly 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
multicellular organismal aging 114 1.25 1.12 1.11 -1.02 1.16 1.37 1.25
acireductone dioxygenase [iron(II)-requiring] activity 1 1.79 1.32 -1.5 1.17 -1.1 1.63 1.03
phosphatidylinositol-5-phosphate binding 1 -1.49 -1.24 1.29 1.46 1.49 -1.4 1.3
membrane invagination 183 1.09 1.08 1.18 1.07 1.21 1.18 1.13
response to gamma radiation 1 4.35 1.1 2.37 1.09 1.77 2.6 1.18
carboxyl-O-methyltransferase activity 2 1.17 1.1 1.15 1.29 1.38 1.07 -1.31
response to trehalose stimulus 3 3.3 1.01 1.16 -1.06 1.46 2.79 1.63
chromocenter 17 1.14 1.05 1.1 1.07 1.29 1.12 1.07
temperature compensation of the circadian clock 3 -1.23 1.31 1.47 1.09 1.08 -1.19 1.12
double-stranded methylated DNA binding 1 -1.16 -1.01 -1.17 -1.19 -1.26 -1.13 -1.25
regulation of G2/M transition of mitotic cell cycle 72 1.2 1.14 1.34 1.2 1.4 1.22 1.12
polyprenyldihydroxybenzoate methyltransferase activity 1 -1.1 1.09 1.22 1.29 1.3 1.24 -1.16
carotenoid dioxygenase activity 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
histone H3-K36 methylation 1 1.08 1.46 1.5 -1.1 1.11 1.44 1.39
regulation of cell fate commitment 26 1.1 1.06 1.12 1.01 1.18 -1.03 1.12
negative regulation of cell fate commitment 18 1.02 1.09 1.22 1.03 1.24 1.12 1.22
centriole-centriole cohesion 1 3.23 -1.13 1.38 1.13 1.64 2.38 1.04
light-activated ion channel activity 2 -1.34 -1.15 -1.19 1.14 -1.2 -1.27 -1.19
negative regulation of peptidase activity 3 -1.25 -1.08 1.67 1.12 1.52 -1.68 -1.23
gene expression 762 1.22 1.11 1.2 1.16 1.23 1.2 1.03
regulation of gene expression 882 1.18 1.08 1.18 1.07 1.18 1.19 1.12
regulation of receptor activity 4 1.16 1.09 1.49 1.02 1.37 1.48 1.2
H3 histone acetyltransferase activity 2 -1.3 1.39 1.24 1.21 1.14 1.24 1.37
H4 histone acetyltransferase activity 4 1.11 1.19 1.15 1.22 1.15 1.12 1.31
cytoplasmic stress granule 1 1.54 1.07 -1.03 1.11 1.17 1.09 1.04
intercellular transport 2 1.93 -1.45 -1.44 -1.31 -1.47 2.84 3.08
proteasomal protein catabolic process 20 1.05 1.14 1.1 1.07 1.12 -1.0 1.14
regulation of autophagy 16 1.32 1.1 1.02 1.05 1.1 1.13 1.1
negative regulation of autophagy 4 -1.64 1.35 -1.16 1.08 -1.15 -1.93 1.04
positive regulation of autophagy 2 -1.18 1.26 1.3 1.29 1.13 -1.31 -1.09
regulation of phospholipase activity 8 1.04 1.1 1.09 1.07 1.01 1.07 1.0
positive regulation of phospholipase activity 6 1.13 1.12 1.17 1.04 1.09 1.14 1.05
negative regulation of phospholipase activity 2 -1.21 1.05 -1.16 1.19 -1.24 -1.13 -1.15
regulation of calcium ion transport into cytosol 1 -1.3 1.21 1.06 1.22 1.05 1.22 1.37
regulation of transposition, RNA-mediated 2 1.32 1.05 -1.25 1.18 -1.12 1.33 1.08
negative regulation of transposition, RNA-mediated 2 1.32 1.05 -1.25 1.18 -1.12 1.33 1.08
regulation of transposition 5 1.07 1.14 -1.03 1.17 1.03 1.08 1.04
negative regulation of transposition 5 1.07 1.14 -1.03 1.17 1.03 1.08 1.04
regulation of macromolecule biosynthetic process 732 1.15 1.08 1.17 1.06 1.17 1.17 1.13
positive regulation of macromolecule biosynthetic process 215 1.13 1.05 1.14 1.04 1.15 1.2 1.16
negative regulation of macromolecule biosynthetic process 214 1.18 1.08 1.18 1.04 1.23 1.23 1.17
regulation of glycoprotein biosynthetic process 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
positive regulation of phosphorus metabolic process 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
negative regulation of phosphorus metabolic process 8 1.4 1.03 1.23 1.05 1.2 1.33 1.24
regulation of cell cycle process 162 1.23 1.12 1.27 1.13 1.35 1.28 1.15
regulation of cellular ketone metabolic process 2 -1.15 1.19 1.31 -1.0 1.1 1.01 1.21
metalloenzyme regulator activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
regulation of adenylate cyclase activity involved in G-protein signaling pathway 3 -1.05 1.08 -1.04 1.0 -1.08 -1.13 -1.16
positive regulation of adenylate cyclase activity by G-protein signaling pathway 3 -1.05 1.08 -1.04 1.0 -1.08 -1.13 -1.16
miRNA metabolic process 2 3.15 1.1 1.2 1.08 -1.05 1.81 1.29
regulation of lamellipodium assembly 7 -1.2 1.11 1.6 1.12 1.38 -1.25 -1.04
negative regulation of lamellipodium assembly 1 -1.18 1.31 1.55 1.08 1.49 1.22 1.14
regulation of cytoplasmic mRNA processing body assembly 4 1.22 1.35 1.4 1.26 1.29 1.4 1.26
positive regulation of macromolecule metabolic process 246 1.12 1.06 1.17 1.04 1.15 1.2 1.17
negative regulation of macromolecule metabolic process 317 1.21 1.06 1.17 1.04 1.21 1.24 1.14
positive regulation of cytoplasmic mRNA processing body assembly 1 3.49 1.22 2.63 -1.09 2.31 4.69 1.68
posttranscriptional regulation of gene expression 115 1.33 1.09 1.24 1.07 1.27 1.32 1.17
developmental programmed cell death 22 1.05 1.15 1.23 1.16 1.43 1.1 1.06
regulation of intracellular protein kinase cascade 60 1.06 1.18 1.27 1.1 1.28 1.26 1.23
positive regulation of gene expression 207 1.12 1.04 1.14 1.04 1.14 1.2 1.15
negative regulation of gene expression 260 1.2 1.06 1.15 1.04 1.2 1.23 1.14
epithelial cell migration 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
regulation of epithelial cell migration 5 2.13 -1.29 -1.2 -1.27 1.01 -1.13 2.14
positive regulation of organelle organization 20 1.05 1.11 1.26 1.08 1.36 1.03 1.17
negative regulation of organelle organization 35 1.05 1.13 1.38 1.11 1.41 1.3 1.13
regulation of cell communication 252 1.17 1.1 1.28 1.06 1.25 1.25 1.23
positive regulation of cell communication 85 1.13 1.11 1.24 1.05 1.27 1.19 1.24
negative regulation of cell communication 150 1.2 1.1 1.31 1.06 1.28 1.31 1.25
epithelial structure maintenance 13 1.3 -1.11 1.06 -1.15 1.26 1.38 1.31
negative regulation of reactive oxygen species metabolic process 1 1.06 1.25 -1.01 1.13 1.01 1.03 -1.27
regulation of cellular carbohydrate metabolic process 3 -1.56 -1.05 -1.43 -1.32 1.05 1.6 2.11
positive regulation of cell development 6 1.51 1.15 1.49 1.06 1.33 1.5 1.37
negative regulation of cell development 24 -1.03 1.15 1.31 1.07 1.41 1.21 1.2
positive regulation of intracellular protein kinase cascade 18 1.04 1.19 1.27 1.03 1.17 1.26 1.3
negative regulation of intracellular protein kinase cascade 22 1.11 1.14 1.33 1.09 1.28 1.12 1.13
positive regulation of sodium ion transport 5 1.02 1.03 1.03 1.0 -1.03 1.03 -1.06
regulation of cell morphogenesis involved in differentiation 44 1.03 1.15 1.39 1.08 1.37 1.26 1.18
meiotic DNA double-strand break formation involved in reciprocal meiotic recombination 1 1.2 1.16 1.39 1.21 1.2 1.13 -1.2
regulation of multivesicular body size 3 1.32 -1.02 1.33 1.3 1.34 1.03 -1.24
regulation of multivesicular body size involved in endosome transport 3 1.32 -1.02 1.33 1.3 1.34 1.03 -1.24
regulation of peptidyl-threonine phosphorylation 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
positive regulation of peptidyl-threonine phosphorylation 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
regulation of cell-substrate adhesion 2 1.91 1.0 2.08 1.07 1.96 1.63 1.31
negative regulation of cell-substrate adhesion 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
regulation of hormone levels 36 1.14 -1.24 -1.31 -1.23 -1.11 -1.09 1.2
regulation of mitochondrion organization 6 1.18 1.14 1.11 1.16 1.06 -1.11 -1.04
positive regulation of mitochondrion organization 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
regulation of centrosome duplication 4 1.33 1.11 1.56 1.02 1.41 1.58 1.14
transcription regulatory region DNA binding 73 1.02 1.03 1.06 1.02 1.11 1.14 1.07
regulation of chromatin assembly 3 1.21 1.11 1.43 1.11 1.52 1.35 1.11
cyclase regulator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
calcium-dependent protein kinase activity 3 1.12 1.04 2.13 -1.07 1.01 3.21 -1.04
endopeptidase regulator activity 75 1.41 -1.46 -1.42 -1.47 -1.28 1.49 1.04
positive regulation of phospholipase C activity 6 1.13 1.12 1.17 1.04 1.09 1.14 1.05
regulation of triglyceride biosynthetic process 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
lipid localization 42 -1.57 -1.37 -1.54 1.04 -1.02 -1.33 -1.47
regulation of lipid storage 14 1.04 1.01 -1.06 1.04 1.43 -1.14 1.14
positive regulation of lipid storage 1 -2.11 1.69 -1.72 -1.16 2.47 -2.75 -1.82
negative regulation of lipid storage 2 1.04 1.46 1.79 1.31 1.26 1.68 1.1
regulation of sequestering of triglyceride 2 1.65 1.42 1.72 -1.12 -1.11 1.9 1.54
negative regulation of sequestering of triglyceride 1 1.15 1.61 -1.09 1.48 -1.24 1.35 -1.03
regulation of glucose metabolic process 2 -1.67 -1.02 -1.57 -1.22 -1.25 -1.34 1.83
regulation of phosphatase activity 3 1.09 1.05 1.0 1.06 1.03 1.05 -1.09
cellular component assembly 455 1.19 1.06 1.24 1.05 1.23 1.24 1.12
anatomical structure formation involved in morphogenesis 388 1.14 1.06 1.21 1.03 1.22 1.22 1.17
cellular component assembly involved in morphogenesis 135 1.25 1.03 1.17 1.01 1.15 1.18 1.06
regulation of cell death 118 1.1 1.14 1.31 1.07 1.3 1.2 1.22
positive regulation of cell death 49 -1.01 1.15 1.2 1.09 1.32 1.04 1.24
negative regulation of cell cycle process 32 1.06 1.12 1.28 1.15 1.41 1.18 1.22
positive regulation of endopeptidase activity 14 1.01 1.14 1.25 1.19 1.42 1.19 1.06
negative regulation of endopeptidase activity 3 -1.25 -1.08 1.67 1.12 1.52 -1.68 -1.23
positive regulation of peptidase activity 14 1.01 1.14 1.25 1.19 1.42 1.19 1.06
negative regulation of protein processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
regulation of metal ion transport 15 1.16 1.05 1.17 1.01 1.06 1.2 1.1
magnesium ion homeostasis 1 -1.13 1.01 1.23 1.08 1.32 1.53 1.35
regulation of microtubule nucleation 1 2.49 1.3 2.87 -1.0 2.26 3.13 2.77
microtubule-based transport 27 -1.04 1.2 1.25 1.11 1.21 1.22 1.11
positive regulation of G2/M transition of mitotic cell cycle 1 -1.03 1.05 1.22 1.04 1.19 1.13 -1.03
negative regulation of G2/M transition of mitotic cell cycle 4 -1.01 -1.0 1.12 1.16 1.35 1.03 -1.06
regulation of neuron projection development 47 1.05 1.15 1.4 1.08 1.39 1.28 1.2
anaphase-promoting complex binding 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
regulation of translational initiation by eIF2 alpha phosphorylation 3 3.45 -1.5 -1.27 -1.43 1.18 2.31 1.49
induction of programmed cell death 35 1.04 1.13 1.16 1.09 1.31 1.02 1.25
endomembrane system 185 1.08 1.13 1.2 1.11 1.22 1.13 1.18
ER to Golgi transport vesicle membrane 1 1.02 1.56 2.15 1.06 2.07 2.36 2.5
trans-Golgi network transport vesicle membrane 3 -1.23 1.16 1.44 1.05 1.28 1.6 1.31
regulation of gliogenesis 4 1.83 1.22 1.55 -1.02 1.23 1.76 1.45
negative regulation of gliogenesis 2 1.15 1.57 1.36 1.13 1.31 1.77 1.58
positive regulation of gliogenesis 2 2.9 -1.05 1.75 -1.19 1.16 1.75 1.33
neuroblast differentiation 35 1.06 1.07 1.2 1.05 1.26 1.03 1.17
neuroblast fate commitment 27 1.15 1.09 1.19 1.07 1.25 1.03 1.13
neuroblast fate specification 1 2.48 -1.28 1.14 -1.16 1.81 2.29 3.17
neuroblast development 10 -1.17 1.02 1.2 1.03 1.26 1.07 1.3
mesenchymal cell development 1 1.47 1.13 -1.02 1.1 -1.07 -1.03 1.1
glutamate secretion 1 -3.47 -4.26 1.06 2.44 2.17 -3.37 -7.09
postsynaptic density 3 1.62 -1.01 1.32 -1.1 1.45 2.01 1.64
response to organic cyclic compound 31 -1.0 1.1 -1.1 -1.05 1.23 1.17 1.37
response to tropane 13 1.28 1.17 1.57 1.07 1.39 1.83 1.27
response to purine-containing compound 4 1.2 1.25 -1.32 -1.41 -1.17 1.21 1.42
response to amine stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
oscillatory muscle contraction 1 -1.18 -1.0 1.06 -1.02 -1.12 1.04 1.04
striated muscle tissue development 84 1.16 1.1 1.25 1.03 1.19 1.34 1.17
muscle cell migration 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
regulation of skeletal muscle contraction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
phasic smooth muscle contraction 1 1.69 1.43 1.3 1.01 1.12 1.63 -1.01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction 1 2.24 1.81 -38.59 -31.15 -18.58 -3.21 4.55
skeletal myofibril assembly 7 2.48 -1.3 1.04 -1.21 1.0 1.67 -1.05
myotube differentiation 27 1.01 1.06 1.27 -1.02 1.21 1.27 1.14
heme-copper terminal oxidase activity 18 -1.12 -1.08 1.07 -1.07 1.03 1.19 -1.31
heparan sulfate proteoglycan biosynthetic process 12 1.32 1.18 1.4 1.15 1.27 1.3 1.26
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process 4 1.19 1.5 1.46 1.15 1.54 1.21 1.67
[heparan sulfate]-glucosamine N-sulfotransferase activity 1 -1.1 1.79 1.14 1.04 1.02 -1.23 2.55
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity 3 1.19 -1.06 -1.32 -1.33 -1.21 1.07 3.7
glucuronosyltransferase activity 34 -1.54 -1.06 -1.26 1.13 1.11 -1.57 -1.05
anchored to membrane 3 3.1 -2.01 -3.22 -2.43 -1.37 2.44 1.37
Cajal body 5 1.06 1.13 1.3 1.24 1.31 1.06 -1.03
protein transport 243 1.06 1.16 1.3 1.12 1.23 1.13 1.15
oxygen binding 5 1.41 1.03 1.12 -1.03 -1.27 1.23 -1.13
protein disulfide oxidoreductase activity 22 1.16 1.02 1.01 1.16 1.07 -1.06 -1.11
peptide disulfide oxidoreductase activity 6 1.07 1.19 -1.04 1.07 1.14 -1.12 1.05
NADPH-adrenodoxin reductase activity 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
retinal binding 6 3.18 -5.84 -5.89 -2.35 -1.77 1.79 1.62
gastrin receptor activity 2 -1.2 -1.05 1.02 -1.05 -1.23 -1.25 -1.17
1-phosphatidylinositol-3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
1-phosphatidylinositol-4-phosphate 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
phosphatidylinositol-4,5-bisphosphate 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
DNA integration 1 1.07 -1.04 -1.16 1.02 1.48 -1.27 -1.22
ion transmembrane transporter activity 490 -1.13 -1.04 -1.12 -1.11 -1.07 1.14 -1.07
monovalent inorganic cation transmembrane transporter activity 190 -1.23 -1.03 -1.22 -1.16 -1.14 1.14 -1.18
hydrogen ion transmembrane transporter activity 82 -1.19 -1.01 1.17 -1.07 -1.05 1.38 -1.22
potassium ion transmembrane transporter activity 49 -1.01 -1.08 -1.08 -1.16 -1.05 1.13 -1.06
sodium ion transmembrane transporter activity 81 -1.48 -1.05 -1.89 -1.26 -1.27 1.0 -1.16
calcium ion transmembrane transporter activity 11 -1.32 1.18 1.08 -1.02 1.12 -1.09 1.13
copper uptake transmembrane transporter activity 1 1.39 1.37 1.47 1.19 1.52 2.16 1.06
organic cation transmembrane transporter activity 36 -1.2 -1.18 -1.56 -1.22 -1.06 1.61 -1.27
inorganic anion transmembrane transporter activity 44 -1.75 -1.05 -1.79 -1.14 -1.41 1.18 -1.54
arsenite transmembrane transporter activity 2 2.24 1.06 1.22 -1.13 -1.15 2.07 1.19
bicarbonate transmembrane transporter activity 1 1.2 -1.03 1.07 -1.04 1.13 1.1 1.23
chloride transmembrane transporter activity 4 -2.12 -1.32 1.67 -1.4 1.05 1.49 -1.53
phosphate ion transmembrane transporter activity 28 -2.04 -1.01 -2.2 -1.07 -1.55 -1.11 -1.87
sulfate transmembrane transporter activity 11 -1.38 -1.18 -1.62 -1.28 -1.18 2.41 -1.09
thiosulfate transmembrane transporter activity 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
bile acid transmembrane transporter activity 2 -3.13 1.41 -2.05 1.29 -3.5 -4.18 -1.28
oxaloacetate transmembrane transporter activity 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
citrate transmembrane transporter activity 6 1.66 1.03 1.2 -1.17 -1.14 1.49 1.13
malate transmembrane transporter activity 6 -1.06 -1.19 1.21 -1.11 1.09 1.9 -1.26
succinate transmembrane transporter activity 2 1.52 -1.49 2.44 -1.88 1.67 5.92 1.16
urate transmembrane transporter activity 2 1.45 -1.07 1.88 1.03 1.06 1.31 1.14
carbohydrate transmembrane transporter activity 35 -1.0 -1.02 -1.46 -1.04 -1.16 -1.22 1.12
monosaccharide transmembrane transporter activity 21 -1.07 -1.11 -1.82 -1.2 -1.34 -1.42 1.07
hexose transmembrane transporter activity 18 -1.2 -1.08 -1.91 -1.2 -1.46 -1.81 1.09
cocaine binding 1 -1.02 1.06 -1.1 1.08 -1.08 1.0 -1.01
disaccharide transmembrane transporter activity 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
pyrimidine nucleotide sugar transmembrane transporter activity 8 1.01 1.23 -1.01 1.24 1.15 -1.17 1.39
polyol transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
glycerol transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
glycerol-3-phosphate transmembrane transporter activity 1 -2.04 1.18 -1.02 1.21 1.32 -1.45 1.81
acidic amino acid transmembrane transporter activity 4 -2.07 1.33 -5.17 -2.48 -1.62 -1.72 -2.15
aromatic amino acid transmembrane transporter activity 2 3.0 -1.1 1.15 -1.28 -1.42 2.49 1.13
neutral amino acid transmembrane transporter activity 5 -1.05 -1.63 -1.94 -1.23 1.36 1.17 1.17
L-amino acid transmembrane transporter activity 14 -1.06 -1.11 -2.62 -1.34 1.08 -1.05 -1.21
L-aspartate transmembrane transporter activity 2 1.6 1.38 -6.52 -5.62 -4.41 -1.75 2.45
L-cystine transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
L-gamma-aminobutyric acid transmembrane transporter activity 3 1.55 1.3 -1.41 -1.0 1.17 -1.0 1.21
glycine transmembrane transporter activity 3 -1.07 1.29 1.01 -1.05 -1.24 -1.24 1.3
L-proline transmembrane transporter activity 1 1.01 -1.09 -1.18 -1.18 1.11 -1.08 -1.12
peptide transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
oligopeptide transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
nucleobase transmembrane transporter activity 1 2.22 1.18 2.27 1.0 1.25 2.33 2.07
purine nucleoside transmembrane transporter activity 2 1.45 1.3 1.01 1.18 1.09 1.6 1.46
choline transmembrane transporter activity 1 1.01 -1.09 -1.18 -1.18 1.11 -1.08 -1.12
serotonin transmembrane transporter activity 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
vitamin transporter activity 7 -1.0 1.07 -1.8 -1.21 1.11 -1.18 1.04
cofactor transporter activity 6 -1.15 1.2 1.13 1.16 1.09 -1.08 1.03
carnitine transporter activity 6 -1.28 1.49 -1.43 -1.09 -1.24 -2.46 -1.13
acyl carnitine transporter activity 2 1.23 1.21 -1.11 1.11 1.06 -1.22 -1.1
heme transporter activity 4 -1.09 1.3 1.25 1.23 1.07 -1.15 -1.06
thiamine transmembrane transporter activity 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
drug transmembrane transporter activity 14 -1.4 1.1 -1.22 1.07 1.18 -1.23 1.11
fatty acid transporter activity 7 -2.15 1.3 -1.32 -1.52 -2.35 -1.39 -1.5
sterol transporter activity 1 -1.06 1.09 -1.0 1.4 1.63 -1.48 -1.12
water channel activity 5 -2.72 1.35 -1.04 -1.24 -3.15 -2.7 -1.32
sugar transmembrane transporter activity 26 -1.05 -1.08 -1.66 -1.14 -1.28 -1.32 1.13
channel activity 217 1.02 1.0 -1.01 -1.05 -1.07 1.03 -1.01
calcium-activated potassium channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
outward rectifier potassium channel activity 4 1.21 1.23 1.58 -1.53 -1.48 1.98 -1.52
ATP-activated inward rectifier potassium channel activity 1 -2.21 1.6 1.01 1.47 -3.02 -10.91 -2.13
ligand-gated ion channel activity 108 1.02 1.0 -1.0 -1.08 -1.14 1.0 -1.02
kainate selective glutamate receptor activity 11 2.2 -1.06 1.07 -1.1 -1.06 1.26 1.02
calcium-release channel activity 4 2.09 1.04 1.5 1.02 1.16 2.3 1.48
store-operated calcium channel activity 4 1.41 -1.11 1.15 1.07 1.1 1.6 1.28
ligand-gated sodium channel activity 3 1.09 -1.09 -1.08 -1.02 -1.08 -1.08 -1.06
porin activity 1 -1.24 1.02 -1.02 1.01 -1.17 -1.1 1.01
pore complex 32 1.22 1.16 1.46 1.19 1.42 1.4 1.18
symporter activity 76 -1.49 -1.09 -1.95 -1.27 -1.28 -1.09 -1.13
solute:cation symporter activity 74 -1.49 -1.1 -1.98 -1.28 -1.29 -1.08 -1.14
solute:hydrogen symporter activity 10 1.17 -1.04 -1.27 -1.11 -1.11 -1.04 1.72
anion:cation symporter activity 36 -2.03 -1.02 -2.27 -1.32 -1.7 -1.35 -1.62
antiporter activity 25 -1.4 1.02 1.06 -1.09 -1.06 1.2 -1.02
solute:cation antiporter activity 13 -1.59 1.16 -1.1 1.0 -1.16 1.34 1.01
solute:hydrogen antiporter activity 6 -1.84 1.01 -1.18 -1.0 -1.46 2.19 -1.2
solute:solute antiporter activity 24 -1.43 1.01 1.06 -1.1 -1.08 1.21 -1.06
anion:anion antiporter activity 7 -1.5 -1.45 1.6 -1.5 -1.11 1.16 -1.09
organophosphate:inorganic phosphate antiporter activity 1 1.19 1.35 1.39 1.1 1.22 1.13 2.76
sodium:inorganic phosphate symporter activity 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
sodium-dependent phosphate transmembrane transporter activity 1 -1.14 1.17 1.24 1.15 -1.13 -1.05 2.26
secondary active oligopeptide transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
cationic amino acid transmembrane transporter activity 5 -2.27 1.25 -1.58 -1.02 1.06 1.04 -1.06
sodium-independent organic anion transmembrane transporter activity 3 -1.97 -1.09 1.04 1.04 1.56 -1.02 -1.01
secondary active monocarboxylate transmembrane transporter activity 6 -2.96 -1.49 -1.43 1.36 1.66 1.29 -1.83
calcium:cation antiporter activity 7 -1.41 1.31 -1.04 1.01 1.05 -1.14 1.2
solute:sodium symporter activity 58 -1.57 -1.09 -2.44 -1.32 -1.33 -1.17 -1.25
monovalent anion:sodium symporter activity 7 1.13 -1.12 -1.82 -1.93 -1.54 -1.43 1.18
glycine:sodium symporter activity 1 -1.01 1.0 1.27 1.1 -1.12 1.05 -1.06
cation:chloride symporter activity 4 -2.12 -1.32 1.67 -1.4 1.05 1.49 -1.53
potassium:chloride symporter activity 1 -4.23 -1.01 5.33 -1.14 1.37 -4.42 -4.03
membrane docking 27 -1.1 1.16 1.4 1.15 1.26 1.14 1.1
high affinity sulfate transmembrane transporter activity 8 -1.57 -1.12 -2.1 -1.3 -1.39 2.29 -1.04
sodium:hydrogen antiporter activity 4 -2.37 -1.01 -1.35 1.01 -1.74 3.33 -1.27
nucleoside transmembrane transporter activity, down a concentration gradient 1 1.01 1.49 1.07 1.13 1.13 1.28 1.42
primary active transmembrane transporter activity 143 -1.07 -1.01 1.05 -1.04 1.03 1.15 -1.05
P-P-bond-hydrolysis-driven transmembrane transporter activity 143 -1.07 -1.01 1.05 -1.04 1.03 1.15 -1.05
manganese-transporting ATPase activity 1 1.04 1.04 -1.04 -1.09 -1.16 -1.14 -1.1
arsenite-transmembrane transporting ATPase activity 1 1.35 1.29 1.36 1.08 1.19 1.34 1.11
P-P-bond-hydrolysis-driven protein transmembrane transporter activity 23 -1.01 1.13 1.18 1.11 1.07 1.12 -1.06
potassium channel regulator activity 2 1.41 1.19 1.44 1.03 1.46 1.62 1.3
acetylcholine receptor activity 2 1.0 1.08 1.1 1.16 1.17 1.06 1.05
G-protein activated inward rectifier potassium channel activity 1 4.33 -4.87 -19.75 -19.08 -6.11 18.23 -1.15
cholesterol binding 2 1.08 1.11 1.07 1.26 1.29 -1.19 -1.05
cation:cation antiporter activity 11 -1.7 1.18 -1.14 1.01 -1.19 1.42 1.03
gamma-aminobutyric acid:hydrogen symporter activity 2 1.74 1.43 -1.72 -1.09 1.17 -1.0 1.38
glutamate:sodium symporter activity 2 1.6 1.38 -6.52 -5.62 -4.41 -1.75 2.45
C4-dicarboxylate transmembrane transporter activity 7 1.08 -1.13 1.39 -1.2 1.08 1.99 -1.07
thiamine pyrophosphate-transporting ATPase activity 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
actin cytoskeleton 94 -1.06 -1.02 1.2 1.01 1.23 1.08 -1.0
microtubule cytoskeleton 439 1.11 1.04 1.13 1.04 1.19 1.16 1.06
tubulin binding 67 1.1 1.03 1.32 1.0 1.34 1.37 1.25
fatty acid ligase activity 7 1.81 -1.3 -1.35 1.09 1.2 -1.91 -1.26
quaternary ammonium group transmembrane transporter activity 6 -1.28 1.49 -1.43 -1.09 -1.24 -2.46 -1.13
alcohol transmembrane transporter activity 2 -1.44 1.12 -1.06 1.14 1.1 -1.2 1.33
gas transport 3 2.18 1.01 1.23 -1.11 -1.43 1.5 -1.22
oxygen transport 3 2.18 1.01 1.23 -1.11 -1.43 1.5 -1.22
monovalent inorganic cation transport 136 -1.06 -1.02 1.06 -1.08 -1.06 1.22 -1.09
copper ion import 2 -1.71 1.19 -1.03 1.03 -1.3 -1.51 1.21
plasma membrane copper ion transport 1 1.39 1.37 1.47 1.19 1.52 2.16 1.06
intracellular copper ion transport 1 1.35 1.23 -1.1 1.09 -1.09 -1.29 1.14
cadmium ion transport 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
organic cation transport 6 -1.21 -1.29 -1.94 -1.42 -1.18 1.53 1.11
ammonium transport 1 -1.13 -1.02 -1.13 -1.06 -1.15 -1.01 -1.16
quaternary ammonium group transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
inorganic anion transport 18 -1.11 1.04 -1.32 -1.05 1.11 1.94 -1.22
bicarbonate transport 1 1.2 -1.03 1.07 -1.04 1.13 1.1 1.23
thiosulfate transport 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
organic anion transport 23 -1.44 -1.02 -1.33 -1.21 -1.04 -1.01 -1.2
monocarboxylic acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
oxaloacetate transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
taurine transport 2 -1.75 -2.01 -1.02 1.55 1.44 -1.8 -2.32
C4-dicarboxylate transport 5 -1.06 -1.22 1.26 -1.12 1.12 2.23 -1.26
succinate transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
citrate transport 6 1.38 1.1 -1.07 -1.11 -1.31 1.27 -1.04
monosaccharide transport 5 1.14 -1.11 -1.24 -1.1 1.05 1.47 1.25
galactose transport 1 -3.25 1.38 -1.03 -1.03 -1.21 -3.18 3.55
glucose transport 1 -1.11 -1.03 -1.12 1.1 -1.16 -1.22 -1.12
disaccharide transport 3 1.57 -1.8 -1.19 -1.63 -1.17 2.95 1.2
sucrose transport 1 2.52 -1.26 -1.18 -1.09 -1.25 2.25 1.03
trehalose transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
oligosaccharide transport 3 1.57 -1.8 -1.19 -1.63 -1.17 2.95 1.2
nucleotide-sugar transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
pyrimidine nucleotide-sugar transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
CMP-N-acetylneuraminate transport 3 -1.73 1.25 -1.03 1.28 -1.06 -1.84 1.23
GDP-fucose transport 2 -1.26 1.19 -1.04 1.47 1.01 -1.41 -1.39
GDP-mannose transport 2 -1.26 1.19 -1.04 1.47 1.01 -1.41 -1.39
UDP-galactose transport 3 -1.67 1.25 -1.02 1.2 1.18 -1.82 1.71
UDP-glucose transport 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
UDP-glucuronic acid transport 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
UDP-N-acetylglucosamine transport 3 -1.11 1.21 1.01 1.37 1.12 -1.24 1.06
UDP-N-acetylgalactosamine transport 2 -2.31 1.25 -1.08 1.21 1.09 -2.5 1.48
UDP-xylose transport 2 1.09 1.26 1.09 1.3 1.0 1.02 1.39
polyol transport 1 -1.32 1.18 1.15 1.08 1.65 -1.36 1.01
myo-inositol transport 1 -1.32 1.18 1.15 1.08 1.65 -1.36 1.01
acidic amino acid transport 4 -2.92 -1.1 -4.98 -1.98 -1.32 -2.35 -3.75
branched-chain aliphatic amino acid transport 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
neutral amino acid transport 6 -1.07 -2.12 -1.83 1.1 1.71 -1.03 1.19
L-amino acid transport 3 -7.27 -2.77 -15.38 -1.15 4.25 -1.2 -8.88
L-cystine transport 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
leucine transport 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
ornithine transport 1 1.32 1.45 -1.5 1.71 1.05 1.03 -1.1
proline transport 1 1.41 1.17 -1.02 1.18 -1.05 -1.09 1.18
peptide transport 4 1.61 -1.15 -1.24 -1.1 1.08 1.07 1.44
amine transport 43 -1.38 -1.14 -1.77 -1.23 -1.02 -1.05 -1.16
synaptic vesicle amine transport 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
monoamine transport 3 2.07 -1.32 -1.3 -1.21 -1.34 1.32 -1.28
organic acid transport 54 -1.28 -1.1 -1.53 -1.18 -1.03 1.07 -1.12
organic alcohol transport 3 1.93 -1.21 -1.24 -1.15 -1.08 -1.25 -1.26
nucleoside transport 3 1.64 1.2 1.17 1.2 1.5 1.69 1.3
purine nucleoside transport 1 1.9 1.27 1.23 1.06 1.26 2.28 1.58
purine nucleotide transport 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
ADP transport 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
ATP transport 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
purine ribonucleotide transport 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
dopamine transport 2 3.07 -1.44 -1.47 -1.28 -1.45 -1.2 -1.42
vitamin transport 5 -1.7 1.08 -1.68 1.05 1.16 -1.37 -1.11
cofactor transport 6 -1.04 1.23 -1.1 1.14 1.09 -1.22 -1.05
carnitine transport 2 1.34 1.32 -1.91 1.22 1.14 -1.7 -1.23
folic acid transport 1 -1.3 -1.21 1.08 -1.14 1.42 1.82 -1.08
heme transport 2 -1.43 1.37 1.44 1.16 1.01 -1.14 -1.05
thiamine transport 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
cobalamin transport 1 -1.04 1.01 1.04 1.07 -1.1 -1.21 1.08
drug transport 5 -1.71 1.01 -2.04 -1.18 1.46 -1.6 -1.08
fatty acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
long-chain fatty acid transport 2 1.54 1.0 1.06 1.2 -1.29 1.7 1.68
phospholipid transport 7 -2.51 1.11 -1.27 1.27 1.28 -1.64 -1.28
sterol transport 9 -4.78 -2.96 -3.21 1.02 -1.76 -3.24 -5.0
aspartate oxidase activity 2 -2.82 -1.69 -2.22 1.7 1.95 -1.63 -1.83
mannosidase activity 15 -4.86 1.01 -3.54 1.28 -1.09 -4.24 -6.43
mannosyl-oligosaccharide mannosidase activity 7 1.72 1.11 -1.23 -1.05 -1.05 2.48 1.36
galactosidase activity 3 -4.2 1.61 -2.03 -1.24 -2.09 -1.97 -1.23
glucosidase activity 16 -6.01 -1.16 -3.27 1.15 -2.07 -4.27 -2.24
trehalase activity 3 -2.73 1.23 -2.68 1.17 -1.22 -2.41 1.01
fucosidase activity 1 -1.1 -1.19 -1.53 -1.9 -1.86 -1.28 7.99
hexosaminidase activity 7 1.77 -1.0 -1.28 -1.06 1.05 1.54 1.4
glutamate synthase activity 2 2.76 -1.53 2.1 -1.11 -1.64 -1.33 1.55
nucleobase-containing compound transport 53 -1.03 1.16 1.23 1.13 1.28 1.19 1.02
nucleobase-containing compound transmembrane transporter activity 7 -1.27 1.29 -1.17 1.12 -1.04 -1.15 1.06
large ribosomal subunit 95 1.2 1.04 1.16 1.13 1.2 1.31 -1.19
small ribosomal subunit 62 1.2 1.05 1.17 1.13 1.19 1.3 -1.18
coenzyme A metabolic process 5 1.35 1.24 1.03 1.25 1.35 -1.15 -1.04
coenzyme A biosynthetic process 5 1.35 1.24 1.03 1.25 1.35 -1.15 -1.04
methane metabolic process 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
methanogenesis 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
nucleobase-containing small molecule interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
pyrimidine nucleotide interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
pyrimidine deoxyribonucleotide interconversion 1 2.25 -1.1 -1.03 1.28 1.09 2.14 -1.24
guanosine tetraphosphate metabolic process 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
guanosine tetraphosphate catabolic process 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
energy derivation by oxidation of reduced inorganic compounds 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
carbon utilization 1 3.68 1.14 -1.19 1.01 1.66 1.38 1.25
energy derivation by oxidation of organic compounds 106 1.09 1.04 1.19 1.01 1.12 1.62 -1.17
proton transport 51 -1.18 1.0 1.25 -1.1 -1.04 1.38 -1.15
energy coupled proton transport, down electrochemical gradient 18 1.37 -1.0 1.2 -1.02 1.12 1.7 -1.2
ATP synthesis coupled proton transport 18 1.37 -1.0 1.2 -1.02 1.12 1.7 -1.2
energy coupled proton transport, against electrochemical gradient 32 -1.37 -1.01 1.29 -1.18 -1.14 1.31 -1.13
ATP hydrolysis coupled proton transport 32 -1.37 -1.01 1.29 -1.18 -1.14 1.31 -1.13
phospholipase activator activity 2 -1.41 1.32 1.65 1.18 1.23 1.2 -1.03
phospholipase A2 activator activity 1 -1.23 1.24 1.06 1.3 1.12 1.05 -1.17
Nebenkern 6 -1.27 1.23 1.24 1.01 -1.05 1.16 -1.05
mitochondrial derivative 3 1.07 1.03 -1.0 1.03 -1.06 -1.03 -1.02
dystrophin-associated glycoprotein complex 8 1.62 1.02 1.14 1.04 1.13 1.2 1.02
dystroglycan complex 4 2.12 1.06 1.24 1.03 1.2 1.2 1.03
sarcoglycan complex 3 2.49 -1.02 1.02 1.01 1.11 1.14 -1.09
syntrophin complex 2 -1.29 -1.06 1.25 1.01 1.12 -1.18 1.08
dystrobrevin complex 1 4.45 -1.13 -1.95 -1.08 1.28 3.01 -1.11
morphogen activity 7 2.09 -1.17 1.11 -1.12 1.1 1.31 1.31
peptidoglycan receptor activity 3 2.74 -1.01 1.12 -1.1 1.04 2.17 1.15
cytoplasmic membrane-bounded vesicle 103 1.04 1.04 1.12 1.04 1.15 1.13 1.16
CDP-diacylglycerol biosynthetic process 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
inaD signaling complex 9 -1.03 -1.05 1.17 1.01 -1.08 -1.04 -1.07
rhabdomere 27 -1.04 1.03 1.2 1.01 1.03 -1.05 1.0
subrhabdomeral cisterna 3 2.2 -1.44 1.68 1.01 -1.15 1.14 1.11
maleylacetoacetate isomerase activity 2 1.58 1.0 1.35 1.16 1.16 1.96 -1.03
zeta DNA polymerase complex 1 -1.03 1.1 1.04 -1.05 1.06 2.37 1.1
light absorption 2 -1.17 1.01 -1.19 -1.1 -1.37 -1.21 -1.18
absorption of visible light 1 -1.32 1.03 -1.29 -1.1 -1.47 -1.43 -1.25
absorption of UV light 1 -1.04 -1.01 -1.1 -1.1 -1.27 -1.03 -1.11
glutamate synthase (NADH) activity 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
lipid catabolic process 41 -1.2 -1.2 -1.43 1.05 1.03 -1.9 -1.34
cellular component organization 1674 1.17 1.07 1.21 1.06 1.23 1.22 1.13
cellular membrane organization 260 1.07 1.1 1.21 1.08 1.23 1.18 1.13
detection of bacterium 5 -1.12 -2.27 1.01 1.08 -1.9 -1.65 -3.19
detection of temperature stimulus 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
vesicle organization 37 -1.12 1.13 1.35 1.17 1.24 1.09 1.12
carbohydrate biosynthetic process 54 1.37 -1.06 -1.04 -1.09 1.09 1.31 1.23
carbohydrate catabolic process 70 1.14 -1.3 -1.52 -1.28 -1.28 1.14 1.27
organic acid biosynthetic process 65 1.05 -1.1 -1.35 -1.11 -1.17 1.1 1.09
organic acid catabolic process 40 1.0 -1.07 -1.2 -1.06 1.05 1.14 -1.23
rhodopsin mediated signaling pathway 9 1.31 -1.0 1.3 -1.05 1.29 1.08 1.04
regulation of membrane potential in photoreceptor cell 4 -1.04 1.04 1.07 -1.03 1.02 1.09 -1.02
maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling 1 -1.2 -1.13 -1.12 -1.01 -1.14 -1.07 -1.41
deactivation of rhodopsin mediated signaling 13 1.3 1.02 1.13 1.05 1.11 1.08 1.05
metarhodopsin inactivation 4 1.14 1.05 1.18 1.1 1.25 1.13 1.01
regulation of light-activated channel activity 1 -1.83 1.06 1.22 1.16 1.68 -1.18 -1.24
adaptation of rhodopsin mediated signaling 4 -1.08 1.14 1.07 1.08 1.11 -1.0 -1.04
rhodopsin biosynthetic process 8 -1.84 -1.59 -2.1 1.54 1.04 -1.85 -2.07
immunoglobulin mediated immune response 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
type I hypersensitivity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
RNA metabolic process 549 1.22 1.14 1.23 1.19 1.27 1.18 1.08
mRNA metabolic process 247 1.19 1.12 1.23 1.21 1.31 1.2 1.04
rRNA metabolic process 29 1.2 1.17 1.21 1.31 1.31 1.05 1.06
snRNA metabolic process 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
rRNA catabolic process 1 1.49 1.15 1.39 1.19 1.14 2.46 1.32
synaptic vesicle exocytosis 49 -1.1 1.08 1.28 1.15 1.24 1.11 1.09
synaptic vesicle docking involved in exocytosis 20 -1.08 1.18 1.42 1.17 1.28 1.13 1.1
synaptic vesicle priming 13 -1.03 1.07 1.48 1.09 1.32 1.19 1.13
myostimulatory hormone activity 1 -1.18 1.06 1.01 1.05 -1.08 -1.09 -1.08
myoinhibitory hormone activity 2 -14.64 -2.67 -1.05 2.16 -1.19 -12.67 -5.89
negative regulation of juvenile hormone biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
ecdysiostatic hormone activity 1 -2.55 -1.98 -1.56 2.24 -1.62 -2.75 -2.3
positive regulation of translation 11 1.29 1.21 1.33 1.03 1.33 1.35 1.45
positive regulation of nucleobase-containing compound metabolic process 222 1.11 1.05 1.13 1.03 1.13 1.18 1.15
positive regulation of lipid biosynthetic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
prenol metabolic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
prenol biosynthetic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
diterpenoid metabolic process 3 1.01 -1.01 1.02 1.05 -1.08 1.07 -1.1
sesquiterpenoid biosynthetic process 2 1.77 -2.92 -3.1 -3.09 -1.69 -1.43 2.62
sesquiterpenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
tetraterpenoid metabolic process 3 -1.97 -1.44 -2.29 1.38 1.12 -1.8 -2.35
tetraterpenoid biosynthetic process 1 -1.0 1.21 -1.05 1.12 1.06 -1.02 -1.03
terpenoid biosynthetic process 3 1.46 -1.92 -2.16 -2.04 -1.39 -1.28 1.88
terpenoid catabolic process 4 -1.67 1.21 -1.1 -1.05 -1.31 -3.02 1.26
carotenoid metabolic process 3 -1.97 -1.44 -2.29 1.38 1.12 -1.8 -2.35
carotenoid biosynthetic process 1 -1.0 1.21 -1.05 1.12 1.06 -1.02 -1.03
carotene metabolic process 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
sterol metabolic process 14 1.26 1.04 1.06 1.05 1.15 1.45 1.17
sterol biosynthetic process 8 1.11 1.02 1.04 1.06 -1.03 1.15 1.03
sterol catabolic process 1 -1.19 1.24 1.2 1.43 1.53 -1.12 -1.13
glycoside metabolic process 7 1.73 -1.53 -1.79 -1.54 -1.23 1.97 1.32
glycoside biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
glycoside catabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
O-glycoside metabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
O-glycoside catabolic process 2 -1.06 -1.02 -1.16 -1.17 -1.27 -1.11 2.75
translation release factor activity, codon specific 2 1.29 1.19 1.11 1.18 1.06 1.64 1.05
formyltetrahydrofolate dehydrogenase activity 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
amylase activity 2 -34.84 -2.22 -3.89 2.13 -10.58 -52.06 -2.46
superoxide-generating NADPH oxidase activity 1 2.71 -1.01 1.01 -1.06 -1.03 2.12 1.84
synaptic vesicle coating 12 1.12 1.15 1.39 1.12 1.27 1.41 1.31
synaptic vesicle budding from presynaptic membrane 14 1.04 1.17 1.47 1.12 1.28 1.36 1.24
synaptic vesicle maturation 1 1.21 1.12 1.66 1.2 1.79 2.51 1.99
endosome transport 27 1.15 1.15 1.49 1.14 1.32 1.29 1.14
axon choice point recognition 24 1.17 1.11 1.3 1.03 1.22 1.12 1.17
axon midline choice point recognition 19 1.15 1.12 1.41 1.02 1.3 1.17 1.22
synaptic target attraction 3 1.93 -1.35 1.08 -1.19 1.21 2.92 1.18
synaptic target inhibition 1 -1.51 -1.03 1.25 1.21 2.96 -2.96 1.02
regulation of striated muscle tissue development 47 1.01 1.1 1.22 1.05 1.15 1.1 1.16
determination of muscle attachment site 4 1.72 1.1 1.18 1.13 1.38 1.37 1.04
selenocysteine methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
4-coumarate-CoA ligase activity 5 -15.09 -1.26 -3.1 -1.62 -4.07 -3.87 -5.45
AMP binding 1 3.48 1.38 -1.48 1.01 -2.42 1.73 1.65
antioxidant activity 35 1.06 1.04 -1.09 -1.06 -1.08 -1.08 1.01
ammonia ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
kynurenine-oxoglutarate transaminase activity 1 1.14 1.23 -1.25 1.13 -1.05 1.32 1.04
acyl-CoA desaturase activity 8 -1.57 -1.03 -1.33 1.02 -1.14 -1.74 1.05
procollagen-proline 4-dioxygenase complex 17 -1.04 -1.0 -1.12 -1.02 -1.15 -1.03 -1.07
iron-sulfur cluster assembly 7 1.2 1.16 1.26 1.15 1.02 1.28 -1.07
steroid dehydrogenase activity 8 3.51 -1.74 -1.02 -1.08 -1.5 -2.16 -1.12
sphingomyelin phosphodiesterase activator activity 1 -1.61 1.4 2.58 1.07 1.35 1.37 1.11
beta-N-acetylglucosaminidase activity 3 3.05 -1.03 -1.72 -1.02 1.13 -1.04 1.42
HNK-1 sulfotransferase activity 2 2.01 1.05 1.17 1.04 1.08 1.34 -1.13
telomere capping 7 1.48 1.09 1.57 1.16 1.48 1.55 1.18
macroautophagy 6 1.33 1.14 1.38 1.2 1.17 1.27 1.01
regulation of macroautophagy 2 -1.22 1.35 1.01 1.16 1.29 1.48 -1.02
negative regulation of macroautophagy 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
RNA interference 28 -1.01 -1.0 1.16 1.07 1.32 1.18 1.02
channel regulator activity 8 1.18 1.06 1.08 1.02 1.08 1.11 1.04
N-sulfoglucosamine sulfohydrolase activity 1 -1.48 -1.35 -1.19 -1.31 -1.2 -1.3 1.23
attachment of GPI anchor to protein 2 1.49 1.08 1.21 1.27 1.12 -1.05 -1.02
selenocysteine metabolic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
selenocysteine biosynthetic process 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
protein N-acetylglucosaminyltransferase activity 3 1.03 1.05 1.06 1.08 1.08 -1.0 1.16
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity 1 -3.7 1.32 1.71 1.03 1.54 -3.12 1.7
death 156 1.07 1.04 1.16 1.06 1.25 1.12 1.15
O-glycan processing 3 -2.23 1.15 1.26 1.19 1.31 -2.5 1.12
O-glycan processing, core 1 1 -3.7 1.32 1.71 1.03 1.54 -3.12 1.7
tissue death 79 -1.03 1.02 1.13 1.07 1.24 1.12 1.1
prefoldin complex 10 1.4 -1.02 1.21 1.29 1.23 1.13 -1.24
arginine N-methyltransferase activity 9 1.19 1.07 1.15 1.17 1.1 1.02 1.01
protein-arginine N-methyltransferase activity 9 1.19 1.07 1.15 1.17 1.1 1.02 1.01
lysine N-methyltransferase activity 14 1.29 1.27 1.5 1.07 1.4 1.43 1.38
protein-lysine N-methyltransferase activity 14 1.29 1.27 1.5 1.07 1.4 1.43 1.38
eukaryotic 43S preinitiation complex 1 2.17 1.18 1.52 -1.1 1.33 2.16 1.32
small conductance calcium-activated potassium channel activity 1 1.12 -1.04 1.03 1.09 -1.03 1.27 -1.03
glycerone-phosphate O-acyltransferase activity 1 2.26 1.05 1.14 1.04 1.53 -1.65 1.6
CoA hydrolase activity 4 1.3 1.08 1.01 1.04 -1.02 1.91 -1.09
myristoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
palmitoyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
acyl-[acyl-carrier-protein] hydrolase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
lipase activity 84 -1.92 -1.25 -1.55 -1.09 -1.32 -2.03 -1.49
negative regulation of G-protein coupled receptor protein signaling pathway 11 1.43 1.12 1.43 1.14 1.25 1.34 1.24
kinase activity 351 1.18 1.1 1.21 1.06 1.23 1.3 1.12
phosphorylation 353 1.17 1.09 1.23 1.06 1.23 1.4 1.08
dephosphorylation 108 1.34 1.06 1.15 1.03 1.19 1.32 1.14
inositol bisphosphate phosphatase activity 1 3.45 -1.15 1.32 1.0 -1.07 1.6 -1.16
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
ommatidial rotation 26 1.05 1.09 1.3 1.04 1.44 1.22 1.4
mushroom body development 51 1.06 1.12 1.3 1.08 1.25 1.26 1.19
endoplasmic reticulum membrane fusion 2 1.13 1.31 -1.2 1.21 1.07 -1.49 1.37
female meiosis chromosome segregation 30 1.12 1.08 1.2 1.12 1.26 1.19 1.16
neuron remodeling 18 1.16 1.02 1.26 1.04 1.45 1.47 1.09
basolateral plasma membrane 34 1.42 1.0 1.32 -1.08 1.36 1.58 1.36
apical plasma membrane 27 1.33 1.11 1.29 1.04 1.28 1.55 1.44
oocyte microtubule cytoskeleton organization 31 1.08 1.2 1.51 1.08 1.36 1.59 1.25
apicolateral plasma membrane 50 1.77 -1.05 1.29 -1.11 1.27 2.3 1.5
lateral plasma membrane 9 2.47 -1.11 1.23 -1.25 1.22 2.79 1.7
regulation of apoptotic process 92 1.16 1.13 1.27 1.08 1.29 1.25 1.23
second mitotic wave involved in compound eye morphogenesis 8 1.1 1.21 1.15 1.19 1.36 1.3 1.21
morphogenesis of embryonic epithelium 105 1.16 1.08 1.34 1.03 1.31 1.33 1.31
establishment or maintenance of polarity of embryonic epithelium 8 1.29 1.17 1.66 1.02 1.38 1.51 1.32
morphogenesis of follicular epithelium 30 1.19 1.16 1.46 1.13 1.44 1.35 1.23
establishment or maintenance of polarity of follicular epithelium 20 1.28 1.14 1.48 1.13 1.41 1.28 1.19
morphogenesis of larval imaginal disc epithelium 8 1.12 1.06 1.78 1.05 1.53 1.28 1.0
establishment or maintenance of polarity of larval imaginal disc epithelium 4 1.09 1.11 2.19 -1.04 1.64 1.48 1.2
cell-cell adhesion 54 1.19 -1.01 1.06 -1.05 1.29 1.29 1.35
calcium-dependent cell-matrix adhesion 2 -3.06 1.2 1.48 1.02 1.55 -3.22 1.1
catenin complex 2 1.43 1.06 1.57 1.11 1.6 1.7 1.6
meiotic chromosome movement towards spindle pole 1 1.13 1.05 -1.04 1.47 1.34 -1.18 -1.11
male meiotic chromosome movement towards spindle pole 1 1.13 1.05 -1.04 1.47 1.34 -1.18 -1.11
imaginal disc-derived leg joint morphogenesis 8 -2.19 1.03 -1.69 -1.64 2.1 1.1 1.32
dendrite development 132 1.18 1.12 1.28 1.11 1.28 1.22 1.16
sensory organ precursor cell fate determination 19 1.13 1.05 1.17 1.04 1.28 1.16 1.21
activin receptor activity, type I 1 -1.85 1.82 2.01 1.27 1.8 1.64 1.57
palmitoyl-CoA oxidase activity 3 1.38 -1.55 -1.39 1.44 1.71 -2.77 -1.43
pristanoyl-CoA oxidase activity 2 -15.88 1.87 -3.13 -1.51 -1.49 -10.5 -1.82
dimethylargininase activity 1 1.77 1.6 1.45 1.13 1.23 1.13 1.16
CoA-ligase activity 13 -2.56 -1.1 -1.57 -1.26 -1.84 -1.46 -2.12
carnitine O-acyltransferase activity 5 1.08 1.06 -1.39 1.16 1.37 -1.36 -1.1
acetyltransferase activity 54 -1.01 1.14 1.0 1.14 1.18 -1.11 1.03
C-acyltransferase activity 8 1.16 1.02 1.03 1.15 1.21 -1.21 -1.3
palmitoyltransferase activity 25 -1.15 1.11 1.19 1.13 1.12 -1.19 -1.11
N-acyltransferase activity 45 -1.1 1.17 1.02 1.17 1.18 -1.19 1.02
acylglycerol O-acyltransferase activity 7 -1.48 -1.12 1.19 1.18 2.2 -2.06 -1.75
O-acetyltransferase activity 5 1.07 1.05 -1.14 1.08 1.21 -1.26 -1.0
O-octanoyltransferase activity 1 2.33 -1.31 -2.71 1.32 2.24 -2.61 1.02
octanoyltransferase activity 2 2.01 -1.16 -1.62 1.18 1.39 -1.12 -1.11
O-palmitoyltransferase activity 1 1.55 1.41 -1.09 1.13 1.34 -1.06 1.05
S-acyltransferase activity 27 1.03 1.08 1.14 1.06 1.1 1.04 -1.05
S-acetyltransferase activity 3 2.46 1.01 1.19 -1.13 1.38 2.35 1.7
S-malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
malonyltransferase activity 3 2.14 -1.05 -1.1 -1.07 1.17 1.47 1.42
CoA carboxylase activity 3 2.45 1.39 1.08 -1.18 1.31 2.01 1.86
mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity 2 1.39 1.18 1.42 1.45 1.47 1.2 1.02
tRNA (guanine) methyltransferase activity 2 1.37 1.35 1.16 1.36 1.21 1.09 1.14
tRNA (adenine) methyltransferase activity 1 1.03 1.07 -1.39 1.43 1.1 -1.31 -1.42
tRNA (cytosine) methyltransferase activity 1 -1.06 1.07 1.05 1.57 1.09 -1.37 -1.08
tRNA (cytosine-5-)-methyltransferase activity 1 -1.06 1.07 1.05 1.57 1.09 -1.37 -1.08
tRNA (adenine-N1-)-methyltransferase activity 1 1.03 1.07 -1.39 1.43 1.1 -1.31 -1.42
rRNA (adenine) methyltransferase activity 2 1.61 1.27 1.44 1.22 1.57 1.46 1.13
rRNA (uridine) methyltransferase activity 3 1.55 1.21 1.1 1.32 1.19 1.02 -1.14
posttranscriptional gene silencing 37 1.12 1.04 1.18 1.1 1.27 1.33 1.07
RNA-induced silencing complex 7 -1.01 1.19 1.52 1.03 1.34 1.15 1.36
bidentate ribonuclease III activity 1 -1.14 1.08 1.42 -1.27 1.25 1.05 1.3
somatic cell DNA recombination 1 -1.03 1.26 1.39 1.47 1.41 -1.54 -1.18
C-acetyltransferase activity 3 1.18 1.04 -1.11 1.03 -1.14 1.32 -1.35
C-palmitoyltransferase activity 2 -2.24 1.07 2.48 1.17 1.31 -1.71 -1.18
X chromosome located dosage compensation complex, transcription activating 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome 3 1.47 1.24 1.5 1.08 1.32 1.62 1.47
gene silencing 82 1.19 1.1 1.25 1.12 1.3 1.29 1.13
myosin complex 26 -1.12 1.01 1.34 -1.05 1.23 1.03 1.01
myosin II complex 7 2.46 -1.39 1.28 -1.33 1.16 2.04 -1.08
unconventional myosin complex 8 -1.34 1.12 1.71 1.02 1.43 -1.05 1.11
pyrophosphatase activity 545 1.04 1.07 1.18 1.06 1.17 1.12 1.03
vacuolar proton-transporting V-type ATPase complex 25 -1.7 1.0 1.39 -1.2 -1.2 1.32 -1.15
regulation of embryonic cell shape 30 1.15 1.18 1.42 1.07 1.45 1.47 1.31
cell migration 188 1.14 1.09 1.33 1.05 1.37 1.23 1.22
negative regulation of transcription from RNA polymerase III promoter 2 2.38 1.05 1.63 1.37 1.48 1.65 1.1
cytoplasmic transport 18 -1.19 1.13 1.22 1.09 1.2 -1.37 -1.03
tryptophan hydroxylase activator activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
peptidase activator activity 8 1.1 1.12 1.28 1.11 1.16 -1.1 1.31
peptide hormone processing 2 -3.69 1.49 2.0 -1.05 1.12 -3.53 1.27
structural constituent of peritrophic membrane 24 -1.99 -1.49 -1.95 -1.18 -1.6 -2.02 1.66
protein-hormone receptor activity 6 1.04 -1.23 -1.1 -1.21 -1.12 1.72 -1.28
pheromone receptor activity 1 1.02 1.0 -1.07 1.11 1.03 1.03 -1.03
apoptotic protease activator activity 3 1.67 1.11 1.24 1.1 1.19 1.2 1.4
mitochondrial fatty acid beta-oxidation multienzyme complex 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
long-chain-enoyl-CoA hydratase activity 1 2.19 1.13 1.21 -1.05 1.43 2.22 1.16
long-chain-3-hydroxyacyl-CoA dehydrogenase activity 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
core-binding factor complex 2 1.8 -1.02 -1.19 1.07 -1.13 1.06 -1.05
growth hormone-releasing hormone receptor activity 3 1.44 -1.06 -1.09 -1.03 -1.2 1.08 -1.08
latrotoxin receptor activity 1 -1.05 -1.14 -1.15 1.03 1.21 1.62 2.05
sarcoplasm 4 2.04 -1.34 1.12 -1.41 -1.15 -1.13 1.11
sarcoplasmic reticulum 3 2.05 -1.41 1.18 -1.55 -1.18 -1.27 1.12
metallochaperone activity 3 1.48 1.1 1.32 1.12 1.03 1.6 -1.13
microvillus assembly 1 -2.22 -1.56 -1.05 -1.91 -2.01 -2.21 7.0
copper chaperone activity 2 1.54 1.13 1.31 -1.02 -1.15 1.51 -1.05
superoxide dismutase copper chaperone activity 1 1.35 1.23 -1.1 1.09 -1.09 -1.29 1.14
cyclin-dependent protein kinase 5 holoenzyme complex 2 -1.11 1.16 1.23 1.19 1.1 -1.28 -1.16
cyclin-dependent protein kinase 5 activator activity 1 1.11 1.03 1.17 1.14 1.15 -1.04 -1.04
cyclin-dependent protein kinase regulator activity 19 1.26 1.15 1.26 1.19 1.43 1.03 1.11
intein-mediated protein splicing 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
protein autoprocessing 4 1.71 -1.09 1.55 1.25 1.59 1.29 -1.21
male courtship behavior, orientation prior to leg tapping and wing vibration 2 -1.07 1.03 1.04 -1.02 -1.04 -1.08 1.02
male courtship behavior, veined wing vibration 13 1.07 1.04 1.44 1.14 1.09 -1.01 1.01
male courtship behavior, proboscis-mediated licking 1 1.27 1.02 1.28 1.01 1.16 1.03 1.05
base conversion or substitution editing 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
mRNA modification 1 1.13 1.14 1.55 1.01 1.4 2.0 1.26
protein import into peroxisome matrix 1 -1.21 1.08 -2.37 1.65 1.29 -3.85 -2.28
peroxisome fission 3 2.08 -1.17 -1.4 1.43 1.51 -1.91 1.09
protein import into peroxisome matrix, docking 1 -1.21 1.08 -2.37 1.65 1.29 -3.85 -2.28
positive regulation of transcription, DNA-dependent 201 1.12 1.04 1.13 1.04 1.13 1.19 1.15
negative regulation of transcription, DNA-dependent 184 1.17 1.08 1.16 1.04 1.22 1.22 1.16
chromatin modification 91 1.23 1.19 1.32 1.15 1.35 1.32 1.23
covalent chromatin modification 63 1.22 1.17 1.31 1.16 1.35 1.33 1.21
histone modification 63 1.22 1.17 1.31 1.16 1.35 1.33 1.21
histone methylation 26 1.36 1.2 1.41 1.14 1.42 1.43 1.28
histone phosphorylation 7 -1.05 1.06 1.11 1.18 1.26 -1.01 1.01
histone acetylation 14 1.4 1.24 1.42 1.18 1.37 1.44 1.29
histone deacetylation 5 1.19 1.12 1.01 1.23 1.22 1.44 1.15
histone demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
histone deubiquitination 5 1.17 1.1 1.27 1.13 1.23 1.11 1.2
protein deubiquitination 12 1.11 1.1 1.41 1.13 1.34 1.22 1.21
Sin3 complex 3 1.26 1.15 1.58 1.16 1.67 1.6 1.21
NuRD complex 4 1.58 1.23 1.59 1.18 1.53 1.55 1.45
non-covalent chromatin modification 1 1.45 1.01 1.08 1.38 1.13 -1.44 -1.23
nucleosome positioning 3 1.19 1.07 1.82 1.21 1.88 1.74 1.38
chromatin remodeling complex 70 1.23 1.14 1.26 1.2 1.32 1.19 1.11
NURF complex 5 1.15 1.22 1.63 1.19 1.59 1.56 1.32
ACF complex 5 1.33 -1.77 -1.21 -1.79 1.3 2.26 1.17
DNA-directed RNA polymerase II, holoenzyme 51 1.34 1.12 1.26 1.2 1.28 1.16 1.09
mediator complex 32 1.41 1.08 1.29 1.24 1.33 1.23 1.06
Cdc73/Paf1 complex 2 -1.06 1.05 1.02 1.24 1.1 1.21 -1.3
amino acid binding 15 -1.42 -1.07 -1.49 1.17 1.15 -1.1 -1.49
protein arginylation 1 1.03 1.39 1.46 1.24 1.37 1.69 1.36
flotillin complex 1 3.68 -1.06 -1.03 1.16 1.0 1.99 -1.04
Rac protein signal transduction 2 -1.38 1.43 1.79 1.19 1.71 -1.05 1.42
CCAAT-binding factor complex 1 4.06 1.06 1.04 1.34 1.6 1.05 1.52
glutaminyl-peptide cyclotransferase activity 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
nuclear body 27 -1.05 1.08 1.11 1.12 1.17 1.02 -1.04
nuclear speck 12 -1.25 1.18 1.12 1.11 1.16 -1.02 -1.07
oxidoreductase activity, acting on CH-OH group of donors 112 1.18 -1.01 -1.4 -1.09 -1.09 1.09 1.07
malate dehydrogenase activity 6 -1.07 1.16 1.1 -1.34 -1.06 1.05 1.38
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 74 1.28 1.01 -1.37 -1.14 -1.09 1.12 1.17
malate dehydrogenase (oxaloacetate-decarboxylating) activity 4 -1.07 1.26 1.14 -1.52 -1.06 1.05 1.65
oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor 34 1.38 -1.54 -1.84 -1.66 -1.29 1.37 1.27
oxidoreductase activity, acting on the aldehyde or oxo group of donors, cytochrome as acceptor 1 2.72 -3.32 -2.57 -3.03 -1.93 22.15 -2.83
oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor 7 -1.14 1.15 1.33 1.02 1.18 1.45 -1.19
oxidoreductase activity, acting on the aldehyde or oxo group of donors 42 1.3 -1.42 -1.6 -1.54 -1.21 1.48 1.15
oxidoreductase activity, acting on the CH-CH group of donors 38 1.11 1.12 -1.03 1.1 1.11 -1.16 -1.13
oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor 5 1.34 1.13 1.06 1.07 1.1 1.13 1.09
oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor 11 -1.64 1.16 -1.22 1.19 1.14 -2.19 -1.33
oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor 6 -1.06 1.13 1.29 1.05 -1.01 1.24 -1.27
oxidoreductase activity, acting on the CH-NH2 group of donors 13 1.11 -1.17 -1.04 1.09 1.13 1.04 -1.25
oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor 3 1.19 -1.14 1.18 -1.25 1.27 2.68 -1.22
oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor 8 -1.02 -1.07 -1.3 1.32 1.19 -1.15 -1.32
oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor 1 -1.37 -1.08 -1.16 -1.21 -1.14 1.68 -1.06
oxidoreductase activity, acting on the CH-NH group of donors 20 1.39 -1.16 -1.24 -1.21 -1.13 1.8 -1.06
oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor 13 1.38 -1.17 -1.24 -1.18 -1.19 1.9 -1.08
transferase activity, transferring amino-acyl groups 10 1.86 -1.26 -1.16 -1.23 1.18 1.3 1.33
oxidoreductase activity, acting on the CH-NH group of donors, disulfide as acceptor 4 1.29 1.17 1.1 1.04 1.18 -1.03 1.04
oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor 1 2.09 1.59 -1.41 1.19 1.36 1.02 -1.19
oxidoreductase activity, acting on NADH or NADPH, heme protein as acceptor 2 1.22 1.18 1.02 1.17 1.12 -1.17 1.16
oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
oxidoreductase activity, acting on NADH or NADPH, nitrogenous group as acceptor 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
oxidoreductase activity, acting on other nitrogenous compounds as donors 2 2.03 -1.43 -1.4 -1.33 -1.08 1.05 -1.28
oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
oxidoreductase activity, acting on a sulfur group of donors 43 1.04 1.02 -1.07 1.17 1.05 -1.05 -1.15
oxidoreductase activity, acting on a sulfur group of donors, NAD or NADP as acceptor 3 -1.35 1.14 1.07 -1.01 -1.07 1.01 -1.04
oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor 6 -1.13 1.15 1.03 1.17 1.02 1.31 -1.14
oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor 3 -1.6 -1.4 -2.5 1.38 -1.37 -2.12 -1.83
oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor 4 1.29 1.17 1.1 1.04 1.18 -1.03 1.04
oxidoreductase activity, acting on a heme group of donors 18 -1.12 -1.08 1.07 -1.07 1.03 1.19 -1.31
oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor 18 -1.12 -1.08 1.07 -1.07 1.03 1.19 -1.31
oxidoreductase activity, acting on diphenols and related substances as donors 14 -1.21 -1.11 -1.11 -1.13 -1.22 1.0 -1.09
oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor 10 -1.05 1.06 1.14 1.09 1.02 1.34 -1.41
oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor 4 -1.73 -1.69 -2.0 -1.92 -2.12 -2.06 1.73
oxidoreductase activity, acting on peroxide as acceptor 22 -1.07 -1.02 -1.12 -1.17 -1.19 -1.23 1.01
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen 34 1.11 -1.05 -1.11 -1.04 -1.12 1.08 -1.07
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen 33 1.07 -1.01 -1.07 -1.0 -1.09 1.03 -1.05
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen 168 -1.09 -1.09 -1.25 -1.02 -1.03 -1.11 -1.07
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors 45 -1.05 1.04 -1.04 1.03 1.0 1.02 -1.01
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen 7 1.08 -1.49 -2.16 -1.08 -1.58 -1.06 -1.04
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen 3 1.14 -1.23 -1.27 -1.21 -1.15 1.59 -1.01
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen 4 1.53 1.13 1.14 1.01 1.23 1.29 1.28
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen 3 1.29 1.11 -1.09 -1.0 -1.13 -1.11 -1.01
oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water 10 -1.69 -1.14 -1.69 -1.05 -1.38 -1.35 1.04
oxidoreductase activity, acting on superoxide radicals as acceptor 5 1.45 1.15 -1.15 1.12 -1.07 1.37 -1.06
oxidoreductase activity, oxidizing metal ions 4 -1.43 -2.04 -1.83 -1.64 1.18 -1.2 1.72
oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor 1 1.59 1.02 1.27 1.16 1.58 1.37 1.04
oxidoreductase activity, oxidizing metal ions, oxygen as acceptor 3 -1.88 -2.6 -2.43 -2.04 1.07 -1.41 2.03
oxidoreductase activity, acting on CH or CH2 groups 4 -1.34 1.29 1.11 1.02 1.25 -1.45 1.04
oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor 2 1.25 1.78 -1.17 -1.32 -1.19 -1.3 1.66
oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor 2 -2.27 -1.06 1.44 1.36 1.87 -1.61 -1.54
oxidoreductase activity, acting on iron-sulfur proteins as donors 2 -1.02 1.13 1.16 1.22 1.24 -1.06 -1.06
oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor 2 -1.02 1.13 1.16 1.22 1.24 -1.06 -1.06
transferase activity 1025 1.03 1.07 1.07 1.05 1.15 1.03 1.07
transferase activity, transferring one-carbon groups 103 1.29 1.11 1.16 1.16 1.2 1.21 1.03
hydroxymethyl-, formyl- and related transferase activity 5 1.33 1.06 1.25 1.15 1.17 1.45 -1.08
carboxyl- or carbamoyltransferase activity 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
transferase activity, transferring aldehyde or ketonic groups 3 2.36 1.15 -2.0 1.02 -1.05 1.23 1.57
transferase activity, transferring acyl groups 158 -1.13 1.02 -1.11 1.07 1.11 -1.28 -1.14
transferase activity, transferring acyl groups other than amino-acyl groups 137 -1.17 1.03 -1.11 1.09 1.1 -1.33 -1.17
succinyltransferase activity 2 1.41 1.15 1.17 -1.16 -1.1 2.22 -1.06
N-succinyltransferase activity 1 1.58 1.36 -1.31 -1.09 -1.26 1.25 1.23
S-succinyltransferase activity 1 1.27 -1.02 1.79 -1.24 1.05 3.95 -1.37
myosin I binding 1 -1.18 1.13 1.19 1.15 1.38 -1.04 1.11
transferase activity, transferring glycosyl groups 167 -1.11 -1.01 -1.01 1.01 1.1 -1.1 1.15
transferase activity, transferring hexosyl groups 139 -1.18 -1.01 -1.03 1.01 1.11 -1.14 1.16
transferase activity, transferring pentosyl groups 19 1.06 1.01 1.09 -1.01 -1.01 -1.15 1.07
transferase activity, transferring alkyl or aryl (other than methyl) groups 58 -1.11 1.06 1.05 -1.09 1.02 -1.25 1.03
spermine synthase activity 1 -1.46 1.37 1.59 1.23 1.4 2.11 1.08
transferase activity, transferring nitrogenous groups 19 -1.08 1.17 -1.23 -1.08 -1.02 -1.02 1.19
transferase activity, transferring phosphorus-containing groups 487 1.08 1.11 1.15 1.05 1.2 1.16 1.12
phosphotransferase activity, alcohol group as acceptor 326 1.17 1.11 1.21 1.07 1.25 1.31 1.14
phosphotransferase activity, carboxyl group as acceptor 3 -2.35 1.21 -1.51 -1.01 -1.08 -1.33 1.07
phosphotransferase activity, nitrogenous group as acceptor 6 1.06 -1.03 1.15 -1.01 1.23 1.37 -1.18
phosphotransferase activity, phosphate group as acceptor 19 1.61 -1.01 1.22 1.02 1.17 1.37 -1.03
diphosphotransferase activity 4 1.52 1.16 1.32 1.12 1.12 1.57 1.12
nucleotidyltransferase activity 70 1.17 1.12 1.21 1.13 1.2 1.05 1.07
phosphotransferase activity, for other substituted phosphate groups 9 -1.26 1.22 1.5 1.13 1.37 -1.13 1.06
phosphotransferase activity, paired acceptors 2 1.76 1.25 1.23 1.04 1.04 1.62 -1.07
transferase activity, transferring sulfur-containing groups 28 1.25 1.07 1.14 1.01 1.07 1.02 1.1
transferase activity, transferring selenium-containing groups 1 6.68 -1.68 1.43 -1.05 1.36 2.98 1.28
hydrolase activity 1780 -1.23 -1.08 -1.14 -1.01 -1.01 -1.21 -1.14
hydrolase activity, acting on ester bonds 445 1.01 -1.0 -1.06 1.01 1.06 -1.01 -1.04
thiolester hydrolase activity 39 1.28 1.18 1.36 1.14 1.33 1.38 1.2
phosphatase activity 173 1.11 1.02 -1.05 1.0 1.12 1.12 1.01
diphosphoric monoester hydrolase activity 1 1.81 -1.03 1.57 1.17 1.71 1.48 -1.14
exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters 24 1.21 1.16 1.16 1.21 1.26 1.12 1.05
hydrolase activity, acting on glycosyl bonds 100 -1.69 -1.27 -2.25 -1.21 -1.43 -1.66 -1.24
hydrolase activity, hydrolyzing N-glycosyl compounds 6 2.07 -1.07 1.03 -1.04 1.05 1.76 1.02
hydrolase activity, acting on ether bonds 7 -2.36 -1.14 -1.27 1.0 -1.04 -1.57 1.01
trialkylsulfonium hydrolase activity 3 -2.93 -1.82 -1.21 -1.07 1.22 1.86 -1.16
ether hydrolase activity 4 -2.01 1.25 -1.31 1.06 -1.24 -3.52 1.14
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds 85 -1.06 -1.12 -1.21 -1.01 -1.05 -1.02 -1.1
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides 51 -1.18 -1.24 -1.25 1.0 -1.05 -1.18 -1.25
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides 4 1.19 1.06 1.03 1.24 1.04 -1.03 -1.09
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines 3 1.74 1.1 1.15 1.01 -1.04 1.8 1.17
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines 20 1.0 1.02 -1.24 -1.12 -1.14 1.23 1.04
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles 2 1.33 1.42 -1.12 1.25 1.47 1.28 -1.05
hydrolase activity, acting on acid anhydrides 553 1.04 1.07 1.17 1.06 1.16 1.12 1.03
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 551 1.04 1.07 1.17 1.06 1.16 1.12 1.03
hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances 120 -1.08 -1.04 1.03 -1.07 1.02 1.16 -1.05
hydrolase activity, acting on acid carbon-carbon bonds 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances 1 2.81 -1.06 -1.21 -1.09 1.58 2.01 -1.24
hydrolase activity, acting on acid sulfur-nitrogen bonds 1 -1.48 -1.35 -1.19 -1.31 -1.2 -1.3 1.23
lyase activity 125 1.07 1.01 -1.04 -1.02 1.05 1.11 1.03
carbon-carbon lyase activity 32 1.06 -1.12 -1.24 1.0 -1.0 1.08 -1.03
carboxy-lyase activity 25 1.06 -1.19 -1.28 -1.05 -1.03 1.05 -1.03
aldehyde-lyase activity 4 -1.25 1.0 -1.2 1.35 1.18 -1.18 -1.45
oxo-acid-lyase activity 1 -1.23 1.82 1.48 1.33 1.52 1.63 1.08
carbon-oxygen lyase activity 52 1.11 1.04 1.1 -1.06 1.02 1.15 1.05
hydro-lyase activity 45 1.04 1.04 1.1 -1.08 -1.01 1.14 1.04
carbon-oxygen lyase activity, acting on polysaccharides 1 1.35 1.02 1.15 1.05 1.09 1.1 1.03
carbon-oxygen lyase activity, acting on phosphates 1 2.12 1.31 1.32 1.23 1.73 1.01 2.0
carbon-nitrogen lyase activity 5 -2.25 -1.05 -1.88 1.19 2.05 -1.63 -1.2
ammonia-lyase activity 1 -3.81 -2.74 -2.14 -1.15 11.07 -1.69 -3.46
amidine-lyase activity 2 -3.73 1.28 -2.46 1.25 1.21 -1.91 1.03
amine-lyase activity 2 -1.04 1.14 -1.34 1.32 1.5 -1.36 1.15
strictosidine synthase activity 2 -1.04 1.14 -1.34 1.32 1.5 -1.36 1.15
carbon-sulfur lyase activity 6 1.18 1.18 1.05 1.05 1.02 1.08 -1.01
1-aminocyclopropane-1-carboxylate synthase activity 2 1.14 1.17 -1.17 -1.01 1.02 1.07 -1.0
carbon-halide lyase activity 1 -1.05 1.06 1.25 -1.2 1.21 -1.46 1.19
phosphorus-oxygen lyase activity 28 1.14 1.04 -1.01 -1.01 1.03 1.2 1.09
isomerase activity 93 1.39 1.07 1.04 1.1 1.15 1.21 1.08
racemase and epimerase activity 9 1.08 1.08 -1.25 -1.0 1.14 -1.19 1.12
racemase and epimerase activity, acting on carbohydrates and derivatives 8 -1.09 1.13 -1.29 -1.06 1.05 -1.3 1.17
cis-trans isomerase activity 29 1.39 1.03 1.12 1.15 1.24 1.15 1.02
intramolecular oxidoreductase activity 26 1.67 1.02 1.03 1.12 1.09 1.42 1.03
intramolecular oxidoreductase activity, interconverting aldoses and ketoses 5 2.55 1.17 -1.07 1.0 1.07 1.9 1.31
intramolecular oxidoreductase activity, interconverting keto- and enol-groups 11 1.16 1.01 1.21 1.13 1.12 1.18 1.09
intramolecular oxidoreductase activity, transposing C=C bonds 10 2.03 -1.04 -1.1 1.17 1.08 1.51 -1.15
intramolecular oxidoreductase activity, transposing S-S bonds 10 1.1 -1.01 1.22 1.11 1.12 1.08 1.12
intramolecular transferase activity 19 1.31 1.16 1.03 1.05 1.07 1.29 1.12
intramolecular transferase activity, phosphotransferases 8 1.0 1.04 1.02 1.02 1.07 -1.12 1.12
intramolecular lyase activity 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
ligase activity 206 1.04 1.13 1.16 1.09 1.14 1.1 1.07
ligase activity, forming carbon-oxygen bonds 40 -1.07 1.26 1.26 1.14 1.18 1.05 1.09
ligase activity, forming aminoacyl-tRNA and related compounds 40 -1.07 1.26 1.26 1.14 1.18 1.05 1.09
ligase activity, forming carbon-sulfur bonds 20 -1.5 -1.17 -1.49 -1.12 -1.4 -1.6 -1.77
acid-thiol ligase activity 13 -2.56 -1.1 -1.57 -1.26 -1.84 -1.46 -2.12
ligase activity, forming carbon-nitrogen bonds 138 1.14 1.14 1.23 1.1 1.21 1.21 1.16
acid-ammonia (or amide) ligase activity 2 1.91 -1.99 2.01 -1.44 1.52 -1.73 -1.25
acid-amino acid ligase activity 111 1.11 1.16 1.34 1.13 1.26 1.19 1.18
cyclo-ligase activity 3 1.09 1.06 1.12 1.21 1.12 1.24 -1.09
carbon-nitrogen ligase activity, with glutamine as amido-N-donor 13 1.37 1.08 -1.29 -1.04 -1.04 1.51 1.21
ligase activity, forming carbon-carbon bonds 4 2.44 1.26 -1.08 -1.11 1.01 1.91 1.62
ligase activity, forming phosphoric ester bonds 5 1.2 1.22 1.08 1.19 1.21 1.0 1.01
endodeoxyribonuclease activity, producing 5'-phosphomonoesters 2 2.29 1.05 1.61 -1.06 1.36 1.86 1.38
endodeoxyribonuclease activity, producing 3'-phosphomonoesters 2 1.96 -1.84 -1.77 -1.88 -1.43 -1.2 2.09
endoribonuclease activity, producing 5'-phosphomonoesters 12 1.14 1.09 1.3 1.19 1.29 1.24 1.0
endoribonuclease activity, producing 3'-phosphomonoesters 2 1.91 1.08 1.3 1.12 1.28 1.27 1.22
endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters 14 1.26 1.08 1.34 1.15 1.3 1.31 1.05
endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters 4 1.94 -1.3 -1.17 -1.3 -1.06 1.03 1.6
exodeoxyribonuclease activity, producing 5'-phosphomonoesters 7 -1.09 1.11 1.04 1.05 1.14 -1.05 -1.01
exoribonuclease activity, producing 5'-phosphomonoesters 18 1.38 1.17 1.2 1.26 1.28 1.2 1.08
oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor 1 1.11 1.03 -1.05 1.12 4.21 1.26 -1.02
oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor 1 1.07 1.03 -1.07 1.05 -1.1 -1.02 -1.18
oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor 5 -1.02 -1.05 1.01 1.08 1.13 1.19 -1.09
G-protein coupled acetylcholine receptor activity 2 1.0 1.08 1.1 1.16 1.17 1.06 1.05
SAP kinase activity 5 1.03 1.11 1.44 1.2 1.45 -1.1 -1.04
GABA receptor activity 7 1.0 1.05 -1.0 -1.01 -1.08 -1.05 -1.12
ligand-dependent nuclear receptor binding 5 1.26 1.45 1.61 1.27 1.41 1.59 1.27
thyroid hormone receptor binding 1 -1.32 1.3 -1.05 1.3 1.04 2.32 -1.33
protein sumoylation 3 1.29 1.14 1.26 1.29 1.5 1.22 -1.02
SUMO-specific protease activity 1 1.48 1.3 2.69 1.46 2.61 3.81 1.95
extracellular-glycine-gated ion channel activity 7 -1.5 1.06 -1.1 -1.52 -1.91 -1.85 1.36
extracellular-glycine-gated chloride channel activity 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
glycine-gated chloride channel complex 4 -1.54 1.26 1.47 -1.43 -1.72 -1.63 -1.04
short-branched-chain-acyl-CoA dehydrogenase activity 2 -1.12 1.32 -1.16 1.05 1.12 -1.93 1.2
kinesin II complex 1 1.07 1.09 1.33 1.24 1.41 1.98 -1.06
natriuretic peptide receptor activity 1 -1.36 1.26 1.17 1.07 -1.37 -1.35 1.16
insulin-like growth factor binding protein complex 2 -1.01 -1.08 -1.05 -1.02 1.09 -1.07 -1.03
flavin-linked sulfhydryl oxidase activity 5 -1.04 1.15 1.04 1.11 1.03 1.33 -1.08
thiol oxidase activity 5 -1.04 1.15 1.04 1.11 1.03 1.33 -1.08
poly(A)+ mRNA export from nucleus 6 1.05 1.1 1.12 1.19 1.19 -1.03 -1.02
lipoate-protein ligase activity 2 1.65 1.07 1.42 1.08 1.12 2.67 -1.13
lipoate synthase activity 1 1.58 1.18 1.95 1.1 1.45 3.43 -1.02
cell wall macromolecule catabolic process 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
antibiotic metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
antibiotic biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
activin-activated receptor activity 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
protein-heme linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
cytochrome complex assembly 3 1.45 1.07 1.3 1.03 1.04 1.58 -1.23
3'-tyrosyl-DNA phosphodiesterase activity 1 -1.61 -1.07 -1.0 -1.17 -1.28 -1.58 -1.34
protein-tetrapyrrole linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
regulation of transforming growth factor beta receptor signaling pathway 9 1.43 1.09 1.33 -1.08 1.27 1.44 1.24
Ras GTPase binding 26 1.1 1.19 1.47 1.12 1.32 1.31 1.35
MAP kinase tyrosine/serine/threonine phosphatase activity 3 1.18 1.17 1.3 1.08 1.35 1.14 1.33
myosin phosphatase activity 3 1.52 1.01 1.94 -1.04 1.33 1.77 1.57
myosin phosphatase regulator activity 1 -3.34 1.3 1.86 1.22 1.27 -2.0 1.07
myosin binding 23 -1.09 1.05 1.41 1.02 1.21 1.04 1.08
myosin phosphatase complex 1 5.19 -1.26 2.54 -1.39 1.19 2.56 1.75
TBP-class protein binding 3 1.62 1.22 1.38 1.2 1.3 1.46 1.18
protein stabilization 15 1.39 1.17 1.1 1.12 1.19 1.04 1.03
potassium:amino acid symporter activity 5 -1.79 -1.85 -2.57 -1.19 1.65 1.54 1.09
Rap guanyl-nucleotide exchange factor activity 1 -1.08 1.15 1.11 1.03 1.11 -1.08 1.02
protein import 66 1.08 1.15 1.27 1.17 1.26 1.18 1.02
positive regulation of hormone secretion 1 1.12 1.15 1.24 1.0 1.0 1.1 -1.06
peptide hormone binding 2 1.14 1.03 1.06 1.02 -1.01 -1.0 -1.03
Rho GTPase binding 7 1.11 1.18 1.37 1.08 1.39 1.46 1.35
GTP-Rho binding 1 -1.55 1.88 -1.17 -1.09 -1.11 -1.68 1.84
D-erythro-sphingosine kinase activity 3 2.17 1.08 -1.12 -1.03 -1.02 1.22 1.39
retinol dehydratase activity 2 1.19 -1.09 -1.04 -1.04 1.02 1.11 -1.06
transcriptional repressor complex 14 1.34 1.2 1.42 1.15 1.41 1.35 1.31
negative cofactor 2 complex 2 1.34 1.17 1.22 1.42 1.42 1.02 -1.0
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly 3 1.71 1.26 1.41 1.3 1.44 1.38 1.2
structural constituent of nuclear pore 4 1.27 1.07 1.32 1.35 1.49 1.29 1.1
6-phosphogluconolactonase activity 1 2.54 1.2 -1.43 1.17 1.05 -1.15 1.18
FH1 domain binding 2 1.0 1.2 1.28 1.34 1.19 -1.05 -1.08
serine C-palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
S-methyl-5-thioadenosine phosphorylase activity 2 -1.31 1.03 -1.18 1.26 1.0 -1.49 -1.34
respiratory chain complex III assembly 1 1.04 1.04 1.01 -1.04 -1.1 1.13 -1.12
fatty acid amide hydrolase activity 4 1.42 1.22 -1.76 -1.03 -1.09 2.22 1.2
single-strand selective uracil DNA N-glycosylase activity 1 1.26 1.08 -1.14 1.16 1.06 -1.01 -1.01
tyrosine-ester sulfotransferase activity 1 -11.7 1.38 -1.27 1.16 1.17 -8.03 1.02
U6 snRNA binding 2 1.33 1.17 1.11 1.38 1.29 1.09 -1.1
intracellular cyclic nucleotide activated cation channel complex 2 -1.19 -1.0 1.11 -1.1 1.07 1.05 -1.33
syntaxin-1 binding 1 -1.34 1.17 1.4 1.35 1.51 1.53 1.84
purine nucleotide binding 813 1.08 1.1 1.19 1.09 1.22 1.17 1.09
oxidative phosphorylation uncoupler activity 5 -1.29 -1.01 -1.03 -1.02 1.03 -1.07 -1.18
heat shock protein binding 40 1.19 1.15 1.18 1.12 1.14 1.12 1.13
sodium channel regulator activity 1 -1.11 -1.01 1.04 -1.05 -1.05 -1.14 -1.0
delta1-pyrroline-5-carboxylate synthetase activity 1 -29.94 1.93 -2.31 -1.05 -1.13 -7.63 1.24
3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex 2 1.67 1.29 1.69 -1.02 1.34 1.99 1.11
mitochondrial processing peptidase complex 1 -1.11 1.21 1.34 -1.03 -1.05 2.16 -1.38
glycolipid transporter activity 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
meprin A complex 4 -1.05 -1.07 -1.08 1.07 1.0 -1.08 -1.08
AU-rich element binding 1 -1.76 1.11 1.26 1.23 1.05 -1.22 -1.69
heparan sulfate 6-O-sulfotransferase activity 1 1.37 -1.51 7.55 1.04 1.53 1.73 1.66
sulfonylurea receptor binding 1 2.98 -1.49 1.51 -1.4 1.16 14.12 1.01
very-long-chain-acyl-CoA dehydrogenase activity 1 1.8 1.71 -1.79 -1.14 1.11 -1.09 1.11
aminoacyl-tRNA synthetase multienzyme complex 3 1.11 1.2 1.09 1.15 1.05 -1.07 1.06
anion exchanger adaptor activity 1 -1.15 1.11 1.03 1.13 1.14 1.45 1.27
glutamate-cysteine ligase complex 3 -1.79 1.47 -1.22 1.17 -1.04 -1.53 1.26
Rab guanyl-nucleotide exchange factor activity 2 -1.44 1.17 1.82 1.09 1.3 1.78 1.08
dihydropyrimidine dehydrogenase (NADP+) activity 1 -2.4 1.52 -1.09 1.53 -1.18 -2.54 -1.54
peptidase inhibitor activity 76 1.39 -1.53 -1.49 -1.55 -1.32 1.49 1.05
single-stranded DNA-dependent ATP-dependent DNA helicase activity 3 1.08 1.14 1.41 1.15 1.37 -1.0 1.15
single-stranded DNA-dependent ATP-dependent DNA helicase complex 1 -1.41 1.08 1.3 1.52 1.33 -1.66 -1.08
lipoyltransferase activity 1 1.33 -1.19 1.85 1.0 1.1 2.24 -1.59
Golgi transport complex 2 1.23 1.33 1.33 1.17 1.27 1.38 1.89
protein N-acetylglucosaminyltransferase complex 2 1.22 1.13 1.2 1.2 1.16 1.19 1.37
Ral GTPase activator activity 1 1.09 1.26 1.08 1.12 1.12 1.3 1.36
SH3 domain binding 8 1.15 1.04 1.33 1.04 1.19 1.55 1.28
deoxycytidyl transferase activity 1 1.75 -1.08 2.07 1.17 1.37 2.15 1.01
nucleologenesis 1 1.32 1.42 1.69 1.17 1.76 1.08 1.69
cholesterol transporter activity 1 -1.06 1.09 -1.0 1.4 1.63 -1.48 -1.12
phospholipid scramblase activity 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
triglyceride binding 1 4.36 -1.08 -1.33 -1.1 1.06 2.49 1.49
uridine-rich cytoplasmic polyadenylylation element binding 1 1.17 -1.07 -1.05 1.02 -1.05 -1.03 -1.08
cyclic nucleotide-dependent guanyl-nucleotide exchange factor activity 2 -1.1 1.13 1.09 -1.05 -1.04 -1.02 -1.01
mitochondrial electron transfer flavoprotein complex 2 1.33 1.29 -1.39 1.04 1.01 -1.08 -1.3
fibroblast growth factor binding 1 3.07 1.39 2.07 1.3 2.02 1.75 1.45
enzyme binding 116 1.3 1.11 1.41 1.1 1.33 1.31 1.26
NAD-dependent histone deacetylase activity 2 1.85 1.16 1.29 1.09 1.23 1.67 1.46
Rab GTPase binding 6 1.23 1.16 1.16 1.13 1.22 1.16 1.33
response to arsenic-containing substance 8 1.07 1.17 1.52 1.13 1.46 1.14 1.14
insecticide metabolic process 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
drug metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
stem cell division 64 -1.0 1.13 1.32 1.11 1.34 1.07 1.11
N-methyl-D-aspartate selective glutamate receptor complex 3 -3.51 1.06 1.06 -1.04 1.07 -1.9 1.09
Wnt-protein binding 11 1.57 -1.01 1.22 -1.02 1.31 -1.0 1.28
negative regulation of translation 26 1.35 1.03 1.33 1.02 1.32 1.38 1.31
tRNA dihydrouridine synthase activity 4 1.57 1.16 1.09 1.25 1.12 1.12 -1.03
DEAD/H-box RNA helicase binding 2 1.24 1.45 1.49 1.18 1.41 1.54 1.43
sodium:dicarboxylate symporter activity 3 1.33 1.26 -3.33 -3.11 -2.74 -1.43 1.86
semaphorin receptor activity 2 1.69 1.12 2.14 -1.0 1.95 2.34 1.53
regulation of exocytosis 9 -1.22 1.13 1.23 1.07 1.14 1.53 1.05
regulation of calcium ion-dependent exocytosis 1 -1.33 -1.11 -1.13 -1.17 -1.09 12.66 1.12
pantetheine hydrolase activity 3 -3.81 -1.17 -3.75 2.31 -1.17 -3.72 -1.67
Ral GTPase binding 3 1.22 1.31 1.26 1.22 1.29 1.46 1.42
aryl hydrocarbon receptor binding 1 1.71 1.13 1.25 1.13 1.02 1.11 -1.02
vinculin binding 1 2.93 1.13 1.23 -1.06 1.04 3.7 1.38
5-oxoprolinase (ATP-hydrolyzing) activity 1 -1.27 -1.09 -1.84 1.84 -1.17 -2.01 -1.59
CDP-alcohol phosphatidyltransferase activity 6 -1.0 1.26 1.69 1.08 1.28 -1.12 1.22
KU70 binding 1 -1.09 -1.0 1.57 1.36 1.26 1.16 -2.0
serine hydrolase activity 290 -2.22 -1.39 -1.61 -1.12 -1.45 -2.28 -1.59
cysteine dioxygenase activity 1 1.24 1.05 1.09 -1.01 -1.04 1.21 1.11
glycine N-methyltransferase activity 1 1.02 -2.19 -1.44 -1.75 -1.84 4.35 -2.08
phosphatidylinositol N-acetylglucosaminyltransferase activity 4 1.26 1.36 1.66 1.37 1.48 -1.0 1.01
glucosidase II complex 4 -1.98 1.19 -1.8 1.24 1.01 1.0 -1.01
peptidyl-diphthamide metabolic process 3 1.96 1.14 1.33 1.22 1.29 1.28 -1.07
peptidyl-diphthamide biosynthetic process from peptidyl-histidine 3 1.96 1.14 1.33 1.22 1.29 1.28 -1.07
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
peptidyl-glutamic acid carboxylation 1 1.13 1.29 1.08 1.08 -1.09 -1.02 1.13
N-terminal peptidyl-methionine acetylation 1 -1.5 1.47 2.65 1.15 1.31 -1.14 -1.06
N-terminal peptidyl-L-cysteine N-palmitoylation 1 1.07 1.32 1.75 1.48 1.85 -1.07 -1.03
peptidyl-lysine methylation 4 1.32 1.26 1.73 1.16 1.81 1.88 1.52
peptidyl-lysine trimethylation 3 1.35 1.23 1.68 1.16 1.73 1.61 1.45
histone-lysine N-methyltransferase activity 14 1.29 1.27 1.5 1.07 1.4 1.43 1.38
peptidyl-lysine monomethylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
peptidyl-lysine dimethylation 1 1.41 1.59 1.77 1.23 1.83 1.65 1.69
cytochrome c-heme linkage 1 1.66 1.03 1.71 1.06 1.0 2.28 -1.41
protein-cofactor linkage 1 -1.1 1.02 -1.19 -1.23 -1.41 1.01 -1.14
protein polyglycylation 2 -1.15 -1.05 -1.18 -1.0 -1.15 -1.19 -1.18
peptidyl-serine phosphorylation 3 1.28 1.07 1.17 1.15 1.14 1.08 -1.08
peptidyl-histidine phosphorylation 1 1.67 -1.54 1.2 -1.13 7.02 3.44 1.09
peptidyl-threonine phosphorylation 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
peptidyl-tyrosine phosphorylation 5 1.6 1.02 1.5 1.02 1.17 1.5 1.38
heterocycle biosynthetic process 146 1.22 1.04 1.02 -1.01 1.0 1.25 1.03
peptide cross-linking 3 3.33 -1.61 -1.45 -1.67 -1.2 1.72 1.67
peptidyl-pyrromethane cofactor linkage 1 -1.1 1.02 -1.19 -1.23 -1.41 1.01 -1.14
C-terminal protein-tyrosinylation 1 1.09 -1.0 -1.03 1.18 -1.04 1.05 -1.03
peptidyl-amino acid modification 62 1.26 1.09 1.2 1.06 1.19 1.24 1.17
peptidyl-arginine modification 3 1.19 1.12 1.45 1.13 1.36 1.2 1.09
peptidyl-asparagine modification 3 -1.19 1.11 1.12 1.13 1.21 1.27 1.61
peptidyl-cysteine modification 2 -1.01 1.16 1.21 1.1 1.15 -1.03 -1.08
peptidyl-glutamine modification 2 2.71 -1.35 -1.37 -1.7 -1.26 -1.18 2.94
peptidyl-glutamic acid modification 1 1.13 1.29 1.08 1.08 -1.09 -1.02 1.13
peptidyl-histidine modification 4 1.89 -1.01 1.3 1.12 1.97 1.64 -1.03
peptidyl-lysine modification 20 1.35 1.22 1.43 1.16 1.42 1.47 1.29
peptidyl-methionine modification 2 1.17 1.23 1.52 -1.02 1.0 -1.03 -1.15
peptidyl-proline modification 15 -1.0 1.02 -1.1 -1.04 -1.12 1.01 -1.04
peptidyl-threonine modification 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
peptidyl-tyrosine modification 6 1.5 1.01 1.39 1.05 1.14 1.41 1.3
protein carboxylation 1 1.13 1.29 1.08 1.08 -1.09 -1.02 1.13
protein phosphopantetheinylation 1 1.84 1.09 2.09 1.3 2.04 2.34 1.11
peptidyl-arginine methylation 3 1.19 1.12 1.45 1.13 1.36 1.2 1.09
biotin-protein ligase activity 1 1.43 1.46 1.44 1.24 1.28 1.18 1.38
protein N-linked glycosylation via asparagine 3 -1.19 1.11 1.12 1.13 1.21 1.27 1.61
protein tyrosinylation 1 1.09 -1.0 -1.03 1.18 -1.04 1.05 -1.03
protein palmitoylation 22 -1.11 1.1 1.13 1.12 1.09 -1.16 -1.11
protein myristoylation 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
glycoprotein 3-alpha-L-fucosyltransferase activity 1 -1.29 1.13 -1.16 1.54 2.78 1.39 1.18
internal peptidyl-lysine acetylation 14 1.4 1.24 1.42 1.18 1.37 1.44 1.29
peptidyl-lysine acetylation 14 1.4 1.24 1.42 1.18 1.37 1.44 1.29
peptidyl-proline hydroxylation to 4-hydroxy-L-proline 15 -1.0 1.02 -1.1 -1.04 -1.12 1.01 -1.04
C-terminal protein amino acid modification 2 -1.4 1.08 1.03 1.29 1.32 -1.28 -1.35
translation release factor complex 1 1.2 1.24 1.0 1.1 -1.06 1.25 1.2
prothoracicotrophic hormone activity 1 -1.06 -1.47 -1.01 -1.23 -1.12 1.54 -1.14
acetoacetyl-CoA reductase activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
alkane 1-monooxygenase activity 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
S-formylglutathione hydrolase activity 1 1.41 1.06 -1.13 1.33 1.12 -1.09 -1.51
alkyl sulfatase activity 1 2.4 1.23 1.72 -1.4 3.44 4.52 1.64
DDT-dehydrochlorinase activity 1 -1.05 1.06 1.25 -1.2 1.21 -1.46 1.19
1-aminocyclopropane-1-carboxylate metabolic process 2 1.14 1.17 -1.17 -1.01 1.02 1.07 -1.0
organic ether metabolic process 26 1.41 -1.13 -1.09 -1.07 1.17 -1.17 1.01
phenol-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
molting cycle, protein-based cuticle 55 1.16 -1.03 1.01 -1.09 -1.04 1.19 1.17
ecdysis, chitin-based cuticle 7 1.02 1.08 1.04 -1.01 -1.03 1.01 1.06
oviposition 12 1.07 1.1 -1.02 -1.01 -1.06 -1.03 -1.02
germ-line sex determination 5 1.56 1.08 1.18 1.1 1.06 1.51 1.13
somatic sex determination 17 1.27 1.15 1.28 1.11 1.21 1.09 1.12
guanyl nucleotide binding 161 1.17 1.08 1.28 1.07 1.23 1.1 1.07
GDP binding 3 2.03 -1.04 1.6 1.01 1.54 1.95 1.24
molybdopterin synthase complex 1 2.51 1.28 2.88 1.18 3.18 1.65 1.8
farnesoic acid O-methyltransferase activity 2 3.79 -5.16 -3.85 -4.65 -1.93 1.64 2.51
virion 7 -1.09 -1.36 -1.17 -1.1 -1.08 1.28 -1.28
viral capsid 6 -1.3 -1.35 -1.31 -1.0 -1.02 -1.17 -1.33
viral envelope 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
viral envelope fusion with host membrane 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
virus-host interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
viral infectious cycle 3 -1.12 1.07 1.27 -1.16 -1.11 1.69 1.21
initiation of viral infection 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
mitochondrial rRNA export from mitochondrion 1 3.27 1.48 4.47 -1.01 2.24 5.65 2.22
mitochondrial RNA localization 1 3.27 1.48 4.47 -1.01 2.24 5.65 2.22
pole plasm mRNA localization 37 1.02 1.19 1.31 1.15 1.26 1.21 1.17
reproductive behavior 89 1.01 -1.08 -1.02 -1.04 -1.07 1.01 1.09
female germ-line sex determination 4 1.82 1.02 1.1 1.07 1.07 1.73 1.13
female somatic sex determination 5 1.87 1.25 1.34 1.23 1.35 1.16 1.18
male somatic sex determination 2 2.22 1.29 1.1 1.16 1.11 -1.15 1.06
myristoyltransferase activity 1 -1.49 1.29 1.71 1.24 1.7 1.05 1.0
deoxynucleoside kinase activity 1 1.02 1.09 1.32 1.32 1.3 -1.29 -1.13
trans-2-enoyl-CoA reductase (NADPH) activity 1 1.29 -1.03 1.55 1.16 1.07 1.93 -1.33
3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity 2 3.49 -1.07 -1.08 -1.15 1.4 1.97 2.1
histamine-gated chloride channel activity 2 -1.17 1.03 -1.13 1.06 -1.2 -1.2 -1.2
histamine-gated chloride channel complex 2 -1.17 1.03 -1.13 1.06 -1.2 -1.2 -1.2
nonribosomal peptide biosynthetic process 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
snRNA-activating protein complex 2 1.7 1.14 1.37 1.1 1.36 1.18 1.22
acyl-CoA N-acyltransferase activity 1 1.2 1.15 1.75 1.03 1.4 1.08 1.36
beta-1,4-mannosyltransferase activity 2 -2.16 1.25 1.27 1.12 1.95 -1.56 -1.08
transmembrane receptor protein phosphatase activity 6 1.57 1.05 1.23 1.03 1.35 2.22 1.25
transmembrane receptor protein kinase activity 26 1.41 1.03 1.2 1.02 1.21 1.47 1.43
carbohydrate kinase activity 14 1.04 1.03 -1.21 1.04 1.14 1.34 -1.15
nucleotide kinase activity 13 1.94 -1.05 1.14 -1.01 1.08 1.44 -1.06
amino acid kinase activity 4 -2.33 1.24 -1.02 1.02 -1.11 -1.42 -1.1
carbohydrate phosphatase activity 5 3.03 -1.36 1.1 -1.47 -1.11 2.72 1.19
nucleotide phosphatase activity 3 1.37 1.12 -1.02 1.28 1.23 -1.07 1.06
nucleobase-containing compound kinase activity 24 1.52 -1.0 1.19 1.05 1.13 1.31 -1.03
nucleoside kinase activity 7 1.64 -1.1 1.15 -1.01 1.03 1.51 1.03
kinase regulator activity 45 1.15 1.13 1.2 1.14 1.29 1.05 1.1
phosphatase regulator activity 34 1.39 -1.03 1.21 1.04 1.21 1.41 1.13
kinase activator activity 5 1.59 1.12 1.23 1.13 1.26 1.27 1.08
kinase inhibitor activity 6 1.32 1.13 1.13 1.05 1.2 1.27 1.35
phosphatase activator activity 3 1.39 1.03 1.11 1.1 1.16 1.44 1.03
phosphatase inhibitor activity 9 1.54 -1.03 1.13 1.03 1.34 1.35 1.05
deacetylase activity 12 1.36 1.08 1.02 1.17 1.14 1.18 1.05
regulation of lipid metabolic process 9 -2.45 -1.13 1.14 1.12 1.3 -2.52 -1.85
regulation of fatty acid metabolic process 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
regulation of steroid metabolic process 1 -1.55 1.2 1.21 -1.19 -1.12 1.05 1.03
regulation of nucleobase-containing compound metabolic process 796 1.13 1.09 1.18 1.07 1.17 1.17 1.12
regulation of phosphate metabolic process 80 1.29 1.13 1.33 1.09 1.29 1.35 1.2
regulation of metabolic process 1137 1.19 1.08 1.19 1.06 1.18 1.19 1.13
transmission of nerve impulse 223 1.08 1.07 1.2 1.03 1.19 1.22 1.13
neuronal action potential propagation 1 -1.57 1.18 1.51 1.08 1.08 -1.02 1.18
regulation of action potential in neuron 6 1.77 -1.07 1.38 -1.13 1.24 3.0 1.46
sensory perception of pain 2 2.05 -1.17 1.22 1.13 1.44 2.13 1.2
response to pheromone 18 1.24 -1.22 -1.2 -1.21 -1.23 1.03 -1.13
cyclohydrolase activity 4 2.83 -1.76 -1.94 -1.6 -1.8 1.77 1.28
deaminase activity 18 -1.26 1.14 -1.1 -1.04 -1.01 1.04 -1.06
mannose biosynthetic process 1 -1.31 1.22 1.33 1.17 1.22 -1.88 1.41
inositol catabolic process 1 3.92 -4.04 -3.69 -3.19 -2.14 5.76 -2.59
hexose metabolic process 62 -1.54 -1.05 -1.7 1.0 -1.08 -1.5 -1.54
hexose biosynthetic process 7 -1.14 -1.06 -1.03 -1.11 1.17 1.01 -1.0
hexose catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
pentose metabolic process 5 1.48 1.18 -1.47 1.14 -1.1 -1.06 1.13
phenol-containing compound catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
cysteine biosynthetic process via cystathionine 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
cysteine biosynthetic process 1 1.25 1.1 1.48 -1.98 -7.11 -1.17 2.59
nicotinate nucleotide biosynthetic process 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinate nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nicotinamide nucleotide biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyridine nucleotide metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
pyridine nucleotide biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyridine nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
fatty acid elongation, unsaturated fatty acid 1 -5.51 -5.31 -5.23 -5.58 -5.15 -5.86 15.65
leukotriene biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
glycolipid catabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
fatty acid oxidation 13 -1.06 1.08 -1.52 1.06 1.2 -2.01 -1.29
alditol metabolic process 16 -1.18 1.1 -1.05 1.11 1.01 -1.33 -1.11
alditol catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
allantoin biosynthetic process 1 3.87 -2.08 -2.11 -2.0 -1.26 -1.05 -1.64
removal of superoxide radicals 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
triglyceride biosynthetic process 1 -1.05 1.33 3.49 1.16 1.98 2.09 1.25
triglyceride catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
aromatic compound biosynthetic process 24 1.66 -1.07 -1.13 -1.07 -1.14 1.23 1.24
aromatic compound catabolic process 8 -1.06 -1.01 -1.07 -1.04 -1.14 1.17 -1.07
tryptophan catabolic process to kynurenine 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
4-hydroxyproline metabolic process 15 -1.0 1.02 -1.1 -1.04 -1.12 1.01 -1.04
D-amino acid catabolic process 1 1.5 1.05 1.18 1.45 -1.04 1.27 -1.33
beta-alanine metabolic process 1 1.44 -1.11 -1.15 1.16 -1.17 -1.1 -1.2
beta-alanine biosynthetic process 1 1.44 -1.11 -1.15 1.16 -1.17 -1.1 -1.2
L-methionine salvage from methylthioadenosine 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
peptidyl-proline hydroxylation 15 -1.0 1.02 -1.1 -1.04 -1.12 1.01 -1.04
protein metabolic process 1632 -1.11 -1.03 1.01 1.05 1.08 -1.08 -1.1
arginine catabolic process to glutamate 1 -13.01 1.26 -21.51 1.04 1.21 -8.69 1.74
arginine catabolic process to ornithine 1 1.27 -1.42 -1.22 -1.31 -1.39 3.47 -1.56
glutamate catabolic process to 2-oxoglutarate 2 -1.13 -1.34 1.15 -1.41 1.89 2.28 -2.14
glycerol catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
catechol-containing compound catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
urea metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
organophosphate metabolic process 108 1.04 -1.04 1.02 1.03 1.24 1.03 -1.05
GDP-mannose metabolic process 2 -2.16 1.21 1.23 1.27 1.35 -2.29 1.03
NAD metabolic process 4 1.51 1.15 -1.0 -1.2 1.44 1.73 1.09
choline metabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
protein-cysteine S-palmitoleyltransferase activity 21 -1.12 1.09 1.11 1.11 1.07 -1.16 -1.11
protein-cysteine S-acyltransferase activity 21 -1.12 1.09 1.11 1.11 1.07 -1.16 -1.11
Mo-molybdopterin cofactor metabolic process 5 1.14 1.31 1.37 1.14 1.16 -1.34 1.2
B cell mediated immunity 2 -2.37 1.1 1.16 -1.04 1.34 -1.89 1.24
cellular homeostasis 118 1.06 1.01 1.08 -1.01 1.03 1.15 1.0
antimicrobial humoral response 59 1.29 -1.22 -1.15 -1.21 1.01 1.23 1.27
antibacterial humoral response 22 1.72 -1.69 -1.59 -1.57 -1.23 1.37 1.27
antifungal humoral response 8 4.25 -1.39 -1.37 -1.5 -1.09 3.13 1.41
regulation of isoprenoid metabolic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
secondary metabolic process 53 1.57 -1.09 -1.23 -1.11 -1.05 1.14 1.21
cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte 1 -3.92 1.08 1.44 1.19 1.39 -1.01 -1.05
polyol metabolic process 18 -1.04 -1.02 -1.13 1.01 -1.03 -1.13 -1.13
carboxylic acid metabolic process 239 -1.01 -1.01 -1.15 -1.03 1.0 1.06 -1.05
proteasome core complex, alpha-subunit complex 10 1.29 -1.03 1.04 1.15 1.11 -1.27 -1.17
NEDD8 activating enzyme activity 3 1.18 1.04 1.17 1.22 1.25 -1.07 -1.14
small conjugating protein-specific protease activity 9 1.26 1.18 1.74 1.17 1.51 1.89 1.35
NEDD8-specific protease activity 1 2.27 1.0 1.29 1.04 1.1 1.44 -1.06
small conjugating protein ligase activity 84 1.15 1.18 1.44 1.14 1.34 1.23 1.22
NEDD8 ligase activity 2 -1.0 -1.06 1.71 -1.01 1.42 -1.21 -1.32
SUMO ligase activity 1 1.22 1.25 1.21 1.04 1.21 1.26 1.19
procollagen-proline dioxygenase activity 26 -1.01 -1.0 -1.08 -1.01 -1.13 -1.04 -1.05
tubulin N-acetyltransferase activity 2 1.47 -1.06 1.07 -1.01 1.13 1.11 1.06
oxygen sensor activity 1 -1.13 -1.1 -1.21 -1.08 -1.27 -1.0 -1.19
stem cell maintenance 50 1.1 1.12 1.31 1.12 1.35 1.12 1.22
response to cadmium ion 7 -1.02 1.14 1.52 1.17 1.43 -1.04 1.03
isoprenoid binding 10 1.91 -4.39 -4.6 -2.0 -1.48 1.68 1.12
retinol binding 1 1.33 -27.02 -29.08 -25.07 -1.99 8.32 -2.83
vitamin binding 93 -1.14 -1.23 -1.54 -1.07 -1.09 -1.09 -1.12
rRNA binding 11 1.14 1.1 1.07 1.22 1.14 1.03 -1.12
pyrimidine base biosynthetic process 6 1.66 -1.0 1.02 -1.03 -1.03 1.11 1.08
uracil metabolic process 1 1.44 -1.11 -1.15 1.16 -1.17 -1.1 -1.2
flagellum 7 1.02 1.05 1.0 1.02 -1.02 1.02 1.03
organelle inner membrane 160 1.06 1.05 1.17 1.05 1.11 1.38 -1.22
outer membrane 27 1.24 -1.02 1.15 1.09 1.2 1.39 1.01
protein phosphatase regulator activity 31 1.4 -1.05 1.16 1.02 1.17 1.37 1.12
pteridine metabolic process 5 2.4 -1.22 -1.26 -1.24 -1.16 -1.04 1.7
kinesin binding 7 1.13 1.16 1.23 1.15 1.17 1.39 1.05
axon transport of mitochondrion 3 1.06 1.09 1.22 1.23 1.2 1.22 -1.08
extrinsic to plasma membrane 31 1.23 1.05 1.3 1.05 1.11 1.03 1.06
extrinsic to membrane 45 1.12 1.02 1.14 1.05 1.1 1.06 1.1
kinase binding 30 1.28 1.21 1.48 1.12 1.41 1.31 1.33
protein kinase binding 24 1.38 1.18 1.53 1.14 1.4 1.3 1.3
phosphatase binding 25 1.23 -1.0 1.19 1.06 1.18 1.25 1.15
protein phosphatase binding 25 1.23 -1.0 1.19 1.06 1.18 1.25 1.15
protein domain specific binding 37 1.41 1.06 1.28 1.05 1.2 1.48 1.26
syntaxin binding 3 -1.34 1.02 1.2 1.13 1.16 1.09 1.32
nuclear cyclin-dependent protein kinase holoenzyme complex 7 1.06 1.09 1.22 1.21 1.41 -1.23 -1.12
[pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
mitochondrial pyruvate dehydrogenase (lipoamide) phosphatase complex 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
lipid storage 14 1.31 1.0 1.02 1.14 1.38 1.02 1.12
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine 3 1.19 1.12 1.45 1.13 1.36 1.2 1.09
second-messenger-mediated signaling 22 1.04 1.12 1.05 -1.04 -1.06 1.14 1.04
cAMP-mediated signaling 12 1.11 1.19 1.15 -1.07 1.01 1.19 1.11
cGMP-mediated signaling 1 -1.03 -1.03 -1.03 -1.11 -1.15 1.16 -1.29
cyclic-nucleotide-mediated signaling 13 1.1 1.17 1.14 -1.08 -1.0 1.18 1.08
phosphatidylinositol-mediated signaling 4 -1.13 1.15 1.6 1.12 1.84 1.36 1.05
inositol phosphate-mediated signaling 4 1.12 1.13 1.06 1.07 1.06 1.07 1.09
inositol lipid-mediated signaling 4 -1.13 1.15 1.6 1.12 1.84 1.36 1.05
protein neddylation 3 1.49 1.06 1.55 1.26 1.54 1.44 -1.06
SUMO activating enzyme activity 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
SMT3-dependent protein catabolic process 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
sexual reproduction 596 1.13 1.1 1.22 1.05 1.25 1.21 1.19
translesion synthesis 4 1.17 1.02 1.32 1.08 1.28 1.43 1.07
negative regulation of anti-apoptosis 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
charged-tRNA amino acid modification 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
septate junction assembly 24 2.8 -1.27 1.3 -1.27 1.2 2.89 1.48
diacylglycerol binding 24 1.82 -1.05 1.33 -1.08 1.26 1.8 1.26
heme binding 133 -1.06 -1.16 -1.25 -1.06 -1.02 -1.05 -1.12
spinal cord development 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
spinal cord patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
spinal cord dorsal/ventral patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
telencephalon development 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
medulla oblongata development 2 -1.31 1.27 1.45 1.03 1.47 -1.24 1.48
central nervous system morphogenesis 3 -1.29 1.06 1.02 -1.08 -1.1 -1.62 1.35
central nervous system formation 1 2.75 -1.14 -1.16 -1.07 -1.18 1.11 1.67
nerve development 4 1.97 -1.1 1.31 -1.24 1.47 2.5 1.71
nerve maturation 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
developmental maturation 131 1.17 1.08 1.28 1.04 1.26 1.43 1.24
glial cell fate commitment 3 1.44 1.3 1.68 1.12 1.63 1.5 1.59
glial cell development 20 2.6 -1.18 1.22 -1.13 1.22 1.95 1.32
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
BMP signaling pathway involved in spinal cord dorsal/ventral patterning 1 6.63 -1.06 1.58 -1.04 1.02 3.09 1.27
central nervous system projection neuron axonogenesis 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
central nervous system neuron differentiation 4 -1.09 -1.06 1.3 1.23 1.45 1.03 -1.16
central nervous system neuron development 4 -1.09 -1.06 1.3 1.23 1.45 1.03 -1.16
central nervous system neuron axonogenesis 3 -1.36 -1.18 1.1 1.26 1.32 -1.27 -1.53
anterior commissure morphogenesis 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
neurogenesis 1058 1.13 1.07 1.21 1.08 1.23 1.18 1.13
regulation of rhodopsin mediated signaling pathway 13 1.3 1.02 1.13 1.05 1.11 1.08 1.05
cell cycle process 518 1.19 1.1 1.22 1.11 1.27 1.19 1.09
cell cycle phase 443 1.2 1.1 1.22 1.11 1.26 1.19 1.09
molting cycle process 32 1.34 -1.12 -1.05 -1.15 -1.08 1.23 1.26
regulation of cell-cell adhesion 11 1.5 1.16 1.29 1.11 1.45 1.61 1.51
negative regulation of cell-cell adhesion 8 1.85 1.18 1.27 1.06 1.22 1.87 1.48
positive regulation of cell-cell adhesion 2 1.24 1.07 1.55 1.24 2.26 1.04 1.52
circadian sleep/wake cycle process 17 -1.14 1.18 1.14 -1.02 1.04 1.12 1.16
cellular component disassembly 27 -1.1 1.18 1.3 1.14 1.29 1.09 1.04
cellular process involved in reproduction in multicellular organism 70 1.23 1.09 1.22 1.06 1.2 1.11 1.16
reproductive process 803 1.12 1.07 1.17 1.04 1.2 1.16 1.15
viral reproductive process 3 -1.12 1.07 1.27 -1.16 -1.11 1.69 1.21
chaeta development 83 1.13 1.09 1.31 1.05 1.21 1.1 1.15
digestive system process 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
ovulation cycle process 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
regulation of anatomical structure morphogenesis 194 1.14 1.09 1.33 1.05 1.32 1.28 1.21
regulation of cell morphogenesis 139 1.13 1.12 1.38 1.05 1.36 1.36 1.25
establishment of proximal/distal cell polarity 3 1.72 -1.01 1.03 -1.08 1.97 1.34 1.24
multicellular organism adhesion 11 -1.06 1.01 -1.06 -1.01 -1.12 -1.06 -1.12
multicellular organism adhesion to substrate 11 -1.06 1.01 -1.06 -1.01 -1.12 -1.06 -1.12
biological adhesion 172 1.2 -1.06 1.06 -1.06 1.19 1.34 1.23
dormancy process 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
gland morphogenesis 122 1.06 1.0 1.13 1.04 1.25 1.23 1.18
ribonucleoprotein complex biogenesis 81 1.26 1.15 1.26 1.26 1.3 1.14 1.07
DNA strand elongation 3 -1.21 -1.08 1.4 1.14 1.61 -1.08 -1.25
extracellular matrix disassembly 3 -2.47 1.3 1.22 1.11 1.41 -1.09 1.18
ribonucleoprotein complex assembly 33 1.24 1.13 1.29 1.19 1.29 1.24 1.1
proteasome accessory complex 25 1.35 1.08 1.25 1.18 1.19 1.07 1.06
cytosolic ribosome 83 1.38 1.02 1.1 1.01 1.14 1.19 1.07
passive transmembrane transporter activity 217 1.02 1.0 -1.01 -1.05 -1.07 1.03 -1.01
active transmembrane transporter activity 330 -1.26 -1.06 -1.28 -1.12 -1.06 1.14 -1.11
substrate-specific transmembrane transporter activity 609 -1.14 -1.03 -1.14 -1.09 -1.07 1.09 -1.07
potassium ion symporter activity 5 -1.79 -1.85 -2.57 -1.19 1.65 1.54 1.09
potassium ion antiporter activity 5 -1.42 1.17 -1.18 1.1 -1.14 -1.59 -1.02
copper-transporting ATPase activity 1 -2.22 1.33 3.02 1.07 -1.16 -1.12 1.08
wide pore channel activity 7 -1.65 -1.07 -1.04 -1.07 -1.24 -1.19 1.29
voltage-gated channel activity 44 1.07 -1.01 1.02 -1.09 -1.09 1.15 -1.09
mechanically gated channel activity 1 -1.05 1.0 -1.06 -1.03 -1.14 1.01 1.95
ligand-gated channel activity 108 1.02 1.0 -1.0 -1.08 -1.14 1.0 -1.02
gated channel activity 149 1.05 1.0 1.02 -1.05 -1.09 1.03 -1.02
substrate-specific channel activity 210 1.03 1.0 -1.0 -1.05 -1.07 1.04 -1.01
ion gated channel activity 3 -1.25 -1.55 1.25 1.49 -1.39 -1.46 -1.49
voltage-gated cation channel activity 35 1.13 -1.03 1.01 -1.13 -1.12 1.09 -1.13
macromolecule transmembrane transporter activity 33 1.03 1.14 1.21 1.1 1.12 1.16 -1.01
inorganic cation transmembrane transporter activity 219 -1.22 -1.02 -1.2 -1.15 -1.13 1.1 -1.15
substrate-specific transporter activity 669 -1.12 -1.02 -1.12 -1.08 -1.06 1.1 -1.06
regulation of transmembrane transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
neurotransmitter receptor activity 51 1.09 -1.06 1.03 -1.05 -1.03 1.12 -1.01
cellular response to amino acid stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
termination of signal transduction 9 1.61 1.14 1.6 1.12 1.38 1.47 1.34
paracrine signaling 3 -1.1 1.05 1.09 1.11 1.21 -1.07 1.08
cellular response to stress 329 1.18 1.1 1.23 1.1 1.28 1.2 1.12
signaling 1219 1.14 1.03 1.15 1.03 1.17 1.18 1.11
cellular response to chemical stimulus 143 1.16 1.06 1.21 1.05 1.2 1.2 1.12
regulation of signaling 409 1.15 1.12 1.28 1.06 1.24 1.27 1.22
cellular response to mechanical stimulus 1 -1.7 -15.86 -19.15 -19.05 -4.94 3.57 1.25
positive regulation of signaling 85 1.13 1.11 1.24 1.05 1.27 1.19 1.24
negative regulation of signaling 149 1.2 1.1 1.31 1.06 1.27 1.32 1.25
adaptation of signaling pathway 4 -1.08 1.14 1.07 1.08 1.11 -1.0 -1.04
signal release 101 -1.07 1.04 1.24 1.13 1.26 1.1 1.03
cellular cation homeostasis 29 1.01 1.02 1.39 -1.05 -1.07 1.29 1.04
cellular monovalent inorganic cation homeostasis 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
cellular divalent inorganic cation homeostasis 11 1.74 1.02 1.47 -1.09 -1.04 1.57 1.16
TRAPP complex 3 1.9 1.04 1.48 1.37 1.5 1.53 1.03
maintenance of cell polarity 12 -1.07 1.19 1.56 1.06 1.35 1.28 1.22
CCR4-NOT complex 7 1.25 1.15 1.58 1.15 1.35 1.67 1.21
myofibril 29 2.16 -1.42 -1.09 -1.18 1.24 1.83 -1.17
sarcomere 28 2.2 -1.44 -1.09 -1.19 1.26 1.88 -1.18
Z disc 19 1.85 -1.41 -1.18 -1.11 1.31 1.7 -1.14
extracellular matrix binding 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
lamellipodium 1 -1.44 1.23 1.5 1.23 1.55 1.34 1.29
actin filament-based process 163 1.17 1.03 1.35 -1.03 1.3 1.31 1.17
cell projection organization 408 1.12 1.08 1.23 1.04 1.24 1.23 1.23
cell projection assembly 64 -1.14 1.06 1.16 1.07 1.16 1.01 1.05
lamellipodium assembly 7 1.05 1.14 1.49 1.08 1.51 1.25 1.41
microvillar actin bundle assembly 1 -2.22 -1.56 -1.05 -1.91 -2.01 -2.21 7.0
actin filament reorganization involved in cell cycle 3 -1.25 1.17 1.3 1.13 1.1 -1.42 -1.1
contractile actin filament bundle assembly 1 2.13 1.0 -1.14 -1.14 1.0 1.74 1.58
cell junction 105 1.39 -1.0 1.25 -1.05 1.25 1.62 1.33
cell-substrate junction 22 1.32 1.08 1.37 1.01 1.39 1.3 1.26
desmosome 1 1.71 1.23 1.34 1.26 1.67 -1.28 -1.04
L-malate dehydrogenase activity 2 -1.06 -1.01 1.02 -1.02 -1.07 1.05 -1.04
mitochondrial crista 1 1.79 1.07 1.12 1.18 1.43 1.54 -1.19
mitochondrial tricarboxylic acid cycle enzyme complex 5 1.01 -1.02 1.12 -1.1 1.02 1.43 -1.32
regulation of mitotic metaphase/anaphase transition 22 1.12 1.08 1.16 1.15 1.3 1.05 -1.0
protein repair 1 2.93 1.03 1.2 1.19 1.05 1.97 1.02
hemopoiesis 41 1.12 1.09 1.4 1.05 1.34 1.25 1.41
regulation of endocytosis 16 1.17 1.02 1.49 1.1 1.26 1.72 1.22
water homeostasis 2 -1.06 -1.23 1.57 -1.02 -2.03 1.99 1.2
regulation of Wnt receptor signaling pathway 46 1.23 1.14 1.25 1.09 1.25 1.37 1.32
membrane coat 25 -1.02 1.18 1.24 1.13 1.15 1.19 1.33
clathrin coat 12 -1.14 1.2 1.34 1.14 1.23 1.23 1.26
vesicle coat 14 -1.23 1.19 1.13 1.12 1.05 1.13 1.37
AP-3 adaptor complex 1 1.85 1.2 1.21 1.06 1.07 1.4 1.37
clathrin vesicle coat 4 -1.28 1.18 1.41 1.09 1.26 1.54 1.36
COPII vesicle coat 1 1.02 1.56 2.15 1.06 2.07 2.36 2.5
clathrin coat of synaptic vesicle 1 -1.18 1.22 1.63 -1.04 1.48 2.58 1.85
clathrin coat of trans-Golgi network vesicle 3 -1.23 1.16 1.44 1.05 1.28 1.6 1.31
clathrin adaptor complex 9 -1.11 1.2 1.31 1.16 1.2 1.14 1.2
clathrin coat of coated pit 2 -1.13 1.16 1.51 1.02 1.41 1.68 1.45
coated vesicle 76 1.02 1.11 1.19 1.09 1.21 1.14 1.2
clathrin-coated vesicle 62 1.02 1.11 1.23 1.08 1.25 1.15 1.16
trans-Golgi network transport vesicle 6 -1.41 1.21 1.34 1.14 1.2 1.25 1.25
manganese ion binding 18 -1.13 1.08 -1.01 1.1 1.02 -1.14 -1.09
sphingolipid biosynthetic process 7 -1.12 1.12 1.25 -1.02 1.07 -1.09 1.53
sphingolipid catabolic process 7 -6.83 -3.3 -2.99 1.5 -1.08 -6.52 -5.81
molybdenum ion binding 3 -1.62 1.26 -1.41 1.36 -1.14 -1.63 -1.18
cell differentiation 1609 1.15 1.07 1.19 1.06 1.21 1.19 1.12
regulation of cell adhesion 16 1.49 1.13 1.37 1.1 1.52 1.6 1.42
protein xylosyltransferase activity 1 1.17 1.3 1.39 1.35 1.31 1.22 1.24
receptor signaling complex scaffold activity 2 1.19 1.14 1.28 -1.02 1.24 1.13 1.22
regulation of proteolysis 37 1.34 1.07 1.14 1.08 1.15 1.29 1.22
protein catabolic process 123 1.15 1.11 1.28 1.14 1.26 1.07 1.08
PDZ domain binding 5 1.3 1.06 1.19 -1.03 1.16 1.22 1.15
proteoglycan biosynthetic process 17 1.25 1.14 1.21 1.06 1.15 1.25 1.53
pyridoxal phosphate binding 40 1.01 1.02 -1.27 -1.04 -1.03 -1.02 1.04
integral to Golgi membrane 5 1.35 1.04 -1.19 1.04 1.29 1.43 1.52
filopodium 4 1.02 1.09 1.65 -1.04 1.56 1.24 1.53
integral to endoplasmic reticulum membrane 10 -1.46 1.11 1.14 1.2 1.05 -1.72 -1.17
positive regulation of Wnt receptor signaling pathway 14 1.4 1.13 1.25 1.11 1.22 1.24 1.36
negative regulation of Wnt receptor signaling pathway 21 1.2 1.09 1.17 1.1 1.24 1.55 1.3
neuron differentiation 458 1.15 1.09 1.26 1.04 1.27 1.27 1.24
extracellular matrix organization 25 -1.06 1.03 1.16 -1.04 1.09 -1.05 1.22
heparan sulfate proteoglycan metabolic process 12 1.32 1.18 1.4 1.15 1.27 1.3 1.26
heparin metabolic process 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
glycosaminoglycan metabolic process 24 1.12 -1.18 -1.02 1.02 -1.21 -1.06 1.02
chondroitin sulfate metabolic process 7 1.31 1.13 1.16 1.13 1.24 1.3 1.08
chondroitin sulfate biosynthetic process 7 1.31 1.13 1.16 1.13 1.24 1.3 1.08
heparin biosynthetic process 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
semaphorin receptor binding 2 -1.18 -1.21 1.16 -1.17 1.87 1.3 1.34
lipoprotein particle receptor activity 11 1.16 1.12 1.24 -1.03 -1.04 1.29 1.1
enzyme regulator activity 311 1.18 -1.04 1.06 -1.06 1.1 1.22 1.12
female sex determination 10 1.73 1.13 1.2 1.13 1.18 1.32 1.12
male sex determination 2 2.22 1.29 1.1 1.16 1.11 -1.15 1.06
myofibril assembly 27 2.23 -1.17 1.24 -1.18 1.21 1.85 1.04
skeletal muscle thin filament assembly 2 3.07 -1.51 -1.03 -1.18 1.0 1.63 -1.62
skeletal muscle myosin thick filament assembly 4 2.6 -1.28 1.1 -1.18 1.07 1.9 -1.04
polysaccharide binding 116 -1.88 -1.54 -1.66 -1.39 -1.53 -1.88 1.19
guanylate cyclase regulator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
guanylate cyclase activator activity 1 4.81 -1.03 -1.02 1.21 1.81 1.05 1.23
lipid modification 43 1.21 1.09 -1.03 1.03 1.31 1.05 1.06
lipid glycosylation 1 1.27 1.12 -1.0 1.34 1.08 1.05 -1.38
entry into host cell 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
chromosome condensation 38 1.16 1.12 1.26 1.12 1.35 1.24 1.15
apoptotic nuclear change 3 1.86 1.09 1.48 1.14 1.43 1.6 1.67
glyoxylate reductase (NADP) activity 2 -4.26 1.85 -1.64 1.04 -1.41 -1.97 -1.08
5-formyltetrahydrofolate cyclo-ligase activity 2 -1.02 1.01 1.07 1.18 1.07 1.18 -1.17
clathrin binding 3 -1.33 1.27 1.39 1.12 1.36 1.07 1.24
integral to synaptic vesicle membrane 3 1.11 1.05 1.2 1.05 1.1 1.09 1.09
dynein complex 40 -1.02 1.05 1.06 1.02 -1.01 1.01 -1.05
outer membrane-bounded periplasmic space 9 1.87 -1.07 1.01 -1.1 -1.04 1.24 -1.01
protein phosphatase 4 complex 1 -1.33 1.33 1.64 1.24 1.24 1.44 1.37
protein serine/threonine kinase inhibitor activity 4 1.69 1.03 1.25 1.04 1.29 1.67 1.38
protein tyrosine kinase inhibitor activity 1 1.36 1.39 1.33 -1.1 1.25 1.42 1.59
protein kinase activator activity 5 1.59 1.12 1.23 1.13 1.26 1.27 1.08
protein tyrosine kinase activator activity 3 1.95 1.11 1.44 1.07 1.38 1.82 1.28
cholesterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
positive regulation of cell growth 16 1.03 1.18 1.5 1.1 1.49 1.39 1.32
negative regulation of cell growth 9 1.27 1.11 1.45 1.06 1.45 1.67 1.24
external encapsulating structure 31 1.33 -1.01 -1.0 1.0 -1.04 -1.02 -1.02
cell envelope 11 1.96 -1.06 1.02 -1.08 -1.01 1.22 1.03
junctional membrane complex 1 2.03 -1.16 -1.04 -1.08 -1.05 1.25 1.07
sperm motility 9 -1.26 1.06 1.05 1.04 1.04 -1.0 -1.05
stabilization of membrane potential 2 1.77 1.24 2.44 -1.13 1.42 2.96 1.8
DNA damage response, signal transduction by p53 class mediator 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
cyclin binding 6 1.08 1.2 1.43 1.19 1.34 -1.04 1.0
regulation of cell migration 10 2.17 -1.1 1.06 -1.11 1.21 1.34 1.71
negative regulation of cell migration 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
DNA polymerase processivity factor activity 2 -1.29 1.09 1.33 1.22 1.3 -1.6 -1.28
iron-responsive element binding 2 1.36 1.24 1.32 -1.06 1.1 1.69 1.16
translation repressor activity 10 1.56 1.06 1.57 1.02 1.3 1.21 1.77
ligand-dependent nuclear receptor transcription coactivator activity 3 1.32 1.16 1.48 1.23 1.62 1.33 1.22
chorion-containing eggshell pattern formation 8 1.93 1.01 1.22 1.01 1.3 1.72 1.37
sperm mitochondrion organization 5 1.07 1.08 1.53 1.1 1.13 1.48 -1.14
symbiosis, encompassing mutualism through parasitism 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
membrane disassembly 3 1.03 1.27 1.04 1.1 -1.14 -1.28 1.1
defecation 1 1.59 -1.18 -1.24 -1.07 -1.14 4.1 -1.27
production of siRNA involved in RNA interference 8 1.41 1.15 1.49 1.04 1.38 1.34 1.32
targeting of mRNA for destruction involved in RNA interference 4 1.09 1.13 1.5 1.03 1.41 1.21 1.37
axon 64 1.18 1.07 1.23 -1.05 1.23 1.51 1.31
dendrite 39 1.09 1.05 1.22 1.05 1.15 1.21 1.12
growth cone 8 1.23 1.14 1.47 1.06 1.36 1.38 1.21
site of polarized growth 8 1.23 1.14 1.47 1.06 1.36 1.38 1.21
sleep 24 1.02 1.2 1.17 1.06 1.06 1.1 1.2
peristalsis 1 1.69 1.43 1.3 1.01 1.12 1.63 -1.01
ER-associated protein catabolic process 5 1.01 1.28 -1.09 1.11 -1.01 -1.06 1.46
nuclear migration along microtubule 1 2.24 -1.02 -1.01 1.05 1.3 1.83 1.39
actin cap 1 1.67 1.22 2.78 1.16 2.89 2.99 1.93
tRNA methylation 2 1.26 1.07 -1.2 1.26 1.13 -1.1 -1.17
midbody 13 1.0 1.04 1.38 1.14 1.39 -1.01 1.0
fatty acid elongation 3 1.23 -2.04 -1.81 -2.67 -2.07 -1.23 3.6
ankyrin binding 2 -1.35 1.17 1.37 -1.02 1.05 1.36 1.56
spectrin binding 2 2.03 1.57 2.46 1.05 2.04 3.15 3.44
BMP signaling pathway 11 1.35 1.07 1.35 1.04 1.18 1.02 1.19
regulation of BMP signaling pathway 13 -1.0 1.15 1.18 1.21 1.31 -1.14 1.09
positive regulation of transforming growth factor beta receptor signaling pathway 1 2.13 -1.08 1.11 -1.24 -1.05 1.06 1.61
negative regulation of transforming growth factor beta receptor signaling pathway 6 1.52 1.09 1.44 -1.04 1.19 1.36 1.28
positive regulation of BMP signaling pathway 2 -1.03 1.19 -1.01 1.09 1.24 -1.15 1.05
negative regulation of BMP signaling pathway 6 -1.26 1.23 1.3 1.36 1.55 -1.44 1.09
snoRNA binding 5 1.02 1.09 1.38 1.3 1.36 -1.14 -1.0
regulation of axon extension 7 -1.17 1.19 1.37 1.14 1.29 1.18 1.05
negative regulation of axon extension 3 -1.29 1.15 1.64 1.15 1.3 -1.22 -1.1
intracellular steroid hormone receptor signaling pathway 8 1.35 1.22 1.56 1.09 1.48 1.56 1.37
intracellular receptor mediated signaling pathway 12 1.17 1.24 1.48 1.1 1.54 1.37 1.29
dihydrolipoamide S-acyltransferase activity 2 1.46 1.31 1.81 -1.03 1.35 2.15 1.15
male genitalia development 16 1.31 1.09 1.3 1.05 1.18 1.05 1.22
female genitalia development 6 1.5 1.12 1.14 1.04 1.07 1.14 1.13
receptor regulator activity 3 1.55 1.1 1.06 1.1 1.12 1.11 1.09
receptor activator activity 1 1.23 1.27 1.15 1.19 1.2 1.15 1.07
receptor inhibitor activity 2 1.75 1.03 1.01 1.06 1.08 1.1 1.1
cyclic nucleotide binding 2 -1.42 -1.32 -1.55 -1.36 -1.51 4.6 1.1
adenyl nucleotide binding 654 1.06 1.1 1.17 1.09 1.22 1.18 1.09
rRNA modification guide activity 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
RNA pseudouridylation guide activity 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
rRNA pseudouridylation guide activity 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
phosphatidyltransferase activity 1 1.31 1.29 1.34 1.27 1.36 1.03 -1.44
nuclear body organization 2 -1.19 1.31 1.94 1.17 1.95 1.12 1.41
Cajal body organization 1 -1.52 1.47 1.59 1.32 1.75 -1.53 1.07
quinone cofactor methyltransferase activity 2 -1.09 1.1 1.25 1.35 1.18 1.22 -1.29
[methionine synthase] reductase activity 1 1.59 1.02 1.27 1.16 1.58 1.37 1.04
pseudocleavage 8 1.05 1.14 1.52 1.06 1.52 1.39 1.23
pseudocleavage involved in syncytial blastoderm formation 8 1.05 1.14 1.52 1.06 1.52 1.39 1.23
U1 snRNA binding 2 1.15 1.06 1.1 1.32 1.06 1.17 -1.28
U2 snRNA binding 1 1.41 -1.11 1.3 1.34 1.31 1.54 -1.14
U4 snRNA binding 1 1.3 1.4 1.21 1.52 1.46 1.03 1.12
regulation of cellular pH 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
beta-lactam antibiotic metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
beta-lactam antibiotic biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
cytoplasmic vesicle membrane 19 -1.14 1.1 1.06 1.04 1.1 1.17 1.23
Golgi-associated vesicle membrane 12 -1.24 1.16 1.06 1.12 -1.01 1.05 1.29
coated vesicle membrane 19 -1.14 1.1 1.06 1.04 1.1 1.17 1.23
COPI coated vesicle membrane 9 -1.24 1.16 -1.05 1.14 -1.11 -1.1 1.28
clathrin coated vesicle membrane 9 -1.07 1.0 1.1 -1.06 1.25 1.39 1.09
endocytic vesicle membrane 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
clathrin-coated endocytic vesicle membrane 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
synaptic vesicle membrane 5 1.15 -1.2 -1.07 -1.2 1.32 1.44 -1.03
axolemma 1 -1.08 -1.3 -1.04 1.04 1.56 8.15 2.89
Rac guanyl-nucleotide exchange factor activity 1 1.08 -1.14 -1.07 -1.55 -1.02 9.19 -1.47
ribonuclease P complex 2 1.64 1.07 1.01 1.46 1.23 -1.08 -1.15
multimeric ribonuclease P complex 1 1.84 1.03 1.1 1.42 1.17 1.05 -1.14
preribosome 5 1.04 1.05 1.31 1.3 1.34 1.02 1.07
preribosome, small subunit precursor 1 1.41 1.31 1.41 1.25 1.47 1.04 1.34
GTPase regulator activity 122 1.05 1.14 1.35 1.03 1.25 1.23 1.19
chromatin silencing at centromere 1 1.04 -1.03 1.41 1.25 1.4 1.24 -1.08
eggshell formation 78 1.18 1.1 1.22 1.06 1.23 1.11 1.17
vitelline membrane formation 12 1.14 1.01 -1.05 -1.02 -1.08 1.01 -1.0
cytoskeleton-dependent intracellular transport 28 -1.03 1.2 1.26 1.11 1.22 1.23 1.11
germarium-derived oocyte differentiation 23 1.09 1.17 1.19 1.1 1.16 1.23 1.19
ovarian follicle cell development 187 1.09 1.13 1.29 1.07 1.3 1.15 1.19
germarium-derived female germ-line cyst encapsulation 9 1.21 1.23 1.43 1.1 1.5 1.55 1.38
border follicle cell delamination 3 1.2 1.5 1.32 1.16 1.13 2.96 1.24
regulation of border follicle cell delamination 1 3.22 -1.06 2.29 -1.13 1.79 4.58 1.49
ovarian follicle cell stalk formation 16 -1.03 1.22 1.34 1.13 1.46 1.2 1.15
anterior/posterior axis specification, follicular epithelium 1 8.32 -1.09 1.22 1.02 1.27 3.95 1.61
oocyte fate determination 22 1.1 1.16 1.25 1.08 1.23 1.33 1.24
karyosome formation 21 1.16 1.07 1.12 1.15 1.26 1.08 1.12
germ-line stem cell maintenance 36 -1.0 1.11 1.27 1.1 1.34 1.06 1.14
P granule organization 3 2.26 1.16 2.01 1.13 1.7 2.29 1.38
oocyte localization involved in germarium-derived egg chamber formation 13 -1.17 1.14 1.37 1.1 1.6 1.17 1.26
spectrosome organization 3 -1.62 1.17 1.61 1.01 1.24 1.17 1.31
establishment of oocyte nucleus localization involved in oocyte dorsal/ventral axis specification 7 1.43 1.14 1.16 1.14 1.19 1.51 1.04
ovarian fusome organization 6 1.09 1.08 1.09 1.13 1.4 1.4 1.34
germline ring canal formation 11 1.15 1.08 1.31 1.05 1.36 1.36 1.33
male germline ring canal formation 1 1.93 1.13 1.83 -1.03 2.06 4.41 1.79
germarium-derived female germ-line cyst formation 10 -1.08 1.02 1.11 1.01 1.24 1.43 1.14
ovulation 4 1.89 -1.58 -1.76 -1.74 -1.47 1.25 -1.0
sequestering of triglyceride 5 1.07 1.21 1.1 1.17 1.11 1.16 1.09
regulation of cyclic nucleotide metabolic process 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of cyclic nucleotide metabolic process 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of cyclic nucleotide metabolic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of cyclic nucleotide biosynthetic process 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of cyclic nucleotide biosynthetic process 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of cyclic nucleotide biosynthetic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of nucleotide biosynthetic process 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of nucleotide biosynthetic process 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of nucleotide biosynthetic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of nucleotide catabolic process 43 1.08 1.16 1.36 1.06 1.3 1.31 1.21
regulation of cAMP metabolic process 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of cAMP metabolic process 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of cAMP metabolic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of cAMP biosynthetic process 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of cAMP biosynthetic process 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of cAMP biosynthetic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of actin filament polymerization 15 -1.69 1.07 1.43 1.05 1.39 -1.34 1.16
regulation of actin filament depolymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
negative regulation of actin filament depolymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
negative regulation of actin filament polymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of actin filament polymerization 6 -1.15 1.12 1.25 -1.02 1.29 -1.11 1.29
inhibition of phospholipase C activity involved in G-protein coupled receptor signaling pathway 2 -1.21 1.05 -1.16 1.19 -1.24 -1.13 -1.15
epithelial cell differentiation 29 1.27 1.07 1.39 1.01 1.31 1.36 1.32
regulation of epithelial cell differentiation 1 2.56 -1.26 -1.08 -1.5 1.05 6.9 -1.01
positive regulation of epithelial cell differentiation 1 2.56 -1.26 -1.08 -1.5 1.05 6.9 -1.01
polarized epithelial cell differentiation 7 1.7 1.04 1.19 -1.07 1.56 1.4 1.47
cortical cytoskeleton 9 -1.53 1.16 1.66 1.07 1.5 1.1 1.12
cortical actin cytoskeleton 5 -1.47 1.27 2.09 1.06 1.65 1.57 1.46
cortical cytoskeleton organization 14 -1.11 1.14 1.62 1.14 1.46 -1.07 1.15
cortical actin cytoskeleton organization 11 -1.18 1.16 1.79 1.14 1.58 -1.08 1.2
rough endoplasmic reticulum membrane 12 -1.63 1.34 -1.12 1.02 -1.3 -1.73 1.28
Mre11 complex 1 1.57 1.18 2.73 1.11 1.99 2.12 1.59
RNA polymerase complex 23 1.32 1.14 1.23 1.25 1.26 1.12 1.07
VCB complex 1 2.69 1.18 1.72 1.15 -1.01 -1.18 -1.08
replisome 11 1.14 1.11 1.17 1.2 1.33 1.04 -1.23
actin-dependent ATPase activity 2 -1.22 1.77 3.71 -1.0 2.23 2.34 2.03
forebrain development 2 -1.33 -1.42 -1.06 1.28 1.22 -1.65 -2.16
hindbrain development 2 -1.31 1.27 1.45 1.03 1.47 -1.24 1.48
retromer complex 2 1.62 1.07 1.77 1.2 1.41 1.97 1.23
protein splicing 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
sheet-forming collagen 2 1.15 -1.7 -1.07 -1.48 -1.42 2.42 -1.33
endoplasmic reticulum signal peptide binding 1 1.36 1.21 -1.06 1.16 -1.01 -1.2 1.16
establishment or maintenance of microtubule cytoskeleton polarity 37 1.09 1.2 1.47 1.08 1.38 1.52 1.25
establishment or maintenance of cytoskeleton polarity 37 1.09 1.2 1.47 1.08 1.38 1.52 1.25
astral microtubule organization 2 1.07 1.11 1.15 1.21 1.27 1.05 1.05
potassium ion binding 7 1.18 1.01 1.0 -1.0 -1.04 1.2 -1.0
NADH dehydrogenase complex 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
ER-nuclear sterol response pathway 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
endoplasmic reticulum unfolded protein response 1 -1.05 1.27 -1.17 -1.24 -1.49 -1.01 1.19
thiamine pyrophosphate transport 1 1.18 1.26 -1.06 1.24 -1.11 -1.61 1.34
thiamine pyrophosphate binding 3 -3.01 1.15 -1.69 1.18 1.27 -2.15 -1.66
cortical microtubule cytoskeleton 1 -1.44 1.19 -1.03 1.43 1.32 -1.27 -1.21
mismatched DNA binding 4 1.52 1.1 1.22 1.23 1.58 1.11 -1.01
regulation of centriole-centriole cohesion 1 2.67 1.08 1.26 1.12 2.08 1.82 1.58
response to caffeine 4 1.2 1.25 -1.32 -1.41 -1.17 1.21 1.42
filamin binding 1 2.75 1.01 2.14 1.09 1.93 1.21 1.34
ISWI complex 5 1.15 1.22 1.63 1.19 1.59 1.56 1.32
Ino80 complex 8 -1.11 1.07 1.14 1.13 1.24 -1.05 -1.02
extracellular matrix 65 1.16 -1.04 1.03 -1.11 1.03 1.19 -1.0
microtubule organizing center organization 110 1.16 1.09 1.19 1.09 1.24 1.12 1.07
actomyosin structure organization 47 1.76 -1.18 1.14 -1.18 1.17 1.52 1.04
myosin filament organization 6 1.72 -1.12 1.39 -1.09 1.33 1.39 1.1
myosin filament assembly 6 1.72 -1.12 1.39 -1.09 1.33 1.39 1.1
myosin II filament assembly 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
myosin II filament organization 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
gene silencing by RNA 41 1.1 1.05 1.18 1.09 1.27 1.3 1.1
chromatin silencing by small RNA 2 1.38 1.18 -1.01 1.15 1.25 2.63 1.7
dsRNA fragmentation 11 1.46 1.17 1.45 1.09 1.32 1.46 1.31
primary miRNA processing 2 1.34 1.2 1.3 1.21 1.21 1.82 1.22
pre-miRNA processing 4 1.68 1.08 1.58 -1.04 1.19 1.45 1.4
regulation of histone modification 9 1.21 1.16 1.45 1.22 1.51 1.41 1.3
negative regulation of histone modification 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
positive regulation of histone modification 4 1.11 1.17 1.59 1.27 1.57 1.16 1.28
regulation of histone methylation 3 -1.02 1.15 1.32 1.21 1.25 1.37 1.13
positive regulation of histone methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
regulation of histone deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
positive regulation of histone deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
cysteine desulfurase activity 1 1.7 1.2 1.13 1.08 -1.16 -1.08 1.29
nuclear pore distribution 1 1.83 -1.06 1.02 1.15 1.17 1.57 -1.03
BLOC complex 6 1.36 1.17 1.47 1.26 1.26 1.6 -1.09
BLOC-1 complex 6 1.36 1.17 1.47 1.26 1.26 1.6 -1.09
organelle membrane 349 1.02 1.08 1.15 1.06 1.12 1.24 -1.04
stress-activated protein kinase signaling cascade 29 1.02 1.15 1.45 1.1 1.49 1.28 1.37
regeneration 11 -1.06 -1.0 1.1 -1.11 1.08 1.32 1.38
neuron projection regeneration 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
axon regeneration 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
septin complex 6 -1.44 1.09 1.11 1.19 1.4 -1.24 1.03
septin ring organization 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
microtubule polymerization or depolymerization 5 1.02 1.15 1.12 1.21 1.35 1.08 1.04
regulation of microtubule polymerization or depolymerization 19 1.09 1.15 1.37 1.05 1.35 1.41 1.25
negative regulation of microtubule polymerization or depolymerization 15 1.06 1.15 1.48 1.04 1.41 1.59 1.26
positive regulation of microtubule polymerization or depolymerization 3 1.06 1.09 1.14 1.01 1.16 1.07 1.17
regulation of microtubule polymerization 2 1.39 -1.03 1.05 -1.01 1.01 -1.16 1.04
regulation of microtubule depolymerization 17 1.06 1.18 1.41 1.05 1.4 1.5 1.28
positive regulation of microtubule polymerization 2 1.39 -1.03 1.05 -1.01 1.01 -1.16 1.04
positive regulation of microtubule depolymerization 1 -1.6 1.37 1.36 1.04 1.54 1.63 1.47
rRNA pseudouridine synthesis 2 1.38 1.09 1.14 1.35 1.29 -1.02 -1.04
snRNA pseudouridine synthesis 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
cytoplasmic microtubule organization 15 1.2 1.09 1.19 1.18 1.22 1.27 -1.01
RNA 3'-end processing 29 1.37 1.09 1.31 1.15 1.34 1.62 1.18
mRNA 3'-end processing 27 1.4 1.1 1.31 1.15 1.35 1.67 1.18
sister chromatid biorientation 1 1.13 1.05 -1.04 1.47 1.34 -1.18 -1.11
proteasome localization 1 2.41 1.38 1.34 1.27 1.62 1.86 1.17
anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process 4 1.26 1.09 1.04 1.07 1.05 -1.03 -1.01
metallo-sulfur cluster assembly 7 1.2 1.16 1.26 1.15 1.02 1.28 -1.07
rRNA methylation 1 1.49 1.34 1.76 1.04 1.9 2.28 1.25
neuron projection development 326 1.14 1.09 1.25 1.03 1.26 1.25 1.26
phosphopantetheine binding 4 -2.32 -1.22 -1.89 1.2 1.1 -1.46 -1.99
peptide modification 1 2.74 1.3 1.75 1.08 1.98 1.97 2.28
POZ domain binding 1 1.78 1.16 2.67 1.12 2.53 3.19 2.15
endoplasmic reticulum palmitoyltransferase complex 1 -1.92 1.11 2.34 1.27 1.64 -1.44 -1.26
RSF complex 2 1.1 1.15 1.49 -1.01 1.37 1.36 1.37
auditory behavior 1 -1.09 1.11 1.03 1.13 -1.08 1.11 -1.0
intrinsic to membrane 1136 -1.03 -1.03 -1.04 -1.04 -1.01 1.02 1.0
intrinsic to plasma membrane 198 1.09 -1.05 -1.0 -1.04 -1.0 1.06 1.06
intrinsic to endoplasmic reticulum membrane 20 -1.13 1.18 1.26 1.14 1.28 -1.24 1.07
intrinsic to Golgi membrane 5 1.35 1.04 -1.19 1.04 1.29 1.43 1.52
intrinsic to nuclear inner membrane 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
intrinsic to peroxisomal membrane 5 1.37 1.29 -1.51 1.15 1.08 -1.33 -1.13
extrinsic to internal side of plasma membrane 18 1.39 1.11 1.42 1.06 1.22 1.03 1.1
external side of cell outer membrane 1 5.43 -1.29 -1.04 -1.06 1.21 1.62 1.41
protein acetyltransferase complex 1 2.72 1.09 2.08 1.56 2.05 2.2 1.21
cell leading edge 10 1.31 1.13 1.5 1.03 1.41 1.43 1.48
cell projection membrane 4 -1.03 1.05 1.14 1.11 1.34 1.84 1.38
leading edge membrane 2 -1.25 -1.03 1.2 1.13 1.56 3.31 1.93
lamellipodium membrane 1 -1.44 1.23 1.5 1.23 1.55 1.34 1.29
Ndc80 complex 7 1.37 1.01 1.12 1.26 1.43 1.16 -1.13
small GTPase binding 26 1.1 1.19 1.47 1.12 1.32 1.31 1.35
regulation of cyclase activity 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
negative regulation of cyclase activity 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of cyclase activity 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
retinal ganglion cell axon guidance 11 1.15 1.11 1.28 1.05 1.21 1.18 1.12
intrinsic to organelle membrane 38 1.02 1.11 1.12 1.13 1.26 -1.1 1.02
integral to organelle membrane 28 -1.02 1.06 1.03 1.14 1.16 -1.18 -1.09
intrinsic to mitochondrial inner membrane 1 -1.27 1.34 1.46 1.01 -1.06 2.1 -1.33
integral to mitochondrial inner membrane 1 -1.27 1.34 1.46 1.01 -1.06 2.1 -1.33
intrinsic to mitochondrial outer membrane 1 1.09 1.16 1.56 1.4 1.39 1.34 -1.11
integral to mitochondrial outer membrane 1 1.09 1.16 1.56 1.4 1.39 1.34 -1.11
regulation of cellular metabolic process 989 1.17 1.09 1.19 1.06 1.18 1.19 1.14
negative regulation of cellular metabolic process 253 1.16 1.07 1.18 1.05 1.21 1.19 1.14
positive regulation of cellular metabolic process 273 1.17 1.04 1.14 1.02 1.14 1.21 1.18
regulation of cellular biosynthetic process 770 1.16 1.07 1.16 1.05 1.17 1.16 1.13
negative regulation of cellular biosynthetic process 219 1.16 1.07 1.18 1.04 1.23 1.2 1.14
positive regulation of cellular biosynthetic process 251 1.16 1.03 1.12 1.02 1.13 1.2 1.17
regulation of cellular catabolic process 68 1.17 1.13 1.25 1.07 1.22 1.25 1.16
negative regulation of cellular catabolic process 7 -1.14 1.23 -1.01 1.15 -1.01 -1.46 1.01
positive regulation of cellular catabolic process 7 1.19 1.14 1.23 1.17 1.1 1.13 1.03
RNAi effector complex 7 -1.01 1.19 1.52 1.03 1.34 1.15 1.36
negative regulation of protein complex assembly 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of protein complex assembly 11 1.26 1.07 1.19 -1.02 1.17 1.16 1.39
regulation of vesicle fusion 1 1.15 1.03 1.12 1.08 1.15 1.15 -1.08
negative regulation of vesicle fusion 1 1.15 1.03 1.12 1.08 1.15 1.15 -1.08
regulation of cell projection organization 59 1.08 1.13 1.42 1.08 1.39 1.17 1.18
negative regulation of cell projection organization 13 -1.04 1.17 1.5 1.06 1.4 1.02 1.24
positive regulation of cell projection organization 6 1.15 1.11 1.56 1.11 1.48 -1.16 1.25
regulation of defense response 35 1.89 -1.19 -1.0 -1.08 -1.03 1.26 1.14
negative regulation of defense response 5 2.13 -1.29 1.2 -1.05 -1.19 -1.21 -1.11
positive regulation of defense response 6 2.51 -1.09 1.1 -1.06 1.06 1.76 1.22
N-terminal protein amino acid modification 3 -1.27 1.36 1.99 1.28 1.6 -1.05 -1.03
translation initiation factor binding 10 1.25 1.1 1.24 1.01 1.08 1.15 1.37
eukaryotic initiation factor 4G binding 7 1.14 1.02 1.05 -1.04 -1.09 -1.04 1.26
bursicon neuropeptide hormone complex 2 -1.74 -1.0 -1.2 1.19 1.42 -1.55 -1.19
regulation of protein ubiquitination 10 1.62 1.07 1.68 1.03 1.28 1.35 1.26
negative regulation of protein ubiquitination 2 1.45 1.11 1.45 1.15 1.24 1.19 1.21
positive regulation of protein ubiquitination 2 -1.0 -1.14 1.48 -1.16 1.16 -1.27 -1.27
regulation of protein modification process 92 1.25 1.15 1.39 1.12 1.32 1.39 1.2
negative regulation of protein modification process 10 1.3 1.16 1.35 1.1 1.31 1.4 1.13
positive regulation of protein modification process 11 1.08 1.11 1.65 1.11 1.39 1.35 1.2
carboxylic acid binding 52 -1.23 -1.12 -1.35 1.02 1.06 -1.11 -1.28
cytoplasmic vesicle 114 1.02 1.01 1.1 1.05 1.12 1.08 1.1
L-ascorbic acid binding 26 -1.0 1.01 -1.07 -1.0 -1.07 1.07 -1.07
cobalamin binding 1 -1.04 1.01 1.04 1.07 -1.1 -1.21 1.08
alkali metal ion binding 7 1.18 1.01 1.0 -1.0 -1.04 1.2 -1.0
response to methotrexate 11 -1.41 1.08 -1.36 -1.03 1.36 -1.33 1.53
box H/ACA snoRNP complex 1 1.3 1.21 1.13 1.29 1.21 1.06 1.05
M band 6 1.68 1.03 -1.27 -1.02 1.18 1.68 1.16
mitogen-activated protein kinase kinase binding 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
regulation of mRNA 3'-end processing 5 1.3 1.09 1.27 1.06 1.11 1.44 1.1
negative regulation of mRNA 3'-end processing 1 1.92 1.01 1.57 -1.13 1.41 2.91 1.31
positive regulation of mRNA 3'-end processing 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
regulation of heterochromatin assembly 3 1.21 1.11 1.43 1.11 1.52 1.35 1.11
negative regulation of heterochromatin assembly 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
positive regulation of heterochromatin assembly 2 1.21 1.02 1.16 1.13 1.43 1.09 -1.08
cullin-RING ubiquitin ligase complex 30 1.33 1.16 1.26 1.17 1.29 1.15 1.13
Cul3-RING ubiquitin ligase complex 3 1.11 1.17 1.23 1.18 1.27 1.3 1.21
nuclear envelope reassembly 4 1.3 1.11 1.08 1.3 1.24 -1.17 -1.07
myosin III binding 1 -1.23 1.03 1.03 -1.15 -1.01 -1.11 -1.09
myosin VI complex 3 -1.98 1.02 1.13 1.07 1.24 -1.12 -1.15
chromatin DNA binding 10 1.28 1.12 1.17 1.21 1.23 1.07 1.13
nucleosome binding 2 -1.08 1.25 1.65 1.07 1.57 1.08 1.51
nucleosomal DNA binding 1 -1.26 1.34 1.15 1.09 1.13 -1.62 1.24
chromatin assembly 32 1.01 1.07 1.31 1.14 1.26 -1.03 1.08
protein complex localization 2 2.1 1.14 1.17 1.2 1.38 1.71 1.06
heterochromatin assembly 4 -1.26 1.27 1.36 1.02 1.42 1.07 1.46
SUMO activating enzyme complex 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
nonmotile primary cilium 2 -1.07 -1.03 -1.02 1.13 -1.1 -1.09 -1.15
PcG protein complex 15 1.41 1.18 1.36 1.09 1.31 1.34 1.26
Myb complex 11 1.43 1.19 1.32 1.2 1.4 1.5 1.18
microvillus membrane 1 1.23 1.27 1.15 1.19 1.2 1.15 1.07
actin cytoskeleton reorganization 9 1.38 1.0 1.56 1.0 1.39 1.59 1.34
minus-end directed microtubule sliding 1 -1.34 -1.01 1.11 1.33 1.45 -1.15 -1.3
plus-end directed microtubule sliding 1 1.34 1.07 1.06 1.01 1.45 -1.14 -1.53
positive regulation of exit from mitosis 1 2.76 -2.65 -2.69 -2.98 -1.9 34.44 -1.85
peptidyl-proline dioxygenase activity 27 1.0 -1.0 -1.07 1.0 -1.1 -1.02 -1.07
peptidyl-proline 4-dioxygenase activity 27 1.0 -1.0 -1.07 1.0 -1.1 -1.02 -1.07
contractile ring maintenance involved in cell cycle cytokinesis 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
DNA integrity checkpoint 70 1.22 1.15 1.38 1.19 1.41 1.3 1.15
mitotic cell cycle G1/S transition DNA damage checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
G2/M transition DNA damage checkpoint 63 1.23 1.15 1.36 1.2 1.39 1.27 1.14
mitotic cell cycle G1/S transition checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
G2/M transition checkpoint 63 1.23 1.15 1.36 1.2 1.39 1.27 1.14
spindle checkpoint 10 1.07 1.09 1.16 1.15 1.32 1.1 1.03
AMP-activated protein kinase complex 1 1.2 1.33 1.18 -1.01 -1.15 1.3 1.08
cell-substrate adhesion 18 -1.4 1.01 1.22 -1.05 1.29 -1.09 1.19
neuromuscular junction 29 1.64 -1.02 1.13 -1.17 1.09 1.63 1.22
spindle pole centrosome 3 1.78 1.17 1.45 -1.07 1.38 1.95 1.49
NMS complex 3 1.88 1.01 1.19 1.2 1.44 1.48 -1.09
nuclear centromeric heterochromatin 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
receptor internalization 3 1.27 -1.02 1.22 -1.05 1.11 1.66 1.17
ubiquitin conjugating enzyme binding 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
ubiquitin protein ligase binding 9 1.11 1.17 1.66 1.19 1.63 1.3 1.36
synaptic vesicle fusion to presynaptic membrane 2 -3.55 -1.94 -2.8 1.67 -1.37 -8.1 -3.92
regulation of synaptic vesicle fusion to presynaptic membrane 1 1.15 1.03 1.12 1.08 1.15 1.15 -1.08
negative regulation of synaptic vesicle fusion to presynaptic membrane 1 1.15 1.03 1.12 1.08 1.15 1.15 -1.08
regulation of neuronal synaptic plasticity in response to neurotrophin 1 2.75 -1.14 -1.16 -1.07 -1.18 1.11 1.67
zymogen activation 4 3.67 -1.44 -1.39 -1.42 -1.27 2.44 1.48
regulation of neurological system process 37 1.13 1.11 1.3 1.03 1.17 1.29 1.22
negative regulation of neurological system process 2 -1.06 1.07 1.19 1.01 1.07 1.19 1.07
positive regulation of neurological system process 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
regulation of protein stability 27 1.47 1.17 1.27 1.1 1.25 1.18 1.11
regulation of cyclin-dependent protein kinase activity involved in G2/M 1 1.18 1.23 1.07 1.21 1.0 1.04 -1.03
response to nutrient levels 42 1.1 -1.0 1.12 -1.03 1.15 1.24 1.18
cellular response to extracellular stimulus 16 1.0 1.13 1.15 1.05 1.11 1.4 1.14
cellular response to nutrient levels 15 -1.0 1.14 1.14 1.06 1.09 1.4 1.13
cellular response to nutrient 1 -36.3 1.49 1.05 1.2 1.58 -8.6 -1.57
I band 19 1.85 -1.41 -1.18 -1.11 1.31 1.7 -1.14
lipid particle transport along microtubule 3 -1.08 1.32 -1.03 -1.05 1.05 -1.42 -1.07
late endosome membrane 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
microbody membrane 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
telomeric heterochromatin 2 -1.21 1.23 1.23 1.13 1.5 -1.12 1.13
regulation of chromatin silencing 19 1.34 1.17 1.13 1.09 1.19 1.43 1.42
negative regulation of chromatin silencing 6 1.15 1.16 1.19 1.25 1.26 1.19 1.22
positive regulation of chromatin silencing 3 1.21 1.14 -1.1 -1.08 1.08 1.29 1.99
filamentous actin 6 -1.28 -1.05 1.22 -1.12 1.0 1.16 1.38
beta-alanyl-histamine hydrolase activity 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
nuclear membrane 16 1.66 -1.06 1.3 1.05 1.4 1.42 1.19
mitochondrial membrane 181 1.05 1.06 1.17 1.06 1.11 1.4 -1.2
organelle envelope 277 1.12 1.07 1.19 1.07 1.16 1.37 -1.11
organelle outer membrane 24 1.17 -1.02 1.15 1.1 1.19 1.35 1.0
organelle envelope lumen 13 1.07 1.12 1.22 1.17 1.15 1.4 -1.16
membrane-enclosed lumen 601 1.19 1.12 1.23 1.16 1.24 1.22 -1.0
envelope 288 1.15 1.07 1.18 1.06 1.15 1.36 -1.1
nuclear lumen 436 1.23 1.14 1.25 1.18 1.27 1.15 1.08
vesicle 126 -1.01 1.01 1.1 1.06 1.15 1.08 1.1
organelle subcompartment 9 1.35 -1.0 1.2 1.12 1.08 1.27 1.25
Golgi cisterna 6 1.05 1.2 1.02 1.18 1.21 1.34 1.32
locomotion involved in locomotory behavior 14 -1.12 1.15 1.42 1.11 1.53 1.07 1.2
membrane-bounded vesicle 107 1.03 1.05 1.13 1.04 1.17 1.14 1.16
bombesin receptor signaling pathway 2 1.03 1.12 1.37 -1.03 -1.15 1.42 1.13
mRNA export from nucleus in response to heat stress 2 -1.27 1.03 1.6 -1.01 1.13 1.81 1.1
regulation of TOR signaling cascade 3 -2.06 1.16 1.27 1.19 1.19 -1.72 1.0
negative regulation of TOR signaling cascade 1 1.13 1.46 1.84 1.15 1.31 1.41 1.45
positive regulation of TOR signaling cascade 2 -3.14 1.04 1.05 1.2 1.13 -2.68 -1.2
regulation of ARF protein signal transduction 14 -1.12 1.16 1.23 1.01 1.21 1.19 1.55
NELF complex 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
myosin light chain binding 13 -1.01 1.07 1.48 -1.0 1.2 1.25 1.17
myosin head/neck binding 2 -1.4 -1.01 1.0 1.02 1.17 -1.17 -1.2
myosin II light chain binding 1 -1.26 1.24 1.29 1.08 1.1 -1.05 1.16
myosin heavy chain binding 5 -1.16 1.05 1.2 1.06 1.23 -1.26 -1.0
myosin II heavy chain binding 1 -1.26 1.24 1.29 1.08 1.1 -1.05 1.16
small-subunit processome 4 -1.04 -1.0 1.29 1.31 1.31 1.02 1.02
mitochondrial DNA metabolic process 5 -1.01 1.2 1.25 1.15 1.21 1.2 -1.15
cardiolipin metabolic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
cardiolipin biosynthetic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
clathrin heavy chain binding 2 -1.49 1.38 1.52 1.18 1.43 -1.03 1.15
microtubule basal body organization 2 1.48 1.06 1.18 1.02 1.1 1.35 1.01
cortical protein anchoring 1 -1.33 1.57 2.09 1.17 1.77 1.11 1.58
regulation of nuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of nuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
SAM domain binding 1 1.45 1.28 1.83 1.25 2.05 1.81 1.62
regulation of response to food 2 -2.4 -1.4 3.96 -1.44 -2.81 -4.01 -2.19
regulation of response to external stimulus 9 -1.23 1.03 1.62 -1.03 -1.11 -1.21 -1.18
negative regulation of response to external stimulus 2 1.19 1.12 1.18 1.18 1.31 1.07 -1.1
regulation of response to extracellular stimulus 4 -1.71 -1.02 2.0 -1.11 -1.48 -1.65 -1.49
negative regulation of response to extracellular stimulus 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
regulation of response to nutrient levels 4 -1.71 -1.02 2.0 -1.11 -1.48 -1.65 -1.49
negative regulation of response to nutrient levels 1 -1.06 1.16 1.2 1.34 1.78 -1.33 -1.11
chromosome passenger complex 2 -1.25 -1.08 -1.11 1.09 1.18 -1.16 -1.19
activation of protein kinase activity 19 1.27 1.12 1.2 1.07 1.14 1.38 1.17
cell division site 12 -1.06 1.09 1.54 1.06 1.53 1.28 1.13
cell division site part 12 -1.06 1.09 1.54 1.06 1.53 1.28 1.13
septin cytoskeleton 6 -1.44 1.09 1.11 1.19 1.4 -1.24 1.03
small conjugating protein binding 3 1.59 1.33 1.88 1.29 1.84 1.63 1.43
SUMO binding 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
septin cytoskeleton organization 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
contractile ring localization involved in cell cycle cytokinesis 2 -1.56 1.16 1.2 1.2 1.28 -1.0 1.03
maintenance of contractile ring localization involved in cell cycle cytokinesis 1 -1.85 1.14 1.04 1.39 1.46 -1.41 -1.29
transposition 1 1.07 -1.04 -1.16 1.02 1.48 -1.27 -1.22
telomere organization 14 1.19 1.12 1.39 1.17 1.35 1.2 1.11
regulation of synaptic transmission, cholinergic 1 -1.1 1.17 -1.13 -1.04 -1.08 -1.08 1.11
regulation of actin filament bundle assembly 3 1.54 1.04 1.3 -1.03 2.35 1.13 1.3
regulation of calcium ion transport via store-operated calcium channel activity 3 1.93 -1.03 1.33 1.03 1.24 2.17 1.55
positive regulation of calcium ion transport via store-operated calcium channel activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
activation of store-operated calcium channel activity 1 2.63 1.01 1.53 -1.05 1.46 2.52 1.76
regulation of nucleobase-containing compound transport 1 1.52 1.17 1.71 1.25 2.2 8.74 2.48
negative regulation of nucleobase-containing compound transport 1 1.52 1.17 1.71 1.25 2.2 8.74 2.48
methylation 53 1.32 1.18 1.3 1.18 1.32 1.25 1.12
regulation of cellular protein metabolic process 160 1.3 1.11 1.31 1.08 1.29 1.35 1.22
negative regulation of cellular protein metabolic process 47 1.33 1.04 1.25 1.02 1.25 1.33 1.24
positive regulation of cellular protein metabolic process 25 1.12 1.15 1.46 1.08 1.34 1.24 1.28
regulation of protein polymerization 17 -1.53 1.06 1.38 1.05 1.34 -1.31 1.14
negative regulation of protein polymerization 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of protein polymerization 8 -1.02 1.08 1.2 -1.02 1.21 -1.12 1.22
double-stranded RNA-specific ribonuclease activity 1 6.73 -1.62 -1.13 -2.09 1.01 8.39 1.39
mismatch repair complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
MutSalpha complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
MutSbeta complex 1 2.58 -1.1 1.19 1.19 2.02 -1.05 -1.35
regulation of ARF GTPase activity 8 -1.06 1.12 1.2 1.04 1.17 1.01 1.53
regulation of Rab GTPase activity 25 1.14 1.15 1.4 1.07 1.25 1.3 1.16
regulation of Rac GTPase activity 1 1.08 -1.14 -1.07 -1.55 -1.02 9.19 -1.47
regulation of Rap GTPase activity 1 -1.22 2.43 -1.06 -1.67 1.03 1.44 -1.08
regulation of Ras GTPase activity 38 1.08 1.17 1.37 1.04 1.27 1.32 1.23
regulation of Rho GTPase activity 4 1.14 1.13 1.64 1.03 1.74 2.44 1.19
positive regulation of Ras GTPase activity 3 1.01 1.31 1.81 1.2 1.9 1.82 1.38
positive regulation of Rho GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
molybdopterin cofactor biosynthetic process 5 1.14 1.31 1.37 1.14 1.16 -1.34 1.2
regulation of hormone metabolic process 4 -4.19 -1.34 1.3 1.27 1.23 -3.79 -2.08
negative regulation of hormone metabolic process 2 -15.63 -2.03 1.53 1.8 1.58 -15.3 -4.44
negative regulation of hormone biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
intracellular lipid transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
regulation of lipid transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
regulation of sterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
regulation of cholesterol transport 1 2.58 -1.39 1.67 -1.07 1.62 11.34 1.83
regulation of intracellular transport 36 1.16 1.11 1.23 1.1 1.23 1.22 1.22
negative regulation of intracellular transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
positive regulation of intracellular transport 23 1.1 1.07 1.2 1.09 1.25 1.08 1.14
DNA geometric change 3 1.03 1.28 -1.01 1.04 -1.04 1.08 1.21
protein complex binding 19 1.04 1.06 1.22 1.11 1.09 1.09 1.1
regulation of transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
positive regulation of transporter activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
regulation of ion transmembrane transporter activity 7 1.44 -1.04 1.16 -1.02 1.15 1.52 1.13
positive regulation of ion transmembrane transporter activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
beta-N-acetylgalactosaminidase activity 1 3.13 1.28 1.73 1.05 1.33 2.12 2.37
actin filament bundle 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
filopodium tip 2 1.13 -1.0 1.96 -1.15 1.62 1.33 1.8
regulation of proteasomal ubiquitin-dependent protein catabolic process 4 1.63 1.06 1.19 1.23 1.22 1.17 1.04
negative regulation of proteasomal ubiquitin-dependent protein catabolic process 3 1.42 1.07 1.19 1.26 1.18 -1.01 -1.02
positive regulation of proteasomal ubiquitin-dependent protein catabolic process 1 2.44 1.03 1.21 1.16 1.33 1.95 1.23
melanosome organization 1 -1.21 1.04 -1.11 1.04 -1.07 -1.17 -1.01
protein modification by small protein conjugation 47 1.14 1.13 1.39 1.16 1.27 1.17 1.12
demethylase activity 6 1.22 1.23 1.76 1.12 1.66 1.8 1.31
histone demethylase activity 6 1.22 1.23 1.76 1.12 1.66 1.8 1.31
histone demethylase activity (H3-K4 specific) 2 1.08 1.42 1.76 1.01 1.58 2.53 1.88
histone demethylase activity (H3-K9 specific) 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
endocytic recycling 5 1.33 1.24 1.42 1.12 1.35 1.65 1.25
regulation of cytokinesis 1 -1.32 1.18 1.39 1.03 1.12 1.4 1.35
endoplasmic reticulum calcium ion homeostasis 1 4.45 1.05 -1.49 1.14 1.22 1.67 1.4
regulation of Rab protein signal transduction 25 1.14 1.15 1.4 1.07 1.25 1.3 1.16
regulation of Rap protein signal transduction 1 -1.22 2.43 -1.06 -1.67 1.03 1.44 -1.08
response to peptidoglycan 1 9.16 -1.23 -1.57 -1.54 -1.3 2.66 -1.01
response to lipopolysaccharide 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
muramyl dipeptide binding 1 9.16 -1.23 -1.57 -1.54 -1.3 2.66 -1.01
multicellular organismal process 2813 1.13 1.04 1.13 1.03 1.14 1.16 1.1
developmental process 2455 1.15 1.04 1.14 1.03 1.17 1.2 1.12
multicellular organism reproduction 694 1.11 1.06 1.17 1.03 1.19 1.16 1.16
cytokinetic process 22 1.13 -1.06 1.1 -1.09 1.19 1.19 1.11
maintenance of protein location in cell 37 1.15 1.12 1.29 1.08 1.31 1.23 1.24
DNA duplex unwinding 3 1.03 1.28 -1.01 1.04 -1.04 1.08 1.21
endosome transport via multivesicular body sorting pathway 3 1.32 -1.02 1.33 1.3 1.34 1.03 -1.24
protein exit from endoplasmic reticulum 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
microvillus organization 4 -2.72 -1.1 -1.32 -1.18 -1.23 -2.04 1.51
follicle cell microvillus organization 2 1.82 -1.12 -1.27 -1.14 -1.29 -1.07 1.07
regulation of microvillus organization 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of follicle cell microvillus organization 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of microvillus length 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of follicle cell microvillus length 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
regulation of cellular component size 73 1.0 1.15 1.35 1.07 1.31 1.17 1.21
regulation of cell projection size 1 3.92 -1.13 -1.16 -1.25 -1.38 1.21 1.43
sulfiredoxin activity 1 1.25 1.26 1.21 1.31 1.36 1.11 -1.04
mitochondrial translation 1 1.16 1.26 1.14 1.19 1.28 1.6 -1.22
ribonucleoside binding 3 -1.45 1.22 1.02 1.14 1.27 -1.3 1.2
ribonucleotide binding 807 1.08 1.1 1.19 1.08 1.22 1.17 1.09
purine ribonucleotide binding 807 1.08 1.1 1.19 1.08 1.22 1.17 1.09
adenyl ribonucleotide binding 653 1.06 1.1 1.17 1.09 1.22 1.18 1.1
guanyl ribonucleotide binding 159 1.18 1.08 1.28 1.06 1.23 1.12 1.08
O-linoleoyltransferase activity 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidylcholine:cardiolipin O-linoleoyltransferase activity 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
Golgi cisterna membrane 3 1.17 1.23 -1.14 1.08 -1.09 1.82 1.37
neuron projection membrane 1 -1.08 -1.3 -1.04 1.04 1.56 8.15 2.89
integral to mitochondrial membrane 3 -1.04 1.18 1.43 1.19 1.11 1.64 -1.32
regulation of monooxygenase activity 2 1.57 1.18 -1.18 1.24 1.17 1.04 1.44
negative regulation of monooxygenase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
positive regulation of monooxygenase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
RNA biosynthetic process 151 1.27 1.12 1.21 1.16 1.26 1.16 1.12
Piccolo NuA4 histone acetyltransferase complex 1 -1.06 -1.13 1.02 1.06 -1.15 1.02 -1.14
ELL-EAF complex 8 1.25 1.11 1.53 1.07 1.44 1.46 1.18
monocarboxylic acid metabolic process 78 1.06 -1.1 -1.24 -1.08 -1.06 -1.06 -1.03
positive regulation of CREB transcription factor activity 1 2.75 1.33 1.9 1.11 2.22 3.34 2.0
low-density lipoprotein receptor particle metabolic process 1 2.53 -1.21 1.11 1.26 1.02 1.58 1.04
carboxy-terminal domain protein kinase complex 9 1.46 1.1 1.45 1.27 1.49 1.36 1.12
tumor necrosis factor receptor superfamily binding 2 1.39 1.0 -1.11 -1.04 2.69 -1.2 2.61
distributive segregation 6 1.23 -1.03 -1.06 1.1 1.19 1.15 1.25
cell projection cytoplasm 1 1.03 1.24 1.01 1.09 1.02 -1.11 1.01
regulation of homeostatic process 3 1.14 1.14 1.39 1.16 1.04 1.71 1.47
positive regulation of Rab GTPase activity 1 1.3 1.23 1.1 1.08 1.16 2.99 1.24
positive regulation of Rac GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Ras GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Rho GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
activation of Rac GTPase activity 2 -1.11 1.35 2.32 1.27 2.42 1.41 1.46
response to insulin stimulus 20 -1.09 1.13 1.2 1.13 1.18 1.07 1.2
cellular response to insulin stimulus 20 -1.09 1.13 1.2 1.13 1.18 1.07 1.2
cellular response to hormone stimulus 52 1.07 1.12 1.17 1.08 1.23 1.19 1.21
regulation of stress-activated MAPK cascade 33 -1.0 1.2 1.31 1.13 1.3 1.36 1.17
negative regulation of stress-activated MAPK cascade 12 1.09 1.13 1.44 1.11 1.23 1.18 1.08
positive regulation of stress-activated MAPK cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
regulation of DNA endoreduplication 5 -1.5 1.1 1.17 1.11 1.42 -1.56 1.43
negative regulation of DNA endoreduplication 2 -3.55 -1.04 1.42 1.03 1.59 -2.82 2.09
positive regulation of DNA endoreduplication 3 1.19 1.21 1.03 1.17 1.31 -1.05 1.11
regulation of localization 163 1.09 1.07 1.21 1.06 1.19 1.26 1.15
regulation of protein localization 48 1.04 1.11 1.27 1.11 1.24 1.15 1.16
regulation of polysaccharide metabolic process 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
regulation of microtubule-based process 29 1.19 1.14 1.41 1.06 1.41 1.52 1.27
regulation of spindle elongation 1 -1.34 -1.01 1.11 1.33 1.45 -1.15 -1.3
regulation of mitotic spindle elongation 1 -1.34 -1.01 1.11 1.33 1.45 -1.15 -1.3
circadian regulation of gene expression 3 1.48 1.24 1.41 1.04 1.37 1.9 1.48
activin receptor signaling pathway 3 -2.1 2.02 -1.27 -1.55 -1.26 -1.31 1.66
regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
negative regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
positive regulation of activin receptor signaling pathway 1 1.88 -1.02 -1.08 -1.19 -1.0 2.96 -1.02
SREBP-mediated signaling pathway 6 1.15 1.2 1.22 1.13 1.33 -1.04 1.13
sterol binding 17 -2.71 -1.57 -1.93 1.12 -1.21 -2.6 -2.64
secretion by cell 139 -1.02 1.06 1.22 1.11 1.23 1.11 1.08
protein complex scaffold 2 1.19 1.14 1.28 -1.02 1.24 1.13 1.22
regulation of cytokinetic process 1 -1.32 1.18 1.39 1.03 1.12 1.4 1.35
regulation of actin cytoskeleton organization 30 -1.3 1.08 1.43 1.03 1.44 -1.08 1.19
inositol phosphate biosynthetic process 3 -1.14 1.2 -1.03 -1.06 1.01 -1.08 1.11
positive regulation of transcription elongation from RNA polymerase II promoter 10 -1.01 1.29 1.32 -1.05 1.22 1.32 1.65
regulation of actin filament-based process 30 -1.3 1.08 1.43 1.03 1.44 -1.08 1.19
mitochondrial respiratory chain complex I assembly 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
myosin filament 3 2.91 -1.49 1.05 -1.32 1.04 2.39 -1.29
macromolecular complex disassembly 16 1.02 1.16 1.29 1.14 1.31 1.19 1.04
ribonucleoprotein complex disassembly 1 1.69 1.29 1.56 1.32 1.6 1.63 1.44
cellular component morphogenesis 513 1.16 1.08 1.23 1.03 1.24 1.24 1.21
cell part morphogenesis 359 1.11 1.08 1.23 1.04 1.24 1.23 1.23
macromolecular complex 1903 1.15 1.08 1.19 1.09 1.19 1.19 1.03
protein-carbohydrate complex 1 2.19 1.14 2.0 1.19 2.09 1.71 1.7
protein-DNA complex 35 -1.03 1.07 1.21 1.2 1.27 -1.15 -1.1
tetrapyrrole metabolic process 13 1.13 1.17 1.08 1.1 -1.02 1.13 -1.08
tetrapyrrole biosynthetic process 12 1.08 1.18 1.02 1.11 -1.05 1.06 -1.1
tetrapyrrole catabolic process 1 2.0 1.05 2.09 1.06 1.46 2.34 1.12
bitter taste receptor activity 2 -1.31 -1.2 -1.22 -1.24 3.17 1.22 -1.17
sweet taste receptor activity 2 -1.42 -1.09 -1.0 1.18 -1.03 -1.26 -1.15
regulation of organelle organization 124 1.1 1.1 1.3 1.07 1.34 1.17 1.17
regulation of chromosome organization 15 1.16 1.17 1.39 1.18 1.42 1.32 1.27
multicellular organismal reproductive behavior 73 -1.01 -1.11 -1.02 -1.04 -1.08 -1.0 1.04
cellular pigmentation 11 1.07 1.19 1.37 1.13 1.22 1.15 1.17
ocellus pigmentation 18 1.35 1.13 1.12 1.06 1.06 1.08 1.16
mitochondrial respiratory chain complex assembly 2 1.06 1.05 1.15 -1.01 -1.01 1.5 -1.3
negative regulation of RNA splicing 5 1.21 1.27 1.23 1.22 1.16 1.36 1.08
regulation of purine nucleotide catabolic process 43 1.08 1.16 1.36 1.06 1.3 1.31 1.21
regulation of GTP catabolic process 42 1.08 1.16 1.35 1.05 1.29 1.31 1.21
acetylcholine receptor binding 1 -1.02 1.16 1.08 1.02 1.02 1.28 1.01
regulation of intracellular protein transport 35 1.17 1.1 1.23 1.1 1.24 1.22 1.23
regulation of protein import into nucleus, translocation 2 -1.04 1.19 1.3 1.1 -1.02 1.0 1.13
positive regulation of protein import into nucleus, translocation 2 -1.04 1.19 1.3 1.1 -1.02 1.0 1.13
conversion of ds siRNA to ss siRNA involved in RNA interference 1 1.02 1.47 1.88 1.06 1.63 2.09 1.83
histone H3-K9 demethylation 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
protein-DNA loading ATPase activity 3 1.23 1.05 1.23 1.24 1.24 1.1 -1.01
proton-transporting V-type ATPase complex 28 -1.62 -1.0 1.32 -1.18 -1.18 1.26 -1.13
proton-transporting two-sector ATPase complex, proton-transporting domain 24 -1.5 1.0 1.3 -1.13 -1.09 1.2 -1.21
proton-transporting two-sector ATPase complex, catalytic domain 24 1.11 -1.0 1.24 -1.09 -1.02 1.63 -1.09
proton-transporting V-type ATPase, V0 domain 15 -2.14 -1.02 1.29 -1.23 -1.29 1.0 -1.25
proton-transporting V-type ATPase, V1 domain 14 -1.13 1.02 1.36 -1.11 -1.05 1.59 1.0
response to hydroperoxide 1 2.0 -1.09 -1.07 1.14 1.47 1.02 -1.28
DNA helicase complex 9 -1.14 1.07 1.16 1.17 1.25 -1.1 -1.02
cell cycle cytokinesis 34 1.28 1.02 1.18 -1.01 1.3 1.18 1.14
cytokinesis after meiosis 19 1.55 1.01 1.2 -1.08 1.35 1.45 1.26
iron assimilation 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
dsRNA transport 22 -1.32 1.18 1.23 1.09 1.33 1.1 1.01
regulation of cellular amine metabolic process 3 1.05 1.06 1.07 1.15 1.1 -1.22 1.43
regulation of S phase 16 1.38 1.18 1.34 1.13 1.4 1.63 1.43
axon part 31 1.25 1.05 1.11 -1.11 1.16 1.72 1.28
monocarboxylic acid binding 11 -1.61 -1.59 -2.07 -1.15 1.3 -1.68 -1.56
cell cycle comprising mitosis without cytokinesis 14 1.58 -1.04 1.19 -1.07 1.25 1.21 1.5
meiotic cell cycle checkpoint 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
protein localization to organelle 102 1.05 1.19 1.2 1.14 1.18 1.07 1.13
pronuclear migration 4 -1.16 1.07 1.08 1.03 1.23 -1.25 -1.05
carbohydrate homeostasis 5 1.14 1.16 -1.21 -1.59 -1.34 1.07 1.69
fatty acid beta-oxidation using acyl-CoA oxidase 1 -1.23 1.06 -2.67 1.58 1.11 -5.4 -1.98
MAP kinase phosphatase activity 3 1.18 1.17 1.3 1.08 1.35 1.14 1.33
multicellular organismal response to stress 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
Slx1-Slx4 complex 1 1.24 1.01 -1.1 -1.01 -1.04 1.25 -1.13
protein deacetylase activity 8 1.29 1.14 1.07 1.21 1.24 1.41 1.17
unsaturated fatty acid metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
dorsal/ventral axon guidance 2 1.25 1.19 1.54 1.04 1.22 1.73 1.43
protein glycosylation in endoplasmic reticulum 1 2.78 -1.05 1.02 -1.07 1.12 2.02 1.06
protein glycosylation in Golgi 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
rhabdomere membrane 1 1.12 1.01 1.02 -1.01 1.1 -1.08 -1.09
Elongator holoenzyme complex 1 -1.53 1.18 -1.12 1.34 -1.02 -1.63 -1.29
activating transcription factor binding 9 1.49 -1.18 -1.05 -1.08 1.1 1.31 1.18
mitochondrial proton-transporting ATP synthase complex assembly 1 1.02 1.07 1.3 1.18 1.05 1.56 -1.57
membrane protein proteolysis 4 -1.09 1.28 1.16 1.23 1.32 -1.25 1.31
cell adhesion mediated by integrin 2 -1.31 -1.12 -1.25 -1.23 -1.34 -1.41 -1.27
regulation of cell adhesion mediated by integrin 2 -1.34 1.03 1.08 -1.01 1.21 -1.37 1.03
regulation of growth of symbiont in host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of growth of symbiont in host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of kinase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
positive regulation of kinase activity 25 1.18 1.14 1.29 1.1 1.23 1.49 1.19
nucleotide-excision repair, DNA incision 1 1.98 1.16 1.33 1.18 1.39 1.07 1.02
cellular polysaccharide biosynthetic process 11 1.69 1.06 -1.03 1.08 1.23 1.68 1.33
establishment of ribosome localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 3 2.12 -1.18 -1.46 -1.03 -1.03 1.26 -1.06
steroid dehydrogenase activity, acting on the CH-CH group of donors 1 -1.31 1.28 -1.32 1.3 1.08 -2.32 -1.18
SUMO-targeted ubiquitin ligase complex 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity 1 1.31 1.46 -1.17 -1.24 1.74 -1.95 3.54
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity 2 -1.04 1.82 1.08 1.06 -1.12 -1.39 1.31
nucleoside bisphosphate metabolic process 6 1.42 1.19 1.1 1.23 1.41 -1.05 -1.06
ribonuclease T2 activity 1 2.66 -1.03 1.81 1.01 1.48 1.86 1.52
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity 1 -1.77 -1.11 1.92 1.18 1.33 -1.27 -1.19
cis-stilbene-oxide hydrolase activity 3 -2.11 1.3 -1.14 -1.06 -1.44 -4.35 1.38
cytoplasmic mRNA processing body assembly 5 1.3 1.16 1.47 1.28 1.54 1.31 1.13
5-(carboxyamino)imidazole ribonucleotide mutase activity 1 1.05 -1.55 -1.44 -1.5 -1.3 3.7 1.09
endosomal vesicle fusion 4 1.19 1.07 2.26 1.26 1.71 1.76 1.23
response to anoxia 5 1.07 1.07 1.2 1.15 1.24 1.28 1.15
DNA polymerase activity 19 1.07 1.12 1.2 1.07 1.19 1.1 -1.04
RNA polymerase activity 28 1.31 1.12 1.19 1.24 1.24 1.06 1.0
cellular response to amino acid starvation 4 -1.04 1.16 1.31 1.01 1.16 1.47 1.31
peptide N-acetyltransferase activity 4 1.05 1.16 1.37 1.09 1.14 1.03 1.01
ion transmembrane transport 73 -1.07 1.02 1.16 -1.11 -1.07 1.38 -1.11
GPI anchor binding 1 -1.1 1.17 -1.13 -1.04 -1.08 -1.08 1.11
regulation of transcription elongation from RNA polymerase II promoter 14 1.05 1.24 1.29 1.01 1.21 1.26 1.46
negative regulation of transcription elongation from RNA polymerase II promoter 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
response to monosaccharide stimulus 2 -1.1 1.06 1.16 1.15 1.11 -1.04 -1.08
response to disaccharide stimulus 5 2.19 -1.05 1.25 1.03 1.35 1.69 1.35
response to maltose stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
detection of monosaccharide stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
detection of disaccharide stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
detection of maltose stimulus 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
primary alcohol metabolic process 2 1.95 -1.28 -2.91 -1.89 1.06 1.72 1.15
diol metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
diol biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
diol catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
Arp2/3 complex-mediated actin nucleation 2 -1.4 1.24 1.37 1.14 1.19 -1.91 1.02
cell junction assembly 37 1.87 -1.1 1.3 -1.15 1.23 2.13 1.42
cell junction organization 46 1.6 -1.06 1.34 -1.1 1.25 1.87 1.32
cell junction maintenance 9 -1.01 1.16 1.73 1.07 1.49 1.28 1.13
adherens junction organization 12 1.06 1.11 1.42 1.06 1.32 1.17 1.09
adherens junction assembly 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
adherens junction maintenance 7 -1.01 1.13 1.67 1.07 1.42 1.13 -1.02
macromolecular complex remodeling 5 1.21 1.11 1.42 1.33 1.33 1.15 1.09
lipid particle organization 6 1.5 -1.3 -1.62 1.09 1.28 -1.38 1.28
nuclear periphery 14 1.25 1.15 1.12 1.25 1.18 1.1 1.05
nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3' 1 -1.45 1.76 1.14 1.42 1.29 -1.3 1.32
lipid oxidation 14 -1.0 1.05 -1.49 1.08 1.25 -1.91 -1.22
ubiquitin-ubiquitin ligase activity 2 1.19 1.09 1.35 1.16 1.35 1.16 1.36
microtubule anchoring 6 -1.07 1.06 1.1 1.13 1.24 1.02 -1.0
microtubule anchoring at centrosome 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
ncRNA processing 64 1.28 1.14 1.2 1.24 1.22 1.11 1.01
chondroitin sulfotransferase activity 2 -1.02 1.22 1.17 1.01 1.0 1.01 -1.01
heparan sulfate sulfotransferase activity 6 1.58 1.12 1.54 1.02 1.18 1.11 1.46
protein localization to kinetochore 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
protein localization to chromosome 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
protein localization to nucleus 38 1.16 1.19 1.34 1.21 1.35 1.22 1.15
centromere complex assembly 3 1.0 1.03 -1.07 1.16 1.05 -1.12 -1.1
box C/D snoRNA binding 1 1.11 -1.14 1.0 1.3 1.17 -1.17 -1.17
RNA cap binding complex 4 1.34 1.15 1.34 1.16 1.42 1.43 1.2
mitochondrial respiratory chain complex III assembly 1 1.04 1.04 1.01 -1.04 -1.1 1.13 -1.12
piRNA binding 2 1.58 1.07 1.4 1.11 1.03 1.55 1.05
phosphatidylinositol phosphate 4-phosphatase activity 1 -1.07 1.22 1.09 1.37 -1.04 -1.17 -1.02
cellular response to oxidative stress 17 1.07 -1.16 -1.22 -1.13 -1.0 1.33 -1.03
cellular response to heat 20 -1.11 -1.25 -1.29 -1.41 -1.07 1.17 1.13
cellular protein localization 214 1.06 1.16 1.29 1.13 1.23 1.14 1.17
cellular response to reactive oxygen species 11 -1.03 1.06 1.07 1.16 1.2 -1.19 -1.14
cellular response to unfolded protein 1 -1.05 1.27 -1.17 -1.24 -1.49 -1.01 1.19
cellular macromolecular complex subunit organization 173 1.07 1.1 1.28 1.14 1.27 1.11 1.03
cellular macromolecular complex assembly 143 1.05 1.09 1.28 1.14 1.27 1.07 1.01
cellular macromolecular complex disassembly 16 1.02 1.16 1.29 1.14 1.31 1.19 1.04
cellular protein complex localization 2 2.1 1.14 1.17 1.2 1.38 1.71 1.06
cellular carbohydrate biosynthetic process 22 1.52 -1.16 -1.16 -1.14 1.15 1.68 1.12
cellular nitrogen compound metabolic process 1149 1.16 1.09 1.14 1.11 1.19 1.16 1.05
establishment of mitochondrion localization, microtubule-mediated 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
cellular response to UV 11 -1.5 -1.74 -2.0 -1.64 -1.56 -1.07 -1.13
cellular macromolecule biosynthetic process 627 1.18 1.09 1.17 1.11 1.21 1.19 1.03
histone demethylase activity (H3-trimethyl-K4 specific) 2 1.08 1.42 1.76 1.01 1.58 2.53 1.88
nucleobase-containing compound biosynthetic process 98 1.15 1.06 1.08 1.01 1.06 1.29 -1.01
nucleobase-containing compound catabolic process 55 -1.05 1.01 -1.01 1.05 1.04 -1.13 1.03
ncRNA metabolic process 107 1.13 1.19 1.23 1.2 1.21 1.08 1.04
ncRNA catabolic process 1 1.49 1.15 1.39 1.19 1.14 2.46 1.32
tripeptidase activity 1 -2.16 -1.91 -1.31 1.97 1.89 -1.93 -2.32
ion channel complex 41 -1.0 1.04 1.08 -1.03 -1.06 -1.06 -1.04
cation channel complex 25 1.07 1.02 1.08 1.02 1.04 -1.01 -1.04
calcium channel complex 4 1.36 -1.08 -1.02 1.02 -1.08 1.17 -1.12
potassium channel complex 18 1.03 1.03 1.1 1.02 1.05 -1.06 -1.0
sodium channel complex 1 1.49 1.1 1.18 1.37 1.22 1.19 1.04
chloride channel complex 6 -1.41 1.18 1.24 -1.25 -1.53 -1.47 -1.09
methyltransferase complex 16 1.51 1.16 1.4 1.13 1.36 1.38 1.21
histone H3-K4 demethylation 3 1.04 1.4 1.66 1.06 1.46 1.94 1.65
histone H3-K4 demethylation, trimethyl-H3-K4-specific 1 1.33 1.27 1.61 -1.08 1.55 2.66 1.67
DNA replication-independent nucleosome organization 1 -1.49 1.47 -1.04 1.39 1.42 -1.65 -1.06
cellular hormone metabolic process 22 1.12 -1.16 -1.13 -1.16 -1.01 1.05 1.21
regulation of transmembrane transport 35 1.19 1.08 1.22 1.07 1.22 1.3 1.2
negative regulation of transmembrane transport 6 1.84 1.13 1.25 1.03 1.14 1.94 1.57
positive regulation of transmembrane transport 18 1.13 1.06 1.22 1.1 1.37 1.17 1.13
regulation of ion transmembrane transport 8 1.33 -1.01 1.17 -1.03 1.1 1.52 1.12
negative regulation of ion transmembrane transport 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
basement membrane disassembly 3 -2.47 1.3 1.22 1.11 1.41 -1.09 1.18
histone H4-K20 methylation 3 1.22 1.28 1.67 1.2 1.75 1.82 1.4
histone H4-K20 monomethylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
histone H4-K20 dimethylation 1 1.41 1.59 1.77 1.23 1.83 1.65 1.69
histone H4-K20 trimethylation 2 1.21 1.25 1.58 1.24 1.6 1.43 1.25
histone lysine methylation 19 1.48 1.18 1.43 1.13 1.43 1.45 1.28
histone arginine methylation 2 1.3 1.22 1.14 1.25 1.27 1.38 1.31
response to endoplasmic reticulum stress 3 -1.16 1.37 1.28 -1.02 1.1 -1.11 1.57
NAD-dependent protein deacetylase activity 2 1.85 1.16 1.29 1.09 1.23 1.67 1.46
mitochondrial protein processing 2 1.16 1.04 1.32 1.16 1.03 1.09 -1.27
iron chaperone activity 1 1.38 1.05 1.33 1.44 1.46 1.81 -1.29
dorsal trunk growth, open tracheal system 4 1.59 -1.02 1.16 -1.15 1.19 1.9 1.23
liquid clearance, open tracheal system 6 1.48 1.17 1.29 1.11 1.28 1.82 1.45
subapical complex 13 1.4 1.1 1.14 1.01 1.29 2.02 1.24
phosphatidylinositol 3-kinase activity 3 -1.46 1.15 1.53 1.18 1.77 -1.09 -1.14
melanization defense response 12 2.45 -1.25 -1.18 -1.23 1.2 1.6 1.51
regulation of melanization defense response 3 10.08 -1.98 -1.97 -2.05 -1.49 4.83 1.41
positive regulation of melanization defense response 1 13.93 -2.44 -2.81 -2.18 -1.62 11.32 -1.11
negative regulation of melanization defense response 1 23.01 -3.14 -2.9 -3.17 -2.48 1.73 2.58
encapsulation of foreign target 6 2.07 -1.07 1.2 -1.17 1.1 1.42 1.52
melanotic encapsulation of foreign target 2 5.77 -1.55 -1.53 -1.72 -1.45 1.51 1.76
polytene chromosome, telomeric region 5 1.25 1.13 1.41 1.18 1.43 1.46 1.14
myosuppressin receptor activity 1 13.14 -1.35 -1.29 -1.22 -1.17 -1.49 -1.27
phosphatidylinositol 3-kinase regulator activity 1 -2.08 1.8 1.08 1.22 1.65 -1.22 1.26
elongation of arista core 2 -1.25 1.12 -1.06 -1.0 -1.17 -1.12 -1.24
cuticle pattern formation 23 1.0 1.04 1.21 -1.06 1.14 1.06 1.51
adult chitin-based cuticle pattern formation 1 -1.38 -1.23 -1.19 -1.18 -1.36 -1.47 -1.32
somatic stem cell maintenance 13 1.07 1.2 1.28 1.19 1.34 1.15 1.3
regulation of Rac protein signal transduction 2 1.51 1.07 1.28 -1.16 1.49 6.25 1.07
negative regulation of Rac protein signal transduction 1 2.11 1.3 1.76 1.16 2.29 4.26 1.69
regulation of Rho protein signal transduction 26 1.09 1.14 1.48 1.09 1.46 1.56 1.26
positive regulation of Rho protein signal transduction 1 2.11 1.3 1.76 1.16 2.29 4.26 1.69
leading edge cell differentiation 5 1.03 1.07 2.19 -1.04 1.49 -1.17 1.24
leading edge cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
leading edge cell fate determination 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
dorsal closure, leading edge cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
phosphatidylinositol 3-kinase complex, class III 1 -1.02 1.18 1.13 1.36 1.14 1.29 -1.24
female pronucleus assembly 2 1.19 1.0 1.34 1.1 1.22 1.11 -1.19
male pronucleus assembly 4 -1.1 1.36 1.12 1.11 -1.05 1.25 1.15
sperm chromatin decondensation 3 -1.17 1.37 1.22 1.18 1.07 -1.09 1.13
fertilization, exchange of chromosomal proteins 3 -1.17 1.37 1.22 1.18 1.07 -1.09 1.13
sperm aster formation 4 -1.22 1.05 -1.0 1.07 1.17 -1.34 -1.21
sperm plasma membrane disassembly 1 -1.22 1.14 1.06 1.01 -1.52 -1.37 1.04
splicing factor protein import into nucleus 1 -1.2 1.18 -1.09 1.33 -1.05 -1.15 -1.23
juvenile hormone acid methyltransferase activity 1 2.57 -9.13 -9.92 -9.08 -2.93 -2.21 6.69
embryonic heart tube development 14 -1.03 1.04 1.18 1.02 1.18 -1.05 1.47
cardiac cell differentiation 20 1.36 -1.01 1.21 -1.08 1.08 1.53 1.21
dorsal vessel aortic cell fate commitment 1 -1.23 1.26 -1.02 -1.1 -1.2 1.25 -1.03
dorsal vessel heart proper cell fate commitment 2 1.33 1.12 1.13 1.09 1.14 1.5 1.21
embryonic heart tube anterior/posterior pattern specification 3 1.13 1.16 1.08 1.02 1.03 1.41 1.13
nonmotile primary cilium assembly 11 -1.06 1.06 -1.03 1.1 1.07 1.03 -1.06
RCAF complex 1 -1.52 1.22 1.31 1.37 1.19 -1.61 -1.48
brahma complex 9 1.16 1.17 1.42 1.17 1.47 1.4 1.29
omega speckle 4 -1.04 1.25 1.21 1.21 1.23 1.2 -1.07
nuclear speck organization 1 1.08 1.17 2.37 1.04 2.17 1.91 1.84
methylated histone residue binding 6 1.3 1.14 1.32 1.26 1.24 1.32 1.04
regulation of histone acetylation 5 1.41 1.17 1.61 1.2 1.61 1.62 1.46
positive regulation of histone acetylation 2 1.41 1.2 1.81 1.29 1.46 1.33 1.45
negative regulation of histone acetylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
micro-ribonucleoprotein complex 1 -1.57 1.18 1.13 1.01 1.08 -1.1 1.28
larval midgut histolysis 8 -1.09 1.19 1.22 1.19 1.25 1.0 1.3
salivary gland histolysis 73 -1.0 1.0 1.1 1.06 1.24 1.15 1.1
salivary gland cell autophagic cell death 70 1.04 -1.0 1.1 1.06 1.23 1.21 1.11
ecdysone-mediated induction of salivary gland cell autophagic cell death 11 1.07 1.06 1.25 1.02 1.27 1.36 1.36
pupariation 7 1.31 1.04 1.24 -1.05 1.2 2.66 1.16
response to ecdysone 27 1.12 1.07 1.54 1.02 1.35 1.59 1.26
ecdysone receptor-mediated signaling pathway 8 1.35 1.22 1.56 1.09 1.48 1.56 1.37
induction of programmed cell death by ecdysone 12 1.05 1.07 1.28 1.03 1.29 1.32 1.33
polytene chromosome puffing 3 1.97 -1.0 -1.28 -1.11 1.05 -1.03 2.22
heat shock-mediated polytene chromosome puffing 3 1.97 -1.0 -1.28 -1.11 1.05 -1.03 2.22
induction of programmed cell death by hormones 13 1.07 1.08 1.33 1.05 1.34 1.34 1.34
axoneme assembly 9 -1.07 1.1 1.21 1.07 1.11 -1.04 -1.0
cilium axoneme assembly 2 -1.34 1.15 1.69 1.06 -1.04 -1.19 -1.09
flagellar axoneme assembly 7 -1.01 1.09 1.1 1.07 1.15 -1.0 1.02
flagellar axoneme 1 1.03 1.24 1.01 1.09 1.02 -1.11 1.01
siRNA loading onto RISC involved in RNA interference 4 1.18 1.15 1.71 1.01 1.53 1.21 1.39
establishment or maintenance of apical/basal cell polarity 32 1.32 1.09 1.43 1.03 1.37 1.42 1.25
establishment of apical/basal cell polarity 8 1.65 1.12 1.18 -1.06 1.49 1.45 1.45
maintenance of apical/basal cell polarity 7 1.32 1.27 1.59 1.12 1.39 1.26 1.25
phosphatidylinositol binding 27 1.13 1.11 1.46 1.09 1.31 1.15 1.26
sperm chromatin condensation 2 1.06 1.0 -1.08 -1.02 -1.08 -1.04 -1.06
spermatogenesis, exchange of chromosomal proteins 1 -1.14 -1.02 -1.18 -1.04 -1.12 -1.15 -1.23
response to nicotine 5 -1.06 -1.07 -1.59 -1.13 1.17 1.09 1.28
behavioral response to nicotine 1 1.09 1.23 3.2 1.05 2.53 1.91 1.95
larval midgut cell programmed cell death 3 2.11 1.08 -1.08 1.13 -1.02 1.36 1.42
histone methyltransferase complex 16 1.51 1.16 1.4 1.13 1.36 1.38 1.21
ESC/E(Z) complex 6 1.41 1.17 1.31 1.05 1.17 1.23 1.16
hemocyte migration 16 -1.09 1.08 1.4 1.01 1.37 1.08 1.3
ecdysone binding 1 2.23 1.01 -1.05 1.07 1.28 -1.09 1.2
FACT complex 2 -1.26 1.35 1.06 1.07 1.01 -1.19 1.27
PRC1 complex 10 1.56 1.15 1.36 1.07 1.32 1.49 1.36
sterol regulatory element binding protein cleavage 4 1.66 1.17 1.17 1.07 1.36 1.15 1.2
positive regulation of transcription via sterol regulatory element binding 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
appendage morphogenesis 236 1.25 1.06 1.22 1.01 1.29 1.34 1.3
limb morphogenesis 54 -1.01 1.08 1.1 1.01 1.36 1.25 1.25
imaginal disc-derived limb morphogenesis 54 -1.01 1.08 1.1 1.01 1.36 1.25 1.25
genitalia morphogenesis 15 1.33 1.08 1.32 1.05 1.19 1.03 1.22
imaginal disc-derived appendage morphogenesis 234 1.25 1.06 1.23 1.01 1.29 1.34 1.31
post-embryonic appendage morphogenesis 227 1.26 1.06 1.23 1.01 1.3 1.36 1.32
post-embryonic genitalia morphogenesis 13 1.4 1.09 1.4 1.06 1.26 1.05 1.3
post-embryonic limb morphogenesis 53 -1.02 1.08 1.1 1.01 1.37 1.25 1.26
exon-exon junction complex 4 1.04 1.14 -1.13 1.22 1.04 -1.18 -1.31
tube fusion 19 -1.07 1.1 1.35 1.01 1.36 1.22 1.46
branch fusion, open tracheal system 19 -1.07 1.1 1.35 1.01 1.36 1.22 1.46
tube formation 13 1.06 1.1 1.18 -1.05 1.05 1.27 1.36
lumen formation, open tracheal system 7 1.09 1.3 1.35 1.04 1.16 1.14 1.27
regulation of tube size 46 2.31 -1.17 1.1 -1.22 1.13 2.15 1.48
regulation of tube size, open tracheal system 43 2.4 -1.2 1.11 -1.24 1.13 2.23 1.49
regulation of tube architecture, open tracheal system 66 1.86 -1.09 1.16 -1.16 1.17 1.89 1.38
epithelial cell type specification, open tracheal system 8 1.08 1.1 1.45 1.06 1.34 -1.23 1.4
terminal cell fate specification, open tracheal system 2 -1.05 1.29 1.38 1.19 1.27 -1.18 1.03
negative regulation of terminal cell fate specification, open tracheal system 4 -1.37 1.26 1.57 1.19 1.57 1.09 1.17
fusion cell fate specification 2 -1.28 -1.08 2.4 -1.03 1.63 -2.97 1.01
negative regulation of fusion cell fate specification 3 1.21 1.19 1.16 1.18 1.53 1.57 1.32
regulation of tube diameter, open tracheal system 9 2.29 -1.02 1.09 -1.22 -1.05 2.19 1.55
regulation of tube length, open tracheal system 24 1.81 -1.04 1.23 -1.13 1.27 1.82 1.36
maintenance of epithelial integrity, open tracheal system 12 1.32 -1.13 1.03 -1.19 1.26 1.44 1.38
imaginal disc lineage restriction 11 1.07 1.0 1.1 1.09 1.33 1.19 1.21
embryonic hemopoiesis 23 -1.0 1.08 1.34 1.06 1.31 1.07 1.27
embryonic hemocyte differentiation 4 1.2 1.09 1.17 1.11 1.18 1.01 1.15
embryonic plasmatocyte differentiation 2 1.05 1.01 1.06 1.01 1.02 -1.02 1.01
embryonic crystal cell differentiation 4 1.2 1.09 1.17 1.11 1.18 1.01 1.15
post-embryonic hemopoiesis 11 1.28 1.08 1.31 1.05 1.27 1.44 1.7
larval lymph gland hemopoiesis 11 1.28 1.08 1.31 1.05 1.27 1.44 1.7
larval lymph gland hemocyte differentiation 9 1.36 1.08 1.37 1.04 1.33 1.5 1.66
lymph gland plasmatocyte differentiation 1 1.08 1.07 1.03 1.0 -1.04 -1.0 -1.04
lymph gland crystal cell differentiation 4 1.1 1.01 1.11 1.06 1.31 1.74 2.25
lamellocyte differentiation 4 1.23 1.27 1.61 1.19 1.65 1.45 1.54
hemocyte proliferation 10 1.23 1.17 1.5 1.16 1.47 1.44 1.37
histone kinase activity 3 1.34 1.23 1.39 1.12 1.46 1.54 1.4
histone serine kinase activity 2 1.43 1.39 1.53 1.13 1.4 1.89 1.58
histone kinase activity (H3-S10 specific) 1 1.82 1.38 1.39 1.27 1.17 2.09 1.46
social behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
larval foraging behavior 1 -12.04 -1.69 9.34 -2.59 -11.09 -12.8 -6.11
larval wandering behavior 2 -1.11 1.48 1.63 -1.09 1.06 -1.13 1.6
female germline ring canal outer rim 1 2.22 1.2 -1.59 -1.27 1.13 5.56 1.6
female germline ring canal inner rim 2 2.33 1.09 -1.29 -1.15 -1.06 2.19 1.56
histone threonine kinase activity 1 1.19 -1.04 1.15 1.11 1.6 1.03 1.09
preblastoderm mitotic cell cycle 2 6.0 -2.29 -2.45 -2.24 -2.05 -1.18 2.53
syncytial blastoderm mitotic cell cycle 12 1.27 1.1 1.43 1.06 1.46 1.29 1.37
hatching behavior 2 -5.42 -1.46 -1.97 1.51 -1.45 -12.25 -3.05
hatching 3 -2.59 -1.22 -1.47 1.31 -1.21 -4.45 -1.84
Rb-E2F complex 5 1.18 1.3 1.41 1.2 1.32 1.41 1.26
syncytial nuclear migration 6 1.4 1.18 1.66 1.17 1.63 1.47 1.43
nuclear axial expansion 3 1.16 1.2 2.08 1.13 1.79 1.3 1.53
larval central nervous system remodeling 7 1.02 -1.0 1.26 -1.02 1.21 -1.11 1.24
posttranscriptional gene silencing by RNA 37 1.12 1.04 1.18 1.1 1.27 1.33 1.07
gene silencing by miRNA 19 1.25 1.18 1.35 1.1 1.27 1.48 1.29
siRNA binding 4 -1.07 -1.68 -1.17 -1.84 -1.07 1.05 2.69
salt aversion 1 1.12 1.06 1.12 -1.01 1.01 1.05 -1.06
tracheal pit formation in open tracheal system 4 1.93 -1.11 -1.01 -1.1 1.21 1.33 1.64
regulation of lamellocyte differentiation 4 1.31 1.15 -1.09 -1.04 1.03 1.64 1.15
negative regulation of lamellocyte differentiation 3 1.53 1.17 -1.05 -1.05 1.11 2.06 1.23
regulation of hemocyte proliferation 3 1.68 1.14 1.31 -1.06 1.35 1.48 1.49
negative regulation of hemocyte proliferation 2 1.12 1.36 1.4 1.12 1.42 1.34 1.46
pupal development 6 2.46 -1.28 -1.05 -1.42 -1.1 2.95 -1.08
prepupal development 9 1.36 1.03 1.2 -1.03 1.16 2.15 1.14
spermathecum morphogenesis 3 -1.12 1.12 -1.01 1.14 1.01 1.1 1.03
cell competition in a multicellular organism 8 -1.44 1.26 1.72 1.12 1.65 1.02 1.13
clypeo-labral disc development 6 1.03 1.0 1.19 1.01 1.08 1.14 1.54
eye-antennal disc development 54 1.23 1.06 1.23 1.07 1.21 1.28 1.16
genital disc development 42 1.3 -1.04 1.13 1.03 1.23 1.17 1.1
haltere disc development 10 1.31 -1.02 -1.01 1.12 1.13 -1.17 1.04
labial disc development 4 1.69 -1.22 1.25 -1.11 1.22 1.33 1.1
leg disc development 68 1.06 1.07 1.11 1.01 1.33 1.23 1.24
wing disc development 298 1.28 1.06 1.23 1.02 1.24 1.31 1.31
genital disc pattern formation 8 -1.0 -1.63 -1.11 1.02 1.25 1.06 -1.49
wing disc pattern formation 64 1.33 1.02 1.11 1.04 1.23 1.29 1.24
leg disc pattern formation 17 1.41 1.01 1.1 1.07 1.05 1.04 1.19
genital disc anterior/posterior pattern formation 8 -1.0 -1.63 -1.11 1.02 1.25 1.06 -1.49
determination of genital disc primordium 10 1.07 1.03 1.07 -1.02 1.18 1.04 1.37
glutamate-cysteine ligase catalytic subunit binding 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
regulation of glutamate-cysteine ligase activity 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
positive regulation of glutamate-cysteine ligase activity 1 -1.69 1.43 -1.23 1.48 -1.02 -3.82 -1.18
cytoneme assembly 2 -1.85 -1.12 1.68 1.29 1.66 1.71 -2.53
germ cell attraction 1 -1.72 -1.51 1.07 1.74 1.86 -2.25 -3.98
germ cell repulsion 2 1.22 1.02 1.17 1.16 2.02 -1.19 -1.06
germ cell programmed cell death 6 1.26 1.15 1.12 1.12 1.68 1.26 1.1
ionotropic glutamate receptor signaling pathway 2 -1.26 1.06 -1.07 1.01 -1.06 -1.06 1.04
proctolin receptor activity 1 -1.08 -1.05 -1.14 1.14 -1.06 -1.04 1.03
corazonin receptor activity 1 1.24 1.25 1.2 1.13 1.08 -1.04 1.04
vitamin A biosynthetic process 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
tube morphogenesis 104 1.21 1.02 1.27 1.0 1.31 1.36 1.2
protein-arginine omega-N monomethyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
protein-arginine omega-N asymmetric methyltransferase activity 2 1.08 1.15 1.55 1.17 1.64 1.08 1.14
peptidyl-arginine N-methylation 3 1.19 1.12 1.45 1.13 1.36 1.2 1.09
peptidyl-arginine omega-N-methylation 3 1.19 1.12 1.45 1.13 1.36 1.2 1.09
alpha-1,4-N-acetylgalactosaminyltransferase activity 1 3.56 1.12 1.2 1.23 1.49 1.56 1.46
synaptic transmission, glutamatergic 2 -1.04 1.09 1.07 1.06 1.14 1.17 1.1
UDP-galactosyltransferase activity 13 -1.53 1.04 1.17 1.15 1.2 -1.26 -1.01
UDP-glucosyltransferase activity 10 1.76 -1.24 -1.02 -1.41 1.08 1.69 1.09
UDP-xylosyltransferase activity 1 1.17 1.3 1.39 1.35 1.31 1.22 1.24
ciliary rootlet 1 1.02 1.34 1.17 1.22 -1.17 1.04 1.06
nuclear hormone receptor binding 4 1.17 1.22 1.31 1.27 1.44 1.44 1.01
steroid hormone receptor binding 2 1.48 1.23 1.51 1.28 1.77 1.32 1.19
external genitalia morphogenesis 1 -1.17 -1.03 -1.15 -1.16 -1.43 -1.09 -1.47
gonad morphogenesis 4 -1.42 1.18 1.32 1.12 1.16 -1.2 1.04
genital disc sexually dimorphic development 5 1.78 1.05 1.16 -1.11 -1.05 -1.07 1.31
multicellular organism growth 3 1.09 1.05 1.05 -1.19 -1.03 1.35 1.92
organ growth 18 1.41 1.18 1.37 1.13 1.39 1.29 1.29
NuA4 histone acetyltransferase complex 5 1.44 1.1 1.23 1.2 1.27 1.53 -1.03
protein mannosylation 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
protein O-linked mannosylation 2 1.57 1.01 1.07 -1.18 -1.11 1.61 1.23
endocrine system development 5 1.34 1.03 1.09 -1.08 -1.01 1.09 1.11
ring gland development 5 1.34 1.03 1.09 -1.08 -1.01 1.09 1.11
exocrine system development 141 1.08 1.0 1.15 1.05 1.27 1.18 1.17
phthalate binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
diphenyl phthalate binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
dibutyl phthalate binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
ethanol binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
spiracle morphogenesis, open tracheal system 16 1.23 1.0 1.11 1.01 1.19 1.45 1.19
miRNA loading onto RISC involved in gene silencing by miRNA 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
segmentation 206 1.14 1.07 1.24 1.03 1.25 1.25 1.21
central nervous system segmentation 4 -1.45 -1.33 2.24 -1.39 -1.52 -1.44 -1.38
brain segmentation 4 -1.45 -1.33 2.24 -1.39 -1.52 -1.44 -1.38
appendage segmentation 20 -1.29 1.07 -1.1 -1.14 1.65 1.34 1.29
imaginal disc-derived leg segmentation 20 -1.29 1.07 -1.1 -1.14 1.65 1.34 1.29
head segmentation 22 1.16 -1.02 1.07 1.04 -1.04 -1.02 1.02
anterior head segmentation 9 1.09 -1.1 1.06 1.06 -1.02 -1.13 -1.01
posterior head segmentation 15 1.05 -1.01 1.05 -1.0 1.02 1.0 1.07
trunk segmentation 15 1.21 -1.04 -1.03 1.0 -1.02 1.0 1.11
specification of segmental identity, intercalary segment 1 -1.22 1.08 -1.24 -1.01 -1.23 -1.21 -1.07
specification of segmental identity, trunk 5 1.18 1.16 1.14 1.3 -1.04 1.14 -1.03
chitin-based larval cuticle pattern formation 9 -1.18 1.14 1.32 1.06 1.18 -1.12 1.22
tube development 132 1.13 1.03 1.25 1.01 1.26 1.33 1.19
regulation of tube diameter 12 2.01 1.03 1.06 -1.16 1.02 1.94 1.48
regulation of Malpighian tubule diameter 3 1.35 1.21 -1.03 1.01 1.25 1.33 1.29
regulation of Malpighian tubule size 4 1.53 1.16 1.13 -1.02 1.37 1.52 1.41
inositol pentakisphosphate 2-kinase activity 1 -1.11 1.15 1.19 1.05 1.03 1.14 1.11
Hedgehog signaling complex 4 2.07 1.18 1.21 1.01 1.19 2.13 1.37
ecdysteroid 25-hydroxylase activity 1 1.02 -1.19 -1.05 1.18 -1.22 -1.04 -1.19
regulation of dephosphorylation 8 1.15 1.12 1.06 1.12 1.09 1.13 1.04
regulation of protein dephosphorylation 6 1.25 1.15 1.13 1.13 1.17 1.25 1.12
negative regulation of dephosphorylation 4 1.52 1.1 1.03 1.13 1.22 1.28 1.01
negative regulation of protein dephosphorylation 4 1.52 1.1 1.03 1.13 1.22 1.28 1.01
wing and notum subfield formation 12 1.93 -1.1 1.05 -1.1 1.08 1.14 1.87
notum cell fate specification 4 1.88 -1.36 -1.26 -1.21 1.01 1.16 3.54
wing cell fate specification 3 -1.07 1.05 1.06 -1.14 1.2 -1.05 2.07
wound healing, spreading of epidermal cells 1 -1.04 -1.12 1.46 1.28 1.4 -1.15 1.1
scab formation 1 1.24 1.07 1.06 1.19 1.06 1.05 1.04
hair cell differentiation 41 1.43 1.05 1.43 -1.01 1.36 1.42 1.36
non-sensory hair organization 41 1.43 1.05 1.43 -1.01 1.36 1.42 1.36
imaginal disc-derived wing hair organization 40 1.38 1.06 1.45 -1.0 1.37 1.37 1.36
imaginal disc-derived wing hair outgrowth 1 -2.13 1.07 2.17 -1.03 1.35 -1.42 -1.02
imaginal disc-derived wing hair site selection 3 1.72 -1.01 1.03 -1.08 1.97 1.34 1.24
maintenance of imaginal disc-derived wing hair orientation 3 1.52 1.13 1.79 1.02 1.81 2.37 1.98
male germline ring canal 3 -1.27 1.18 1.18 1.26 1.55 -1.01 1.01
female germline ring canal 3 1.66 1.08 -1.16 1.04 1.18 1.57 1.3
enhancer binding 18 1.2 1.05 1.07 -1.02 1.0 1.04 1.19
transcriptionally active chromatin 19 1.06 1.16 1.2 1.2 1.33 1.29 1.09
transcriptionally silent chromatin 1 1.82 1.17 1.65 -1.11 1.49 1.95 1.38
hippo signaling cascade 7 1.44 1.16 1.3 1.05 1.29 1.47 1.15
regulation of hippo signaling cascade 2 3.69 1.25 1.96 -1.14 1.8 2.24 2.45
negative regulation of hippo signaling cascade 1 3.54 1.08 1.48 -1.26 1.42 1.25 1.69
fatty-acyl-CoA metabolic process 4 1.86 1.19 1.27 1.15 1.54 1.19 1.01
histone locus body 7 1.03 1.04 1.16 1.17 1.27 1.05 1.03
microtubule plus end 2 1.59 1.18 1.94 -1.04 1.66 1.95 1.8
thioester metabolic process 6 2.01 1.03 1.27 1.12 1.42 1.33 1.06
thioester biosynthetic process 5 2.3 1.04 1.28 1.15 1.53 1.22 1.09
Roundabout signaling pathway 2 1.81 1.11 1.52 1.11 1.43 1.62 1.25
regulation of Roundabout signaling pathway 1 1.04 1.02 -1.06 1.23 1.3 3.59 1.24
histone-serine phosphorylation 1 1.24 1.29 1.32 1.24 1.1 -1.34 -1.14
regulation of mitotic prometaphase 1 1.18 -1.09 1.06 1.12 1.44 -1.15 -1.22
protein localization to synapse 1 1.3 1.23 1.1 1.08 1.16 2.99 1.24
copper ion transmembrane transport 4 -1.26 1.17 1.07 1.07 -1.01 -1.03 1.07
phosphate ion transmembrane transport 4 -1.25 -1.17 -1.77 -1.14 -1.01 2.78 -1.28
maintenance of protein localization in endoplasmic reticulum 3 -1.9 1.28 -1.09 1.08 -1.19 -2.08 1.34
regulation of chromatin binding 3 -1.0 1.07 1.16 1.27 1.61 -1.41 -1.14
non-canonical Wnt receptor signaling pathway 6 1.09 -1.01 1.23 -1.1 1.27 1.47 1.72
purinergic receptor activity 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
signaling adaptor activity 10 1.08 1.02 1.26 1.08 1.17 1.33 -1.04
establishment of protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
positive regulation of Wnt receptor signaling pathway by establishment of Wnt protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
protein deacylation 11 1.53 1.15 1.12 1.23 1.27 1.36 1.13
RNA stem-loop binding 2 1.54 -1.06 1.11 1.22 1.17 1.23 -1.02
snRNA stem-loop binding 1 1.41 -1.11 1.3 1.34 1.31 1.54 -1.14
ceramide transporter activity 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
ER to Golgi ceramide transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
juvenile hormone mediated signaling pathway 3 -1.19 1.31 1.42 1.17 1.93 1.0 1.17
ceramide transport 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
maintenance of blood-brain barrier 1 7.29 -3.52 -1.24 -1.54 -1.02 7.02 -1.25
multicellular organismal signaling 223 1.08 1.07 1.2 1.03 1.19 1.22 1.13
signal maturation 3 -1.03 1.15 1.23 1.08 1.5 -1.16 1.1
purine ribonucleoside triphosphate binding 806 1.08 1.1 1.19 1.08 1.22 1.17 1.09
exploration behavior 1 3.78 1.32 1.35 -1.13 1.11 1.73 1.58
locomotory exploration behavior 1 3.78 1.32 1.35 -1.13 1.11 1.73 1.58
oligopeptide transmembrane transporter activity 3 1.69 -1.17 -1.51 -1.15 -1.07 1.17 1.2
cell proliferation involved in compound eye morphogenesis 1 -1.2 1.15 1.53 1.19 1.27 1.15 1.24
ribonucleoprotein granule 26 1.39 1.14 1.33 1.09 1.3 1.57 1.15
ubiquitin-specific protease activator activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
egg coat formation 12 1.14 1.01 -1.05 -1.02 -1.08 1.01 -1.0
structural constituent of egg coat 5 -1.04 1.0 -1.05 -1.03 -1.16 -1.05 -1.08
egg coat 5 -1.16 -1.01 -1.07 -1.03 -1.18 -1.17 -1.07
reciprocal DNA recombination 22 1.06 1.12 1.07 1.13 1.17 1.01 1.01
ciliary transition zone 2 -1.07 -1.03 -1.02 1.13 -1.1 -1.09 -1.15
skeletal muscle cell differentiation 27 1.01 1.06 1.27 -1.02 1.21 1.27 1.14
response to topologically incorrect protein 2 1.04 1.38 1.16 -1.1 1.05 1.03 1.56
cellular response to topologically incorrect protein 1 -1.05 1.27 -1.17 -1.24 -1.49 -1.01 1.19
peptidyl-threonine dephosphorylation 1 1.22 1.23 -1.22 1.31 1.05 -1.8 -1.36
endodermal cell differentiation 1 8.12 -1.58 1.44 -1.54 1.01 1.69 1.21
pre-mRNA binding 1 1.28 1.07 1.73 1.12 1.48 1.94 1.41
limb joint morphogenesis 8 -2.19 1.03 -1.69 -1.64 2.1 1.1 1.32
filtration diaphragm 3 -3.44 1.01 1.01 1.15 1.01 -2.84 -1.29
filtration diaphragm assembly 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
nephrocyte diaphragm assembly 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
presynaptic periactive zone 2 1.13 1.16 1.42 1.03 1.54 1.68 1.68
acroblast 1 -1.29 1.49 1.22 1.13 1.05 1.04 1.36
fucosylation 2 -1.26 1.19 -1.04 1.47 1.01 -1.41 -1.39
protein O-linked fucosylation 2 -1.26 1.19 -1.04 1.47 1.01 -1.41 -1.39
N-glycan fucosylation 1 -1.64 1.12 -1.15 1.5 1.42 -1.98 -1.63
minus-end specific microtubule depolymerization 2 -1.34 1.21 1.12 1.01 1.15 1.13 1.12
purine nucleotide-sugar transport 2 -1.26 1.19 -1.04 1.47 1.01 -1.41 -1.39
extracellular ammonia-gated ion channel activity 1 -1.06 -1.02 1.01 1.08 -1.26 -1.1 -1.15
extracellular phenylacetaldehyde-gated ion channel activity 1 -1.38 1.0 -1.11 -1.02 -1.17 -1.19 1.01
GDP-fucose import into endoplasmic reticulum lumen 1 1.04 1.26 1.06 1.45 -1.4 -1.0 -1.18
GDP-fucose import into Golgi lumen 1 -1.64 1.12 -1.15 1.5 1.42 -1.98 -1.63
small molecule binding 1251 1.1 1.05 1.07 1.05 1.14 1.14 1.07
fatty acid beta-oxidation multienzyme complex 2 2.42 1.07 -1.08 1.02 1.26 1.66 -1.08
kynurenine aminotransferase activity 1 1.14 1.23 -1.25 1.13 -1.05 1.32 1.04
epidermal growth factor receptor ligand maturation 2 -1.08 1.07 1.03 -1.09 1.34 -1.21 1.17
peptide bond cleavage involved in epidermal growth factor receptor ligand maturation 1 -1.2 -1.0 -1.26 -1.23 1.12 -1.78 1.11
netrin-activated signaling pathway 1 -10.89 1.57 1.23 -1.08 -1.19 -6.39 1.44
signaling receptor activity 360 1.11 -1.02 1.05 -1.02 1.03 1.11 1.05
termination of G-protein coupled receptor signaling pathway 9 1.61 1.14 1.6 1.12 1.38 1.47 1.34
negative regulation of BMP signaling pathway by negative regulation of BMP secretion 1 -1.14 1.11 -1.09 1.17 -1.12 -1.22 -1.05
ERBB signaling pathway 34 1.44 1.08 1.27 1.08 1.29 1.29 1.22
establishment of mitotic spindle localization 9 -1.21 1.28 1.27 1.13 1.32 1.06 1.1
chitin-based cuticle development 75 1.22 -1.06 -1.0 -1.08 -1.04 1.24 1.13
chitin-based cuticle attachment to epithelium 3 6.48 -1.33 -1.2 -1.65 -1.09 5.63 1.91
protein-based cuticle attachment to epithelium 12 1.66 -1.21 -1.1 -1.18 -1.09 1.51 1.5
regulation of growth rate 1 1.08 -1.16 -1.09 1.12 -1.12 1.04 -1.07
locomotion 406 1.12 1.06 1.21 1.02 1.26 1.23 1.22
regulation of locomotion 16 1.62 -1.06 1.25 -1.04 1.18 1.21 1.39
negative regulation of locomotion 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
regulation of multicellular organism growth 30 1.09 1.12 1.29 1.0 1.23 1.41 1.42
negative regulation of multicellular organism growth 4 1.6 1.06 1.17 -1.17 1.27 2.71 1.48
embryonic cleavage 4 1.73 1.15 1.27 1.05 1.09 1.55 1.23
positive regulation of multicellular organism growth 18 -1.05 1.16 1.29 1.01 1.23 1.35 1.42
regulation of meiosis 6 1.06 1.25 1.33 1.14 1.41 1.2 1.19
establishment of nucleus localization 24 1.13 1.16 1.28 1.13 1.3 1.19 1.15
regulation of gene expression, epigenetic 101 1.25 1.1 1.27 1.1 1.29 1.34 1.18
snRNA modification 2 -1.23 1.23 1.84 1.26 1.56 -1.27 1.05
regulation of development, heterochronic 11 1.25 1.11 1.24 1.06 1.18 1.2 1.12
regulation of fibroblast growth factor receptor signaling pathway 2 -1.9 1.49 1.19 1.1 1.08 -1.77 1.19
negative regulation of fibroblast growth factor receptor signaling pathway 2 -1.9 1.49 1.19 1.1 1.08 -1.77 1.19
thermosensory behavior 6 1.6 -1.4 -1.4 -1.32 -1.22 1.3 1.62
DNA endoreduplication 16 1.23 1.15 1.24 1.15 1.47 1.49 1.25
fluid transport 13 1.15 -1.04 -1.12 -1.03 1.05 1.11 1.09
epithelial fluid transport 9 1.44 -1.07 -1.0 -1.13 1.2 1.6 1.1
olfactory behavior 83 1.02 1.05 1.18 -1.02 1.16 1.12 1.18
cellular acyl-CoA homeostasis 6 -3.11 -1.44 -2.62 1.15 1.36 -3.71 -1.6
rhabdomere development 25 1.09 1.1 1.42 -1.0 1.23 1.32 1.22
regulation of dopamine metabolic process 2 1.15 -1.11 1.14 1.21 1.14 -1.17 1.36
histone methyltransferase activity 17 1.26 1.24 1.47 1.08 1.41 1.32 1.32
regulation of epidermal growth factor receptor signaling pathway 30 1.05 1.05 1.28 1.05 1.31 1.06 1.19
negative regulation of epidermal growth factor receptor signaling pathway 20 1.01 1.05 1.24 1.07 1.24 1.05 1.14
wound healing 24 1.08 -1.07 1.03 -1.16 1.04 1.25 1.33
long-term strengthening of neuromuscular junction 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
gliogenesis 57 1.43 -1.08 1.21 -1.07 1.26 1.62 1.2
glial cell growth 6 -1.14 -1.15 -1.08 -1.34 1.14 2.33 1.04
perineurial glial growth 6 -1.14 -1.15 -1.08 -1.34 1.14 2.33 1.04
establishment of ommatidial planar polarity 48 1.14 1.05 1.16 -1.01 1.24 1.16 1.5
regulation of catecholamine metabolic process 3 1.05 1.06 1.07 1.15 1.1 -1.22 1.43
maintenance of oocyte nucleus location involved in oocyte dorsal/ventral axis specification 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
leucokinin receptor activity 1 1.19 -1.18 -1.07 -1.08 2.45 1.28 2.37
intraflagellar transport 4 -1.17 1.08 1.02 1.06 1.03 -1.03 -1.17
cell migration involved in gastrulation 8 1.53 -1.02 1.51 -1.06 1.32 1.72 1.01
germ-line stem cell division 32 1.22 1.09 1.29 1.05 1.29 1.16 1.18
5,10-methylenetetrahydrofolate-dependent methyltransferase activity 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
macrophage activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
regulation of cell proliferation 90 1.31 1.08 1.33 1.08 1.45 1.37 1.19
fructose 1,6-bisphosphate 1-phosphatase activity 1 6.67 1.2 1.32 -2.53 -1.76 2.31 2.31
neurotransmitter metabolic process 6 -1.15 1.13 -1.61 -1.13 -1.28 -2.46 1.45
neurotransmitter catabolic process 2 -1.99 1.48 -3.26 -1.27 -2.14 -11.86 3.38
meiotic DNA double-strand break formation 3 1.11 1.2 1.11 1.16 1.03 1.04 -1.07
early meiotic recombination nodule assembly 1 -1.21 1.44 1.1 1.2 1.03 -1.18 1.17
late meiotic recombination nodule assembly 1 -1.21 1.44 1.1 1.2 1.03 -1.18 1.17
retrograde transport, endosome to Golgi 2 -1.61 1.37 1.68 1.0 1.09 1.3 1.14
lipoprotein metabolic process 52 -1.06 1.01 1.05 1.04 1.15 -1.02 -1.13
lipoprotein biosynthetic process 50 -1.11 1.0 1.04 1.04 1.13 -1.02 -1.14
lipoprotein catabolic process 2 2.75 1.12 1.29 1.19 1.61 1.16 1.22
neurotransmitter binding 1 -1.34 -1.11 -1.08 -1.04 -1.26 -1.15 -1.15
acetylcholine binding 1 -1.34 -1.11 -1.08 -1.04 -1.26 -1.15 -1.15
heme metabolic process 9 1.28 1.21 1.24 1.17 1.12 1.19 -1.04
SH2 domain binding 4 1.97 -1.06 1.04 -1.03 1.04 1.79 1.15
lysophosphatidic acid acyltransferase activity 1 1.37 1.22 1.4 1.12 1.37 1.84 1.71
nuclear outer membrane-endoplasmic reticulum membrane network 66 -1.13 1.17 1.14 1.11 1.13 -1.15 1.14
regulation of protein catabolic process 10 1.41 1.11 1.26 1.18 1.24 1.23 1.21
negative regulation of protein catabolic process 3 1.42 1.07 1.19 1.26 1.18 -1.01 -1.02
xenobiotic catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
cellular ketone metabolic process 259 1.01 -1.01 -1.13 -1.02 1.01 1.08 -1.04
ketone biosynthetic process 12 1.31 -1.17 -1.03 -1.07 1.06 1.52 1.13
ketone catabolic process 1 1.07 -1.12 1.15 -1.13 -1.09 1.14 -1.07
terpene metabolic process 1 1.12 -1.01 1.14 1.06 1.09 1.14 -1.06
1-aminocyclopropane-1-carboxylate biosynthetic process 2 1.14 1.17 -1.17 -1.01 1.02 1.07 -1.0
response to cocaine 13 1.28 1.17 1.57 1.07 1.39 1.83 1.27
response to chemical stimulus 654 1.11 1.04 1.13 1.0 1.14 1.18 1.15
tissue regeneration 8 -1.03 -1.05 -1.06 -1.23 1.0 1.47 1.44
maintenance of polarity of follicular epithelium 2 -2.09 1.21 1.5 1.33 2.17 -1.63 -1.29
establishment of planar polarity of embryonic epithelium 1 -2.32 1.45 1.45 1.19 1.32 -1.02 1.2
maintenance of polarity of embryonic epithelium 1 1.75 -1.09 1.21 -1.06 -1.12 -1.14 -1.06
ribosome assembly 3 1.33 1.18 1.17 1.23 1.06 1.03 1.04
mature ribosome assembly 1 -1.17 1.17 1.23 1.32 1.08 -1.28 1.0
neuropeptide F receptor activity 1 -1.53 -1.53 2.77 -1.11 -1.08 -1.73 1.51
ribosomal large subunit biogenesis 1 1.48 1.28 1.8 1.26 1.7 1.35 1.33
ribosomal small subunit biogenesis 2 1.29 1.16 1.18 1.34 1.24 1.04 1.05
peptide binding 14 -1.09 1.19 -1.02 1.09 -1.0 -1.25 1.18
host cell surface receptor binding 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity 1 -1.04 -1.0 1.06 -1.08 -1.02 -1.02 -1.17
sphingolipid delta-4 desaturase activity 1 -6.62 1.41 1.16 1.17 1.23 -3.29 -1.25
xylosyltransferase activity 1 1.17 1.3 1.39 1.35 1.31 1.22 1.24
structural constituent of cuticle 133 1.15 -1.12 -1.18 -1.14 -1.24 -1.07 -1.1
molting cycle 55 1.16 -1.03 1.01 -1.09 -1.04 1.19 1.17
regulation of fatty acid biosynthetic process 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
specification of segmental identity, mandibular segment 2 -1.03 1.02 1.14 1.06 -1.05 -1.03 1.17
regulation of protein import into nucleus 30 1.19 1.1 1.26 1.1 1.28 1.31 1.24
positive regulation of protein import into nucleus 18 1.13 1.06 1.22 1.1 1.37 1.17 1.13
negative regulation of protein import into nucleus 5 2.19 1.12 1.26 1.06 1.21 2.05 1.7
protein kinase C deactivation 1 -1.49 1.25 1.1 1.05 -1.11 -1.19 1.29
penicillin metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
penicillin biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
regulation of phosphorylation 73 1.32 1.12 1.35 1.09 1.31 1.39 1.22
negative regulation of phosphorylation 4 1.29 -1.03 1.47 -1.02 1.17 1.39 1.53
positive regulation of phosphorylation 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
heparan sulfate N-acetylglucosaminyltransferase activity 1 1.03 1.3 1.31 1.09 1.28 -1.03 1.49
taxis 226 1.11 1.04 1.18 -1.0 1.24 1.24 1.24
phototaxis 14 1.37 -1.07 1.01 -1.18 -1.0 1.35 1.36
gravitaxis 12 1.09 -1.01 1.03 1.04 1.1 1.2 -1.03
cuticle development 99 1.22 -1.04 1.03 -1.07 -1.01 1.25 1.21
cuticle development involved in protein-based cuticle molting cycle 13 1.28 -1.16 -1.04 -1.21 -1.09 1.14 1.17
cuticle development involved in chitin-based cuticle molting cycle 13 1.28 -1.16 -1.04 -1.21 -1.09 1.14 1.17
regulation of NF-kappaB import into nucleus 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
positive regulation of NF-kappaB import into nucleus 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
GDP-L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
'de novo' GDP-L-fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
fucose biosynthetic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
L-fucose metabolic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
GDP-4-dehydro-D-rhamnose reductase activity 1 1.27 1.21 1.12 1.11 1.24 -1.28 1.03
thiamine diphosphate metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
fat-soluble vitamin biosynthetic process 2 1.28 1.03 1.33 -1.0 1.21 1.44 1.16
water-soluble vitamin biosynthetic process 7 1.81 1.34 -1.5 -1.06 -1.3 1.43 1.2
vitamin K biosynthetic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
vitamin K metabolic process 1 1.46 1.06 1.55 -1.07 1.35 1.82 1.43
quinone cofactor metabolic process 6 1.17 1.16 1.19 1.16 1.13 1.18 -1.0
hemolymph coagulation 4 2.28 -1.81 -1.98 -1.93 -1.56 2.0 -1.05
sarcolemma 1 1.33 1.32 2.26 1.11 1.52 1.39 1.48
cilium assembly 33 -1.14 1.06 1.0 1.05 -1.01 -1.08 -1.05
myosin III complex 1 1.02 1.14 1.09 1.03 -1.02 -1.07 1.03
hemocyte differentiation 21 1.07 1.13 1.28 1.06 1.25 1.24 1.45
plasmatocyte differentiation 4 1.61 1.03 1.11 -1.07 1.04 1.16 1.15
regulation of membrane potential 25 1.35 1.01 -1.06 -1.33 -1.11 1.68 1.19
ecdysis, protein-based cuticle 7 1.02 1.08 1.04 -1.01 -1.03 1.01 1.06
cellular modified amino acid biosynthetic process 9 -1.29 1.26 -1.08 1.13 -1.05 -1.2 1.04
cellular biogenic amine biosynthetic process 15 1.13 -1.22 -1.12 -1.08 -1.06 1.41 1.13
cellular biogenic amine catabolic process 5 -1.3 1.11 -1.68 -1.14 -1.45 -2.28 1.45
dopamine biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
dopamine metabolic process 6 -1.15 -1.33 -1.39 -1.24 -1.48 -1.23 1.83
dopamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
catecholamine biosynthetic process 3 -1.04 -2.12 -1.47 -1.4 -1.53 1.41 2.4
catecholamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
choline catabolic process 1 2.27 1.23 -5.17 -1.59 -2.2 -9.9 9.42
serotonin biosynthetic process 3 1.22 -1.67 -1.93 -1.69 -1.72 1.14 2.21
serotonin metabolic process 4 -1.49 -1.27 -1.96 -1.49 -1.8 -1.76 1.9
serotonin catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
indole-containing compound metabolic process 10 1.08 -1.21 -1.47 -1.12 -1.41 1.12 1.14
indole-containing compound biosynthetic process 5 1.73 -1.47 -1.62 -1.41 -1.53 1.76 1.53
indole-containing compound catabolic process 3 -1.86 1.07 -1.41 -1.17 -1.45 -1.76 -1.05
melanin biosynthetic process 4 1.82 -1.08 -1.09 -1.03 -1.18 1.82 -1.13
ethanolamine-containing compound metabolic process 9 -1.03 1.01 -1.15 -1.07 -1.12 -1.49 1.71
pigment metabolic process 65 1.43 -1.06 -1.1 1.04 1.04 1.15 1.03
eye pigment metabolic process 30 1.05 -1.06 -1.17 1.17 1.04 -1.09 -1.16
hormone metabolic process 36 1.14 -1.24 -1.31 -1.23 -1.11 -1.09 1.2
hormone biosynthetic process 17 1.38 -1.6 -1.55 -1.49 -1.23 1.24 1.42
hormone catabolic process 5 -1.49 1.14 -1.05 -1.06 -1.26 -2.36 1.19
arginine biosynthetic process via ornithine 1 -15.39 1.51 -7.96 1.39 1.15 -4.77 -1.11
purine nucleoside biosynthetic process 7 1.07 1.09 -1.03 1.13 1.19 -1.05 -1.12
ribonucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
ribonucleoside biosynthetic process 7 1.07 1.09 -1.03 1.13 1.19 -1.05 -1.12
photoreceptor cell development 72 1.13 1.13 1.31 1.04 1.26 1.19 1.22
eye photoreceptor cell development 61 1.11 1.13 1.34 1.04 1.25 1.22 1.23
ocellus photoreceptor cell development 2 -1.04 1.07 -1.15 -1.03 -1.15 -1.11 1.0
regulation of eye photoreceptor cell development 11 1.05 1.08 1.34 1.01 1.28 1.07 1.22
positive regulation of eye photoreceptor cell development 1 2.02 1.25 1.56 1.13 1.49 2.5 1.69
negative regulation of eye photoreceptor cell development 3 -1.04 -1.04 1.09 -1.03 1.27 -1.29 1.13
aspartic endopeptidase activity, intramembrane cleaving 2 -1.09 1.35 -1.07 1.16 -1.03 -1.2 1.46
regulation of tyrosine phosphorylation of STAT protein 1 1.28 1.03 1.08 -1.21 -1.11 1.23 -1.01
negative regulation of tyrosine phosphorylation of STAT protein 1 1.28 1.03 1.08 -1.21 -1.11 1.23 -1.01
benzene-containing compound metabolic process 9 -1.02 -1.18 -1.26 -1.16 -1.28 -1.1 1.52
hyperosmotic salinity response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
response to hydrogen peroxide 9 -1.09 1.06 -1.06 1.22 1.22 -1.32 -1.19
neuron maturation 19 1.17 -1.01 1.21 1.01 1.4 1.66 1.06
pteridine-containing compound metabolic process 19 1.66 1.0 1.01 1.02 -1.03 1.17 1.15
pteridine-containing compound biosynthetic process 17 1.71 -1.0 -1.01 -1.01 -1.05 1.15 1.18
pteridine-containing compound catabolic process 1 -1.35 1.22 1.7 1.18 1.15 -1.09 1.03
hormone binding 9 1.25 1.01 1.03 1.03 1.09 1.15 1.08
retinol metabolic process 1 -1.07 1.02 1.03 -1.03 -1.28 1.11 -1.06
retinal metabolic process 2 1.02 1.01 1.08 1.02 -1.08 1.12 -1.06
DNA polymerase complex 7 1.2 1.16 1.12 1.11 1.16 1.17 -1.15
lipid phosphatase activity 2 -1.51 1.0 1.16 1.09 1.56 -1.48 -1.22
phosphoric ester hydrolase activity 206 1.06 1.0 -1.06 1.02 1.1 1.08 1.0
microbody 39 1.3 -1.06 -1.53 1.05 1.16 -1.5 -1.16
peptide deformylase activity 2 1.03 1.02 -2.05 1.3 1.27 -1.09 -2.35
homeostatic process 183 1.07 1.02 1.12 -1.0 1.08 1.18 1.06
glucose homeostasis 1 1.23 1.27 1.15 1.19 1.2 1.15 1.07
response to starvation 29 1.1 -1.06 1.01 -1.06 1.08 -1.01 1.16
behavioral response to starvation 4 -1.14 -2.62 -2.82 -2.72 -3.01 -3.18 1.82
periplasmic space 9 1.87 -1.07 1.01 -1.1 -1.04 1.24 -1.01
vesicular fraction 85 -1.05 -1.16 -1.3 -1.04 1.03 -1.24 -1.12
chorion 17 1.11 -1.0 -1.02 1.07 -1.04 -1.16 -1.04
ATPase activity, coupled to transmembrane movement of ions 67 -1.16 1.01 1.26 -1.1 -1.0 1.35 -1.07
mating plug formation 2 1.04 1.05 1.11 1.02 -1.07 -1.15 -1.16
cholesterol homeostasis 3 -6.81 -2.38 -1.29 1.48 -2.64 -3.47 -5.64
actomyosin 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
mitochondrial nucleoid 1 1.18 1.16 1.75 1.38 1.68 1.06 -1.24
ecdysis-triggering hormone receptor activity 1 -1.33 -1.06 -1.14 -1.28 -1.36 -1.06 -1.24
JUN kinase kinase kinase kinase activity 1 -1.25 1.21 1.4 1.19 1.07 1.11 1.44
regulation of cell fate specification 25 1.18 1.07 1.15 1.01 1.2 1.06 1.15
regulation of retinal cone cell fate specification 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
compound eye cone cell differentiation 14 1.25 1.17 1.35 1.14 1.48 1.22 1.4
compound eye cone cell fate commitment 7 1.02 1.24 1.18 1.18 1.59 1.22 1.33
regulation of compound eye cone cell fate specification 2 1.2 1.07 1.13 -1.09 1.23 1.23 1.3
negative regulation of compound eye cone cell fate specification 2 1.2 1.07 1.13 -1.09 1.23 1.23 1.3
cardioblast cell fate commitment 6 1.11 1.0 1.08 1.01 1.1 -1.11 1.03
cardioblast cell fate specification 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
regulation of cardioblast cell fate specification 8 1.02 1.09 1.19 1.04 1.21 -1.01 1.39
crystal cell differentiation 8 1.09 1.04 1.08 1.05 1.19 1.34 1.82
regulation of crystal cell differentiation 7 1.04 1.03 1.09 1.03 1.17 1.42 1.89
negative regulation of crystal cell differentiation 4 1.02 1.05 1.07 1.04 1.02 1.08 1.37
positive regulation of crystal cell differentiation 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
muscle cell differentiation 115 1.29 1.03 1.23 -1.03 1.17 1.35 1.21
muscle cell fate commitment 8 -1.1 -1.16 -1.07 -1.18 -1.07 -1.08 2.39
muscle cell fate specification 3 1.42 1.19 1.29 1.07 1.29 2.0 1.68
ovulation cycle 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
ocellus photoreceptor cell differentiation 2 -1.04 1.07 -1.15 -1.03 -1.15 -1.11 1.0
eye photoreceptor cell fate commitment 51 1.32 1.09 1.23 1.09 1.32 1.24 1.18
succinate-CoA ligase complex 4 1.26 -1.07 1.22 -1.12 1.17 1.73 -1.33
dosage compensation complex assembly 3 1.47 1.24 1.5 1.08 1.32 1.62 1.47
mitochondrial intermembrane space protein transporter complex 6 1.1 1.08 1.31 1.16 1.2 1.34 -1.18
thiamine-containing compound metabolic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
thiamine-containing compound biosynthetic process 1 1.06 1.62 -1.26 1.22 -1.14 -1.11 1.12
flavin-containing compound metabolic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
flavin-containing compound biosynthetic process 2 1.78 2.05 -2.11 -2.16 -2.52 2.14 1.44
D-xylose metabolic process 1 1.17 1.3 1.39 1.35 1.31 1.22 1.24
hydrogen peroxide metabolic process 5 -1.31 1.04 -1.13 1.14 1.05 -1.39 -1.21
hydrogen peroxide catabolic process 5 -1.31 1.04 -1.13 1.14 1.05 -1.39 -1.21
circadian sleep/wake cycle 19 -1.16 1.13 1.1 -1.04 1.16 1.12 1.12
regulation of circadian sleep/wake cycle 16 -1.12 1.18 1.14 -1.02 1.04 1.13 1.15
regulation of circadian rhythm 34 1.14 1.12 1.18 1.01 1.11 1.4 1.23
positive regulation of circadian rhythm 2 1.24 1.16 1.04 -1.02 1.05 1.25 1.29
drinking behavior 2 -1.36 -1.02 1.18 1.1 1.66 -1.79 1.09
long-chain fatty acid biosynthetic process 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
very long-chain fatty acid biosynthetic process 1 12.72 -1.88 -1.16 -3.3 -1.54 3.13 2.87
GPI-anchor transamidase complex 2 1.49 1.08 1.21 1.27 1.12 -1.05 -1.02
nucleosome mobilization 5 1.33 1.2 1.59 1.27 1.63 1.57 1.26
ecdysteroid 22-hydroxylase activity 1 -1.29 -1.12 -1.07 -1.16 -1.36 -1.02 -1.2
ecdysteroid 2-hydroxylase activity 1 -1.19 1.02 -1.06 1.03 -1.14 -1.03 -1.16
signal transduction in response to DNA damage 9 1.53 1.18 1.1 1.13 1.27 1.31 1.44
DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
ATP synthesis coupled electron transport 59 1.05 1.03 1.22 1.05 1.09 1.56 -1.33
mitochondrial ATP synthesis coupled electron transport 57 1.06 1.03 1.23 1.05 1.1 1.56 -1.33
tRNA 3'-trailer cleavage 1 1.37 1.18 1.82 1.25 1.62 1.5 1.42
tRNA 3'-end processing 1 1.37 1.18 1.82 1.25 1.62 1.5 1.42
snRNA transcription from RNA polymerase II promoter 4 1.14 1.21 1.28 1.12 1.26 1.23 1.22
snRNA transcription from RNA polymerase III promoter 3 1.69 1.17 1.43 1.09 1.41 1.27 1.23
tRNA transcription from RNA polymerase III promoter 1 1.67 1.25 1.56 1.07 1.53 1.47 1.26
histone methyltransferase activity (H4-K20 specific) 3 1.11 1.29 1.61 1.13 1.69 1.86 1.45
histone methyltransferase activity (H3-K4 specific) 4 1.72 1.25 1.86 1.03 1.8 2.11 1.88
polo kinase kinase activity 1 1.11 1.2 3.72 1.08 1.65 2.06 2.0
protein homodimerization activity 65 1.35 1.04 1.0 -1.02 1.11 1.22 1.18
protein homooligomerization 4 1.26 1.29 1.33 1.14 1.48 1.55 1.11
actinin binding 1 1.14 -1.01 1.12 1.41 1.03 -1.2 -1.43
fucose binding 2 1.18 -1.09 -1.2 -1.39 -1.4 -1.1 2.98
pheromone metabolic process 9 1.62 -1.49 -1.71 -1.43 -1.39 1.17 1.34
pheromone biosynthetic process 3 1.42 -3.74 -5.02 -3.4 -2.87 -1.24 2.33
vitamin B6 metabolic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
vitamin B6 biosynthetic process 4 2.09 1.04 -1.32 1.26 1.04 1.32 1.12
histone deacetylase binding 13 2.66 -1.15 1.12 1.01 1.08 1.67 1.03
peptidoglycan binding 12 -1.13 -1.64 -1.19 -1.04 -1.82 -1.69 -1.29
amide transport 1 1.41 1.17 -1.02 1.18 -1.05 -1.09 1.18
xenobiotic transporter activity 8 -1.32 1.18 1.1 1.25 1.08 -1.09 1.15
D-amino acid transport 1 -1.04 -22.78 -24.12 -1.99 7.91 4.55 1.12
D-amino acid transmembrane transporter activity 1 -1.04 -22.78 -24.12 -1.99 7.91 4.55 1.12
glucoside transport 2 1.24 -2.16 -1.19 -2.0 -1.13 3.38 1.3
lipoprotein transport 1 -1.18 2.03 -1.34 -1.0 -1.31 -1.12 -1.14
ornithine decarboxylase regulator activity 1 1.05 1.03 -1.12 1.06 -1.03 -1.01 1.05
amyloid precursor protein metabolic process 1 1.02 1.3 1.25 1.11 1.03 1.74 1.33
regulation of transcription factor import into nucleus 22 1.33 1.06 1.24 1.08 1.34 1.31 1.23
negative regulation of transcription factor import into nucleus 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
positive regulation of transcription factor import into nucleus 18 1.13 1.06 1.22 1.1 1.37 1.17 1.13
cell projection 159 1.04 1.05 1.18 -1.0 1.11 1.26 1.13
neuron projection 92 1.14 1.04 1.23 -1.01 1.17 1.39 1.21
maintenance of rDNA 1 1.01 1.1 1.09 1.14 -1.01 1.17 1.11
camera-type eye development 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
gamma-tubulin binding 5 1.28 1.03 1.2 1.09 1.23 1.33 1.14
ribonucleoprotein complex binding 11 1.27 1.17 1.32 1.05 1.14 1.31 1.33
ribosome binding 6 1.66 1.06 1.42 1.03 1.28 1.53 1.23
ribosomal small subunit binding 1 2.01 1.25 1.56 -1.2 1.13 3.31 1.74
neuronal cell body 26 -1.0 -1.02 1.2 1.05 1.13 1.07 1.02
cysteine-type endopeptidase inhibitor activity involved in apoptotic process 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
cysteine-type endopeptidase regulator activity involved in apoptotic process 1 -1.96 -1.03 2.81 1.35 1.53 -2.84 -1.09
costamere 1 1.22 1.1 -1.01 1.09 -1.06 -1.14 -1.04
amino acid activation 42 -1.06 1.25 1.26 1.14 1.18 1.05 1.08
tRNA aminoacylation 41 -1.07 1.25 1.27 1.14 1.19 1.05 1.09
amino acid activation for nonribosomal peptide biosynthetic process 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
amino acid adenylylation by nonribosomal peptide synthase 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
peptide biosynthetic process 4 -2.1 1.35 -1.25 1.15 -1.28 -1.79 1.11
ATP-dependent chromatin remodeling 11 1.15 1.19 1.36 1.14 1.3 1.34 1.2
DNA methylation involved in embryo development 1 1.54 1.07 -1.03 1.11 1.17 1.09 1.04
thermotaxis 16 1.05 -1.29 -1.09 -1.04 1.16 -1.11 -1.04
regulation of forward locomotion 1 1.3 1.0 -1.05 -1.09 1.04 -1.06 -1.0
meiotic metaphase I plate congression 1 -1.17 1.02 -1.13 1.11 -1.02 -1.2 -1.13
extracellular structure organization 38 -1.02 1.05 1.2 -1.0 1.18 1.05 1.23
intercellular bridge organization 13 1.05 1.09 1.3 1.08 1.37 1.26 1.26
flagellum organization 10 -1.03 1.09 1.07 1.09 1.11 1.01 -1.02
positive regulation of apoptotic process 34 1.1 1.17 1.11 1.1 1.27 1.06 1.22
negative regulation of apoptotic process 49 1.26 1.09 1.28 1.03 1.27 1.36 1.28
regulation of programmed cell death 113 1.08 1.13 1.31 1.07 1.3 1.2 1.21
positive regulation of programmed cell death 49 -1.01 1.15 1.2 1.09 1.32 1.04 1.24
negative regulation of programmed cell death 55 1.22 1.09 1.3 1.02 1.24 1.34 1.26
germ cell nucleus 10 -1.1 1.13 1.01 1.03 -1.05 -1.24 1.05
synaptic cleft 1 3.21 -1.32 1.06 -1.26 1.51 5.17 1.89
positive regulation of catalytic activity 62 1.12 1.13 1.26 1.11 1.27 1.29 1.11
negative regulation of catalytic activity 22 1.29 1.1 1.29 1.14 1.27 1.24 1.11
regulation of GTPase activity 42 1.08 1.16 1.35 1.05 1.29 1.31 1.21
amino acid import 4 -2.33 1.09 -2.25 -1.01 1.43 -1.47 -1.72
L-amino acid import 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
cellular metabolic compound salvage 6 1.62 1.11 -1.15 1.11 1.11 1.24 -1.06
regulation of GTP cyclohydrolase I activity 2 6.83 -2.51 -2.16 -2.15 -1.79 -1.27 2.69
purine base salvage 1 1.17 1.37 1.23 1.24 1.3 1.33 -1.5
purine-containing compound salvage 4 1.03 1.11 -1.11 1.23 1.2 1.03 -1.31
amino acid salvage 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
positive regulation of GTP cyclohydrolase I activity 1 1.39 -1.12 1.24 1.31 1.42 -1.23 1.04
receptor metabolic process 7 1.34 -1.03 1.06 -1.07 1.17 1.5 1.02
regulation of I-kappaB kinase/NF-kappaB cascade 2 1.37 1.19 1.03 1.23 1.17 1.39 -1.06
negative regulation of I-kappaB kinase/NF-kappaB cascade 1 1.33 1.06 1.15 1.25 1.2 1.46 -1.1
ubiquitin binding 2 1.76 1.35 1.96 1.2 1.97 1.51 1.56
3'-5' DNA helicase activity 12 -1.05 1.14 1.22 1.27 1.49 -1.11 -1.06
ATP-dependent 3'-5' DNA helicase activity 2 -1.1 1.25 1.24 1.2 1.14 1.04 1.15
single-stranded DNA-dependent ATPase activity 3 1.08 1.14 1.41 1.15 1.37 -1.0 1.15
spindle stabilization 9 1.1 1.19 1.29 1.13 1.34 1.33 1.14
meiotic spindle stabilization 4 1.18 1.25 1.5 1.11 1.42 1.76 1.44
mitotic spindle stabilization 4 1.04 1.15 1.21 1.11 1.33 1.1 -1.02
induction of bacterial agglutination 1 -1.2 -1.21 1.01 1.71 2.04 -1.29 -1.16
entrainment of circadian clock by photoperiod 6 1.21 1.05 -1.08 1.13 -1.05 1.32 1.05
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process 2 1.22 -1.04 1.69 -1.06 1.27 -1.09 -1.19
proteasomal ubiquitin-dependent protein catabolic process 17 1.04 1.17 1.09 1.09 1.14 -1.02 1.15
ion binding 1429 -1.0 1.0 1.0 1.02 1.08 1.03 1.02
anion binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
cation binding 1428 -1.0 1.0 1.0 1.02 1.08 1.03 1.02
macromolecule metabolic process 2469 -1.04 -1.01 1.03 1.06 1.1 -1.03 -1.03
nucleotide salvage 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
nucleoside salvage 4 1.03 1.11 -1.11 1.23 1.2 1.03 -1.31
amine binding 16 -1.41 -1.08 -1.46 1.15 1.12 -1.1 -1.47
alcohol binding 1 1.12 1.0 1.13 1.06 1.1 -1.01 -1.1
rhythmic excitation 1 9.13 1.03 1.44 -1.07 -1.11 1.07 1.06
P granule 13 1.42 1.03 1.1 1.02 1.09 1.51 -1.01
H4/H2A histone acetyltransferase complex 6 1.43 1.08 1.23 1.19 1.24 1.41 -1.02
terminal button 22 1.26 1.08 1.07 -1.18 1.13 1.67 1.31
varicosity 1 -1.06 -1.47 -1.01 -1.23 -1.12 1.54 -1.14
dendritic spine 4 1.47 1.02 1.26 -1.09 1.32 1.72 1.43
response to amino acid stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
perikaryon 1 -1.51 1.58 1.98 1.08 1.74 1.62 1.22
anion transmembrane-transporting ATPase activity 1 1.35 1.29 1.36 1.08 1.19 1.34 1.11
organelle 3099 1.13 1.07 1.15 1.08 1.18 1.16 1.04
membrane-bounded organelle 2551 1.12 1.08 1.16 1.09 1.18 1.16 1.04
non-membrane-bounded organelle 1053 1.16 1.07 1.18 1.08 1.22 1.19 1.04
intracellular organelle 3091 1.13 1.07 1.15 1.08 1.18 1.16 1.04
intracellular membrane-bounded organelle 2548 1.12 1.08 1.16 1.09 1.18 1.16 1.03
intracellular non-membrane-bounded organelle 1053 1.16 1.07 1.18 1.08 1.22 1.19 1.04
organelle lumen 588 1.2 1.12 1.23 1.16 1.24 1.22 -1.0
protein complex 1479 1.14 1.07 1.19 1.07 1.18 1.18 1.05
receptor complex 33 -1.32 1.13 1.15 1.02 1.11 -1.17 1.16
protein complex disassembly 15 -1.02 1.15 1.27 1.13 1.29 1.16 1.02
negative regulation of protein complex disassembly 17 1.02 1.13 1.55 1.04 1.43 1.45 1.22
positive regulation of protein complex disassembly 2 1.03 1.18 1.17 -1.04 1.37 1.47 1.3
regulation of protein complex disassembly 20 1.04 1.15 1.45 1.04 1.4 1.38 1.24
proteasome assembly 2 1.37 1.16 1.24 1.14 1.1 -1.0 1.34
regulation of protein complex assembly 23 -1.13 1.08 1.36 1.07 1.31 -1.05 1.24
laminin complex 1 3.52 1.3 1.81 1.23 2.46 6.46 1.6
regulation of ion transport 23 1.04 1.04 1.16 1.01 1.04 1.18 1.01
positive regulation of ion transport 7 1.34 1.0 1.16 1.0 1.09 1.43 1.16
negative regulation of ion transport 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
apoptotic cell clearance 8 1.13 -1.17 1.05 -1.1 1.15 1.39 1.06
response to alkaloid 20 1.2 1.11 1.03 -1.07 1.16 1.49 1.28
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process 14 1.01 1.14 1.25 1.19 1.42 1.19 1.06
regulation of cysteine-type endopeptidase activity involved in apoptotic process 18 1.12 1.11 1.23 1.18 1.35 1.14 1.01
apocarotenoid metabolic process 2 1.02 1.01 1.08 1.02 -1.08 1.12 -1.06
glutathione binding 1 5.44 1.27 1.83 1.24 1.81 2.29 1.39
apical junction complex 45 1.96 -1.09 1.26 -1.14 1.29 2.5 1.48
apical junction assembly 33 2.06 -1.11 1.37 -1.16 1.26 2.36 1.49
pigment metabolic process involved in developmental pigmentation 30 1.05 -1.06 -1.17 1.17 1.04 -1.09 -1.16
response to dsRNA 11 1.46 1.17 1.45 1.09 1.32 1.46 1.31
positive regulation of DNA binding 1 2.81 1.45 1.89 1.09 1.48 2.58 1.71
negative regulation of DNA binding 3 1.1 1.28 1.83 1.03 1.28 1.14 1.67
regulation of protein binding 1 1.3 1.31 1.72 1.5 1.61 1.9 1.2
proteoglycan binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
heparan sulfate proteoglycan binding 1 3.21 -1.21 1.67 1.12 1.32 6.4 2.23
steroid hormone mediated signaling pathway 19 1.11 1.08 1.02 -1.0 1.09 1.16 1.16
regulation of MAP kinase activity 15 1.26 1.16 1.47 1.13 1.4 1.82 1.2
positive regulation of MAP kinase activity 9 1.14 1.19 1.51 1.11 1.38 1.84 1.15
negative regulation of MAP kinase activity 6 1.46 1.13 1.41 1.17 1.43 1.78 1.28
regulation of MAPK cascade 39 1.06 1.19 1.25 1.1 1.26 1.33 1.23
negative regulation of MAPK cascade 14 1.21 1.15 1.44 1.11 1.27 1.31 1.15
positive regulation of MAPK cascade 15 1.07 1.22 1.31 1.02 1.16 1.33 1.35
macromolecule modification 665 1.18 1.1 1.22 1.08 1.22 1.25 1.13
macromolecule glycosylation 51 1.14 1.04 1.06 1.04 1.1 1.12 1.22
macromolecule methylation 44 1.36 1.18 1.35 1.17 1.37 1.34 1.16
bHLH transcription factor binding 1 1.46 1.06 -1.06 1.12 -1.04 -1.02 1.13
negative regulation of sequence-specific DNA binding transcription factor activity 4 2.01 1.08 1.16 1.02 1.02 1.35 1.88
response to peptide hormone stimulus 20 -1.09 1.13 1.2 1.13 1.18 1.07 1.2
oxoacid metabolic process 239 -1.01 -1.01 -1.15 -1.03 1.0 1.06 -1.05
cellular alkane metabolic process 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
alkane biosynthetic process 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
cellular alkene metabolic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
alkene biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
regulation of secondary metabolic process 6 1.65 -1.7 -1.31 -1.28 -1.22 1.14 -1.32
proton-transporting ATP synthase complex assembly 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
regulation of ATPase activity 1 -1.06 1.13 1.64 1.31 1.74 1.65 1.23
regulation of generation of precursor metabolites and energy 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
pigmentation 60 1.18 -1.08 -1.08 1.07 1.0 -1.05 1.0
pigment metabolic process involved in pigmentation 30 1.05 -1.06 -1.17 1.17 1.04 -1.09 -1.16
regulation of RNA splicing 60 1.18 1.18 1.27 1.17 1.24 1.38 1.08
regulation of RNA stability 2 2.6 1.13 1.81 1.28 1.81 2.02 1.35
regulation of mRNA stability 2 2.6 1.13 1.81 1.28 1.81 2.02 1.35
ATPase activity, coupled to movement of substances 120 -1.08 -1.04 1.03 -1.07 1.02 1.16 -1.05
cell surface binding 17 1.52 -1.27 -1.19 -1.21 -1.12 1.67 1.0
eukaryotic cell surface binding 2 2.1 -1.18 1.11 -1.38 1.18 2.66 3.0
regulation of JUN kinase activity 7 1.24 1.11 1.42 1.16 1.39 1.42 1.27
positive regulation of JUN kinase activity 3 -1.04 1.28 1.57 1.15 1.45 1.3 1.45
negative regulation of JUN kinase activity 4 1.5 -1.01 1.32 1.18 1.35 1.51 1.15
regulation of neuron apoptotic process 11 1.33 1.08 1.15 -1.03 1.14 1.6 1.39
negative regulation of neuron apoptotic process 11 1.33 1.08 1.15 -1.03 1.14 1.6 1.39
protein serine/threonine kinase activator activity 2 1.16 1.13 -1.02 1.22 1.1 -1.36 -1.19
protein acylation 39 1.04 1.16 1.27 1.15 1.2 1.05 1.04
molybdopterin cofactor metabolic process 5 1.14 1.31 1.37 1.14 1.16 -1.34 1.2
molybdopterin cofactor binding 1 1.38 1.39 -1.09 1.59 1.39 -1.89 1.34
positive regulation of GTPase activity 5 1.0 1.24 1.63 1.21 1.82 1.58 1.21
regulation of kinase activity 51 1.28 1.15 1.34 1.13 1.31 1.38 1.19
regulation of translation in response to stress 4 2.6 -1.22 -1.07 -1.29 1.28 1.91 1.61
regulation of translational initiation in response to stress 4 2.6 -1.22 -1.07 -1.29 1.28 1.91 1.61
Ku70:Ku80 complex 1 1.33 1.54 1.93 1.1 1.72 1.13 1.74
sequence-specific DNA binding 271 1.14 1.03 1.1 1.01 1.08 1.09 1.12
structure-specific DNA binding 33 1.17 1.16 1.28 1.17 1.27 1.16 1.07
regulation of insulin-like growth factor receptor signaling pathway 1 -1.19 -1.04 -1.16 -1.01 -1.23 -1.03 -1.09
maintenance of DNA repeat elements 2 1.62 -1.0 1.14 1.16 1.41 1.05 -1.1
peroxisomal transport 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
nuclear replication fork 11 1.14 1.11 1.17 1.2 1.33 1.04 -1.23
nuclear replisome 11 1.14 1.11 1.17 1.2 1.33 1.04 -1.23
cellular amide metabolic process 5 -1.4 -1.19 -1.57 -1.07 -1.0 -1.05 -1.49
amide biosynthetic process 3 -2.21 -1.28 -2.94 -1.05 1.16 -1.62 -1.65
cellular amide catabolic process 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
regulation of DNA-dependent transcription in response to stress 2 -1.52 1.4 1.63 1.11 1.53 1.64 1.52
protein self-association 5 -1.05 1.16 1.37 1.04 1.23 1.34 1.34
cellular protein complex assembly 71 -1.01 1.07 1.26 1.11 1.23 1.07 -1.04
cellular protein complex disassembly 15 -1.02 1.15 1.27 1.13 1.29 1.16 1.02
delta DNA polymerase complex 1 -1.2 -1.0 -1.18 1.32 1.12 -1.14 -1.49
ncRNA 3'-end processing 2 1.0 1.06 1.29 1.13 1.22 1.14 1.21
ncRNA polyadenylation 1 -1.36 -1.04 -1.09 1.02 -1.09 -1.15 1.04
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process 1 -1.36 -1.04 -1.09 1.02 -1.09 -1.15 1.04
RNA polyadenylation 17 1.35 1.11 1.23 1.12 1.29 1.65 1.19
modification-dependent macromolecule catabolic process 95 1.16 1.13 1.32 1.13 1.29 1.1 1.12
polyadenylation-dependent RNA catabolic process 1 -1.36 -1.04 -1.09 1.02 -1.09 -1.15 1.04
polyadenylation-dependent ncRNA catabolic process 1 -1.36 -1.04 -1.09 1.02 -1.09 -1.15 1.04
inositol phosphate metabolic process 7 1.45 1.12 1.25 -1.03 1.17 1.27 1.19
dicarboxylic acid metabolic process 14 -1.06 1.04 1.07 -1.22 1.01 1.26 -1.08
engulfment of apoptotic cell 2 1.24 1.08 1.26 1.1 1.14 1.16 1.03
regulation of phosphoprotein phosphatase activity 3 1.09 1.05 1.0 1.06 1.03 1.05 -1.09
axon terminus 26 1.26 1.07 1.08 -1.15 1.13 1.67 1.27
post-translational protein modification 2 -1.4 1.08 1.03 1.29 1.32 -1.28 -1.35
detection of pheromone 7 1.05 1.03 1.02 -1.0 -1.06 1.05 -1.08
photoreceptor cell fate specification 11 1.11 1.04 1.07 1.17 1.1 -1.16 -1.1
2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity 1 1.67 1.48 1.35 1.44 1.31 1.18 1.35
dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity 1 1.74 1.44 1.67 1.01 1.35 1.38 1.19
cyclic nucleotide-gated ion channel activity 3 -1.19 1.0 1.03 -1.02 1.02 -1.02 -1.19
acireductone synthase activity 1 1.92 1.16 1.15 1.28 1.06 2.87 -1.21
regulation of multi-organism process 51 1.44 -1.06 1.09 -1.01 1.09 1.15 1.1
negative regulation of multi-organism process 14 1.67 -1.01 1.49 1.13 1.44 1.14 -1.02
positive regulation of multi-organism process 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
regulation of symbiosis, encompassing mutualism through parasitism 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
macromolecular complex subunit organization 187 1.08 1.11 1.28 1.14 1.27 1.13 1.04
cellular component maintenance 23 -1.02 1.04 1.3 1.14 1.3 -1.03 1.0
histone H3 acetylation 6 1.33 1.29 1.52 1.18 1.35 1.37 1.35
histone H4 acetylation 4 1.15 1.24 1.16 1.28 1.1 -1.1 1.08
histone H2A acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
histone H3-K9 acetylation 2 1.05 1.43 1.59 1.17 1.33 1.34 1.37
histone H4-K12 acetylation 1 1.24 1.29 1.32 1.24 1.1 -1.34 -1.14
histone H4-R3 methylation 1 1.39 1.1 1.39 1.26 1.71 1.23 1.23
histone H3-S10 phosphorylation 1 1.24 1.29 1.32 1.24 1.1 -1.34 -1.14
histone acetyltransferase activity (H3-K9 specific) 1 -1.13 1.58 1.91 1.11 1.62 2.4 2.13
H2A histone acetyltransferase activity 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
histone methyltransferase activity (H4-R3 specific) 1 1.39 1.1 1.39 1.26 1.71 1.23 1.23
regulation of DNA methylation 3 1.11 1.01 1.05 1.05 1.09 1.06 -1.09
cell wall macromolecule metabolic process 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
glucan metabolic process 9 2.15 1.01 -1.12 1.0 1.05 2.73 1.34
regulation of system process 57 1.06 1.07 1.16 -1.08 1.02 1.2 1.1
regulation of digestive system process 1 1.2 1.33 1.18 -1.01 -1.15 1.3 1.08
regulation of endocrine process 2 -1.1 -1.02 1.14 1.0 1.02 1.69 1.12
regulation of anion transport 6 -1.08 1.02 1.16 1.01 -1.03 1.23 -1.16
cellular component biogenesis 506 1.2 1.07 1.25 1.07 1.24 1.23 1.11
regulation of cellular component biogenesis 111 1.03 1.13 1.34 1.1 1.31 1.14 1.21
positive regulation of cellular component biogenesis 10 -1.05 1.15 1.36 1.13 1.37 1.23 1.36
membrane biogenesis 3 1.33 1.11 1.68 -1.36 1.02 2.57 1.24
negative regulation of molecular function 29 1.35 1.11 1.32 1.11 1.23 1.24 1.25
positive regulation of molecular function 73 1.18 1.14 1.3 1.11 1.31 1.36 1.14
cellular amine metabolic process 179 -1.01 1.03 -1.09 -1.01 1.01 1.13 -1.01
modulation of growth of symbiont involved in interaction with host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
negative regulation of growth of symbiont involved in interaction with host 7 2.04 -1.02 1.37 1.07 1.52 1.47 1.08
histone H3-K14 acetylation 1 1.24 1.29 1.32 1.24 1.1 -1.34 -1.14
'de novo' UMP biosynthetic process 1 1.61 1.06 1.09 1.15 1.38 -1.09 1.01
fully spanning plasma membrane 1 -1.09 1.03 1.58 1.01 1.26 -1.16 1.18
cellular metabolic process 2625 1.15 1.06 1.11 1.08 1.17 1.16 1.03
primary metabolic process 3122 -1.05 -1.03 -1.02 1.03 1.07 -1.05 -1.05
cellular lipid catabolic process 27 -1.83 -1.24 -1.62 1.14 1.08 -2.79 -1.74
regulation of multicellular organismal metabolic process 1 1.86 -1.04 1.59 -1.1 2.08 2.71 1.26
cellular polysaccharide catabolic process 1 2.98 -1.08 1.5 -1.31 1.12 4.86 1.33
cellular catabolic process 329 1.02 1.05 1.09 1.07 1.15 1.03 1.01
cellular biosynthetic process 948 1.19 1.05 1.09 1.06 1.14 1.19 1.03
cellular lipid metabolic process 195 1.01 -1.1 -1.11 -1.02 1.11 -1.13 -1.02
cellular protein catabolic process 106 1.15 1.12 1.31 1.13 1.28 1.07 1.08
cellular macromolecule metabolic process 1842 1.19 1.1 1.2 1.12 1.23 1.19 1.07
cellular carbohydrate metabolic process 165 -1.04 -1.01 -1.23 1.0 1.01 -1.04 -1.1
cellular polysaccharide metabolic process 15 1.66 1.11 1.03 1.05 1.17 1.91 1.35
cellular macromolecule catabolic process 146 1.19 1.11 1.29 1.12 1.29 1.13 1.13
cellular protein metabolic process 1120 1.17 1.09 1.19 1.1 1.21 1.2 1.06
glycerol ether catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
cellular nitrogen compound catabolic process 61 -1.05 1.02 -1.0 1.04 1.03 -1.12 1.02
cellular nitrogen compound biosynthetic process 185 1.18 1.04 -1.04 -1.01 -1.02 1.25 1.03
sulfur compound biosynthetic process 25 1.09 1.17 1.2 1.11 1.05 1.23 1.23
sulfur compound catabolic process 1 1.48 1.28 1.32 1.05 1.07 1.16 -1.01
cellular carbohydrate catabolic process 39 1.53 1.02 -1.21 -1.06 -1.05 1.4 1.2
small molecule metabolic process 599 -1.01 -1.0 -1.11 -1.01 1.02 1.02 -1.06
small molecule catabolic process 81 1.2 -1.02 -1.27 -1.08 -1.02 1.19 -1.01
small molecule biosynthetic process 98 1.12 -1.09 -1.26 -1.12 -1.12 1.16 1.13
dendrite terminus 1 -1.38 1.0 -1.11 -1.02 -1.17 -1.19 1.01
axonal growth cone 3 1.35 1.17 1.49 1.21 1.37 1.33 1.2
cell body 27 -1.0 -1.02 1.19 1.05 1.12 1.07 1.01
neuron projection terminus 26 1.26 1.07 1.08 -1.15 1.13 1.67 1.27
neuron spine 4 1.47 1.02 1.26 -1.09 1.32 1.72 1.43
wound healing, spreading of cells 1 -1.04 -1.12 1.46 1.28 1.4 -1.15 1.1
regulation of transcription involved in anterior/posterior axis specification 2 1.78 1.0 1.2 -1.2 -1.03 1.22 -1.04
dendritic spine head 3 1.62 -1.01 1.32 -1.1 1.45 2.01 1.64
sodium-dependent phosphate transport 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
cellular response to fibroblast growth factor stimulus 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
small conjugating protein ligase binding 9 1.11 1.17 1.66 1.19 1.63 1.3 1.36
small protein conjugating enzyme binding 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
ribosomal subunit 153 1.21 1.04 1.16 1.13 1.19 1.3 -1.18
interspecies interaction between organisms 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
extracellular matrix part 13 1.55 -1.17 1.15 -1.23 1.13 2.04 1.39
extracellular region part 219 1.0 -1.15 -1.2 -1.18 -1.13 -1.0 1.1
organelle part 1903 1.14 1.08 1.18 1.1 1.2 1.19 1.03
virion part 7 -1.09 -1.36 -1.17 -1.1 -1.08 1.28 -1.28
intracellular part 3721 1.14 1.07 1.15 1.08 1.18 1.16 1.05
membrane part 1459 1.01 -1.02 1.01 -1.03 1.01 1.09 1.01
chromosomal part 250 1.18 1.11 1.21 1.15 1.28 1.17 1.07
nuclear part 738 1.22 1.12 1.25 1.18 1.29 1.17 1.07
mitochondrial part 343 1.07 1.07 1.15 1.07 1.12 1.42 -1.24
cytoskeletal part 502 1.11 1.03 1.14 1.03 1.2 1.16 1.06
Golgi apparatus part 80 -1.01 1.12 1.12 1.1 1.15 1.15 1.34
endoplasmic reticulum part 101 -1.09 1.11 1.08 1.08 1.06 -1.11 1.12
cytoplasmic vesicle part 19 -1.14 1.1 1.06 1.04 1.1 1.17 1.23
vacuolar part 30 -1.55 -1.0 1.28 -1.14 -1.08 1.41 -1.12
microbody part 14 1.87 1.14 -1.32 1.28 1.36 -1.33 -1.09
endosomal part 3 -1.2 1.14 1.51 1.07 1.24 1.91 1.43
cilium part 3 -1.04 1.08 1.04 1.16 -1.12 -1.04 -1.07
microtubule-based flagellum part 1 1.03 1.24 1.01 1.09 1.02 -1.11 1.01
cytoplasmic part 1575 1.09 1.05 1.09 1.04 1.13 1.18 -1.01
cytosolic part 124 1.25 1.04 1.13 1.06 1.16 1.14 -1.01
intracellular organelle part 1884 1.13 1.08 1.18 1.1 1.2 1.19 1.03
axoneme part 13 -1.04 1.02 1.03 1.02 -1.05 1.0 -1.11
cell cortex part 52 -1.17 1.2 1.4 1.11 1.36 1.08 1.09
contractile fiber part 31 2.32 -1.44 -1.08 -1.22 1.23 1.92 -1.17
microtubule organizing center part 25 1.19 1.06 1.11 1.1 1.16 1.11 1.02
nucleoplasm part 272 1.24 1.14 1.27 1.18 1.27 1.16 1.09
nucleolar part 9 1.24 1.15 1.22 1.3 1.26 1.11 1.02
nuclear membrane part 2 -1.02 -2.05 1.59 1.21 2.03 -1.95 -2.17
nuclear chromosome part 80 1.18 1.13 1.23 1.15 1.27 1.13 1.03
mitochondrial membrane part 108 1.14 1.02 1.21 1.03 1.09 1.55 -1.26
synapse part 110 1.06 1.08 1.15 -1.02 1.12 1.19 1.17
plasma membrane part 322 1.24 -1.03 1.09 -1.04 1.07 1.24 1.14
flagellum part 1 1.03 1.24 1.01 1.09 1.02 -1.11 1.01
external encapsulating structure part 11 1.96 -1.06 1.02 -1.08 -1.01 1.22 1.03
cell projection part 75 1.15 1.03 1.15 -1.04 1.1 1.34 1.14
cell part 4600 1.14 1.06 1.13 1.06 1.16 1.15 1.06
secondary metabolite biosynthetic process 25 1.42 -1.09 -1.13 -1.11 -1.11 1.14 1.2
double-strand break repair via single-strand annealing 2 1.06 -1.0 1.36 -1.08 1.26 1.06 1.04
double-strand break repair via synthesis-dependent strand annealing 5 1.1 1.19 1.07 1.18 1.1 -1.15 1.06
maintenance of fidelity involved in DNA-dependent DNA replication 1 -1.49 1.01 -1.08 1.09 -1.02 -1.34 -1.39
glycerolipid biosynthetic process 31 -1.11 -1.12 1.05 -1.1 1.14 1.03 -1.04
sensory organ precursor cell division 8 -1.01 1.07 1.27 1.11 1.3 -1.03 -1.04
protein import into mitochondrial inner membrane 7 1.09 1.08 1.28 1.16 1.18 1.3 -1.13
protein targeting to ER 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
regulated secretory pathway 1 4.01 -1.11 1.04 -1.06 1.03 1.05 1.13
regulation of viral genome replication 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
negative regulation of viral genome replication 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
innate immune response 52 1.72 -1.32 -1.33 -1.27 -1.15 1.39 1.14
regulation of innate immune response 11 2.21 -1.14 1.08 -1.08 1.02 1.67 1.13
positive regulation of innate immune response 5 1.98 -1.06 1.18 -1.06 1.11 1.79 1.28
intermediate filament-based process 1 1.1 1.12 1.07 -1.03 -1.01 1.1 1.01
intermediate filament cytoskeleton organization 1 1.1 1.12 1.07 -1.03 -1.01 1.1 1.01
intermediate filament cytoskeleton 2 1.28 1.06 -1.0 1.32 1.15 -1.17 -1.1
membrane raft 3 1.56 1.01 1.01 1.02 1.02 1.3 1.71
meiotic chromosome segregation 51 1.14 1.08 1.19 1.11 1.27 1.14 1.09
uridine-diphosphatase activity 1 -1.51 1.28 -1.3 1.09 -1.1 -3.57 1.37
development of primary sexual characteristics 59 1.13 1.06 1.12 1.07 1.24 1.02 1.08
response to copper ion 3 -14.42 1.56 1.38 1.09 -1.89 -6.59 -1.3
homologous chromosome segregation 4 1.06 1.11 1.04 1.17 1.06 -1.06 -1.12
myosin II binding 2 -1.98 1.16 2.07 1.03 1.58 -1.28 1.01
neuronal ion channel clustering 1 1.29 -1.71 -1.84 -1.91 -1.32 16.38 -1.61
cell fate commitment 405 1.16 1.06 1.16 1.05 1.2 1.16 1.12
asymmetric protein localization involved in cell fate determination 14 -1.35 1.16 1.3 1.08 1.48 1.01 1.07
cell-cell signaling involved in cell fate commitment 189 1.17 1.06 1.11 1.08 1.2 1.17 1.05
fusome 32 -1.08 1.17 1.29 1.05 1.26 1.27 1.27
spectrosome 6 -1.16 1.09 1.81 1.07 1.73 1.26 1.26
intercellular bridge 17 -1.22 1.11 1.21 1.11 1.33 1.25 1.34
germline ring canal 16 -1.22 1.1 1.19 1.11 1.33 1.27 1.35
glutathione dehydrogenase (ascorbate) activity 4 1.29 1.17 1.1 1.04 1.18 -1.03 1.04
basal protein localization 6 -1.45 1.22 1.54 1.08 1.45 -1.08 -1.07
apical protein localization 9 -1.03 1.16 1.11 1.05 1.43 1.01 1.44
apical part of cell 62 1.31 1.12 1.35 1.0 1.28 1.5 1.32
basal part of cell 11 -1.08 1.22 1.48 1.16 1.48 1.32 1.21
apical cortex 27 -1.0 1.23 1.46 1.07 1.36 1.19 1.13
basal cortex 7 -1.21 1.31 1.34 1.19 1.4 -1.05 1.17
glutamate synthase activity, NADH or NADPH as acceptor 1 2.14 1.19 1.24 1.03 -1.73 3.68 2.51
translation regulator activity 15 1.38 1.09 1.42 1.04 1.28 1.17 1.47
establishment of protein localization 251 1.07 1.16 1.31 1.12 1.24 1.13 1.15
maintenance of protein location 41 1.22 1.1 1.26 1.06 1.28 1.3 1.26
zonula adherens assembly 8 -1.0 1.29 1.57 1.09 1.44 1.45 1.58
regulation of circadian sleep/wake cycle, sleep 13 -1.21 1.24 1.19 -1.03 1.06 1.12 1.26
establishment or maintenance of neuroblast polarity 10 -1.07 1.12 1.77 1.0 1.45 1.54 1.19
establishment or maintenance of epithelial cell apical/basal polarity 23 1.37 1.08 1.39 -1.01 1.36 1.42 1.26
establishment of epithelial cell apical/basal polarity 7 1.7 1.04 1.19 -1.07 1.56 1.4 1.47
maintenance of epithelial cell apical/basal polarity 4 1.21 1.16 1.51 1.18 1.38 1.16 1.05
establishment of neuroblast polarity 4 -1.89 1.09 2.72 -1.04 1.73 -1.21 1.17
maintenance of neuroblast polarity 1 1.14 -1.24 1.17 -1.53 1.18 15.9 1.17
synapse 139 1.14 1.05 1.16 -1.03 1.13 1.25 1.17
postsynaptic membrane 29 1.11 1.01 1.05 -1.13 -1.09 1.08 1.16
neurotransmitter receptor metabolic process 3 1.15 1.01 -1.1 -1.21 1.3 1.34 -1.13
sarcomere organization 19 2.14 -1.13 1.26 -1.14 1.25 1.79 -1.0
cell-cell junction organization 45 1.62 -1.06 1.35 -1.1 1.25 1.89 1.32
cell-cell junction maintenance 2 -1.01 1.25 1.94 1.07 1.78 1.99 1.84
zonula adherens maintenance 1 3.86 1.45 2.61 -1.03 2.28 4.0 3.57
tricarboxylic acid cycle enzyme complex 10 1.04 -1.01 1.14 -1.12 -1.04 1.51 -1.27
isocitrate dehydrogenase complex (NAD+) 1 -1.07 1.16 -1.05 -1.13 1.15 1.71 1.06
succinate-CoA ligase complex (GDP-forming) 3 1.16 -1.04 -1.07 -1.04 1.11 1.22 -1.42
electron transfer flavoprotein complex 2 1.33 1.29 -1.39 1.04 1.01 -1.08 -1.3
pyruvate dehydrogenase (lipoamide) phosphatase complex 1 1.97 1.3 1.52 -1.19 1.01 1.99 1.65
succinate dehydrogenase complex (ubiquinone) 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
proton-transporting ATP synthase complex 19 1.33 1.01 1.2 -1.01 1.12 1.63 -1.2
proton-transporting ATP synthase complex, catalytic core F(1) 9 1.58 -1.04 1.09 -1.06 1.03 1.78 -1.26
proton-transporting ATP synthase, central stalk 1 1.03 1.03 1.17 1.01 1.11 1.58 -1.38
respiratory chain complex I 37 1.15 1.04 1.27 1.07 1.11 1.72 -1.29
respiratory chain complex II 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
respiratory chain complex III 11 -1.13 1.03 1.1 1.04 -1.01 1.3 -1.48
respiratory chain complex IV 13 1.04 -1.01 1.2 -1.0 1.14 1.38 -1.29
succinate dehydrogenase complex 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
fumarate reductase complex 6 1.02 1.03 1.28 -1.03 -1.0 1.38 -1.21
luciferin monooxygenase activity 1 2.47 -1.2 -1.84 1.79 2.31 -2.71 -1.43
nuclear mRNA cis splicing, via spliceosome 1 -1.16 -1.03 -1.07 1.26 1.12 -1.31 -1.69
alpha-catenin binding 1 1.17 1.11 1.06 1.15 1.09 1.09 1.68
cadherin binding 2 1.22 -1.01 1.46 1.06 1.25 1.4 1.02
post-mating behavior 20 1.01 -1.06 -1.13 -1.12 -1.11 -1.0 -1.08
tubulin complex 10 -1.16 1.02 1.08 1.02 1.1 -1.0 -1.09
protein phosphorylated amino acid binding 1 -1.42 1.22 1.22 1.19 1.41 -1.04 -1.04
rhabdomere membrane biogenesis 3 1.33 1.11 1.68 -1.36 1.02 2.57 1.24
regulation of compound eye photoreceptor development 10 1.04 1.09 1.37 -1.02 1.29 1.07 1.24
positive regulation of compound eye photoreceptor development 1 2.02 1.25 1.56 1.13 1.49 2.5 1.69
negative regulation of compound eye photoreceptor development 3 -1.04 -1.04 1.09 -1.03 1.27 -1.29 1.13
equator specification 6 -1.25 -1.43 -1.32 -1.53 -1.4 -1.25 3.26
leukocyte activation 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
carnitine biosynthetic process 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
cellular respiration 97 1.02 1.04 1.22 1.01 1.13 1.55 -1.22
clathrin-coated endocytic vesicle 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
farnesyl diphosphate biosynthetic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
farnesyl diphosphate metabolic process 1 4.21 1.14 2.47 -1.3 1.39 2.06 1.87
quinone cofactor biosynthetic process 5 1.2 1.14 1.21 1.14 1.17 1.39 1.02
regulation of nitric oxide biosynthetic process 1 1.39 -1.03 1.89 -1.0 1.66 2.5 1.68
positive regulation of nitric oxide biosynthetic process 1 1.39 -1.03 1.89 -1.0 1.66 2.5 1.68
male courtship behavior, veined wing generated song production 12 1.05 1.04 1.45 1.15 1.09 -1.02 1.01
negative regulation of female receptivity, post-mating 8 -1.24 1.06 1.02 1.03 1.16 -1.13 -1.08
myoblast differentiation 1 -1.07 -1.09 1.09 -1.1 1.09 -1.05 1.02
endothelial cell differentiation 3 1.7 1.01 1.41 -1.21 1.32 4.52 2.14
mitotic cell cycle, embryonic 23 1.34 1.02 1.19 -1.03 1.26 1.27 1.41
bicoid mRNA localization 8 1.29 1.08 1.35 1.13 1.31 1.35 1.11
pole plasm oskar mRNA localization 30 -1.04 1.2 1.34 1.17 1.3 1.21 1.16
ecdysteroid metabolic process 15 1.26 -1.14 -1.0 -1.06 1.15 1.51 1.09
ecdysteroid biosynthetic process 12 1.31 -1.17 -1.03 -1.07 1.06 1.52 1.13
R8 cell development 3 1.3 1.12 1.37 1.13 1.55 1.07 1.27
R8 cell fate specification 9 1.18 1.04 1.11 1.19 1.18 -1.18 -1.1
R8 cell differentiation 17 1.18 1.05 1.21 1.12 1.31 1.03 1.07
R7 cell differentiation 36 1.32 1.13 1.36 1.07 1.37 1.31 1.33
R7 cell development 16 1.23 1.15 1.34 1.07 1.33 1.14 1.28
regulation of R8 cell spacing in compound eye 5 1.17 1.07 1.1 1.16 1.41 1.4 1.18
R8 cell-mediated photoreceptor organization 2 1.29 1.14 1.27 1.19 1.33 1.03 1.2
response to ethanol 44 1.51 1.01 1.21 -1.06 1.21 1.25 1.3
response to ether 3 -1.07 1.05 -1.12 -1.04 -1.19 1.04 -1.17
behavioral response to ethanol 35 1.52 -1.02 1.16 -1.06 1.28 1.26 1.37
behavioral response to ether 2 -1.03 1.05 -1.07 -1.06 -1.12 1.18 -1.13
locomotor rhythm 31 1.06 1.1 1.36 -1.15 -1.02 1.63 1.1
nurse cell apoptotic process 13 1.39 -1.0 1.22 -1.05 1.04 1.07 1.25
regulation of nurse cell apoptotic process 5 1.15 1.23 1.79 1.07 1.35 1.85 1.46
fusome organization 12 1.01 1.08 1.22 1.09 1.28 1.3 1.26
vesicle targeting to fusome 1 -1.29 -1.05 -1.05 1.11 -1.02 -1.43 1.36
photoreceptor cell maintenance 13 1.14 -1.01 1.16 1.18 1.21 -1.08 1.04
pole plasm 19 1.4 1.04 1.1 1.08 1.12 1.3 -1.03
male analia development 2 2.83 1.39 1.21 1.02 1.24 1.39 1.47
female analia development 2 2.83 1.39 1.21 1.02 1.24 1.39 1.47
sex comb development 10 1.42 1.1 1.34 1.21 1.36 1.37 1.07
sevenless signaling pathway 9 1.54 1.11 1.39 1.09 1.39 1.67 1.31
regulation of sevenless signaling pathway 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
dynein binding 7 1.02 1.14 1.3 1.05 1.23 1.2 1.13
dynein light chain binding 1 -1.29 1.22 1.62 1.06 1.22 1.25 1.14
dynein intermediate chain binding 2 1.32 -1.03 1.69 1.08 1.5 1.12 -1.03
gibberellin 20-oxidase activity 1 -2.43 -1.01 2.24 -1.36 -1.68 -4.63 2.94
regulation of imaginal disc growth 19 1.56 1.12 1.34 1.06 1.25 1.29 1.24
negative regulation of imaginal disc growth 3 1.85 1.08 1.39 -1.08 1.25 1.14 1.32
positive regulation of imaginal disc growth 5 1.2 1.16 1.11 1.17 1.32 1.36 1.13
regulation of cell differentiation 237 1.12 1.11 1.33 1.07 1.29 1.21 1.19
negative regulation of cell differentiation 96 1.06 1.11 1.28 1.08 1.32 1.14 1.21
positive regulation of cell differentiation 16 1.4 1.12 1.39 1.03 1.32 1.44 1.39
regulation of hemocyte differentiation 22 1.14 1.14 1.17 1.04 1.25 1.43 1.49
negative regulation of hemocyte differentiation 8 1.16 1.08 1.01 -1.03 1.06 1.37 1.55
positive regulation of hemocyte differentiation 1 -1.18 -1.04 -1.07 -1.26 1.04 1.06 5.07
regulation of neuron differentiation 76 1.07 1.12 1.36 1.07 1.33 1.17 1.17
negative regulation of neuron differentiation 5 -1.22 1.17 1.2 1.05 1.31 -1.53 1.09
positive regulation of neuron differentiation 8 1.3 1.17 1.47 1.09 1.39 1.19 1.25
regulation of R7 cell differentiation 11 1.0 1.13 1.24 1.05 1.3 -1.16 1.17
negative regulation of R7 cell differentiation 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
positive regulation of R7 cell differentiation 5 1.49 1.15 1.41 1.05 1.37 1.23 1.34
regulation of R8 cell differentiation 1 1.01 1.09 1.11 -1.09 -1.01 1.02 -1.12
negative regulation of R8 cell differentiation 1 1.01 1.09 1.11 -1.09 -1.01 1.02 -1.12
regulation of glial cell differentiation 1 1.08 1.07 1.03 1.0 -1.04 -1.0 -1.04
positive regulation of glial cell differentiation 1 1.08 1.07 1.03 1.0 -1.04 -1.0 -1.04
regulation of salivary gland boundary specification 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
negative regulation of salivary gland boundary specification 8 1.56 -1.2 -1.1 1.04 1.14 1.2 -1.02
positive regulation of protein catabolic process 1 2.44 1.03 1.21 1.16 1.33 1.95 1.23
negative regulation of cyclin-dependent protein kinase activity 1 2.05 1.25 2.19 1.12 2.03 2.13 2.15
positive regulation of DNA replication 4 1.13 1.17 1.08 1.14 1.28 -1.01 1.07
positive regulation of epidermal growth factor receptor signaling pathway 8 1.07 1.11 1.54 1.04 1.59 1.25 1.43
negative regulation of Notch signaling pathway 22 1.04 1.15 1.34 1.08 1.39 1.3 1.33
positive regulation of Notch signaling pathway 18 1.04 1.21 1.35 1.11 1.43 1.18 1.26
positive regulation of S phase of mitotic cell cycle 5 1.47 1.12 1.21 1.09 1.33 1.59 1.23
negative regulation of Toll signaling pathway 3 5.73 -1.65 -1.56 -1.86 -1.27 7.14 1.48
positive regulation of Toll signaling pathway 8 1.13 -1.26 -1.25 -1.26 -1.11 -1.13 1.2
regulation of adenylate cyclase activity 7 1.19 1.06 1.12 -1.03 1.03 1.11 -1.03
positive regulation of adenylate cyclase activity 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of anti-apoptosis 2 1.05 1.08 1.9 1.35 1.37 -1.31 1.1
positive regulation of cell adhesion 2 1.24 1.07 1.55 1.24 2.26 1.04 1.52
negative regulation of cell cycle 44 1.23 1.15 1.3 1.13 1.41 1.3 1.26
positive regulation of cell cycle 19 1.15 1.12 1.16 1.12 1.4 1.36 1.11
negative regulation of cell size 13 1.4 1.18 1.18 1.0 1.22 1.64 1.25
positive regulation of cell size 21 1.09 1.23 1.41 1.08 1.42 1.39 1.39
negative regulation of chromatin assembly or disassembly 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
positive regulation of chromatin assembly or disassembly 2 1.21 1.02 1.16 1.13 1.43 1.09 -1.08
negative regulation of eclosion 1 -1.18 1.19 1.16 1.18 1.03 -1.13 1.04
positive regulation of eclosion 1 1.76 1.07 1.13 1.08 1.49 1.28 1.15
negative regulation of endocytosis 1 -1.04 -1.14 1.37 -1.01 1.09 1.23 1.09
positive regulation of endocytosis 9 -1.04 1.12 1.4 1.06 1.19 1.37 1.21
negative regulation of gene expression, epigenetic 41 1.28 1.14 1.29 1.12 1.31 1.29 1.16
positive regulation of gene expression, epigenetic 14 1.54 1.18 1.37 1.13 1.35 1.46 1.35
negative regulation of heart contraction 2 1.15 -1.01 -1.01 1.01 -1.02 1.08 -1.02
positive regulation of heart contraction 1 -1.08 1.01 1.03 1.02 -1.06 -1.21 -1.22
negative regulation of innate immune response 3 3.2 -1.5 -1.25 -1.29 -1.32 1.18 1.06
negative regulation of isoprenoid metabolic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
negative regulation of lipid metabolic process 2 -18.13 -1.6 1.31 1.68 1.16 -11.26 -4.64
positive regulation of lipid metabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
negative regulation of meiosis 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
positive regulation of meiosis 1 -1.51 1.58 1.98 1.08 1.74 1.62 1.22
negative regulation of mitosis 15 1.05 1.11 1.17 1.19 1.35 1.07 1.0
positive regulation of mitosis 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
negative regulation of mitotic metaphase/anaphase transition 12 1.08 1.1 1.18 1.19 1.38 1.04 1.01
positive regulation of mitotic metaphase/anaphase transition 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
negative regulation of striated muscle tissue development 1 -1.17 -1.03 -1.15 -1.16 -1.43 -1.09 -1.47
negative regulation of nurse cell apoptotic process 1 1.41 1.35 1.47 1.02 1.54 2.41 1.84
positive regulation of nurse cell apoptotic process 2 1.07 1.35 1.52 1.17 1.22 1.39 1.44
pH reduction 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
positive regulation of pole plasm oskar mRNA localization 2 -1.78 1.46 1.88 1.15 2.04 -1.01 1.92
regulation of protein kinase activity 51 1.28 1.15 1.34 1.13 1.31 1.38 1.19
positive regulation of protein kinase activity 25 1.18 1.14 1.29 1.1 1.23 1.49 1.19
negative regulation of proteolysis 12 1.33 -1.03 1.04 -1.01 1.08 1.15 1.19
positive regulation of proteolysis 3 -1.32 1.1 1.33 1.18 1.24 -1.5 1.07
negative regulation of sevenless signaling pathway 1 -4.89 -1.17 -1.75 -1.1 -1.11 -9.33 -1.59
negative regulation of smoothened signaling pathway 15 1.43 1.17 1.37 1.01 1.27 1.9 1.34
positive regulation of smoothened signaling pathway 9 1.35 1.08 1.43 1.16 1.54 1.59 1.09
negative regulation of synaptic growth at neuromuscular junction 12 -1.17 1.11 1.26 1.17 1.16 -1.1 1.03
positive regulation of synaptic growth at neuromuscular junction 7 -1.19 1.15 1.24 1.09 1.31 1.0 1.41
regulation of transcription during mitosis 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
regulation of RNA polymerase II transcriptional preinitiation complex assembly 3 1.71 1.26 1.41 1.3 1.44 1.38 1.2
negative regulation of translational elongation 2 1.41 1.28 1.1 1.19 -1.04 -1.13 1.17
positive regulation of translational elongation 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
positive regulation of translational termination 1 1.71 1.01 1.01 -1.13 1.21 1.32 1.15
negative regulation of DNA recombination 2 -1.59 1.15 1.13 1.19 1.42 -1.74 -1.31
negative regulation of exocytosis 1 1.24 1.25 1.11 1.13 1.1 1.34 1.26
positive regulation of exocytosis 4 -1.5 1.3 1.55 1.16 1.38 1.25 1.13
regulation of female receptivity 18 1.06 -1.2 -1.2 -1.22 -1.06 1.34 1.14
negative regulation of growth 41 1.29 1.12 1.35 1.07 1.32 1.34 1.19
positive regulation of growth 42 1.0 1.19 1.31 1.08 1.32 1.25 1.31
negative regulation of juvenile hormone metabolic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
negative regulation of mitotic cell cycle 20 1.24 1.15 1.29 1.14 1.39 1.35 1.29
positive regulation of mitotic cell cycle 13 1.23 1.16 1.25 1.11 1.43 1.47 1.21
negative regulation of muscle contraction 1 13.14 -1.35 -1.29 -1.22 -1.17 -1.49 -1.27
negative regulation of nucleobase-containing compound metabolic process 199 1.16 1.09 1.16 1.05 1.22 1.21 1.14
negative regulation of phosphate metabolic process 8 1.4 1.03 1.23 1.05 1.2 1.33 1.24
positive regulation of phosphate metabolic process 8 1.51 1.21 1.82 1.05 1.45 2.01 1.56
positive regulation of circadian sleep/wake cycle, sleep 2 1.24 1.16 1.04 -1.02 1.05 1.25 1.29
positive regulation of transcription from RNA polymerase II promoter 148 1.13 1.01 1.12 1.01 1.1 1.18 1.12
negative regulation of nucleotide metabolic process 2 1.18 1.06 1.18 1.14 1.04 1.11 -1.15
positive regulation of nucleotide metabolic process 6 1.16 1.07 1.14 -1.06 1.03 1.1 -1.03
regulation of embryonic development 64 1.08 1.16 1.34 1.09 1.37 1.37 1.21
regulation of female receptivity, post-mating 14 1.03 -1.09 -1.21 -1.16 -1.11 1.05 -1.06
regulation of oskar mRNA translation 12 1.38 1.02 1.27 -1.05 1.15 1.71 1.06
positive regulation of oskar mRNA translation 3 1.65 1.1 1.35 -1.02 1.27 1.67 1.22
regulation of transcription from RNA polymerase II promoter, mitotic 4 1.21 1.13 1.22 1.16 1.17 1.14 1.08
ADP metabolic process 2 -1.29 -1.01 -1.04 1.37 1.42 -2.05 -1.57
ATP metabolic process 36 1.35 -1.02 1.24 -1.12 1.07 1.65 -1.08
CTP metabolic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
GMP metabolic process 2 1.15 1.21 1.23 -1.01 1.16 1.11 2.05
GTP metabolic process 41 1.15 1.04 1.16 1.09 1.14 1.08 -1.01
IMP metabolic process 7 1.14 1.03 -1.12 -1.04 -1.13 1.95 -1.01
TMP metabolic process 1 1.02 1.09 1.32 1.32 1.3 -1.29 -1.13
UMP metabolic process 3 1.1 1.3 1.05 1.25 1.1 -1.22 -1.06
UTP metabolic process 4 1.0 1.09 1.36 1.22 1.36 1.06 -1.14
cGMP metabolic process 11 -1.12 1.01 -1.02 -1.0 -1.04 -1.01 -1.06
WW domain binding 3 2.14 -1.08 1.3 -1.28 -1.29 2.35 1.56
dTDP metabolic process 1 1.27 1.13 1.91 1.21 1.41 -1.17 -1.08
dTMP metabolic process 2 1.05 1.03 -1.1 1.26 1.31 1.33 -1.09
dUTP metabolic process 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
adenine metabolic process 1 1.17 1.37 1.23 1.24 1.3 1.33 -1.5
adenine biosynthetic process 1 1.17 1.37 1.23 1.24 1.3 1.33 -1.5
cytidine metabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
nucleobase biosynthetic process 10 1.45 1.05 1.03 1.0 -1.04 1.28 -1.0
nucleobase catabolic process 3 2.92 -1.42 -1.24 -1.35 -1.35 1.45 1.16
guanosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
queuosine metabolic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
7-methylguanosine biosynthetic process 2 -1.08 1.07 1.01 1.12 1.08 -1.67 -1.22
purine ribonucleoside metabolic process 12 1.18 1.15 -1.0 1.18 1.26 -1.09 -1.09
purine ribonucleoside biosynthetic process 7 1.07 1.09 -1.03 1.13 1.19 -1.05 -1.12
pyrimidine ribonucleoside metabolic process 10 -1.32 1.14 1.04 1.22 1.27 -1.25 -1.09
pyrimidine ribonucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
pyrimidine nucleoside catabolic process 3 -2.8 1.04 -1.39 1.2 1.32 -1.87 -1.06
tetrahydrobiopterin metabolic process 4 7.84 -1.48 -1.41 -1.58 -1.23 1.76 2.48
pigment biosynthetic process 48 1.24 -1.02 -1.11 1.1 1.0 1.05 -1.07
ommochrome metabolic process 18 1.35 1.13 1.12 1.06 1.06 1.08 1.16
rhodopsin metabolic process 9 -1.72 -1.52 -1.96 1.48 1.03 -1.74 -1.95
ocellus pigment metabolic process 18 1.35 1.13 1.12 1.06 1.06 1.08 1.16
heme a metabolic process 1 -1.08 1.29 1.99 1.12 1.3 1.57 -1.3
alcohol catabolic process 39 1.48 1.03 -1.37 -1.1 -1.08 1.21 1.22
alcohol biosynthetic process 14 1.09 -1.23 -1.05 -1.2 1.02 1.19 1.3
glycerol-3-phosphate catabolic process 2 1.2 1.12 -1.49 1.16 1.79 -1.21 -1.08
polyol biosynthetic process 1 1.86 -1.46 -1.12 -1.51 1.13 1.83 1.71
polyol catabolic process 3 1.78 -1.48 -2.01 -1.34 1.14 1.58 -1.45
aldehyde catabolic process 1 1.1 -1.81 -2.08 -1.81 -1.6 3.21 -1.83
phenol-containing compound biosynthetic process 1 1.3 1.0 -1.05 -1.09 1.04 -1.06 -1.0
spermidine catabolic process 1 -1.3 1.12 1.08 1.3 1.03 -1.14 -1.27
nitric oxide metabolic process 1 1.08 1.06 1.02 1.1 1.05 -1.07 -1.02
indolalkylamine catabolic process 3 -1.86 1.07 -1.41 -1.17 -1.45 -1.76 -1.05
indolalkylamine biosynthetic process 3 1.22 -1.67 -1.93 -1.69 -1.72 1.14 2.21
regulation of JNK cascade 33 -1.0 1.2 1.31 1.13 1.3 1.36 1.17
negative regulation of JNK cascade 12 1.09 1.13 1.44 1.11 1.23 1.18 1.08
positive regulation of JNK cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
lateral inhibition 189 1.17 1.06 1.11 1.08 1.2 1.17 1.05
SMAD binding 2 1.44 -1.05 -1.06 -1.04 -1.05 -1.04 1.16
octopamine metabolic process 2 -2.63 1.33 -1.47 -1.06 -1.42 -3.88 1.1
octopamine catabolic process 1 -8.98 1.77 -2.05 -1.02 -2.08 -14.22 1.22
ethanolamine biosynthetic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
phosphatidylethanolamine metabolic process 1 1.07 -1.05 2.34 1.23 1.45 3.99 1.1
diacylglycerol metabolic process 3 1.83 -1.12 1.21 -1.09 1.79 -1.71 -1.19
CDP-diacylglycerol metabolic process 1 3.07 1.1 2.07 -1.42 3.13 -1.11 1.4
ecdysteroid catabolic process 1 1.07 -1.12 1.15 -1.13 -1.09 1.14 -1.07
amino sugar biosynthetic process 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
disaccharide biosynthetic process 3 3.57 -2.83 -2.37 -2.36 -1.16 5.45 -1.46
acetyl-CoA catabolic process 36 -1.0 1.09 1.26 -1.05 1.07 1.52 -1.04
monosaccharide biosynthetic process 8 -1.12 -1.06 -1.04 -1.1 1.15 1.01 -1.02
monosaccharide catabolic process 33 1.52 1.06 -1.18 -1.03 -1.06 1.37 1.2
GDP-L-fucose metabolic process 2 -1.67 1.21 1.13 1.24 1.36 -1.89 -1.14
N-acetylneuraminate biosynthetic process 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
CMP-N-acetylneuraminate metabolic process 1 1.0 -1.04 -1.09 -1.07 -1.02 1.03 -1.14
carboxylic acid biosynthetic process 65 1.05 -1.1 -1.35 -1.11 -1.17 1.1 1.09
carboxylic acid catabolic process 40 1.0 -1.07 -1.2 -1.06 1.05 1.14 -1.23
D-amino acid metabolic process 1 1.5 1.05 1.18 1.45 -1.04 1.27 -1.33
regulation of JAK-STAT cascade 17 -1.03 1.16 1.32 1.08 1.3 1.09 1.25
negative regulation of JAK-STAT cascade 5 -1.37 1.15 1.03 1.03 1.17 -1.54 1.05
positive regulation of JAK-STAT cascade 3 -1.1 1.05 1.09 1.11 1.21 -1.07 1.08
organophosphate catabolic process 4 2.25 1.02 1.6 1.03 1.46 1.59 1.17
L-cysteine metabolic process 1 1.24 1.05 1.09 -1.01 -1.04 1.21 1.11
icosanoid biosynthetic process 1 -1.74 1.11 -2.01 1.51 1.27 -1.87 -1.55
neutral lipid biosynthetic process 3 2.65 1.06 2.5 -1.19 1.69 1.64 1.56
neutral lipid catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
acylglycerol biosynthetic process 3 2.65 1.06 2.5 -1.19 1.69 1.64 1.56
acylglycerol catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
membrane lipid catabolic process 7 -6.83 -3.3 -2.99 1.5 -1.08 -6.52 -5.81
membrane lipid biosynthetic process 10 -1.24 1.25 1.26 1.0 1.07 -1.27 1.5
phosphatidylcholine metabolic process 2 -1.14 1.06 1.34 1.11 -1.05 -1.18 1.93
phosphatidylglycerol metabolic process 1 -3.36 1.4 1.32 1.25 1.35 -2.25 1.21
phosphatidic acid metabolic process 1 -3.17 -1.24 -2.56 1.51 2.33 -10.59 -5.09
glycerophospholipid biosynthetic process 29 -1.18 -1.03 1.13 -1.01 1.18 1.02 -1.13
glycosylceramide catabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
glycosphingolipid catabolic process 1 -1.02 1.14 1.14 1.39 1.15 1.04 -1.06
heterocycle metabolic process 248 1.2 1.03 1.01 1.0 1.02 1.19 1.01
ether lipid metabolic process 1 5.42 -21.99 -24.45 -20.82 -3.99 -1.47 6.54
glycerolipid metabolic process 74 1.16 -1.01 1.06 -1.03 1.25 1.16 1.08
glyoxylate metabolic process 2 1.28 -1.08 -1.85 -1.68 -1.27 1.71 -1.21
phosphatidylinositol metabolic process 56 1.09 1.02 1.12 -1.01 1.23 1.24 1.03
nicotinamide nucleotide metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
nicotinate nucleotide metabolic process 1 8.31 1.05 -1.79 -1.54 -1.19 1.17 2.54
S-adenosylmethionine metabolic process 1 1.6 1.05 1.23 -1.23 1.41 1.78 1.98
protoporphyrinogen IX metabolic process 1 1.62 1.26 1.09 -1.07 1.01 1.21 1.32
glycerolipid catabolic process 2 1.6 1.03 -1.14 -1.01 1.9 -1.45 -1.11
glycerol ether biosynthetic process 4 3.17 -2.08 -1.12 -2.44 1.05 1.32 2.23
ceramide biosynthetic process 2 -1.99 1.43 1.45 1.05 1.2 -1.4 -1.17
ceramide catabolic process 3 -3.87 -1.6 -1.06 1.31 -1.04 -6.06 -3.71
hypusine metabolic process 2 1.15 1.07 1.04 1.07 1.11 1.08 -1.05
sphingoid metabolic process 7 -1.82 -1.06 1.22 1.15 1.12 -2.11 -1.7
sphingoid biosynthetic process 2 -1.99 1.43 1.45 1.05 1.2 -1.4 -1.17
sphingoid catabolic process 3 -3.87 -1.6 -1.06 1.31 -1.04 -6.06 -3.71
xylosylprotein 4-beta-galactosyltransferase activity 1 1.66 1.11 1.34 1.35 1.53 1.06 -1.05
glucosyltransferase activity 13 1.53 -1.16 1.01 -1.3 1.09 1.41 1.06
imaginal disc fusion, thorax closure 15 1.03 1.24 1.46 1.13 1.3 1.26 1.21
photoreceptor cell differentiation 133 1.2 1.12 1.3 1.07 1.29 1.24 1.21
regulation of photoreceptor cell differentiation 27 1.02 1.11 1.32 1.05 1.3 -1.01 1.16
negative regulation of photoreceptor cell differentiation 5 -1.22 1.17 1.2 1.05 1.31 -1.53 1.09
positive regulation of photoreceptor cell differentiation 8 1.3 1.17 1.47 1.09 1.39 1.19 1.25
dosage compensation complex 6 1.37 1.23 1.41 1.11 1.23 1.51 1.37
development of primary female sexual characteristics 17 1.27 1.11 1.08 1.01 1.21 1.15 1.13
development of primary male sexual characteristics 21 1.16 1.07 1.22 1.05 1.17 -1.02 1.15
photoreceptor cell fate commitment 53 1.3 1.09 1.22 1.09 1.29 1.22 1.17
regulation of Ras protein signal transduction 76 1.02 1.17 1.37 1.05 1.32 1.3 1.27
positive regulation of Ras protein signal transduction 2 1.82 1.14 1.61 1.13 1.83 2.54 1.37
negative regulation of Ras protein signal transduction 7 -1.35 1.4 1.44 1.09 1.53 1.07 1.44
maintenance of pole plasm mRNA location 3 1.53 1.04 1.01 1.11 1.01 -1.06 -1.06
establishment of pole plasm mRNA localization 1 1.48 -1.03 1.16 1.42 1.58 1.23 -1.33
regulation of centriole replication 2 -1.05 1.36 1.16 1.21 1.29 -1.05 1.21
regulation of mitotic centrosome separation 2 -1.01 1.14 1.18 1.02 1.37 1.57 1.31
regulation of centrosome cycle 6 1.2 1.12 1.42 1.02 1.4 1.58 1.19
regulation of organ growth 37 1.36 1.2 1.4 1.1 1.41 1.43 1.25
negative regulation of organ growth 11 1.66 1.23 1.62 1.04 1.47 1.49 1.37
positive regulation of organ growth 11 1.2 1.28 1.51 1.16 1.65 1.9 1.4
sphingolipid transporter activity 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
sphingolipid binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
regulation of insulin receptor signaling pathway 10 1.25 1.09 1.37 -1.04 1.17 1.16 1.59
negative regulation of insulin receptor signaling pathway 7 1.27 1.12 1.56 -1.01 1.31 1.27 1.5
positive regulation of insulin receptor signaling pathway 2 1.0 -1.0 -1.17 -1.4 -1.23 -1.17 2.26
tetrahydrofolate metabolic process 3 5.63 -2.2 -1.59 -2.04 -1.72 1.86 1.99
tetrahydrofolate biosynthetic process 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
male sex differentiation 23 1.21 1.08 1.19 1.05 1.15 -1.03 1.14
regulation of oviposition 9 -1.14 -1.28 -1.17 -1.58 1.06 -1.04 1.22
dorsal closure, leading edge cell differentiation 5 1.03 1.07 2.19 -1.04 1.49 -1.17 1.24
dorsal closure, amnioserosa morphology change 10 1.22 1.15 1.79 1.05 1.63 1.42 1.38
amnioserosa maintenance 5 -1.1 1.14 1.38 1.06 1.23 -1.08 1.88
retinal cell programmed cell death 11 1.07 1.14 1.21 1.16 1.27 1.33 1.16
compound eye retinal cell programmed cell death 10 1.07 1.14 1.21 1.15 1.3 1.4 1.22
regulation of retinal cell programmed cell death 17 1.06 1.05 1.39 1.1 1.32 1.05 1.22
regulation of compound eye retinal cell programmed cell death 16 -1.01 1.05 1.48 1.08 1.37 1.0 1.24
positive regulation of retinal cell programmed cell death 7 -1.3 1.11 1.24 1.18 1.41 -1.33 1.3
negative regulation of retinal cell programmed cell death 7 1.19 -1.06 1.77 -1.01 1.35 1.16 1.21
positive regulation of compound eye retinal cell programmed cell death 7 -1.3 1.11 1.24 1.18 1.41 -1.33 1.3
negative regulation of compound eye retinal cell programmed cell death 7 1.19 -1.06 1.77 -1.01 1.35 1.16 1.21
induction of retinal programmed cell death 1 1.68 -1.09 1.22 1.16 1.11 1.33 1.07
induction of compound eye retinal cell programmed cell death 1 1.68 -1.09 1.22 1.16 1.11 1.33 1.07
sperm competition 15 1.28 -1.27 -1.33 -1.33 -1.2 1.37 -1.28
sperm storage 8 1.66 -1.63 -1.61 -1.67 -1.3 1.96 -1.5
heterocycle catabolic process 54 1.13 -1.01 1.05 1.01 1.06 1.1 1.01
insecticide catabolic process 4 -1.27 -1.2 -4.97 -1.06 -1.84 -3.14 1.18
galactoside 6-L-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
muscle cell homeostasis 8 1.75 -1.12 1.33 -1.09 1.16 1.67 -1.03
viral entry into host cell 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
microtubule polymerization 2 1.26 1.08 1.08 1.42 1.42 1.11 -1.04
host cell surface binding 1 2.63 -1.41 1.69 -1.89 -1.48 14.61 -1.02
regulation of nucleocytoplasmic transport 32 1.18 1.11 1.26 1.1 1.28 1.29 1.23
negative regulation of nucleocytoplasmic transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
positive regulation of nucleocytoplasmic transport 18 1.13 1.06 1.22 1.1 1.37 1.17 1.13
regulation of protein export from nucleus 1 1.39 1.22 1.43 1.19 1.67 1.14 1.14
negative regulation of protein export from nucleus 1 1.39 1.22 1.43 1.19 1.67 1.14 1.14
lipid phosphorylation 22 1.41 1.06 1.08 -1.0 1.3 1.56 1.24
glycolipid transport 1 -2.99 1.35 -1.24 1.41 -1.1 -2.55 -1.06
phosphorylated carbohydrate dephosphorylation 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
phospholipid dephosphorylation 4 1.17 1.2 1.42 1.09 1.23 1.3 1.22
dorsal appendage formation 31 1.38 1.07 1.32 1.03 1.3 1.21 1.3
micropyle formation 4 -1.04 1.06 1.34 1.1 1.39 -1.07 1.21
branched duct epithelial cell fate determination, open tracheal system 8 2.56 -1.13 -1.03 -1.23 1.24 1.31 1.76
filopodium assembly 7 1.05 1.06 1.31 1.03 1.18 1.91 1.22
phosphatidylinositol phosphorylation 22 1.41 1.06 1.08 -1.0 1.3 1.56 1.24
inositol phosphate dephosphorylation 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
phosphatidylinositol dephosphorylation 4 1.17 1.2 1.42 1.09 1.23 1.3 1.22
isoprenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
terpenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
tetraterpenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
carotenoid transport 1 -6.48 -6.48 -8.02 2.81 1.04 -8.53 -8.65
regulation of hormone secretion 2 -1.01 1.27 1.27 1.12 1.08 1.42 1.16
regulation of hormone biosynthetic process 2 -8.29 -1.83 1.21 1.4 1.08 -7.35 -3.84
regulation of lipid biosynthetic process 6 -3.09 -1.16 1.01 1.27 1.37 -3.44 -2.07
nucleoside triphosphate adenylate kinase activity 1 -1.71 -1.23 1.26 1.63 1.63 -3.14 -2.07
tetrahydrofolylpolyglutamate metabolic process 1 -2.47 1.42 -1.59 1.58 -1.34 -2.64 -1.65
tetrahydrofolylpolyglutamate biosynthetic process 1 -2.47 1.42 -1.59 1.58 -1.34 -2.64 -1.65
regulation of mitochondrial membrane permeability 1 3.39 -1.48 1.02 -1.33 1.2 1.81 1.97
tetrapyrrole binding 134 -1.06 -1.16 -1.25 -1.06 -1.02 -1.06 -1.12
intracellular transport 312 1.03 1.16 1.26 1.14 1.23 1.12 1.12
ion homeostasis 58 1.14 1.02 1.18 -1.16 -1.09 1.41 1.13
transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer 6 1.09 -1.04 -1.0 -1.07 -1.07 1.11 -1.18
transition metal ion binding 1090 1.0 1.02 1.04 1.06 1.12 1.02 -1.02
transition metal ion transmembrane transporter activity 19 -1.09 -1.13 -1.04 -1.14 -1.01 1.11 1.1
alpha-(1->3)-fucosyltransferase activity 4 -1.8 1.18 1.3 1.19 1.58 -1.36 -1.16
alpha-(1->6)-fucosyltransferase activity 1 1.63 1.17 -1.53 -1.05 -1.49 4.17 1.53
peptide-O-fucosyltransferase activity 1 -1.56 -1.04 -1.16 1.31 -1.19 -1.77 -1.4
ER retention sequence binding 1 -1.48 1.27 1.01 1.14 -1.01 -1.37 1.53
regulation of neurotransmitter secretion 11 1.29 1.05 1.09 1.01 1.04 1.26 1.14
nucleotide phosphorylation 8 -1.1 1.06 1.21 1.26 1.33 -1.22 -1.25
carboxylic acid transport 54 -1.28 -1.1 -1.53 -1.18 -1.03 1.07 -1.12
carboxylic acid transmembrane transporter activity 86 -1.42 -1.03 -1.43 -1.14 -1.01 -1.05 -1.13
hydroxylysine metabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
hydroxylysine catabolic process 1 -1.51 -1.6 -1.42 1.8 -1.74 2.0 -2.55
fatty-acyl-CoA biosynthetic process 4 1.86 1.19 1.27 1.15 1.54 1.19 1.01
cellular ketone body metabolic process 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
ketone body catabolic process 1 -1.42 1.61 -1.39 -1.13 -1.97 3.73 -1.22
positive phototaxis 2 1.78 -1.02 1.5 -1.1 1.34 2.13 1.12
negative phototaxis 1 -1.56 1.9 2.35 1.42 1.33 1.03 1.8
nonassociative learning 7 1.25 1.0 1.45 1.14 1.48 1.86 1.46
sensitization 1 1.44 -1.21 -1.33 1.15 1.76 5.15 2.78
3'-phosphoadenosine 5'-phosphosulfate transport 1 1.9 1.27 1.23 1.06 1.26 2.28 1.58
3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity 2 1.45 1.3 1.01 1.18 1.09 1.6 1.46
histone acetyltransferase activity (H4-K16 specific) 1 1.11 1.34 1.12 1.23 1.07 1.27 1.32
histone methyltransferase activity (H3-K9 specific) 4 -1.11 1.13 1.21 1.02 1.08 1.06 -1.09
histone methyltransferase activity (H3-K36 specific) 1 1.08 1.46 1.5 -1.1 1.11 1.44 1.39
histone methyltransferase activity (H3-K27 specific) 3 1.02 1.31 1.33 1.16 1.21 1.01 1.04
beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity 1 1.3 1.32 1.55 1.56 1.38 -1.43 -1.27
protein heterodimerization activity 59 1.16 1.07 1.25 1.01 1.07 1.14 1.08
protein dimerization activity 126 1.25 1.07 1.13 -1.01 1.11 1.21 1.14
N-acetyllactosamine beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
asioloorosomucoid beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity 2 -1.0 -1.2 -1.45 -1.61 -1.38 1.39 5.09
7-beta-hydroxysteroid dehydrogenase (NADP+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
testosterone dehydrogenase (NAD+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
vitamin-K-epoxide reductase (warfarin-sensitive) activity 1 1.07 1.03 -1.07 1.05 -1.1 -1.02 -1.18
inositol tetrakisphosphate 5-kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
glycosylphosphatidylinositol diacylglycerol-lyase activity 2 2.29 1.0 -1.19 -1.05 1.0 1.66 1.76
nucleoside-triphosphate diphosphatase activity 1 -1.36 -1.27 1.07 1.7 1.82 -3.47 -2.13
N-acylneuraminate-9-phosphate synthase activity 1 -1.06 1.35 1.0 -1.13 -1.03 1.09 -1.01
regulation of response to osmotic stress 1 -6.38 -3.77 -11.1 -5.2 -1.19 28.07 -1.66
vesicle transport along microtubule 1 1.21 1.12 1.66 1.2 1.79 2.51 1.99
mitochondrion transport along microtubule 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
3',5'-cyclic-GMP phosphodiesterase activity 5 1.32 1.17 1.39 1.05 1.28 2.17 1.4
acyl-CoA hydrolase activity 2 1.13 1.03 -1.08 1.05 1.02 1.1 -1.09
alanine-oxo-acid transaminase activity 1 -2.33 1.13 1.14 1.09 1.76 1.77 -1.09
bis(5'-adenosyl)-triphosphatase activity 1 2.29 1.26 1.38 1.23 1.51 1.35 -1.03
cysteamine dioxygenase activity 1 2.58 1.06 1.36 1.25 1.89 1.41 1.2
ecdysone oxidase activity 1 1.11 1.03 -1.05 1.12 4.21 1.26 -1.02
insulin-like growth factor receptor signaling pathway 2 -5.92 1.37 1.08 1.24 1.25 -4.11 -1.32
vascular endothelial growth factor receptor signaling pathway 4 -1.2 1.05 1.06 1.13 1.34 -1.18 1.04
receptor antagonist activity 2 1.75 1.03 1.01 1.06 1.08 1.1 1.1
regulation of melanin biosynthetic process 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
negative regulation of melanin biosynthetic process 1 1.36 1.09 1.02 -1.03 -1.16 1.04 1.01
regulation of nuclear mRNA splicing, via spliceosome 58 1.19 1.18 1.28 1.17 1.24 1.4 1.08
negative regulation of nuclear mRNA splicing, via spliceosome 3 1.33 1.28 1.25 1.28 1.23 1.34 1.03
mRNA 5'-UTR binding 1 -1.51 1.63 1.29 1.08 1.13 1.32 1.66
monosaccharide binding 18 -1.33 -1.12 1.17 -1.04 -1.09 -1.32 1.07
heme o metabolic process 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
heme O biosynthetic process 1 -1.18 1.24 1.2 1.18 -1.04 1.79 -1.68
central complex development 6 -1.05 1.15 1.33 1.1 1.3 1.02 1.11
cofactor binding 179 1.0 1.05 -1.16 1.01 1.02 -1.02 1.0
quinone binding 6 1.1 1.03 1.2 1.04 1.1 1.42 -1.29
ubiquinone binding 1 1.51 -1.05 1.4 1.02 1.33 1.88 -1.23
focal adhesion assembly 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
regulation of post-mating oviposition 5 -1.35 -1.04 1.16 -1.45 1.28 -1.43 1.45
mating behavior, sex discrimination 3 -1.02 1.04 -1.06 -1.01 -1.08 -1.1 1.0
R1/R6 cell differentiation 5 1.29 1.11 1.18 -1.01 1.23 1.16 1.34
R1/R6 development 1 2.43 1.22 1.86 1.12 2.17 2.26 2.36
R2/R5 cell differentiation 1 1.01 1.09 1.11 -1.09 -1.01 1.02 -1.12
R3/R4 cell differentiation 15 1.5 1.09 1.17 1.02 1.41 1.3 1.28
R3/R4 development 1 -1.12 -1.06 -1.22 1.01 -1.04 -1.1 1.01
compound eye corneal lens development 2 2.59 1.11 1.99 1.1 2.05 1.65 1.78
negative gravitaxis 4 1.28 -1.05 1.11 1.0 1.1 1.42 1.06
male courtship behavior, veined wing extension 14 1.06 1.04 1.41 1.13 1.09 -1.02 -1.01
developmental pigmentation 55 1.19 -1.1 -1.11 1.06 -1.01 -1.08 -1.01
cuticle pigmentation 11 1.56 -1.44 -1.19 -1.25 -1.22 1.2 1.58
regulation of developmental pigmentation 21 -1.11 1.02 1.05 1.01 1.13 -1.14 1.25
sex-specific pigmentation 3 1.97 1.09 1.06 -1.03 1.05 1.06 1.01
compound eye pigmentation 12 1.67 -1.11 -1.16 -1.06 -1.06 -1.02 1.25
regulation of eye pigmentation 5 -1.48 1.1 1.53 1.11 1.49 -1.35 1.53
regulation of compound eye pigmentation 5 -1.48 1.1 1.53 1.11 1.49 -1.35 1.53
regulation of cuticle pigmentation 13 -1.19 -1.03 -1.1 -1.02 1.03 -1.11 1.21
positive regulation of cuticle pigmentation 1 1.47 1.1 -1.04 -1.06 1.06 -1.18 1.3
regulation of adult chitin-containing cuticle pigmentation 12 -1.25 -1.04 -1.11 -1.02 1.03 -1.11 1.2
adult chitin-containing cuticle pigmentation 5 1.15 -1.36 -1.08 -1.2 -1.43 1.07 1.86
negative regulation of developmental pigmentation 2 2.98 1.16 1.17 1.04 1.29 1.15 1.23
positive regulation of developmental pigmentation 2 1.12 1.03 -1.09 -1.11 -1.16 -1.13 -1.07
regulation of male pigmentation 1 1.95 -1.01 1.39 -1.03 1.33 1.49 1.42
negative regulation of male pigmentation 1 1.95 -1.01 1.39 -1.03 1.33 1.49 1.42
male pigmentation 1 -1.17 -1.03 -1.15 -1.16 -1.43 -1.09 -1.47
antennal joint development 4 -1.02 1.09 1.04 1.04 -1.02 1.19 -1.03
anterior/posterior lineage restriction, imaginal disc 4 1.14 -1.2 1.12 1.11 1.19 -1.1 -1.24
wing disc anterior/posterior pattern formation 12 1.55 -1.26 -1.12 -1.07 1.12 1.32 -1.04
calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity 1 -1.09 -1.0 1.07 1.3 -1.04 -1.15 -1.07
somatic stem cell division 38 -1.22 1.15 1.34 1.17 1.41 -1.02 1.03
establishment of body hair or bristle planar orientation 5 2.56 -1.0 1.21 -1.16 1.38 2.42 1.68
establishment of body hair planar orientation 1 1.7 -1.08 -1.05 -1.16 1.03 1.04 1.05
establishment of thoracic bristle planar orientation 2 1.54 1.4 2.06 1.24 1.94 2.07 1.64
female germ-line stem cell division 10 1.1 1.17 1.12 1.12 1.15 1.0 1.13
male germ-line stem cell division 5 1.44 1.28 1.52 1.25 1.58 1.33 1.36
germ-line cyst formation 30 1.15 1.12 1.06 1.13 1.31 1.13 1.08
female germ-line cyst formation 11 1.0 1.02 1.1 1.01 1.25 1.47 1.16
male germ-line cyst formation 16 1.24 1.16 1.05 1.27 1.48 -1.14 -1.0
spermatocyte division 12 1.41 1.22 1.06 1.3 1.57 -1.11 1.0
germ-line cyst encapsulation 10 1.3 1.19 1.37 1.1 1.51 1.67 1.42
female germ-line cyst encapsulation 10 1.3 1.19 1.37 1.1 1.51 1.67 1.42
male germ-line cyst encapsulation 1 2.54 -1.11 -1.09 1.14 1.59 3.23 1.89
germarium-derived cystoblast division 2 -1.06 1.04 1.19 1.36 1.87 -1.4 -1.21
regulation of synaptic plasticity 12 -1.02 1.07 1.27 1.06 1.18 1.14 1.24
regulation of neuronal synaptic plasticity 7 1.02 1.03 1.32 1.05 1.12 1.11 1.29
regulation of long-term neuronal synaptic plasticity 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
regulation of short-term neuronal synaptic plasticity 5 -1.17 1.04 1.36 1.07 1.04 1.06 1.15
activin receptor complex 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
activin binding 2 -1.14 1.57 1.93 1.23 1.67 1.43 1.4
Set1C/COMPASS complex 8 1.45 1.14 1.33 1.24 1.41 1.36 1.13
wing disc dorsal/ventral pattern formation 40 1.21 1.03 1.1 1.01 1.29 1.34 1.31
Golgi vesicle transport 49 -1.1 1.16 1.21 1.13 1.21 1.13 1.34
Golgi vesicle budding 1 -2.28 1.35 -1.05 1.06 -1.19 -1.24 1.52
vesicle targeting, to, from or within Golgi 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
vesicle targeting, rough ER to cis-Golgi 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
COPII vesicle coating 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
Golgi vesicle fusion to target membrane 1 -1.26 1.22 1.43 1.12 1.39 1.17 -1.02
male gamete generation 151 1.07 1.14 1.22 1.07 1.24 1.12 1.11
mitochondrial iron ion transport 1 -1.62 1.12 -1.09 1.38 1.65 -1.57 1.22
lauric acid metabolic process 1 1.6 1.35 -1.72 -1.6 -1.17 -1.33 1.5
flap endonuclease activity 1 2.54 1.11 1.06 1.23 1.48 1.16 -1.04
regulation of receptor-mediated endocytosis 6 1.03 -1.04 1.28 1.02 1.13 1.2 1.06
positive regulation of receptor-mediated endocytosis 5 1.04 -1.02 1.26 1.02 1.14 1.19 1.06
negative regulation of receptor-mediated endocytosis 1 -1.04 -1.14 1.37 -1.01 1.09 1.23 1.09
determination of dorsal/ventral asymmetry 1 -1.43 -1.07 -1.23 -1.08 -1.37 -1.24 1.3
determination of ventral identity 1 -1.43 -1.07 -1.23 -1.08 -1.37 -1.24 1.3
response to pain 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
behavioral response to pain 2 1.88 -1.18 1.22 1.16 1.43 1.98 1.19
clathrin coat assembly 1 -1.06 1.07 1.15 -1.0 1.23 1.29 1.44
vesicle docking 27 -1.1 1.16 1.4 1.15 1.26 1.14 1.1
vesicle fusion with Golgi apparatus 1 -1.71 1.25 1.03 1.37 1.03 -1.21 1.5
organelle fusion 22 -1.09 1.09 1.26 1.2 1.3 1.01 1.01
organelle fission 154 1.25 1.09 1.26 1.12 1.32 1.24 1.11
calcium-dependent protein binding 1 -1.16 -1.03 -1.2 -1.35 1.14 -1.16 1.14
mitochondrion distribution 4 -1.16 1.47 1.48 1.13 1.3 1.01 1.31
intracellular distribution of mitochondria 3 -1.04 1.59 1.47 1.15 1.39 1.02 1.35
mesoderm morphogenesis 27 1.38 1.0 1.14 -1.07 1.1 1.58 1.18
mesodermal cell differentiation 16 1.47 1.02 1.02 -1.04 1.04 1.32 1.13
retinoic acid receptor signaling pathway 1 1.03 1.25 1.07 1.02 1.08 1.24 1.08
endosomal lumen acidification 2 1.23 1.13 1.3 1.15 1.45 1.18 1.47
cell development 815 1.17 1.08 1.24 1.04 1.25 1.26 1.2
cell maturation 116 1.16 1.11 1.31 1.06 1.29 1.43 1.21
perinuclear region of cytoplasm 31 -1.12 1.12 1.34 1.08 1.32 1.38 1.19
coated membrane 25 -1.02 1.18 1.24 1.13 1.15 1.19 1.33
oogenesis 421 1.13 1.11 1.26 1.07 1.26 1.21 1.2
replication fork protection 1 -1.49 1.01 -1.08 1.09 -1.02 -1.34 -1.39
synaptic vesicle endocytosis 44 1.07 1.17 1.41 1.1 1.29 1.39 1.22
synaptic vesicle transport 94 1.0 1.11 1.34 1.11 1.24 1.22 1.14
anterograde synaptic vesicle transport 3 -1.11 1.21 1.44 1.19 1.33 1.23 1.39
retrograde synaptic vesicle transport 1 -1.08 1.01 1.18 1.12 1.07 -1.04 1.06
synaptic vesicle membrane organization 1 -1.53 1.15 2.49 1.01 1.71 1.37 1.07
signal recognition particle 9 -1.25 1.37 1.01 1.14 -1.09 -1.57 1.26
regulation of timing of cell differentiation 1 -1.09 1.32 1.47 1.06 1.16 1.21 1.23
rhythmic process 57 1.07 -1.04 1.05 -1.19 -1.1 1.29 1.15
circadian behavior 44 -1.03 1.02 1.17 -1.13 -1.04 1.31 1.08
organ development 955 1.15 1.06 1.2 1.03 1.21 1.23 1.17
spermatid differentiation 82 1.02 1.13 1.3 1.04 1.31 1.2 1.17
CARD domain binding 1 1.78 1.11 1.56 1.24 1.76 -1.03 1.11
positive regulation of biological process 520 1.13 1.08 1.2 1.04 1.22 1.19 1.19
negative regulation of biological process 679 1.2 1.08 1.24 1.06 1.24 1.26 1.16
positive regulation of behavior 2 1.24 1.16 1.04 -1.02 1.05 1.25 1.29
negative regulation of behavior 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
positive regulation of cellular process 486 1.12 1.08 1.2 1.04 1.22 1.19 1.2
negative regulation of cellular process 586 1.18 1.09 1.25 1.06 1.25 1.26 1.18
negative regulation of viral reproduction 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
imaginal disc-derived wing expansion 6 2.01 -1.04 1.17 -1.02 1.2 1.5 1.51
beta-1,3-galactosyltransferase activity 10 1.35 1.03 1.08 1.01 -1.01 1.23 1.16
hemopoietic or lymphoid organ development 52 1.16 1.07 1.33 1.05 1.3 1.2 1.34
response to steroid hormone stimulus 41 1.14 1.06 1.3 1.01 1.23 1.41 1.22
digestive tract morphogenesis 61 1.11 -1.08 1.05 -1.02 1.31 1.24 1.17
metalloenzyme inhibitor activity 1 8.96 -2.17 1.12 -1.71 -1.16 3.1 2.84
post-embryonic organ morphogenesis 285 1.23 1.07 1.25 1.02 1.3 1.3 1.29
digestive tract development 87 -1.01 -1.06 1.09 -1.05 1.19 1.11 1.14
embryonic digestive tract development 1 -1.17 -1.0 -1.0 -1.0 -1.17 -1.16 1.21
ectodermal digestive tract morphogenesis 4 1.19 1.28 -1.02 1.12 1.64 1.2 1.13
embryonic organ development 24 -1.01 1.08 1.33 1.05 1.28 1.06 1.27
post-embryonic organ development 300 1.23 1.07 1.25 1.02 1.29 1.29 1.29
regulation of post-embryonic development 5 1.14 1.16 -1.03 -1.07 -1.0 1.5 1.12
regulation of response to stimulus 449 1.14 1.09 1.24 1.03 1.21 1.24 1.19
positive regulation of response to stimulus 91 1.19 1.1 1.22 1.05 1.25 1.21 1.24
negative regulation of response to stimulus 151 1.23 1.1 1.3 1.05 1.27 1.31 1.24
developmental cell growth 36 1.21 1.12 1.29 1.01 1.33 1.3 1.21
developmental growth 107 1.31 1.12 1.33 1.03 1.34 1.41 1.29
eye morphogenesis 209 1.17 1.09 1.26 1.05 1.25 1.21 1.26
embryonic morphogenesis 201 1.18 1.04 1.26 1.01 1.29 1.31 1.22
oocyte development 102 1.15 1.14 1.34 1.08 1.28 1.39 1.24
oocyte morphogenesis 1 1.25 1.21 2.24 1.64 2.85 9.21 1.2
reproductive structure development 42 1.01 1.04 1.05 1.07 1.24 -1.01 1.0
multicellular organismal reproductive process 651 1.12 1.07 1.19 1.04 1.21 1.19 1.17
cellular process involved in reproduction 549 1.13 1.09 1.21 1.05 1.26 1.19 1.17
embryonic hindgut morphogenesis 45 1.28 -1.09 1.1 -1.04 1.28 1.38 1.09
myoblast cell fate commitment 1 -1.07 -1.09 1.09 -1.1 1.09 -1.05 1.02
regulation of muscle organ development 54 1.15 1.07 1.22 1.02 1.13 1.16 1.15
negative regulation of muscle organ development 3 1.43 1.06 1.43 -1.11 1.0 1.31 -1.06
positive regulation of muscle organ development 6 2.17 -1.15 1.0 -1.2 1.03 1.63 1.19
regulation of developmental growth 66 1.12 1.14 1.34 1.08 1.24 1.16 1.2
positive regulation of developmental growth 12 -1.03 1.16 1.18 1.12 1.31 1.14 1.28
negative regulation of developmental growth 18 -1.04 1.11 1.34 1.12 1.2 -1.08 1.05
regulation of skeletal muscle tissue development 39 -1.02 1.12 1.32 1.09 1.24 1.09 1.21
muscle organ morphogenesis 4 2.88 -1.16 1.03 -1.17 1.2 1.86 1.03
organ formation 41 1.13 1.03 1.17 1.07 1.3 1.14 1.19
neuron fate commitment 58 1.29 1.09 1.23 1.1 1.29 1.22 1.17
neuron fate specification 12 1.09 1.06 1.08 1.18 1.13 -1.18 -1.07
neuron development 401 1.13 1.09 1.25 1.03 1.27 1.26 1.25
cell morphogenesis involved in neuron differentiation 329 1.14 1.09 1.26 1.04 1.27 1.25 1.26
collateral sprouting 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
collateral sprouting of injured axon 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
axon extension 21 1.21 1.14 1.27 1.01 1.26 1.1 1.2
axon extension involved in development 6 1.15 1.12 1.61 1.08 1.39 1.07 1.23
response to axon injury 4 -1.08 1.15 1.5 1.12 1.22 -1.04 1.21
sprouting of injured axon 3 -1.12 1.14 1.65 1.16 1.31 -1.01 1.22
generation of neurons 540 1.12 1.09 1.26 1.04 1.27 1.24 1.22
instar larval or pupal morphogenesis 353 1.18 1.06 1.22 1.03 1.28 1.26 1.24
proboscis development 6 1.03 1.0 1.19 1.01 1.08 1.14 1.54
tissue morphogenesis 259 1.2 1.04 1.27 1.02 1.28 1.32 1.25
epidermis morphogenesis 5 1.0 1.15 1.73 1.35 1.48 1.06 1.17
system development 1724 1.15 1.05 1.18 1.04 1.2 1.21 1.14
gland development 163 1.1 1.01 1.16 1.05 1.25 1.17 1.18
proboscis morphogenesis 1 -1.31 1.06 2.72 1.23 2.11 1.21 1.47
haltere morphogenesis 1 5.22 -1.53 1.19 1.44 -1.43 -1.39 -1.19
appendage development 238 1.25 1.06 1.22 1.01 1.29 1.33 1.3
imaginal disc-derived appendage development 236 1.25 1.06 1.22 1.01 1.29 1.33 1.3
cardiac muscle tissue development 5 1.62 -1.11 1.15 -1.06 1.18 1.57 1.06
skeletal muscle fiber development 47 1.2 1.17 1.29 1.08 1.21 1.33 1.23
regulation of skeletal muscle fiber development 39 -1.02 1.12 1.32 1.09 1.24 1.09 1.21
muscle fiber development 55 1.21 1.17 1.27 1.04 1.19 1.31 1.24
compound eye development 252 1.14 1.1 1.26 1.07 1.26 1.21 1.24
compound eye corneal lens morphogenesis 1 2.43 1.22 1.86 1.12 2.17 2.26 2.36
pigment granule organization 11 1.07 1.19 1.37 1.13 1.22 1.15 1.17
branching morphogenesis of a tube 45 1.12 1.12 1.47 1.03 1.34 1.29 1.3
mesenchymal cell differentiation 1 1.47 1.13 -1.02 1.1 -1.07 -1.03 1.1
calcium-induced calcium release activity 1 2.63 1.01 1.53 -1.05 1.46 2.52 1.76
presynaptic active zone 10 1.01 1.21 1.32 1.11 1.33 1.13 1.22
presynaptic cytoskeletal matrix assembled at active zones 1 1.09 1.05 1.11 -1.02 1.12 -1.14 -1.07
cytoskeletal matrix organization at active zone 3 1.12 1.05 1.11 1.12 1.08 -1.03 -1.02
maintenance of presynaptic active zone structure 6 -1.17 1.19 1.5 1.02 1.42 1.14 1.22
calcium ion-dependent exocytosis of neurotransmitter 1 1.37 1.07 1.15 1.12 1.04 1.3 1.03
antennal morphogenesis 13 -1.02 1.09 1.27 1.06 1.16 1.4 1.12
antennal joint morphogenesis 1 1.21 1.22 1.16 1.1 1.2 1.57 1.03
notum morphogenesis 4 -1.53 1.03 1.15 1.08 1.29 -1.65 -1.02
imaginal disc-derived male genitalia morphogenesis 13 1.4 1.09 1.4 1.06 1.26 1.05 1.3
imaginal disc-derived female genitalia morphogenesis 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
imaginal disc-derived genitalia morphogenesis 13 1.4 1.09 1.4 1.06 1.26 1.05 1.3
genitalia development 25 1.49 1.05 1.16 1.03 1.12 1.12 1.21
female genitalia morphogenesis 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
male genitalia morphogenesis 14 1.37 1.09 1.36 1.06 1.24 1.04 1.28
neuron projection morphogenesis 325 1.14 1.09 1.25 1.03 1.26 1.25 1.26
dendrite morphogenesis 132 1.18 1.12 1.28 1.11 1.28 1.22 1.16
regulation of dendrite morphogenesis 19 1.2 1.13 1.22 1.12 1.33 1.36 1.19
ocellus morphogenesis 1 1.15 1.0 -1.08 1.01 -1.06 -1.04 1.1
regulation of axon extension involved in axon guidance 2 -1.17 1.18 1.16 1.13 1.08 -1.15 -1.0
axon extension involved in axon guidance 2 -1.19 -1.04 -1.25 -1.1 -1.33 -1.25 -1.21
brain morphogenesis 15 1.06 1.14 1.38 1.07 1.42 1.16 1.21
anatomical structure development 2169 1.15 1.05 1.16 1.04 1.18 1.2 1.13
cell projection morphogenesis 358 1.11 1.08 1.23 1.04 1.24 1.23 1.23
formation of anatomical boundary 40 1.1 -1.02 1.14 -1.0 1.24 1.07 1.39
stem cell differentiation 55 1.1 1.12 1.3 1.12 1.35 1.1 1.2
stem cell development 50 1.1 1.12 1.31 1.12 1.35 1.12 1.22
stem cell fate commitment 5 1.31 1.03 1.18 1.08 1.47 1.16 1.29
cellular developmental process 1656 1.14 1.07 1.19 1.06 1.2 1.19 1.12
cell motility 198 1.13 1.09 1.32 1.04 1.35 1.22 1.2
multicellular organismal homeostasis 22 1.28 -1.0 1.13 -1.11 1.22 1.43 1.52
chemical homeostasis 84 -1.06 -1.02 1.05 -1.1 -1.06 1.13 1.03
peripheral nervous system neuron differentiation 5 1.37 -1.05 1.2 -1.12 1.36 2.17 1.48
peripheral nervous system neuron development 5 1.37 -1.05 1.2 -1.12 1.36 2.17 1.48
m7G(5')pppN diphosphatase activity 2 -1.05 1.25 1.14 1.39 -1.04 1.03 1.06
inositol oxygenase activity 1 3.92 -4.04 -3.69 -3.19 -2.14 5.76 -2.59
NADH dehydrogenase (quinone) activity 30 1.12 1.03 1.27 1.07 1.1 1.73 -1.3
rhodopsin kinase activity 1 2.38 1.14 1.51 1.03 1.36 1.67 1.26
sphingomyelin phosphodiesterase D activity 1 -1.04 1.38 1.42 1.29 1.65 1.05 1.22
sugar-phosphatase activity 3 1.95 -1.01 1.52 -1.38 -1.21 1.92 1.24
sugar-terminal-phosphatase activity 1 1.02 1.09 1.02 1.0 -1.15 -1.1 -1.14
tau-protein kinase activity 1 1.73 1.2 1.66 1.31 1.35 4.88 1.77
testosterone 17-beta-dehydrogenase (NAD+) activity 1 1.03 -1.04 1.2 -1.01 1.0 2.11 -1.07
trimethyllysine dioxygenase activity 1 1.3 -1.08 -1.07 -1.13 -1.19 1.96 -1.06
transferase activity, transferring alkylthio groups 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity 2 1.46 1.48 1.74 1.25 2.09 1.65 1.44
coenzyme-B sulfoethylthiotransferase activity 1 1.08 1.05 1.26 1.07 1.31 1.33 1.1
glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity 3 2.47 -1.53 -1.66 -1.5 -1.37 1.3 1.19
GDP-L-fucose synthase activity 1 1.27 1.21 1.12 1.11 1.24 -1.28 1.03
chondroitin sulfate proteoglycan biosynthetic process 7 1.31 1.13 1.16 1.13 1.24 1.3 1.08
chondroitin sulfate proteoglycan metabolic process 7 1.31 1.13 1.16 1.13 1.24 1.3 1.08
nucleic acid transport 47 -1.07 1.16 1.25 1.13 1.27 1.15 1.02
RNA transport 47 -1.07 1.16 1.25 1.13 1.27 1.15 1.02
flavin adenine dinucleotide binding 60 1.01 1.02 -1.23 1.0 1.01 -1.05 1.0
NADP binding 12 1.43 1.07 -1.48 -1.04 -1.1 1.24 1.21
coenzyme binding 127 -1.03 1.05 -1.16 1.03 1.04 -1.04 -1.01
oxidoreductase activity, acting on NADH or NADPH, oxygen as acceptor 1 2.71 -1.01 1.01 -1.06 -1.03 2.12 1.84
epithelial cell proliferation 11 1.14 1.03 1.13 -1.0 1.25 1.04 1.44
regulation of epithelial cell proliferation 2 1.23 1.09 1.59 1.34 1.35 -1.03 -1.14
negative regulation of epithelial cell proliferation 1 1.14 1.03 1.49 1.35 1.3 -1.2 -1.41
regulation of mRNA processing 63 1.2 1.17 1.28 1.16 1.23 1.4 1.09
positive regulation of mRNA processing 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
negative regulation of mRNA processing 4 1.46 1.2 1.32 1.17 1.27 1.62 1.09
regulation of defense response to virus 2 1.7 1.18 1.38 1.15 1.21 1.1 1.08
regulation of protein secretion 7 -1.08 1.14 1.13 1.04 -1.11 -1.14 1.11
negative regulation of protein secretion 2 -1.13 1.08 -1.08 -1.02 -1.24 -1.25 -1.14
positive regulation of protein secretion 4 1.08 1.1 1.36 1.08 1.05 1.04 1.2
regulation of peptidyl-tyrosine phosphorylation 3 1.04 1.16 1.54 1.06 1.26 1.21 1.03
negative regulation of peptidyl-tyrosine phosphorylation 2 -1.04 1.11 1.79 -1.0 1.29 1.24 1.01
low-density lipoprotein particle receptor binding 1 3.66 -1.09 1.54 -1.1 1.65 2.15 1.33
regulation of phagocytosis 1 2.18 -2.11 2.19 1.49 1.48 1.37 1.38
regulation of neurogenesis 95 1.06 1.12 1.34 1.07 1.33 1.21 1.16
negative regulation of neurogenesis 22 -1.0 1.18 1.36 1.09 1.44 1.27 1.22
positive regulation of neurogenesis 5 1.42 1.13 1.48 1.05 1.3 1.35 1.31
regulation of axonogenesis 27 -1.08 1.16 1.5 1.05 1.39 1.19 1.15
negative regulation of axonogenesis 5 -1.24 1.29 1.61 1.16 1.56 -1.15 1.13
regulation of dendrite development 22 1.22 1.13 1.27 1.1 1.38 1.38 1.24
negative regulation of dendrite morphogenesis 5 1.32 1.12 1.2 -1.01 1.18 1.31 1.53
positive regulation of dendrite morphogenesis 1 1.25 1.26 1.64 1.09 1.9 1.54 1.83
regulation of immune response 48 1.38 -1.08 1.02 -1.04 1.04 1.2 1.15
negative regulation of immune response 7 1.96 -1.13 1.13 -1.03 1.24 1.15 1.14
positive regulation of immune response 6 1.81 1.02 1.25 1.0 1.15 1.79 1.27
regulation of biological process 2435 1.15 1.06 1.19 1.05 1.18 1.18 1.12
regulation of catalytic activity 148 1.21 1.11 1.27 1.09 1.25 1.25 1.16
regulation of viral reproduction 4 1.27 1.23 1.52 1.17 1.6 1.47 1.34
regulation of developmental process 392 1.17 1.08 1.27 1.05 1.26 1.24 1.19
regulation of cellular process 2258 1.15 1.06 1.19 1.05 1.19 1.18 1.13
regulation of behavior 32 -1.08 1.03 1.08 -1.14 1.06 1.06 1.14
thymidylate synthase (FAD) activity 1 1.78 1.14 -1.44 1.08 1.0 3.89 1.83
circadian sleep/wake cycle, sleep 1 -1.57 1.18 1.13 1.01 1.08 -1.1 1.28
regulation of synapse structure and activity 62 1.04 1.11 1.34 1.06 1.23 1.18 1.19
regulation of synaptic transmission 36 1.13 1.11 1.3 1.02 1.17 1.29 1.22
negative regulation of synaptic transmission 2 -1.06 1.07 1.19 1.01 1.07 1.19 1.07
positive regulation of synaptic transmission 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
regulation of synapse organization 47 -1.01 1.12 1.34 1.09 1.27 1.13 1.21
synapse organization 72 1.22 1.16 1.24 1.06 1.23 1.32 1.22
coagulation 5 1.95 -1.51 -1.67 -1.6 -1.41 1.79 -1.02
regulation of body fluid levels 10 1.04 -1.31 -1.24 -1.25 -1.09 -1.06 -1.17
multicellular organismal movement 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
musculoskeletal movement 2 -1.89 -1.52 -1.42 -1.43 -1.62 -1.61 2.67
cognition 104 1.16 1.04 1.18 -1.01 1.23 1.38 1.22
response to stimulus 1939 1.15 1.01 1.09 -1.01 1.12 1.16 1.12
cobalt ion binding 1 2.85 -1.01 1.16 1.03 -1.08 1.74 -1.1
neuromuscular process 14 1.16 1.16 1.49 1.02 1.5 1.39 1.36
detection of stimulus involved in sensory perception 56 1.14 -1.01 1.02 1.02 1.07 1.15 1.02
detection of chemical stimulus involved in sensory perception 31 1.02 -1.01 -1.04 -1.0 1.05 1.09 -1.03
detection of light stimulus involved in visual perception 19 1.33 1.01 1.14 1.06 1.12 1.18 1.06
detection of chemical stimulus involved in sensory perception of smell 15 -1.07 -1.01 -1.04 1.01 -1.07 1.07 -1.07
sensory perception of bitter taste 2 -1.31 -1.2 -1.22 -1.24 3.17 1.22 -1.17
sensory perception of salty taste 2 1.15 1.12 1.11 1.03 -1.03 1.1 -1.05
sensory perception of sweet taste 10 1.42 1.09 1.21 1.04 1.18 1.17 1.2
positive chemotaxis 5 1.16 -1.25 1.29 -1.0 1.37 2.36 -1.31
negative chemotaxis 4 -1.03 -1.01 1.19 1.16 1.89 -1.4 -1.09
regulation of chemotaxis 5 1.06 1.07 1.36 1.03 1.13 1.06 1.02
negative regulation of chemotaxis 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
pigment cell differentiation 1 1.43 1.13 3.64 1.22 1.75 1.43 1.9
sensory perception of temperature stimulus 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
sensory perception of light stimulus 41 1.14 -1.01 1.16 1.08 1.09 1.11 1.02
thermoception 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
magnetoreception 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
detection of temperature stimulus involved in thermoception 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
detection of temperature stimulus involved in sensory perception 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
detection of light stimulus involved in sensory perception 20 1.33 1.01 1.13 1.06 1.11 1.23 1.07
detection of mechanical stimulus involved in sensory perception 3 1.34 -1.14 1.07 -1.03 1.11 1.5 1.37
detection of light stimulus involved in magnetoreception 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
detection of mechanical stimulus 3 1.34 -1.14 1.07 -1.03 1.11 1.5 1.37
regulation of lipid catabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
negative regulation of lipid catabolic process 1 -3.9 1.39 1.21 1.36 1.18 -2.17 -1.43
regulation of nitric-oxide synthase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
spindle midzone 11 -1.06 1.06 1.11 1.22 1.35 -1.12 -1.06
negative regulation of nitric-oxide synthase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
microtubule plus-end binding 1 1.58 -1.1 -1.13 -1.09 -1.05 -1.25 1.03
microtubule minus-end binding 3 2.17 1.08 1.62 1.15 1.7 2.3 1.31
microtubule sliding 2 -1.0 1.03 1.08 1.16 1.45 -1.14 -1.41
GTPase binding 33 1.09 1.2 1.54 1.1 1.4 1.28 1.4
mRNA transport 21 1.04 1.14 1.2 1.17 1.19 1.11 -1.01
snRNA transport 2 1.9 1.18 1.33 1.29 1.62 1.23 1.13
tRNA transport 1 1.48 1.1 1.33 1.32 1.54 -1.18 -1.04
regulation of endosome size 4 1.23 1.04 1.25 1.26 1.24 -1.0 -1.18
regulation of transcription during meiosis 3 1.04 1.04 1.22 1.08 1.06 -1.01 -1.03
positive regulation of transcription during meiosis 3 1.04 1.04 1.22 1.08 1.06 -1.01 -1.03
regulation of secretion 26 1.02 1.09 1.15 1.04 1.03 1.23 1.1
positive regulation of secretion 9 -1.15 1.19 1.43 1.11 1.18 1.14 1.14
negative regulation of secretion 3 -1.01 1.14 -1.02 1.03 -1.12 -1.05 -1.01
regulation of transport 97 1.11 1.07 1.23 1.06 1.15 1.32 1.13
positive regulation of transport 43 1.03 1.09 1.27 1.08 1.22 1.17 1.12
negative regulation of transport 13 1.41 1.11 1.22 1.06 1.16 1.64 1.33
regulation of DNA metabolic process 23 -1.05 1.12 1.21 1.14 1.34 -1.12 1.07
negative regulation of DNA metabolic process 12 -1.26 1.11 1.2 1.14 1.37 -1.28 1.13
positive regulation of DNA metabolic process 4 1.13 1.17 1.08 1.14 1.28 -1.01 1.07
negative regulation of lipid biosynthetic process 1 -84.21 -3.59 1.42 2.07 1.14 -58.36 -15.07
regulation of small GTPase mediated signal transduction 88 1.04 1.15 1.37 1.03 1.3 1.29 1.25
positive regulation of small GTPase mediated signal transduction 2 1.82 1.14 1.61 1.13 1.83 2.54 1.37
negative regulation of small GTPase mediated signal transduction 7 -1.35 1.4 1.44 1.09 1.53 1.07 1.44
protein tetramerization 3 1.61 1.24 1.33 1.08 1.47 1.59 1.11
meiotic nuclear envelope disassembly 2 1.15 1.34 1.04 1.15 1.01 -1.24 1.13
nuclear envelope disassembly 2 1.15 1.34 1.04 1.15 1.01 -1.24 1.13
'de novo' posttranslational protein folding 2 1.05 1.15 1.39 1.19 1.32 -1.27 1.18
chaperone mediated protein folding requiring cofactor 2 1.05 1.15 1.39 1.19 1.32 -1.27 1.18
regulation of sequence-specific DNA binding transcription factor activity 13 1.34 1.18 1.37 1.07 1.27 1.33 1.33
positive regulation of sequence-specific DNA binding transcription factor activity 8 1.24 1.17 1.52 1.19 1.56 1.5 1.11
positive regulation of NF-kappaB transcription factor activity 2 1.33 1.09 1.29 1.43 1.67 1.2 -1.13
negative regulation of developmental process 122 1.1 1.09 1.28 1.07 1.29 1.11 1.17
positive regulation of developmental process 44 1.22 1.09 1.22 1.05 1.23 1.18 1.21
regulation of binding 11 1.19 1.27 1.43 1.19 1.41 1.05 1.28
positive regulation of binding 1 2.81 1.45 1.89 1.09 1.48 2.58 1.71
negative regulation of binding 3 1.1 1.28 1.83 1.03 1.28 1.14 1.67
regulation of DNA binding 7 1.27 1.36 1.52 1.13 1.3 1.15 1.52
DNA ligation involved in DNA repair 2 1.6 1.14 1.36 1.04 1.35 1.44 1.13
synaptic growth at neuromuscular junction 18 1.09 1.23 1.45 1.08 1.28 1.56 1.28
regulation of cellular component organization 367 1.14 1.11 1.34 1.08 1.34 1.31 1.22
negative regulation of cellular component organization 63 1.04 1.14 1.37 1.11 1.35 1.19 1.15
positive regulation of cellular component organization 47 1.11 1.11 1.32 1.07 1.32 1.16 1.27
striated muscle cell differentiation 106 1.33 1.05 1.26 -1.02 1.19 1.4 1.16
regulation of muscle cell differentiation 40 1.03 1.1 1.31 1.08 1.23 1.12 1.2
regulation of striated muscle cell differentiation 40 1.03 1.1 1.31 1.08 1.23 1.12 1.2
nuclear export 29 1.21 1.09 1.3 1.16 1.26 1.19 1.04
nuclear transport 70 1.17 1.16 1.34 1.19 1.33 1.24 1.11
nuclear import 37 1.11 1.21 1.35 1.2 1.36 1.25 1.16
regulation of nitrogen compound metabolic process 800 1.13 1.09 1.18 1.07 1.17 1.17 1.12
negative regulation of nitrogen compound metabolic process 199 1.16 1.09 1.16 1.05 1.22 1.21 1.14
positive regulation of nitrogen compound metabolic process 222 1.11 1.05 1.13 1.03 1.13 1.18 1.15
regulation of phosphorus metabolic process 80 1.29 1.13 1.33 1.09 1.29 1.35 1.2
meiotic sister chromatid cohesion 4 -1.07 1.07 1.03 1.03 1.12 -1.1 -1.1
coenzyme transporter activity 1 -1.28 1.24 -1.24 1.18 -1.13 -1.69 1.59
cofactor metabolic process 102 1.31 1.1 1.11 1.03 1.09 1.32 1.04
cofactor catabolic process 38 1.01 1.1 1.28 -1.04 1.08 1.52 -1.03
cofactor biosynthetic process 53 1.51 1.12 1.11 1.08 1.1 1.22 1.09
protein insertion into membrane 2 -1.2 1.31 1.29 1.27 1.21 1.76 -1.19
release of sequestered calcium ion into cytosol 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
dioxygenase activity 52 1.01 1.03 -1.04 1.03 1.01 1.06 -1.01
phosphoprotein binding 3 1.02 1.34 1.39 1.03 1.34 1.5 1.35
cytoplasmic sequestering of protein 4 2.74 1.08 1.33 1.02 1.2 2.19 1.75
positive regulation of protein transport 25 1.11 1.07 1.24 1.09 1.26 1.13 1.14
regulation of protein transport 40 1.14 1.11 1.23 1.09 1.2 1.19 1.2
negative regulation of protein transport 8 1.65 1.12 1.19 1.05 1.14 1.51 1.37
spindle assembly 37 1.19 1.02 1.18 -1.02 1.27 1.27 1.15
spindle elongation 74 1.39 1.08 1.2 1.05 1.24 1.22 1.15
establishment of localization 1375 -1.06 1.01 1.01 -1.0 1.07 1.08 1.01
maintenance of location 51 1.21 1.11 1.23 1.06 1.24 1.26 1.22
establishment of RNA localization 48 -1.05 1.16 1.27 1.13 1.3 1.18 1.03
maintenance of RNA location 3 1.53 1.04 1.01 1.11 1.01 -1.06 -1.06
sequestering of metal ion 1 1.04 1.04 -1.04 -1.09 -1.16 -1.14 -1.1
regulation of multicellular organismal process 386 1.12 1.08 1.22 1.02 1.2 1.23 1.19
positive regulation of multicellular organismal process 31 1.01 1.17 1.34 1.03 1.25 1.29 1.33
negative regulation of multicellular organismal process 14 1.3 1.06 1.12 -1.04 1.17 1.15 1.14
regulation of protein metabolic process 182 1.3 1.11 1.31 1.09 1.29 1.35 1.22
positive regulation of protein metabolic process 25 1.12 1.15 1.46 1.08 1.34 1.24 1.28
negative regulation of protein metabolic process 47 1.33 1.04 1.25 1.02 1.25 1.33 1.24
regulation of RNA metabolic process 733 1.14 1.09 1.18 1.07 1.17 1.17 1.12
negative regulation of RNA metabolic process 190 1.17 1.09 1.17 1.04 1.21 1.23 1.16
positive regulation of RNA metabolic process 213 1.11 1.05 1.13 1.03 1.13 1.19 1.15
spindle midzone assembly 2 -1.32 -1.05 -1.11 1.02 1.0 -1.24 -1.14
spindle midzone assembly involved in meiosis 2 -1.32 -1.05 -1.11 1.02 1.0 -1.24 -1.14
protein polymerization 21 -1.19 1.04 1.18 1.11 1.2 -1.18 -1.09
protein oligomerization 7 1.05 1.23 1.4 1.02 1.36 1.37 1.51
protein depolymerization 9 -1.16 1.13 1.31 1.1 1.39 -1.02 -1.01
regulation of cellular component movement 12 1.86 -1.05 1.08 -1.07 1.19 1.24 1.56
negative regulation of cellular component movement 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
regulation of sequestering of calcium ion 2 1.38 1.1 1.6 1.13 1.03 2.02 1.52
negative regulation of sequestering of calcium ion 2 1.38 1.1 1.6 1.13 1.03 2.02 1.52
cell tip 1 3.87 -1.1 1.38 1.1 2.2 1.95 1.38
NAD binding 36 1.03 1.15 -1.0 -1.0 -1.02 1.24 1.11
protein homotetramerization 2 1.92 1.2 1.42 1.06 1.79 1.71 1.14
protein heterotetramerization 1 1.14 1.34 1.17 1.13 1.0 1.38 1.04
protein heterooligomerization 1 1.14 1.34 1.17 1.13 1.0 1.38 1.04
establishment of spindle localization 15 -1.09 1.17 1.26 1.1 1.29 1.1 1.08
establishment of spindle orientation 7 1.09 1.1 1.4 1.07 1.32 1.26 1.14
establishment of meiotic spindle localization 2 1.18 1.0 1.04 1.03 1.06 -1.17 1.01
establishment of meiotic spindle orientation 1 1.58 -1.1 -1.13 -1.09 -1.05 -1.25 1.03
centrosome organization 107 1.17 1.09 1.19 1.09 1.25 1.12 1.07
centrosome duplication 77 1.18 1.09 1.19 1.07 1.26 1.14 1.09
centrosome separation 12 1.08 1.11 1.11 1.12 1.23 1.13 1.05
cell division 175 1.03 1.09 1.25 1.09 1.33 1.06 1.09
regulation of cell division 6 -1.42 1.36 1.46 1.12 1.27 -1.11 1.24
establishment of chromosome localization 18 1.21 1.05 1.2 1.17 1.42 1.12 -1.0
chromosome separation 9 1.18 1.08 1.24 1.13 1.49 1.15 1.05
chromosome movement towards spindle pole 2 1.27 1.03 -1.05 1.3 1.32 -1.33 -1.18
mitotic sister chromatid separation 5 1.35 1.08 1.24 1.1 1.53 1.17 1.04
meiotic chromosome separation 4 1.0 1.09 1.25 1.17 1.45 1.14 1.06
metaphase plate congression 17 1.19 1.05 1.22 1.17 1.43 1.15 1.01
meiotic metaphase plate congression 1 -1.17 1.02 -1.13 1.11 -1.02 -1.2 -1.13
attachment of spindle microtubules to chromosome 5 -1.0 1.08 1.05 1.15 1.21 1.0 1.02
attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation 1 -1.05 1.32 1.38 -1.11 1.3 2.36 1.79
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation 1 -1.24 -1.06 -1.4 -1.21 -1.33 -1.23 -1.12
G1 phase 2 1.34 1.36 1.26 1.22 1.44 1.51 1.45
G2 phase 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
S phase 4 1.02 1.08 1.18 1.25 1.3 1.01 -1.14
meiotic cell cycle 132 1.13 1.09 1.16 1.08 1.21 1.1 1.09
anaphase 25 1.25 1.11 1.26 1.14 1.31 1.3 1.1
metaphase 2 1.14 1.11 1.14 1.15 1.24 1.02 -1.01
prophase 3 1.29 1.04 1.3 -1.01 1.37 1.56 1.26
interphase 85 1.24 1.15 1.34 1.2 1.41 1.23 1.13
telophase 1 1.4 1.02 1.15 1.14 1.72 -1.18 -1.16
M phase of meiotic cell cycle 124 1.1 1.11 1.17 1.11 1.22 1.09 1.08
interphase of meiotic cell cycle 1 1.43 -1.05 1.72 1.27 1.65 1.43 -1.28
interphase of mitotic cell cycle 84 1.23 1.15 1.33 1.2 1.41 1.23 1.14
S phase of meiotic cell cycle 1 1.43 -1.05 1.72 1.27 1.65 1.43 -1.28
regulation of hydrolase activity 77 1.13 1.1 1.24 1.07 1.24 1.19 1.15
regulation of transferase activity 51 1.28 1.15 1.34 1.13 1.31 1.38 1.19
regulation of lyase activity 8 1.21 1.07 1.14 -1.02 1.05 1.21 -1.04
regulation of ligase activity 5 1.5 1.1 1.38 1.2 1.15 -1.03 1.17
regulation of oxidoreductase activity 2 1.57 1.18 -1.18 1.24 1.17 1.04 1.44
positive regulation of hydrolase activity 26 1.05 1.14 1.29 1.16 1.4 1.23 1.08
negative regulation of hydrolase activity 6 -1.1 1.0 1.21 1.14 1.15 -1.28 -1.18
positive regulation of transferase activity 25 1.18 1.14 1.29 1.1 1.23 1.49 1.19
negative regulation of transferase activity 12 1.53 1.14 1.46 1.09 1.41 1.69 1.32
positive regulation of lyase activity 7 1.18 1.07 1.16 -1.04 1.05 1.21 -1.04
negative regulation of lyase activity 1 1.44 1.03 -1.0 1.12 1.06 1.16 -1.02
positive regulation of ligase activity 2 -1.3 1.19 -1.18 1.16 -1.1 -2.07 -1.12
negative regulation of ligase activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
positive regulation of oxidoreductase activity 1 2.28 1.19 1.07 -1.0 1.37 2.2 2.5
negative regulation of oxidoreductase activity 1 1.08 1.16 -1.5 1.55 1.01 -2.04 -1.2
kinetochore assembly 3 1.0 1.03 -1.07 1.16 1.05 -1.12 -1.1
kinetochore organization 7 -1.05 1.08 1.04 1.13 1.18 1.01 1.0
alpha-actinin binding 1 1.14 -1.01 1.12 1.41 1.03 -1.2 -1.43
neuron apoptotic process 2 -1.07 1.32 1.73 -1.0 -1.14 1.12 1.39
stress-activated MAPK cascade 26 -1.01 1.14 1.45 1.09 1.5 1.22 1.4
hormone receptor binding 5 1.32 -1.42 -1.36 -1.38 -1.32 -1.27 1.43
peptide hormone receptor binding 1 2.14 -13.11 -13.63 -12.76 -16.87 -14.38 5.61
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of ubiquitin-protein ligase activity 4 1.88 1.03 1.57 1.14 1.19 1.34 1.27
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
positive regulation of ubiquitin-protein ligase activity 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
negative regulation of ubiquitin-protein ligase activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of meiotic cell cycle 11 1.37 1.1 1.22 1.11 1.24 1.39 1.14
myoblast proliferation 3 -1.05 1.1 1.17 1.05 1.18 1.15 1.02
intracellular pH reduction 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
regulation of intracellular pH 6 -1.56 1.28 1.81 1.0 1.29 1.81 1.32
maintenance of protein location in nucleus 1 1.16 1.03 1.19 1.34 1.67 -1.1 1.01
cytosolic calcium ion homeostasis 4 1.44 1.13 1.5 -1.03 1.13 1.91 1.33
elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger 2 1.11 1.1 1.07 1.07 1.09 1.04 1.11
activation of anaphase-promoting complex activity involved in meiotic cell cycle 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
activation of anaphase-promoting complex activity 1 1.0 -1.01 -1.14 -1.09 -1.19 -1.12 -1.06
regulation of filopodium assembly 9 1.19 1.09 1.6 1.1 1.48 -1.13 1.2
negative regulation of filopodium assembly 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
positive regulation of filopodium assembly 5 1.14 1.08 1.54 1.11 1.41 -1.3 1.15
regulation of cytoskeleton organization 60 -1.04 1.1 1.42 1.04 1.42 1.16 1.22
negative regulation of cytoskeleton organization 17 1.02 1.13 1.55 1.04 1.43 1.45 1.22
positive regulation of cytoskeleton organization 10 1.03 1.13 1.32 -1.01 1.32 1.08 1.35
adenine nucleotide transport 2 -1.19 1.19 1.41 1.1 1.28 1.45 -1.24
regulation of NFAT protein import into nucleus 15 1.13 1.04 1.21 1.07 1.33 1.2 1.19
positive regulation of NFAT protein import into nucleus 15 1.13 1.04 1.21 1.07 1.33 1.2 1.19
iron-sulfur cluster binding 46 1.07 1.12 1.15 1.02 -1.01 1.33 -1.01
2 iron, 2 sulfur cluster binding 15 -1.23 1.2 1.11 1.01 -1.04 -1.03 -1.02
4 iron, 4 sulfur cluster binding 15 1.46 1.1 1.27 -1.03 1.06 1.96 1.05
metal cluster binding 46 1.07 1.12 1.15 1.02 -1.01 1.33 -1.01
mitochondrial calcium ion homeostasis 1 1.37 1.05 1.44 -1.12 1.01 2.39 -1.18
histone H3-K9 methylation 5 1.36 1.11 1.24 1.16 1.32 1.36 1.19
histone H3-K4 methylation 7 1.95 1.22 1.67 1.19 1.69 1.86 1.5
regulation of histone H3-K4 methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
positive regulation of histone H3-K4 methylation 1 -1.35 1.14 1.74 1.14 1.47 1.35 1.12
regulation of neurotransmitter transport 11 1.29 1.05 1.09 1.01 1.04 1.26 1.14
response to calcium ion 3 -1.58 -1.06 -1.06 1.03 1.08 -1.26 -1.33
detection of glucose 1 -1.49 -1.13 1.17 1.11 1.02 -1.25 -1.24
response to methylmercury 1 -1.7 -15.86 -19.15 -19.05 -4.94 3.57 1.25
meiotic recombination checkpoint 1 1.5 1.02 1.68 -1.05 1.78 1.86 1.49
protein maturation 35 1.25 1.0 1.16 1.01 1.14 1.15 1.2
detection of stimulus 142 1.02 -1.06 -1.01 1.02 -1.0 1.02 -1.09
defense response to virus 11 2.24 -1.18 1.31 -1.13 1.34 1.77 1.19
histamine transport 1 9.63 -2.21 -1.97 -1.79 -1.94 -1.46 -1.99
serotonin uptake 1 -1.06 -1.11 -1.0 -1.08 -1.15 3.37 -1.04
bacterial cell surface binding 13 1.62 -1.3 -1.27 -1.27 -1.21 1.78 -1.04
Gram-negative bacterial cell surface binding 6 2.33 -1.4 -1.19 -1.23 -1.04 2.23 1.13
Gram-positive bacterial cell surface binding 1 1.05 1.01 1.06 1.12 1.02 -1.02 -1.17
organelle localization 87 1.05 1.18 1.31 1.13 1.34 1.21 1.16
cellular localization 545 1.05 1.13 1.26 1.13 1.25 1.15 1.12
centrosome localization 6 1.32 1.16 1.58 1.07 1.39 1.47 1.24
endoplasmic reticulum localization 1 1.43 1.44 -1.25 1.13 1.04 -1.73 1.42
Golgi localization 1 1.07 1.7 2.32 1.13 1.82 2.48 3.32
mitochondrion localization 9 -1.42 1.39 1.56 1.16 1.41 1.21 1.26
nucleus localization 28 1.08 1.16 1.28 1.12 1.28 1.24 1.16
vesicle localization 13 -1.05 1.23 1.42 1.15 1.35 1.3 1.29
establishment of localization in cell 458 1.03 1.13 1.26 1.13 1.25 1.13 1.1
Yb body 5 -1.01 1.06 -1.01 1.12 1.04 1.16 1.0
establishment of vesicle localization 12 -1.08 1.24 1.4 1.15 1.31 1.23 1.25
maintenance of location in cell 38 1.15 1.13 1.29 1.07 1.32 1.24 1.25
spindle localization 15 -1.09 1.17 1.26 1.1 1.29 1.1 1.08
establishment of mitochondrion localization 5 -1.72 1.29 1.54 1.18 1.39 1.16 1.27
establishment of organelle localization 75 1.06 1.16 1.3 1.14 1.34 1.17 1.14
maintenance of organelle location 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
maintenance of nucleus location 1 1.08 1.36 1.49 -1.03 1.39 1.74 1.47
oocyte nucleus localization involved in oocyte dorsal/ventral axis specification 10 1.34 1.14 1.18 1.1 1.17 1.62 1.12
nuclear pore localization 1 1.83 -1.06 1.02 1.15 1.17 1.57 -1.03
localization within membrane 4 -1.25 1.15 1.55 1.16 1.41 1.33 -1.14
localization of cell 205 1.13 1.09 1.32 1.04 1.35 1.21 1.21
establishment of Golgi localization 1 1.07 1.7 2.32 1.13 1.82 2.48 3.32
establishment of ER localization 1 1.43 1.44 -1.25 1.13 1.04 -1.73 1.42
cellular oligosaccharide metabolic process 1 -1.04 -1.0 1.06 -1.08 -1.02 -1.02 -1.17
actin filament capping 2 -1.38 -1.03 2.18 1.01 1.59 -1.39 -1.04
interaction with host 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
multi-organism process 285 1.15 -1.16 -1.07 -1.15 -1.05 1.17 1.13
behavioral interaction between organisms 120 1.07 -1.05 1.06 -1.03 1.01 1.21 1.15
cellular response to stimulus 1171 1.16 1.04 1.16 1.04 1.18 1.17 1.11
UTP-monosaccharide-1-phosphate uridylyltransferase activity 1 1.07 -1.0 -1.14 -1.11 -1.05 -1.01 1.08
inositol tetrakisphosphate kinase activity 1 -1.15 1.56 -1.07 1.07 -1.15 -1.25 1.09
inositol trisphosphate kinase activity 5 1.28 1.12 1.04 -1.27 1.01 1.27 1.33
response to redox state 1 1.13 1.09 1.52 1.04 1.43 -1.06 -1.03
behavioral response to nutrient 5 -1.0 -1.02 1.2 1.04 1.13 1.24 1.12
positive regulation of cell division 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
regulation of nuclear division 45 1.26 1.07 1.15 1.07 1.27 1.23 1.12
negative regulation of nuclear division 15 1.05 1.11 1.17 1.19 1.35 1.07 1.0
positive regulation of nuclear division 2 -1.01 1.03 1.05 1.11 1.69 -1.0 -1.02
response to growth factor stimulus 13 1.49 -1.07 1.91 -1.01 1.18 1.43 1.11
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
entry into cell of other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
entry into other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
histone demethylase activity (H3-K36 specific) 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
protein autoubiquitination 1 1.42 -1.23 1.7 1.22 1.08 1.57 -1.21
regulation of mitochondrial membrane potential 1 1.38 1.05 1.33 1.44 1.46 1.81 -1.29
regulation of cardioblast differentiation 8 1.02 1.09 1.19 1.04 1.21 -1.01 1.39
regulation of focal adhesion assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
negative regulation of focal adhesion assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
regulation of protein kinase B signaling cascade 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
negative regulation of protein kinase B signaling cascade 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
membrane depolarization 2 1.57 1.42 -5.94 -5.79 -4.29 -1.73 2.07
peroxiredoxin activity 6 -1.25 1.02 -1.13 1.12 1.03 -1.35 -1.22
regulation of calcium ion transport 9 1.35 1.01 1.15 1.0 1.06 1.49 1.16
regulation of calcium ion transport via voltage-gated calcium channel activity 3 1.48 -1.08 1.0 -1.12 -1.07 1.3 -1.09
negative regulation of calcium ion transport 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
positive regulation of calcium ion transport 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
L-glutamate import 1 -51.3 1.56 -15.93 -1.24 2.78 -3.27 -134.18
regulation of nervous system development 135 1.05 1.12 1.33 1.08 1.3 1.18 1.16
negative regulation of nervous system development 13 -1.19 1.12 1.25 1.16 1.16 -1.1 1.05
positive regulation of nervous system development 8 -1.2 1.13 1.29 1.1 1.32 1.04 1.35
regulation of synapse assembly 42 -1.03 1.11 1.32 1.09 1.24 1.1 1.19
negative regulation of synapse assembly 13 -1.19 1.12 1.25 1.16 1.16 -1.1 1.05
positive regulation of synapse assembly 8 -1.2 1.13 1.29 1.1 1.32 1.04 1.35
regulation of synaptic transmission, glutamatergic 1 1.23 1.13 1.15 1.14 1.01 1.03 1.02
regulation of transmission of nerve impulse 36 1.13 1.11 1.3 1.02 1.17 1.29 1.22
negative regulation of transmission of nerve impulse 2 -1.06 1.07 1.19 1.01 1.07 1.19 1.07
positive regulation of transmission of nerve impulse 2 -1.81 1.29 2.08 -1.04 1.39 1.52 1.29
Se-methyltransferase activity 2 -2.66 1.46 -3.05 1.35 1.97 -1.55 -1.14
protein carboxyl O-methyltransferase activity 2 1.17 1.1 1.15 1.29 1.38 1.07 -1.31
movement in host environment 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
positive energy taxis 2 1.78 -1.02 1.5 -1.1 1.34 2.13 1.12
negative energy taxis 1 -1.56 1.9 2.35 1.42 1.33 1.03 1.8
movement in environment of other organism involved in symbiotic interaction 2 1.04 1.05 1.19 -1.29 -1.39 2.64 1.17
regulation of peptidase activity 20 1.05 1.09 1.25 1.18 1.38 1.06 1.03
regulation of endopeptidase activity 19 1.05 1.1 1.25 1.19 1.39 1.05 -1.01
imidazole-containing compound metabolic process 2 1.02 -1.27 1.33 1.09 1.3 1.8 1.14
inositol monophosphate phosphatase activity 6 1.86 -1.14 -1.69 -1.19 1.02 1.47 1.43
phosphatidylinositol phosphate phosphatase activity 5 1.04 1.17 1.35 1.12 1.16 1.2 1.1
muscle cell development 82 1.48 1.06 1.26 -1.03 1.2 1.47 1.18
striated muscle cell development 81 1.48 1.06 1.26 -1.03 1.2 1.48 1.18
cardiac cell development 1 1.07 1.18 1.43 1.07 1.41 1.26 1.4
cardiac muscle cell differentiation 2 1.04 1.06 1.29 1.05 1.22 1.1 1.23
cardiac muscle cell development 1 1.07 1.18 1.43 1.07 1.41 1.26 1.4
cortical microtubule 1 -1.44 1.19 -1.03 1.43 1.32 -1.27 -1.21
nuclear DNA-directed RNA polymerase complex 23 1.32 1.14 1.23 1.25 1.26 1.12 1.07
Bolwig's organ development 9 1.23 -1.01 1.15 1.06 1.23 1.18 1.03
recycling endosome 4 -1.11 1.29 1.32 1.11 1.24 1.01 1.18
neuroblast division 30 -1.27 1.17 1.36 1.17 1.41 -1.04 1.04
asymmetric neuroblast division 29 -1.27 1.18 1.38 1.18 1.43 -1.04 1.05
asymmetric neuroblast division resulting in ganglion mother cell formation 2 -1.54 1.67 1.31 1.18 1.85 -1.54 1.65
metal ion homeostasis 21 1.18 -1.09 1.18 -1.08 -1.18 1.19 -1.02
divalent inorganic cation homeostasis 12 1.64 1.02 1.45 -1.07 -1.01 1.57 1.18
monovalent inorganic cation homeostasis 9 -1.27 1.25 1.91 -1.01 1.19 1.86 1.45
zinc ion homeostasis 2 -1.14 1.23 2.03 1.09 1.14 1.23 1.14
copper ion homeostasis 6 -1.1 1.23 1.39 1.07 1.02 -1.01 1.17
iron ion homeostasis 8 1.49 -1.19 -1.16 -1.17 -1.18 1.48 1.09
calcium ion homeostasis 10 1.86 -1.02 1.36 -1.1 -1.04 1.64 1.18
transition metal ion homeostasis 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
cation homeostasis 36 1.04 1.04 1.42 -1.04 -1.04 1.32 1.1
cellular chemical homeostasis 58 -1.02 -1.02 1.04 -1.15 -1.07 1.16 1.05
transmembrane transport 398 -1.34 -1.02 -1.21 -1.11 -1.13 1.0 -1.15
nucleobase-containing small molecule metabolic process 189 1.1 1.04 1.03 1.02 1.07 1.12 -1.0
lipid homeostasis 17 -1.32 -1.08 -1.1 1.01 -1.02 -1.16 -1.17
fatty acid homeostasis 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
acylglycerol homeostasis 1 1.16 1.22 2.13 1.14 1.8 2.14 1.55
phospholipid homeostasis 1 -1.95 1.39 1.68 1.01 1.49 -1.24 1.08
sterol homeostasis 4 -4.57 -1.96 -1.16 1.4 -1.7 -2.27 -3.58
response to hyperoxia 1 1.14 1.04 1.05 1.06 1.07 1.1 1.08
entry into diapause 1 -1.14 1.2 1.7 1.09 2.04 1.39 1.74
digestive system development 87 -1.01 -1.06 1.09 -1.05 1.19 1.11 1.14
reflex 5 -1.0 -1.02 1.2 1.04 1.13 1.24 1.12
rhythmic synaptic transmission 1 9.13 1.03 1.44 -1.07 -1.11 1.07 1.06
regulation of synaptic activity 5 1.07 1.03 1.09 -1.04 1.05 1.27 1.1
convergent extension 2 1.27 1.22 1.43 1.14 1.36 1.4 1.35
convergent extension involved in gastrulation 2 1.27 1.22 1.43 1.14 1.36 1.4 1.35
mediolateral intercalation 2 1.27 1.22 1.43 1.14 1.36 1.4 1.35
retina development in camera-type eye 1 -1.1 -1.15 -1.07 -1.18 1.52 1.28 1.24
heart contraction 3 -1.25 1.41 -1.37 -1.01 1.12 1.05 1.18
cardiac muscle contraction 1 -2.87 2.31 -2.71 -1.16 1.45 1.26 1.68
regulation of protein glycosylation 1 -1.37 -1.13 -1.19 -1.54 1.82 7.35 2.8
neurofilament cytoskeleton organization 1 1.1 1.12 1.07 -1.03 -1.01 1.1 1.01
canonical Wnt receptor signaling pathway 8 1.24 1.0 1.39 1.04 1.59 1.21 1.49
Wnt receptor signaling pathway, planar cell polarity pathway 4 1.06 -1.1 1.26 -1.16 1.25 1.67 1.42
large conductance calcium-activated potassium channel activity 1 -2.53 -3.67 1.72 2.84 -2.74 -4.98 -3.6
synapse maturation 2 -1.1 1.15 1.09 1.05 1.27 1.2 1.3
regulation of postsynaptic membrane potential 4 1.21 1.34 -2.02 -2.31 -1.7 1.03 1.76
regulation of excitatory postsynaptic membrane potential 2 1.57 1.42 -5.94 -5.79 -4.29 -1.73 2.07
molecular transducer activity 443 1.09 1.01 1.1 1.0 1.08 1.12 1.06
binding, bridging 17 -1.01 1.02 1.14 1.03 1.09 1.16 1.1
limb development 54 -1.01 1.08 1.1 1.01 1.36 1.25 1.25
male mating behavior 44 -1.08 -1.14 1.03 -1.05 -1.05 -1.07 1.07
female mating behavior 24 -1.01 -1.19 -1.15 -1.08 -1.06 1.22 1.13
cell pole 3 1.46 1.08 1.28 1.11 1.49 1.29 1.1
regulation of lipase activity 8 1.04 1.1 1.09 1.07 1.01 1.07 1.0
negative regulation of lipase activity 2 -1.21 1.05 -1.16 1.19 -1.24 -1.13 -1.15
positive regulation of lipase activity 6 1.13 1.12 1.17 1.04 1.09 1.14 1.05
regulation of nuclear-transcribed mRNA poly(A) tail shortening 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
regulation of retinal cone cell fate commitment 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
lipase activator activity 2 -1.41 1.32 1.65 1.18 1.23 1.2 -1.03
delamination 8 1.85 1.18 1.27 1.06 1.22 1.87 1.48
oenocyte delamination 2 2.23 1.23 1.34 1.08 1.47 1.18 1.41
regulation of mitotic spindle organization 5 -1.03 1.11 1.19 1.15 1.35 1.05 -1.07
anatomical structure homeostasis 48 1.3 1.03 1.25 1.01 1.27 1.36 1.27
germ-line stem-cell niche homeostasis 4 1.24 1.27 1.46 1.22 1.66 1.51 1.42
regulation of glial cell proliferation 4 1.83 1.22 1.55 -1.02 1.23 1.76 1.45
positive regulation of glial cell proliferation 2 2.9 -1.05 1.75 -1.19 1.16 1.75 1.33
negative regulation of glial cell proliferation 2 1.15 1.57 1.36 1.13 1.31 1.77 1.58
regulation of macromolecule metabolic process 998 1.18 1.09 1.19 1.07 1.19 1.2 1.13
regulation of transcription initiation from RNA polymerase II promoter 5 1.43 1.28 1.45 1.26 1.36 1.28 1.29
positive regulation of transcription initiation from RNA polymerase II promoter 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
cilium morphogenesis 33 -1.14 1.06 1.0 1.05 -1.01 -1.08 -1.05
regulation of ovulation 2 1.79 1.12 1.06 1.1 1.24 1.64 1.35
regulation of oocyte development 25 -1.02 1.16 1.34 1.11 1.28 1.31 1.17
regulation of cell development 174 1.05 1.11 1.34 1.08 1.3 1.21 1.18
formation of a compartment boundary 1 1.36 -1.06 1.89 1.07 1.62 -1.06 1.23
long term synaptic depression 1 -1.13 1.08 1.37 1.02 1.39 1.34 1.23
germ plasm 13 1.42 1.03 1.1 1.02 1.09 1.51 -1.01
regulation of sarcomere organization 1 6.86 -1.53 -1.01 -1.17 1.13 2.97 1.11
regulation of cell diameter 3 1.2 1.28 1.27 1.02 1.3 1.13 1.19
GTP cyclohydrolase I regulator activity 1 33.5 -5.63 -5.79 -6.03 -4.58 -1.32 6.94
head development 23 1.18 -1.03 1.07 1.05 -1.03 -1.01 1.01
cell chemotaxis 7 1.41 -1.02 1.42 1.1 1.42 -1.11 -1.12
regulation of cellular localization 84 1.07 1.11 1.24 1.08 1.19 1.26 1.16
leucine import 3 1.2 -1.03 -1.17 1.06 1.15 -1.13 2.49
flight 4 2.08 1.01 -1.1 -1.13 1.05 2.84 1.39
innervation 1 -2.0 1.87 1.43 1.14 2.42 -2.25 1.78
axonogenesis involved in innervation 1 -2.0 1.87 1.43 1.14 2.42 -2.25 1.78
vitelline envelope 4 -1.15 1.03 -1.1 -1.06 -1.17 -1.2 -1.07
cytosolic calcium ion transport 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
calcium ion transport into cytosol 1 2.52 1.29 3.07 -1.16 1.37 5.13 2.97
epithelium development 247 1.17 1.05 1.28 1.02 1.3 1.33 1.27
trachea development 3 1.59 -1.2 1.46 -1.32 -1.06 1.27 -1.04
trachea morphogenesis 1 4.21 -1.18 -1.09 -1.07 -1.3 -1.11 -1.25
branching involved in open tracheal system development 45 1.12 1.12 1.47 1.03 1.34 1.29 1.3
mesenchyme development 1 1.47 1.13 -1.02 1.1 -1.07 -1.03 1.1
regulation of cell projection assembly 14 1.07 1.12 1.53 1.12 1.42 -1.16 1.1
muscle tissue development 86 1.17 1.09 1.24 1.03 1.18 1.33 1.16
skeletal muscle organ development 104 1.28 1.09 1.25 1.02 1.22 1.35 1.19
respiratory system development 181 1.4 1.03 1.27 -1.03 1.25 1.52 1.28
negative regulation of cell death 56 1.23 1.09 1.31 1.02 1.24 1.34 1.27
developmental growth involved in morphogenesis 50 1.3 1.12 1.32 1.02 1.35 1.3 1.31
epithelial tube morphogenesis 85 1.18 1.0 1.24 -1.0 1.3 1.38 1.17
negative regulation of mitotic anaphase-promoting complex activity 1 1.67 1.26 1.32 1.4 1.23 1.13 1.21
regulation of peptide hormone processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
negative regulation of peptide hormone processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
morphogenesis of an epithelial fold 7 1.32 1.05 1.42 1.01 1.41 1.46 1.64
morphogenesis of an epithelial bud 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
multicellular organismal iron ion homeostasis 1 -2.45 1.57 -1.18 1.13 -1.31 -2.1 1.39
nucleoside-triphosphatase regulator activity 126 1.07 1.14 1.34 1.04 1.26 1.22 1.19
ATPase regulator activity 4 1.49 1.1 1.13 1.22 1.27 1.15 1.16
regulation of vesicle-mediated transport 25 1.05 1.04 1.38 1.1 1.22 1.61 1.14
regulation of ER to Golgi vesicle-mediated transport 1 -1.04 1.0 1.09 1.3 1.23 -1.23 -1.03
regulation of microtubule-based movement 2 1.32 1.15 1.52 1.06 1.31 2.78 1.59
regulation of endoribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
regulation of ribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of ribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
negative regulation of endoribonuclease activity 1 1.58 1.16 -1.09 1.12 1.04 1.36 -1.13
ectodermal placode formation 4 -1.14 1.1 1.23 1.12 1.47 -1.2 -1.08
cell fate commitment involved in formation of primary germ layers 17 1.6 1.01 1.08 -1.06 1.04 1.29 1.13
intracellular mRNA localization involved in pattern specification process 42 1.09 1.16 1.32 1.13 1.25 1.24 1.19
intracellular mRNA localization involved in anterior/posterior axis specification 41 1.07 1.17 1.33 1.14 1.26 1.24 1.19
establishment of glial blood-brain barrier 16 2.59 -1.2 1.31 -1.17 1.29 2.35 1.44
cardiac cell fate commitment 9 1.12 1.05 1.08 1.02 1.08 1.04 1.06
cardiac cell fate specification 1 -1.42 1.01 1.2 1.29 2.44 -1.59 1.35
cardiac cell fate determination 4 1.32 1.0 1.08 -1.04 -1.05 -1.0 1.04
heart formation 6 1.11 -1.07 1.07 1.07 1.2 1.27 1.2
regulation of gene silencing by RNA 8 1.82 1.17 1.15 1.09 1.12 1.83 1.43
negative regulation of gene silencing by RNA 5 1.71 1.18 1.16 1.09 1.12 2.11 1.55
regulation of gene silencing 34 1.39 1.19 1.17 1.11 1.2 1.51 1.4
negative regulation of gene silencing 12 1.32 1.18 1.16 1.15 1.16 1.51 1.32
left/right pattern formation 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
kidney morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
regulation of mRNA catabolic process 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
positive regulation of mRNA catabolic process 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
membrane organization 261 1.07 1.1 1.21 1.08 1.23 1.2 1.13
membrane fusion 17 -1.08 1.06 1.29 1.18 1.2 1.18 -1.03
endodermal digestive tract morphogenesis 1 -5.18 1.12 -1.52 1.19 -1.17 -3.69 1.24
ovum-producing ovary development 1 -1.49 2.58 -1.26 -1.23 -1.23 -1.38 1.24
regulation of wound healing 1 9.2 -1.31 -1.17 -1.11 -1.07 7.07 1.71
peptidoglycan recognition protein signaling pathway 8 1.83 1.08 1.26 1.07 1.21 1.54 1.2
regulation of peptidoglycan recognition protein signaling pathway 4 2.19 -1.16 1.49 1.19 -1.07 -1.21 -1.53
positive regulation of peptidoglycan recognition protein signaling pathway 1 8.35 -1.25 -1.3 -1.07 -1.15 1.62 -1.07
negative regulation of peptidoglycan recognition protein signaling pathway 3 1.4 -1.13 1.86 1.28 -1.04 -1.52 -1.72
muscle structure development 204 1.33 1.03 1.2 1.01 1.19 1.28 1.19
regulation of neural retina development 2 -1.43 1.42 1.17 1.08 1.59 -1.55 1.31
chaperone-mediated protein folding 4 1.23 1.17 1.41 1.19 1.43 -1.13 1.19
regulation of protein tyrosine kinase activity 5 1.47 1.14 1.46 -1.01 1.32 1.52 1.27
positive regulation of protein tyrosine kinase activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
negative regulation of protein tyrosine kinase activity 4 1.69 1.13 1.32 1.01 1.3 1.49 1.25
peptidase regulator activity 83 1.36 -1.46 -1.4 -1.48 -1.27 1.43 1.07
morphogenesis of a branching epithelium 45 1.12 1.12 1.47 1.03 1.34 1.29 1.3
establishment of monopolar cell polarity 10 1.54 1.16 1.19 -1.02 1.43 1.47 1.4
type I terminal button 2 2.85 1.08 1.12 -1.03 -1.01 2.59 1.3
establishment or maintenance of bipolar cell polarity 32 1.32 1.09 1.43 1.03 1.37 1.42 1.25
cell surface receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
canonical Wnt receptor signaling pathway involved in heart development 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
renal filtration cell differentiation 11 1.64 -1.04 1.33 -1.09 1.12 1.26 1.37
nephrocyte differentiation 11 1.64 -1.04 1.33 -1.09 1.12 1.26 1.37
pericardial nephrocyte differentiation 9 1.9 -1.04 1.48 -1.11 1.17 1.39 1.52
garland nephrocyte differentiation 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
renal tubule development 62 1.15 -1.03 1.11 -1.01 1.22 1.34 1.08
anterior Malpighian tubule development 12 -1.05 -1.01 1.18 -1.15 1.13 1.62 1.06
posterior Malpighian tubule development 2 1.35 -1.06 1.02 -1.25 -1.0 1.06 2.86
Malpighian tubule stellate cell differentiation 3 1.38 1.01 1.13 1.37 -1.02 -1.07 -1.11
epithelial cell proliferation involved in Malpighian tubule morphogenesis 11 1.14 1.03 1.13 -1.0 1.25 1.04 1.44
Malpighian tubule bud morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
renal tubule morphogenesis 44 1.29 -1.1 1.07 -1.04 1.27 1.38 1.09
cell rearrangement involved in Malpighian tubule morphogenesis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
cell morphogenesis involved in Malpighian tubule morphogenesis 1 3.86 1.45 2.61 -1.03 2.28 4.0 3.57
establishment or maintenance of monopolar cell polarity 10 1.54 1.16 1.19 -1.02 1.43 1.47 1.4
neural precursor cell proliferation 40 -1.13 1.17 1.36 1.16 1.4 1.07 1.11
cell chemotaxis involved in Malpighian tubule morphogenesis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
BMP signaling pathway involved in Malpighian tubule cell chemotaxis 3 2.04 1.05 1.89 -1.07 1.16 1.0 1.3
regulation of Wnt protein secretion 3 1.21 1.05 1.22 1.06 -1.1 -1.07 1.29
positive regulation of Wnt protein secretion 3 1.21 1.05 1.22 1.06 -1.1 -1.07 1.29
Malpighian tubule tip cell differentiation 9 -1.2 1.13 1.24 1.07 1.14 -1.23 1.24
regulation of extent of cell growth 7 -1.17 1.19 1.37 1.14 1.29 1.18 1.05
specification of axis polarity 5 1.18 1.04 1.06 1.17 1.12 -1.03 1.06
intracellular protein transmembrane transport 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
macromolecular complex assembly 152 1.06 1.1 1.27 1.14 1.27 1.1 1.02
protein-DNA complex assembly 42 1.03 1.08 1.27 1.16 1.28 -1.05 1.02
biological regulation 2649 1.15 1.05 1.17 1.04 1.17 1.17 1.12
regulation of biological quality 662 1.12 1.03 1.16 1.01 1.17 1.2 1.14
regulation of molecular function 176 1.23 1.12 1.28 1.09 1.25 1.26 1.18
aspartic-type peptidase activity 19 -1.6 -1.03 1.15 -1.16 -1.46 -1.86 -1.32
threonine-type peptidase activity 23 1.34 -1.02 1.1 1.11 1.12 -1.15 -1.1
serine-type exopeptidase activity 13 -1.19 -1.2 -1.0 -1.01 -1.57 -1.53 1.1
intracellular organelle lumen 588 1.2 1.12 1.23 1.16 1.24 1.22 -1.0
carbon monoxide binding 1 -1.13 -1.1 -1.21 -1.08 -1.27 -1.0 -1.19
nitric oxide binding 1 -1.13 -1.1 -1.21 -1.08 -1.27 -1.0 -1.19
purine NTP-dependent helicase activity 76 1.18 1.21 1.34 1.17 1.3 1.31 1.19
neuron homeostasis 3 -1.16 1.18 1.11 1.05 1.04 -1.04 -1.02
apoptosis in response to endoplasmic reticulum stress 1 -1.56 1.12 -1.6 -1.09 -1.49 -1.56 -1.26
proline-rich region binding 1 -2.96 1.13 1.63 1.21 1.47 -2.66 -1.29
proton-transporting two-sector ATPase complex assembly 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
clustering of voltage-gated calcium channels 1 1.29 -1.71 -1.84 -1.91 -1.32 16.38 -1.61
histone lysine demethylation 6 1.15 1.33 1.71 1.16 1.56 1.61 1.38
glycosylation 53 1.14 1.04 1.06 1.04 1.1 1.12 1.2
synaptic vesicle budding 14 1.04 1.17 1.47 1.12 1.28 1.36 1.24
occluding junction 26 2.55 -1.23 1.25 -1.28 1.23 3.22 1.62
anchoring junction 59 1.24 1.15 1.4 1.04 1.4 1.33 1.31
kynurenine metabolic process 1 1.33 -1.46 -1.36 -1.56 -1.39 2.84 -1.33
chromosome organization involved in meiosis 6 1.05 1.07 1.09 1.05 1.18 -1.08 -1.05
synaptonemal complex organization 3 1.06 1.0 1.13 1.06 1.06 1.25 1.03
synaptonemal complex disassembly 1 1.38 -1.04 1.41 1.16 1.34 2.25 1.03
regulation of establishment of protein localization 42 1.15 1.11 1.24 1.09 1.2 1.21 1.21
actin-mediated cell contraction 4 -1.26 1.28 1.59 1.06 1.39 1.15 1.23
tyrosyl-DNA phosphodiesterase activity 1 -1.61 -1.07 -1.0 -1.17 -1.28 -1.58 -1.34
protein complex biogenesis 81 1.0 1.09 1.27 1.1 1.24 1.13 -1.01
proton-transporting ATP synthase complex biogenesis 2 1.21 1.11 1.39 1.2 1.21 1.72 -1.33
phosphatidylinositol-4-phosphate binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
extracellular matrix constituent secretion 2 1.62 -1.11 1.06 -1.19 1.17 -1.33 -1.09
radical SAM enzyme activity 1 1.58 1.18 1.95 1.1 1.45 3.43 -1.02
ferritin complex 3 -1.78 1.04 1.19 1.02 -1.06 -2.25 -1.21
phosphatidic acid binding 1 1.31 1.26 1.47 1.37 1.45 1.27 1.07
cellular response to hydrogen peroxide 5 -1.31 1.04 -1.13 1.14 1.05 -1.39 -1.21
regulation of stress-activated protein kinase signaling cascade 33 -1.0 1.2 1.31 1.13 1.3 1.36 1.17
negative regulation of stress-activated protein kinase signaling cascade 12 1.09 1.13 1.44 1.11 1.23 1.18 1.08
positive regulation of stress-activated protein kinase signaling cascade 12 1.07 1.28 1.47 1.07 1.29 1.52 1.25
lipoprotein particle receptor binding 1 3.66 -1.09 1.54 -1.1 1.65 2.15 1.33
triglyceride homeostasis 10 -1.54 -1.28 -1.3 -1.03 -1.36 -1.47 -1.44
regulation of ERK1 and ERK2 cascade 3 1.06 1.01 -1.21 -1.22 -1.32 -1.26 1.87
positive regulation of ERK1 and ERK2 cascade 3 1.06 1.01 -1.21 -1.22 -1.32 -1.26 1.87
high mobility group box 1 binding 1 3.82 -1.26 1.16 -1.51 1.23 1.8 1.55
chaperone cofactor-dependent protein refolding 1 1.92 1.17 1.75 1.1 1.32 1.14 1.27
NAD+ binding 7 1.31 1.11 -1.1 1.29 -1.04 1.13 1.25
glutamine binding 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl phosphate metabolic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
carbamoyl phosphate biosynthetic process 1 -1.12 1.14 1.63 1.21 1.33 1.0 1.05
cellular response to cold 2 1.0 1.06 -1.05 1.0 -1.03 -1.07 -1.17
nonhomologous end joining complex 2 -1.03 1.29 1.58 1.29 1.51 -1.21 1.27
elongin complex 1 -1.03 1.24 1.37 1.02 1.36 -1.06 1.29
cell hair 2 1.46 1.0 1.38 -1.02 1.32 1.45 1.21
SAGA-type complex 20 1.38 1.1 1.14 1.26 1.22 1.03 -1.02
plus-end specific microtubule depolymerization 1 1.23 1.19 1.22 1.26 1.69 -1.05 1.08
respiratory chain 68 1.11 1.0 1.19 1.01 1.07 1.57 -1.31
response to oxygen levels 48 1.13 1.14 1.22 1.09 1.26 1.28 1.19
repressing transcription factor binding 13 1.29 -1.04 -1.01 -1.14 1.25 1.49 1.64
regulation of microtubule cytoskeleton organization 27 1.18 1.14 1.4 1.06 1.41 1.45 1.25
death domain binding 1 1.48 1.27 1.15 1.13 1.09 -1.04 1.31
histone H3-K36 demethylation 2 1.08 1.24 1.45 1.25 1.55 1.06 1.05
L-tyrosine aminotransferase activity 1 1.14 1.12 -1.09 -1.15 1.09 -1.15 -1.05
L-glutamine aminotransferase activity 2 -1.0 -1.44 1.48 -1.44 1.38 1.11 2.78
adenylyltransferase activity 11 -1.05 1.19 1.21 1.12 1.08 -1.03 1.08
cytidylyltransferase activity 5 1.44 -1.22 1.18 -1.16 1.33 -1.05 1.53
guanylyltransferase activity 4 -1.18 1.19 1.23 1.25 1.19 -1.14 1.16
uridylyltransferase activity 2 -1.21 -1.06 1.2 -1.1 1.09 -1.36 1.36
cadmium ion transmembrane transport 1 -1.37 1.35 1.68 1.28 1.12 -1.35 -1.15
mitochondrion morphogenesis 2 1.03 1.2 1.34 1.27 1.61 1.2 -1.12
protein localization in mitochondrion 28 1.07 1.09 1.21 1.13 1.12 1.18 -1.1
calcium ion transmembrane transport 7 1.59 1.03 1.19 -1.08 -1.01 1.55 1.32
dendrite self-avoidance 7 1.17 1.14 1.29 1.13 1.33 1.54 1.21
juvenile hormone response element binding 2 -1.22 1.25 1.18 1.1 1.78 -1.07 1.14
SWI/SNF-type complex 10 1.12 1.16 1.37 1.17 1.42 1.35 1.27
PBAF complex 1 -1.21 1.11 -1.01 1.16 1.01 -1.02 1.11
regulation of protein processing 1 -2.9 -1.14 1.64 1.56 2.18 -4.01 -1.31
nucleosome-dependent ATPase activity 2 1.37 1.25 2.22 1.17 1.97 1.84 1.81
proteasome binding 1 1.49 1.1 1.49 1.27 1.56 -1.75 1.05
protein modification by small protein removal 15 1.19 1.08 1.36 1.13 1.29 1.19 1.15
protein modification by small protein conjugation or removal 62 1.15 1.12 1.38 1.15 1.28 1.17 1.13
poly-purine tract binding 5 1.32 1.19 1.41 1.19 1.38 1.34 1.35
cellular macromolecule localization 266 1.06 1.17 1.3 1.13 1.24 1.16 1.17
cyclic nucleotide transport 1 1.9 -1.14 -1.37 1.0 -1.16 1.35 -1.12
cGMP transport 1 1.9 -1.14 -1.37 1.0 -1.16 1.35 -1.12
spindle envelope 4 1.54 1.11 1.47 1.01 1.35 1.6 1.17
histone H3-K27 methylation 3 1.06 1.17 1.29 1.08 1.13 -1.1 -1.05
C2H2 zinc finger domain binding 1 1.47 -1.07 -1.23 1.4 -1.01 -1.35 -1.31
peptidyl-lysine 5-dioxygenase activity 2 1.13 1.08 1.05 -1.04 1.19 1.95 1.17
phosphorylation of RNA polymerase II C-terminal domain 1 -1.89 -1.04 1.09 1.37 2.39 -1.87 -1.49
protoporphyrinogen oxidase activity 2 -1.11 1.24 1.36 1.38 1.3 1.17 -1.16
Sin3-type complex 10 1.24 1.21 1.36 1.21 1.38 1.37 1.15
chromatin maintenance 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
heterochromatin organization 15 1.05 1.16 1.35 1.05 1.34 1.18 1.25
heterochromatin maintenance 1 -1.2 1.03 1.07 -1.11 1.52 -1.28 -1.06
basement membrane assembly 1 -1.47 1.17 2.02 1.22 1.63 -1.12 1.4
divalent metal ion transport 28 1.38 -1.01 1.09 -1.09 1.16 1.51 1.18
growth factor receptor binding 19 2.02 -1.49 -1.23 -1.57 1.04 2.84 1.44
myosin VI binding 3 -1.98 1.02 1.13 1.07 1.24 -1.12 -1.15
myosin VI heavy chain binding 2 -1.4 -1.01 1.0 1.02 1.17 -1.17 -1.2
myosin VI head/neck binding 2 -1.4 -1.01 1.0 1.02 1.17 -1.17 -1.2
myosin VI light chain binding 1 -3.92 1.08 1.44 1.19 1.39 -1.01 -1.05
regulation of protein exit from endoplasmic reticulum 3 -1.03 1.07 -1.01 1.14 -1.11 -1.45 1.2
positive regulation of protein exit from endoplasmic reticulum 2 -1.03 1.1 -1.05 1.06 -1.29 -1.58 1.34
sperm individualization complex 8 -1.42 1.11 1.46 1.09 1.37 -1.03 1.02
investment cone 3 -1.57 1.04 1.08 1.04 1.05 -1.06 -1.09
heterochromatin organization involved in chromatin silencing 6 1.24 1.15 1.45 1.05 1.33 1.19 1.28
regulation of glycogen metabolic process 1 -2.86 1.25 -1.2 1.45 1.26 1.29 -1.32
pre-miRNA binding 1 1.6 1.11 4.34 -1.01 3.45 5.33 3.25
E-box binding 1 1.39 -1.11 1.11 -1.25 1.17 1.75 1.6
production of small RNA involved in gene silencing by RNA 11 1.46 1.17 1.45 1.09 1.32 1.46 1.31
regulation of production of small RNA involved in gene silencing by RNA 2 2.75 1.11 1.02 1.03 -1.06 1.3 1.12
small RNA loading onto RISC 6 1.25 1.16 1.42 1.05 1.43 1.57 1.49
siRNA loading onto RISC involved in chromatin silencing by small RNA 2 1.38 1.18 -1.01 1.15 1.25 2.63 1.7
organelle assembly 50 1.16 1.06 1.16 1.03 1.21 1.22 1.1
contractile ring 5 -1.53 1.2 1.44 1.14 1.64 1.07 1.08
dephosphorylation of RNA polymerase II C-terminal domain 1 1.1 1.03 1.12 1.08 1.22 -1.0 1.51
endoplasmic reticulum exit site 1 -2.09 1.34 1.35 1.01 1.51 -1.24 2.45
protein localization in endoplasmic reticulum 18 -1.3 1.35 -1.06 1.05 -1.19 -1.62 1.27
dendrite guidance 17 1.16 1.07 1.26 1.05 1.37 1.01 1.27
SET domain binding 1 1.32 1.05 1.07 1.15 1.03 -1.21 -1.15
left/right axis specification 1 -1.92 1.09 4.17 -1.09 2.38 -1.63 1.77
demethylation 7 1.18 1.25 1.72 1.13 1.59 1.68 1.3
translation preinitiation complex 1 2.17 1.18 1.52 -1.1 1.33 2.16 1.32
neuron death 2 -1.07 1.32 1.73 -1.0 -1.14 1.12 1.39
response to magnetism 1 1.37 -1.11 -1.04 1.15 1.03 2.71 1.13
precatalytic spliceosome 137 1.14 1.1 1.21 1.22 1.3 1.14 -1.01
catalytic step 2 spliceosome 111 1.16 1.09 1.21 1.23 1.31 1.15 -1.02
RNA surveillance 3 1.11 1.23 1.25 1.23 1.33 1.3 1.34
nuclear RNA surveillance 3 1.11 1.23 1.25 1.23 1.33 1.3 1.34
histone mRNA catabolic process 1 1.7 -1.05 -1.07 -1.09 -1.18 1.33 1.14
DNA conformation change 78 1.1 1.1 1.24 1.13 1.27 1.09 1.11
regulation of cell cycle arrest 84 1.23 1.14 1.35 1.19 1.41 1.29 1.15
ribonucleoprotein complex localization 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
spindle assembly checkpoint 10 1.07 1.09 1.16 1.15 1.32 1.1 1.03
mitotic cell cycle spindle checkpoint 10 1.07 1.09 1.16 1.15 1.32 1.1 1.03
subsynaptic reticulum 1 4.69 -1.04 -1.32 -1.4 -1.38 1.37 -1.05
cellular response to abiotic stimulus 19 -1.22 -1.34 -1.35 -1.33 -1.19 1.12 -1.02
cellular response to biotic stimulus 4 -1.08 1.29 1.46 1.13 1.58 1.05 1.4
cellular response to molecule of bacterial origin 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
cellular response to lipopolysaccharide 2 1.04 1.17 1.37 1.17 1.75 1.28 1.1
cellular response to acid 5 1.44 -1.04 1.24 1.2 1.26 1.13 -1.15
cellular response to inorganic substance 8 1.06 1.09 1.5 1.11 1.42 1.08 1.06
cellular response to arsenic-containing substance 6 1.03 1.11 1.5 1.16 1.48 1.0 1.06
cellular response to carbon dioxide 2 1.12 1.05 1.51 -1.02 1.24 1.35 1.06
cellular response to metal ion 6 1.03 1.11 1.5 1.16 1.48 1.0 1.06
cytoplasmic U snRNP body 6 1.33 -1.0 1.21 1.26 1.29 1.29 -1.06
translocon complex 8 -1.51 1.3 -1.14 -1.0 -1.28 -1.7 1.22
L-methionine biosynthetic process 2 1.35 1.12 -1.14 1.23 1.0 1.41 -1.09
L-methionine salvage 2 1.35 1.12 -1.14 1.23 1.0 1.41 -1.09
cellular response to cadmium ion 6 1.03 1.11 1.5 1.16 1.48 1.0 1.06
cellular response to organic substance 81 1.21 1.09 1.31 1.07 1.23 1.27 1.19
cellular response to dsRNA 11 1.46 1.17 1.45 1.09 1.32 1.46 1.31
cellular response to ethanol 1 1.36 1.32 2.03 1.27 1.67 1.42 1.61
cellular response to growth factor stimulus 12 1.59 -1.08 1.97 -1.01 1.17 1.52 1.1
cellular response to peptide hormone stimulus 20 -1.09 1.13 1.2 1.13 1.18 1.07 1.2
cellular response to steroid hormone stimulus 29 1.17 1.11 1.15 1.05 1.22 1.27 1.21
cellular response to organic nitrogen 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
cellular response to amine stimulus 4 1.59 -1.01 1.38 1.29 1.34 1.2 -1.18
succinate transmembrane transport 1 -1.02 -2.78 1.86 -1.91 2.75 13.01 -1.81
malate transmembrane transport 2 1.03 -1.5 1.48 -1.27 1.66 3.63 -1.34
ribonucleoprotein complex export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
rRNA-containing ribonucleoprotein complex export from nucleus 1 2.15 -1.01 1.44 1.25 1.44 1.28 1.21
cellular response to oxygen radical 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
cellular response to superoxide 2 1.69 1.17 1.01 1.09 1.11 1.41 -1.08
cellular response to oxygen levels 25 1.18 1.19 1.57 1.15 1.38 1.41 1.17
cellular response to anoxia 2 -1.34 -1.15 -1.19 1.14 -1.2 -1.27 -1.19
cellular response to hypoxia 23 1.23 1.22 1.66 1.15 1.44 1.48 1.21
protein localization to chromosome, centromeric region 1 2.47 1.54 1.18 1.04 1.48 1.78 1.43
cellular response to water 1 -1.22 -1.01 1.11 -1.0 -1.07 -1.09 1.17
cellular response to xenobiotic stimulus 10 1.1 -1.02 -1.79 -1.06 -1.28 -1.46 1.06
cellular response to osmotic stress 2 1.01 1.17 1.53 -1.02 1.61 1.26 1.23
cellular response to salt stress 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular hyperosmotic response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular hyperosmotic salinity response 1 1.22 1.33 2.18 1.07 1.72 2.05 1.61
cellular response to radiation 16 -1.25 -1.45 -1.52 -1.39 -1.3 1.12 -1.06
cellular response to ionizing radiation 1 -1.03 1.12 1.58 1.2 2.16 1.52 1.14
cellular response to X-ray 1 -1.03 1.12 1.58 1.2 2.16 1.52 1.14
cellular response to light stimulus 15 -1.27 -1.49 -1.61 -1.44 -1.39 1.09 -1.07
cellular response to light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
cellular response to high light intensity 1 3.41 -1.85 -1.6 -1.39 -1.6 6.88 -1.28
cellular response to endogenous stimulus 68 1.18 1.07 1.29 1.07 1.22 1.24 1.16
cellular response to external stimulus 17 -1.03 -1.05 -1.04 -1.13 1.01 1.48 1.15
cellular response to sterol depletion 1 1.18 1.17 1.43 1.18 1.36 -1.03 1.42
genetic imprinting 1 1.01 1.1 1.09 1.14 -1.01 1.17 1.11
semaphorin-plexin signaling pathway 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
inositol phosphate catabolic process 3 2.42 1.04 1.61 -1.01 1.39 1.64 1.29
cell wall organization or biogenesis 9 -1.18 -1.16 -1.42 -1.31 -1.28 -2.35 -1.08
histone H3-K27 demethylation 1 1.79 1.29 2.63 1.3 1.91 2.12 1.41
response to transforming growth factor beta stimulus 2 1.38 1.12 1.33 1.08 1.33 1.38 1.15
cellular response to transforming growth factor beta stimulus 2 1.38 1.12 1.33 1.08 1.33 1.38 1.15
acyl-CoA biosynthetic process 5 2.3 1.04 1.28 1.15 1.53 1.22 1.09
lysophospholipid acyltransferase activity 4 1.01 1.34 1.66 -1.03 1.72 1.33 1.31
optomotor response 2 1.16 1.09 1.72 1.19 1.37 1.2 2.11
Slit-Robo signaling complex 1 2.19 1.14 2.0 1.19 2.09 1.71 1.7
sensory dendrite 7 -1.01 1.01 1.05 1.03 -1.01 1.05 -1.02
organism emergence from protective structure 18 -1.05 -1.01 1.01 1.0 -1.05 -1.13 1.1
striated muscle myosin thick filament assembly 4 2.6 -1.28 1.1 -1.18 1.07 1.9 -1.04
protein localization in extracellular region 1 1.79 1.14 -1.18 1.07 1.25 -5.71 1.37
anatomical structure maturation 3 3.11 -1.4 1.27 -1.39 1.24 4.46 1.69
ectodermal placode development 4 -1.14 1.1 1.23 1.12 1.47 -1.2 -1.08
ectodermal placode morphogenesis 4 -1.14 1.1 1.23 1.12 1.47 -1.2 -1.08
organic substance transport 97 -1.4 -1.24 -1.57 -1.12 -1.07 -1.03 -1.27
nitrogen compound transport 51 -1.34 -1.08 -1.59 -1.16 1.0 -1.05 -1.09
basement membrane organization 5 -1.2 1.03 1.32 -1.01 1.32 1.16 1.46
detoxification of arsenic-containing substance 1 1.35 1.29 1.36 1.08 1.19 1.34 1.11
transcriptional activation by promoter-enhancer looping 1 -1.14 1.04 1.08 -1.05 -1.05 -1.08 1.07
response to BMP stimulus 1 -1.42 1.06 1.32 1.03 1.22 -1.52 1.31
response to fibroblast growth factor stimulus 10 1.63 -1.12 2.13 -1.03 1.14 1.56 1.09
regulation of cell cycle cytokinesis 1 -1.32 1.18 1.39 1.03 1.12 1.4 1.35
G1/S transition checkpoint 2 1.09 1.49 1.71 1.02 1.44 1.9 1.73
mitotic cell cycle G2/M transition checkpoint 62 1.22 1.15 1.36 1.19 1.38 1.27 1.14
cellular potassium ion transport 10 1.06 1.08 1.11 -1.23 -1.25 1.17 -1.26
potassium ion transmembrane transport 10 1.06 1.08 1.11 -1.23 -1.25 1.17 -1.26
protein transmembrane transport 5 -1.62 1.28 -1.17 -1.01 -1.28 -1.9 1.13
protein complex subunit organization 94 -1.0 1.1 1.26 1.11 1.25 1.13 -1.0
protein-DNA complex subunit organization 47 1.05 1.08 1.28 1.18 1.29 -1.03 1.03
ribonucleoprotein complex subunit organization 34 1.25 1.14 1.3 1.19 1.3 1.25 1.1
cellular component organization or biogenesis 1726 1.17 1.08 1.21 1.06 1.23 1.21 1.12
cellular component organization or biogenesis at cellular level 1496 1.17 1.07 1.22 1.07 1.24 1.21 1.12
cellular component organization at cellular level 1453 1.17 1.07 1.22 1.06 1.24 1.21 1.13
cellular component biogenesis at cellular level 87 1.26 1.15 1.28 1.23 1.29 1.18 1.07
cellular component assembly at cellular level 446 1.19 1.06 1.24 1.05 1.23 1.23 1.12
cellular component disassembly at cellular level 27 -1.1 1.18 1.3 1.14 1.29 1.09 1.04
adrenergic receptor signaling pathway 2 -1.09 1.2 -1.08 -1.0 -1.18 -1.21 -1.07
DNA biosynthetic process 25 1.09 1.18 1.33 1.16 1.4 1.14 1.1
regulation of protein serine/threonine kinase activity 30 1.29 1.16 1.42 1.17 1.4 1.39 1.17
negative regulation of protein serine/threonine kinase activity 7 1.54 1.14 1.5 1.16 1.5 1.83 1.37
positive regulation of protein serine/threonine kinase activity 9 1.14 1.19 1.51 1.11 1.38 1.84 1.15
octopamine signaling pathway 1 1.3 1.0 -1.05 -1.09 1.04 -1.06 -1.0
nitrogen cycle metabolic process 1 -31.89 1.77 -20.72 1.41 1.0 -12.66 -3.5
cell periphery 658 1.15 1.02 1.13 -1.02 1.12 1.22 1.15
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA 1 1.38 1.09 1.78 1.2 1.53 2.7 -1.25
cellular component maintenance at cellular level 12 -1.17 1.2 1.56 1.1 1.45 1.12 1.1
renal system development 69 1.2 -1.03 1.12 -1.01 1.21 1.35 1.08
Malpighian tubule development 62 1.15 -1.03 1.11 -1.01 1.22 1.34 1.08
nephron development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron epithelium development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
kidney epithelium development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule formation 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron tubule development 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
nephron epithelium morphogenesis 3 -1.1 -1.05 -1.04 -1.15 -1.04 1.01 1.54
stem cell proliferation 5 1.52 1.24 1.48 1.18 1.44 1.13 1.17
regulation of stem cell proliferation 2 -1.24 1.36 -1.02 -1.09 1.25 1.32 3.25
epithelial cell fate commitment 3 1.0 1.08 1.89 1.0 1.21 -1.44 -1.04
epithelial tube formation 6 1.03 -1.09 1.01 -1.18 -1.08 1.45 1.48
vesicle uncoating 2 -1.44 1.22 1.71 1.06 1.91 1.53 1.42
volume-sensitive chloride channel activity 1 3.44 -1.08 -1.56 -1.91 1.81 5.18 1.78
chaperone-mediated protein transport 1 1.09 1.09 1.08 -1.0 -1.04 -1.07 -1.01
monocarboxylic acid catabolic process 15 -1.0 1.02 -1.46 1.02 1.13 -1.74 -1.3
monocarboxylic acid biosynthetic process 2 1.14 1.17 -1.17 -1.01 1.02 1.07 -1.0
signal transduction by p53 class mediator 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
signal transduction by p53 class mediator resulting in induction of apoptosis 2 1.7 1.37 1.03 1.24 1.62 1.04 1.2
cellular lactam metabolic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
cellular lactam biosynthetic process 1 -1.31 -1.76 1.72 1.22 1.97 3.11 1.28
modified amino acid binding 5 -1.4 -1.12 -1.47 1.21 1.21 -1.15 -1.62
response to anesthetic 7 1.2 1.01 1.0 1.08 1.05 1.41 -1.12
sulfur compound transport 2 -2.47 -1.07 -3.17 1.42 1.77 -1.97 -2.08
modified amino acid transmembrane transporter activity 1 -7.18 -1.45 -9.47 1.62 3.49 -2.41 -5.84
tricarboxylic acid metabolic process 2 -1.17 -1.01 -1.18 1.04 -1.26 -1.29 -1.1
cardiovascular system development 70 1.28 -1.02 1.19 -1.07 1.17 1.3 1.17
primary cilium 2 -1.07 -1.03 -1.02 1.13 -1.1 -1.09 -1.15
medium-term memory 5 -2.06 1.08 1.11 1.07 -1.16 -1.78 -1.05
organelle transport along microtubule 7 -1.28 1.21 1.46 1.16 1.42 1.38 1.37
microtubule anchoring at microtubule organizing center 1 -1.51 -1.02 1.38 1.04 1.42 1.11 -1.1
ammonium transmembrane transport 1 -1.13 -1.02 -1.13 -1.06 -1.15 -1.01 -1.16
photoreceptor cell axon guidance 3 -1.41 1.34 1.88 1.12 1.32 1.49 1.42
divalent inorganic cation transmembrane transporter activity 19 -1.37 1.2 1.22 1.05 1.11 -1.13 -1.04
divalent inorganic cation transport 29 1.35 1.0 1.1 -1.08 1.16 1.48 1.17
purine-containing compound metabolic process 132 1.15 1.03 1.11 1.02 1.08 1.22 -1.04
purine-containing compound biosynthetic process 74 1.06 1.04 1.09 1.01 1.04 1.27 -1.07
purine-containing compound catabolic process 40 1.18 1.04 1.15 1.09 1.13 1.08 1.01
pyridine-containing compound metabolic process 11 1.88 1.17 -1.48 -1.05 1.08 1.25 1.36
pyridine-containing compound biosynthetic process 3 1.9 1.5 -1.09 1.01 1.09 1.23 1.86
pyrimidine-containing compound metabolic process 22 1.04 1.05 1.04 1.17 1.19 -1.08 -1.06
pyrimidine-containing compound biosynthetic process 14 1.27 1.04 1.16 1.11 1.17 1.08 -1.03
pyrimidine-containing compound catabolic process 6 1.02 -1.16 -1.31 -1.06 -1.01 -1.14 1.05
purine-containing compound transmembrane transport 5 -1.03 1.21 1.18 1.23 1.16 1.19 -1.13
pyrimidine-containing compound transmembrane transport 4 -1.46 1.25 1.0 1.26 1.04 -1.57 1.43
protein phosphatase activator activity 3 1.39 1.03 1.11 1.1 1.16 1.44 1.03
ADP-D-ribose binding 1 1.71 1.0 1.2 1.14 1.43 1.37 1.01
poly-ADP-D-ribose binding 1 1.71 1.0 1.2 1.14 1.43 1.37 1.01
clathrin-mediated endocytosis 1 4.7 -1.51 -1.0 -1.26 1.19 8.29 2.05
DNA topoisomerase (ATP-hydrolyzing) regulator activity 1 1.69 1.07 1.4 1.09 1.95 1.43 1.53
DNA topoisomerase (ATP-hydrolyzing) activator activity 1 1.69 1.07 1.4 1.09 1.95 1.43 1.53
box H/ACA RNP complex 1 1.3 1.21 1.13 1.29 1.21 1.06 1.05
establishment of protein localization to organelle 60 1.01 1.17 1.14 1.11 1.09 1.02 1.1
maintenance of protein localization to organelle 4 -1.56 1.22 -1.02 1.14 -1.0 -1.78 1.25
establishment of protein localization in endoplasmic reticulum 15 -1.21 1.37 -1.05 1.04 -1.19 -1.54 1.26
establishment of protein localization in Golgi 10 -1.16 1.12 1.17 1.04 1.21 1.41 1.65
establishment of protein localization in mitochondrion 28 1.07 1.09 1.21 1.13 1.12 1.18 -1.1
protein localization to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
establishment of protein localization to peroxisome 3 1.5 1.17 -1.6 1.44 1.46 -2.19 -1.64
protein localization to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
establishment of protein localization to vacuole 4 1.47 1.26 2.02 1.17 1.52 1.6 1.47
tubulin complex biogenesis 4 1.19 1.1 1.33 1.15 1.38 -1.02 1.05
mitotic spindle 14 1.25 1.22 1.39 1.19 1.29 1.28 1.12
meiotic spindle 1 -1.24 -1.06 -1.4 -1.21 -1.33 -1.23 -1.12
S-nitrosoglutathione reductase activity 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
regulation of reactive oxygen species metabolic process 8 1.29 1.23 1.39 1.25 1.52 1.58 1.24
3R-hydroxyacyl-CoA dehydratase activity 1 -1.23 1.06 -2.67 1.58 1.11 -5.4 -1.98
regulation of primary metabolic process 957 1.15 1.09 1.2 1.07 1.19 1.19 1.13
regulation of response to stress 72 1.36 -1.02 1.09 1.0 1.13 1.39 1.15
regulation of cellular response to stress 35 -1.02 1.21 1.29 1.13 1.3 1.36 1.16
regulation of nitric oxide metabolic process 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
histone H3-K4 trimethylation 1 1.69 1.2 1.93 1.03 2.02 2.04 1.95
extracellular matrix assembly 12 1.14 1.01 -1.05 -1.02 -1.08 1.01 -1.0
regulation of mitotic anaphase 1 1.43 1.15 2.06 1.04 1.96 1.44 1.33
regulation of chromatin silencing at centromere 1 1.21 1.08 1.29 -1.08 1.41 1.2 1.17
positive regulation of chromatin silencing at centromere 1 1.21 1.08 1.29 -1.08 1.41 1.2 1.17
regulation of trehalose metabolic process 1 1.03 -1.29 -2.06 -2.17 -1.97 -2.33 4.44
positive regulation of microtubule nucleation 1 2.49 1.3 2.87 -1.0 2.26 3.13 2.77
regulation of anatomical structure size 118 1.38 1.02 1.24 -1.04 1.24 1.48 1.3
positive regulation of cell cycle process 13 1.26 1.06 1.08 1.01 1.3 1.62 1.07
regulation of ribosome biogenesis 2 1.63 1.23 1.65 1.22 1.61 2.39 1.43
positive regulation of ribosome biogenesis 2 1.63 1.23 1.65 1.22 1.61 2.39 1.43
positive regulation of sodium ion transport via voltage-gated sodium channel activity 5 1.02 1.03 1.03 1.0 -1.03 1.03 -1.06
translation regulator activity, nucleic acid binding 7 1.85 1.07 2.03 1.03 1.61 1.55 1.78
regulation of peptide transport 1 1.12 1.15 1.24 1.0 1.0 1.1 -1.06
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 23 1.18 1.12 1.35 1.09 1.3 1.19 1.21
regulation of decapentaplegic signaling pathway 6 1.3 1.01 1.61 -1.03 1.09 1.53 1.36
positive regulation of decapentaplegic signaling pathway 1 1.81 1.21 1.48 1.18 1.37 1.47 1.47
negative regulation of decapentaplegic signaling pathway 3 1.28 -1.1 1.11 -1.15 -1.09 1.84 1.01
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 5 1.47 1.09 1.08 -1.01 1.15 1.29 1.21
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 13 1.13 1.1 1.3 1.09 1.27 1.11 1.16
regulation of cell-substrate junction assembly 1 2.96 1.13 1.75 -1.2 1.98 1.94 1.75
COPII-coated vesicle budding 1 -1.49 1.52 1.25 1.12 1.19 1.46 1.78
tissue migration 36 1.66 -1.04 1.31 -1.09 1.2 1.63 1.1
epithelium migration 28 1.66 -1.03 1.29 -1.07 1.21 1.38 1.11
regulation of mitochondrial fission 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
positive regulation of mitochondrial fission 2 -1.0 1.14 -1.27 1.12 -1.13 -1.52 -1.35
endoplasmic reticulum membrane organization 1 -1.04 1.0 1.09 1.3 1.23 -1.23 -1.03
establishment of epithelial cell polarity 11 1.26 1.04 1.35 -1.0 1.51 1.34 1.27
establishment of epithelial cell planar polarity 4 -1.26 1.08 1.52 1.16 1.36 1.11 -1.02
organelle membrane fusion 4 1.13 1.23 1.24 1.17 1.16 1.0 1.22
regulation of establishment of planar polarity 4 1.06 -1.1 1.26 -1.16 1.25 1.67 1.42
microtubule cytoskeleton organization involved in establishment of planar polarity 3 1.57 1.03 1.21 -1.01 1.13 2.03 1.55
gene looping 1 -1.14 1.04 1.08 -1.05 -1.05 -1.08 1.07
regulation of triglyceride metabolic process 2 -1.95 -1.1 -1.54 1.16 1.88 -3.69 -2.32
regulation of spindle organization 10 1.06 1.17 1.27 1.15 1.35 1.28 1.1
regulation of spindle checkpoint 1 1.18 -1.09 1.06 1.12 1.44 -1.15 -1.22
regulation of histone H4 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
positive regulation of histone H4 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
cell-cell adhesion involved in establishment of planar polarity 1 1.3 1.94 1.14 1.03 1.07 1.88 1.31
cell elongation involved in imaginal disc-derived wing morphogenesis 5 1.41 1.11 1.92 1.05 1.98 1.8 1.61
regulation of muscle system process 5 2.39 -1.02 -2.05 -2.54 -2.17 1.16 1.24
positive regulation of canonical Wnt receptor signaling pathway 4 1.23 1.08 1.27 1.09 -1.0 1.0 1.22
regulation of calcium ion import 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
negative regulation of calcium ion import 1 -1.32 1.16 1.21 -1.14 -1.21 1.47 1.08
nucleic acid metabolic process 788 1.2 1.12 1.23 1.17 1.28 1.17 1.07
nucleic acid phosphodiester bond hydrolysis 23 1.3 1.21 1.39 1.25 1.38 1.28 1.18
spindle assembly involved in meiosis 13 -1.1 1.07 1.06 1.07 1.24 -1.2 -1.03
spindle assembly involved in mitosis 3 -1.0 1.13 1.24 1.35 1.53 -1.14 -1.07
regulation of protein deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
positive regulation of protein deacetylation 1 1.03 1.14 1.11 1.37 1.92 -1.3 1.15
regulation of protein targeting to membrane 1 1.09 1.09 1.08 -1.0 -1.04 -1.07 -1.01
positive regulation of protein targeting to membrane 1 1.09 1.09 1.08 -1.0 -1.04 -1.07 -1.01
positive regulation of intracellular protein transport 23 1.1 1.07 1.2 1.09 1.25 1.08 1.14
negative regulation of intracellular protein transport 6 2.03 1.13 1.29 1.08 1.28 1.86 1.59
regulation of olfactory learning 2 1.05 1.07 1.07 1.08 -1.09 1.03 -1.03
regulation of DNA-dependent DNA replication 6 -1.5 1.09 1.13 1.11 1.33 -1.52 1.28
regulation of heart induction 3 1.09 1.1 1.13 1.08 1.18 1.14 2.09
phagosome maturation 1 1.76 1.27 1.35 1.51 1.34 1.49 1.23
organophosphate biosynthetic process 3 -1.14 1.2 -1.03 -1.06 1.01 -1.08 1.11
ceramide binding 1 -2.39 1.47 1.51 1.07 -1.25 -2.16 1.24
adipokinetic hormone receptor activity 2 1.14 1.03 1.06 1.02 -1.01 -1.0 -1.03
adipokinetic hormone binding 2 1.14 1.03 1.06 1.02 -1.01 -1.0 -1.03
adipokinetic hormone receptor binding 1 2.14 -13.11 -13.63 -12.76 -16.87 -14.38 5.61
energy homeostasis 1 1.86 -1.04 1.59 -1.1 2.08 2.71 1.26
microtubule-based flagellar cytoplasm 1 1.03 1.24 1.01 1.09 1.02 -1.11 1.01
mitochondrial respiratory chain complex I biogenesis 1 1.08 1.05 1.31 1.03 1.07 1.99 -1.52
mitochondrial respiratory chain complex III biogenesis 2 1.1 1.08 1.56 1.1 1.12 1.34 -1.21
regulation of membrane lipid distribution 2 2.57 -1.14 1.03 -1.07 2.13 1.16 1.16
perinuclear endoplasmic reticulum 2 -1.1 1.15 1.07 1.1 1.01 1.07 1.17
synaptic membrane 35 -1.01 1.01 1.06 -1.11 -1.05 1.13 1.13
dendritic spine organization 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
dendritic spine maintenance 1 -2.52 1.99 1.32 1.32 1.09 -1.34 1.43
anterior head development 9 1.09 -1.1 1.06 1.06 -1.02 -1.13 -1.01
pre-mRNA intronic binding 1 1.28 1.07 1.73 1.12 1.48 1.94 1.41
activation of cysteine-type endopeptidase activity 13 1.0 1.15 1.25 1.21 1.45 1.21 1.07
renal filtration 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
nephrocyte filtration 2 -1.2 -1.04 -1.19 1.02 -1.08 -1.21 -1.15
cell-type specific apoptotic process 15 1.32 1.04 1.28 -1.05 1.01 1.08 1.27
regulation of cellular response to insulin stimulus 10 1.25 1.09 1.37 -1.04 1.17 1.16 1.59
negative regulation of cellular response to insulin stimulus 7 1.27 1.12 1.56 -1.01 1.31 1.27 1.5
positive regulation of cellular response to insulin stimulus 2 1.0 -1.0 -1.17 -1.4 -1.23 -1.17 2.26
regulation of defense response to fungus 7 2.0 -1.32 -1.17 1.03 1.03 1.92 1.18
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay 4 1.18 1.11 1.21 1.11 1.04 1.21 1.05
regulation of protein localization to nucleus 30 1.19 1.1 1.26 1.1 1.28 1.31 1.24
regulation of phospholipase C activity 6 1.13 1.12 1.17 1.04 1.09 1.14 1.05
regulation of multicellular organismal development 278 1.14 1.08 1.25 1.05 1.25 1.23 1.17
regulation of organ morphogenesis 55 1.11 1.02 1.24 1.04 1.26 1.08 1.17
regulation of planar cell polarity pathway involved in axis elongation 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
regulation of cardiac cell fate specification 8 1.02 1.09 1.19 1.04 1.21 -1.01 1.39
negative regulation of cardiac cell fate specification 7 -1.04 1.07 1.14 1.01 1.15 -1.01 1.35
regulation of G1/S transition of mitotic cell cycle 4 1.12 1.32 1.7 1.08 1.32 1.61 1.38
regulation of non-canonical Wnt receptor signaling pathway 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
regulation of Wnt receptor signaling pathway, planar cell polarity pathway 2 -1.01 1.74 1.54 1.1 1.38 1.44 1.44
negative regulation of DNA-dependent DNA replication 3 -2.66 -1.02 1.24 1.05 1.35 -2.2 1.46
positive regulation of DNA-dependent DNA replication 3 1.19 1.21 1.03 1.17 1.31 -1.05 1.11
regulation of cellular macromolecule biosynthetic process 732 1.15 1.08 1.17 1.06 1.17 1.17 1.13
negative regulation of cellular macromolecule biosynthetic process 214 1.18 1.08 1.18 1.04 1.23 1.23 1.17
regulation of cysteine-type endopeptidase activity 18 1.12 1.11 1.23 1.18 1.35 1.14 1.01
negative regulation of cysteine-type endopeptidase activity 2 1.22 -1.04 1.69 -1.06 1.27 -1.09 -1.19
negative regulation of G1/S transition of mitotic cell cycle 1 1.02 1.34 2.07 -1.09 1.41 2.33 1.77
regulation of transcription initiation, DNA-dependent 5 1.43 1.28 1.45 1.26 1.36 1.28 1.29
positive regulation of transcription initiation, DNA-dependent 2 1.1 1.32 1.52 1.2 1.24 1.14 1.45
regulation of cell motility 10 2.17 -1.1 1.06 -1.11 1.21 1.34 1.71
negative regulation of cell motility 2 2.1 1.1 1.42 -1.08 1.39 1.72 1.26
regulation of ubiquitin-specific protease activity 1 1.14 1.09 1.34 -1.05 1.24 1.35 2.12
regulation of peptidyl-cysteine S-nitrosylation 1 1.29 1.1 1.03 1.22 1.29 1.66 -1.14
regulation of neural precursor cell proliferation 9 -1.33 1.16 1.4 1.11 1.64 1.16 1.09
negative regulation of neural precursor cell proliferation 7 -1.32 1.13 1.47 1.06 1.79 1.22 1.08
positive regulation of neural precursor cell proliferation 2 -1.35 1.28 1.19 1.29 1.21 -1.02 1.09
regulation of reproductive process 47 1.06 1.08 1.28 -1.01 1.27 1.35 1.24
negative regulation of reproductive process 6 1.39 1.2 1.49 1.11 1.54 1.6 1.43
positive regulation of reproductive process 4 -1.29 1.41 1.69 1.16 1.58 1.17 1.66
negative regulation of receptor activity 3 1.29 1.07 1.31 1.06 1.37 1.41 1.15
positive regulation of receptor activity 1 -1.21 1.16 2.16 -1.11 1.4 1.68 1.37
regulation of epithelial cell migration, open tracheal system 5 2.13 -1.29 -1.2 -1.27 1.01 -1.13 2.14
regulation of DNA biosynthetic process 1 1.35 1.23 1.65 1.22 1.74 1.39 1.1
regulation of photoreceptor cell axon guidance 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
regulation of synaptic vesicle exocytosis 3 -1.05 1.27 1.19 1.07 1.12 1.29 1.16
negative regulation of synaptic vesicle exocytosis 1 1.24 1.25 1.11 1.13 1.1 1.34 1.26
positive regulation of synaptic vesicle exocytosis 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance 2 1.11 -1.03 1.73 -1.06 1.28 1.08 1.11
regulation of clathrin-mediated endocytosis 2 -1.04 1.44 1.65 1.12 1.42 2.02 1.59
positive regulation of clathrin-mediated endocytosis 1 -1.65 1.56 1.35 1.0 1.12 1.4 1.32
regulation of cytokinesis, actomyosin contractile ring assembly 1 -1.32 1.18 1.39 1.03 1.12 1.4 1.35
regulation of protein neddylation 1 1.11 1.42 1.38 1.05 1.25 1.67 1.2
negative regulation of protein neddylation 1 1.11 1.42 1.38 1.05 1.25 1.67 1.2
regulation of cell proliferation involved in compound eye morphogenesis 2 1.28 1.17 1.26 1.16 1.36 1.23 1.09
regulation of interphase of mitotic cell cycle 89 1.23 1.14 1.34 1.18 1.39 1.29 1.17
regulation of histone H4-K16 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
positive regulation of histone H4-K16 acetylation 1 1.8 1.23 1.54 1.26 1.37 1.4 1.76
regulation of transcription regulatory region DNA binding 2 -1.31 1.44 1.67 1.2 1.16 1.11 1.5
negative regulation of transcription regulatory region DNA binding 2 -1.31 1.44 1.67 1.2 1.16 1.11 1.5
regulation of peptidyl-lysine acetylation 5 1.41 1.17 1.61 1.2 1.61 1.62 1.46
negative regulation of peptidyl-lysine acetylation 1 1.22 1.34 1.86 1.14 2.08 2.98 1.75
positive regulation of peptidyl-lysine acetylation 2 1.41 1.2 1.81 1.29 1.46 1.33 1.45
regulation of steroid hormone secretion 1 -1.14 1.41 1.3 1.24 1.17 1.85 1.43
positive regulation of cysteine-type endopeptidase activity 14 1.01 1.14 1.25 1.19 1.42 1.19 1.06
starch binding 5 -2.58 1.33 -1.39 1.01 -2.26 -3.22 1.03
regulation of RNA biosynthetic process 671 1.13 1.08 1.17 1.06 1.16 1.15 1.13
negative regulation of chromosome organization 2 1.22 1.33 2.01 1.1 1.89 2.47 1.68
positive regulation of chromosome organization 6 1.14 1.12 1.43 1.22 1.52 1.14 1.15
regulation of cation channel activity 3 1.93 -1.03 1.33 1.03 1.24 2.17 1.55
positive regulation of cation channel activity 2 2.64 -1.06 1.57 1.01 1.45 3.25 1.94
regulation of muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
negative regulation of muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
Roundabout signaling pathway involved in muscle cell chemotaxis toward tendon cell 1 1.49 1.07 1.15 1.04 -1.03 1.53 -1.09
regulation of BMP secretion 1 -1.14 1.11 -1.09 1.17 -1.12 -1.22 -1.05
negative regulation of BMP secretion 1 -1.14 1.11 -1.09 1.17 -1.12 -1.22 -1.05
all 9919 1.03 -1.01 1.01 1.01 1.05 1.03 1.01